Datasets:

nickmuchi

/

trade-the-event-finance

like 10

NEW YORK, March 31, 2021 /PRNewswire/ --Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable onApril 30, 2021, has a record date of April 15, 2021 and has an ex-date of April 14, 2021. Under its level distribution policy, the Fund anticipates that it will make regular monthly distributions, subject to market conditions, of $0.0905 per share of common stock, unless further action is taken to determine another amount. The Fund's ability to maintain its current distribution will depend on a number of factors, including the stability of income received from its investments, the cost of leverage and the level of other Fund expenses. There is no assurance that the Fund will always be able to pay a distribution of any particular amount or that a distribution will consist only of net investment income. Due to an effort to maintain a stable distribution amount, the distribution announced today, as well as future distributions, may consist of net investment income, realized capital gains and return of capital. In compliance with Section 19 of the Investment Company Act of 1940, as amended, a notice would be provided for any distribution that does not consist solely of net investment income. The notice would be for informational purposes and not for tax reporting purposes, and would disclose, among other things, estimated portions of the distribution, if any, consisting of net investment income, capital gains and return of capital. The final determination of the source and tax characteristics of all distributions paid in 2021 will be made after the end of the year. About Neuberger Berman Neuberger Berman, founded in 1939, is a private, independent, employee-owned investment manager. The firm manages a range of strategiesincluding equity, fixed income, quantitative and multi-asset class, private equity, real estate and hedge fundson behalf of institutions, advisors and individual investors globally. With offices in 24 countries, Neuberger Berman's diverse team has over 2,300 professionals. For seven consecutive years, the company has been named first or second in Pensions & Investments Best Places to Work in Money Management survey (among those with 1,000 employees or more).In 2020, the PRI named Neuberger Berman a Leader, a designation awarded to fewer than 1% of investment firms for excellence in Environmental, Social and Governance (ESG) practices. The PRI also awarded Neuberger Berman an A+ in every eligible category for our approach to ESG integration across asset classes. The firm manages $405 billion in client assets as of December 31, 2020. For more information, please visit our website at www.nb.com. Statements made in this release that look forward in time involve risks and uncertainties. Such risks and uncertainties include, without limitation, the adverse effect from a decline in the securities markets or a decline in the Fund's performance, a general downturn in the economy, competition from other closed end investment companies, changes in government policy or regulation, inability of the Fund's investment adviser to attract or retain key employees, inability of the Fund to implement its investment strategy, inability of the Fund to manage rapid expansion and unforeseen costs and other effects related to legal proceedings or investigations of governmental and self-regulatory organizations. Contact: Neuberger Berman Investment Advisers LLCInvestor Information (877) 461-1899 SOURCE Neuberger Berman Related Links www.nb.com

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

MAIDENHEAD, England--(BUSINESS WIRE)--SDL, part of RWS Holdings plc, today announces a strategic partnership with Fuji Xerox Co., Ltd. to offer SDL Contenta Publishing Suite to manufacturers and aerospace and defense organizations in Japan, with a future plan to expand into other Asia-Pacific countries/regions. This marks a significant milestone in SDLs global expansion strategy for technical content creation, management and publishing. Organizations involved in manufacturing and aerospace and defense need to create, manage and publish technical documentation in a secure and functional manner. Technical documents for these industries are highly complex, and often include hundreds of thousands of instructions and graphics to support the operations, maintenance and inspection of complex assets. The combination of SDL and Fuji Xerox will help these organizations to consolidate, standardize, and adopt proven best practices based on standards including the ASD S1000D to achieve substantial efficiencies across their content supply chain. SDL has a long history in delivering high-profile digital transformation projects to some of the globes most demanding and mission critical organizations most recently becoming the enterprise technical data creation, management and delivery solution for the United States Air Force and Navy, said Amane Inoue, Corporate Vice President and Executive General Manager, Advanced Industrial Services Business Group, Fuji Xerox Co., Ltd. Our partnership with SDL is a major step forward for the post-sales support of complex assets, and will enable organizations in Japan to realize the many efficiencies associated with standardizing processes, and transforming content into digital intelligence. The SDL Contenta Publishing Suite is a complete, integrated, industry-proven publishing solution for technical content, with functionality optimized for each step of the publishing process. Based on the S1000D standard, it helps organizations manage millions of pages of complex technical documents and deliver interactive electronic technical publications (IETP) enabling maintenance professionals to rapidly meet mission objectives, reduce mean time to repair (MTTR), and keep assets deployed. Were extremely proud of our partnership with Fuji Xerox, said Tim Russell-Jones, SVP, and General Manager, Government, Aerospace and Defense, SDL. It marks a strategic milestone for SDL and validates a growing global trend for enterprise consolidation, standardization, and adoption of proven best practices that deliver efficiencies across the technical content supply chain. The combination of SDL Contenta Suite, and Fuji Xeroxs understanding of a customers complex operational and maintenance content requirements, creates a powerful proposition for any organization embarking on a digital transformation strategy. SDL Contenta Publishing Suite is the most trusted technical publishing platform for the global aerospace and defense industry. Currently 7 of the top 10 aerospace and defense organizations rely on the technology to create, manage and publish technical content. SDLs expansion strategy is to ensure availability of the Contenta Publishing Suite via strategic relationships with Top Tier reselling experts such as Fuji Xerox in regions across the globe. To learn more or to enquire about potential partnerships, please visit: https://www.sdl.com/partners About SDL SDL, the intelligent language and content company, was acquired by RWS Holdings plc in November 2020. The combination creates the leading language services and technology group in the world, serving 90 of the worlds top 100 brands, the top 10 pharmaceutical companies and approximately half of the top 20 patent filers worldwide. The groups specialist divisions combine the latest technology, proven processes and highly skilled staff to deliver complex services at each stage of the product lifecycle to meet the diverse needs of a global client base spanning Europe, Asia Pacific, and North and South America across a range of sectors including aerospace and defense, automotive, chemical, government, medical, pharmaceutical, and telecommunications. With headquarters in the UK, RWS is publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). For further information, please visit: www.rws.com About Fuji Xerox Founded in 1962, Fuji Xerox Co., Ltd. is a leading company in offering smarter ways to work with its document-related solutions and services, as well as with the world-class office multifunction devices, printers and production printers that we develop and manufacture for worldwide distribution. Fuji Xerox is a wholly owned subsidiary of FUJIFILM Holdings Corporation with direct sales force covering Japan and the Asia-Pacific region including China. As a U.S. 10 billion dollar enterprise, we employ approximately 40,000 people globally, with more than 80 domestic and overseas affiliates / sales subsidiaries. On April 1, 2021, Fuji Xerox will change its corporate name to FUJIFILM Business Innovation Corp. http://www.fujixerox.com

SDL Partnership with Fuji Xerox Marks Strategic Milestone in Global Expansion Fuji Xerox will offer SDL Contenta Publishing Suite for Post-Sales Support of Complex Assets

ALEXANDRIA, Va., April 14, 2020 /PRNewswire/ --With much of the country under stay-at-home orders, the TurfMutt Foundation, which directs the TurfMutt environmental education and stewardship program, urges public officials to allow people to get outdoors in public green spaces, such as parks, public gardens, school yards, golf courses and other community green spaces. For a decade, the TurfMutt Foundation has advocated the importance of managed landscapes and other green space as critical to human health and happiness, and which should be available to everyone. The Outdoor Power Equipment Institute (OPEI) announces the official launch of The TurfMutt Foundation, an organization that will further the mission of the TurfMutt environmental education and stewardship program launched ten years ago. The Foundation will continue to encourage outdoor learning experiences, stewardship of our green spaces, and care for all living landscapes for the benefit of all, and will likely expand into new areas in the next few years. Learn more at www.TurfMutt.com. (PRNewsfoto/Outdoor Power Equipment Institu) "The ability to get outside, reconnect with nature and destress is even more critical today than ever before," says Kris Kiser, President of the TurfMutt Foundation. "During this pandemic, your yard is safe green space, but if you don't have oneand many people in cities don'tparks and other public green spaces should be available so long as people act responsibly and follow all guidelines for physical distancing." Research has proven the criticality of green space for physical and mental health and well-being, and in fact, it is a lifeline for people in cities who do not have access to a home yard. Unfortunately, public parks and gardens have come under scrutiny and a stage for "social distancing shaming" and infringement crackdowns. "People are compressed in the city, and at some point you have to give people an avenue to get outside, get some fresh air and respite from being indoors," says Kiser. "It's incumbent on people to be responsible, but not allowing them to go to the park will only exacerbate the stress families feel from being cooped up during stay-at-home orders. You can't have people locked in forever."The pandemic also has shown a general lack of local green space, which is only exacerbated when parks, trails and public gardens are closed to the public. According to the Trust for Public Land, 100 million people(28 million children included) in the U.S. do not have a neighborhood park within a 10-minute walk from home. Even small neighborhood green spaces, including plazas, triangles, and other open spaces could be helping during the pandemic "but only if shaming of people trying to get outside stops," adds Kiser. "We should be urging physical distancing and responsible behavior, but by all means allow people to destress through the calming effects of trees, grass, shrubs and plants."Kiser is hopeful that the country will emerge from the pandemic with a "greater appreciation for our landscapes and see more people getting outdoors."He also adds when the country turns a corner on the pandemic "we need to address green space equityor lack of itwith more access, funding and space. We hope thatcities realize the importance of their green space, and officials reinvigorate our critical green infrastructure. Access to nature shouldn't be just for certain people. It should be available to all, for the benefit of all. A stressed-out public doesn't do anyone any good."About TurfMuttTurfMutt was created by the Outdoor Power Equipment Institute's (OPEI) TurfMutt Foundation and has reached more than 70 million children, educators and families since 2009. Through classroom materials developed with Scholastic, TurfMutt teaches students and teachers how to "save the planet, one yard at a time." TurfMutt is an official USGBCEducation Partner and part of their global LEARNING LAB. TurfMutt is an education resource at the U.S. Department of Education's Green Ribbon Schools, the U.S. Department of Energy, the U.S. Environmental Protection Agency, Green Apple, the Center for Green Schools, the Outdoors Alliance for Kids, the National Energy Education Development (NEED) project, Climate Change Live, Petfinder and the U.S. Fish and Wildlife Service. In 2017, the TurfMutt animated video series won the coveted Cynopsis Kids Imagination Award for Best Interstitial Series.TurfMutt's personal, home habitat is featured in the 2017-2019 Wildlife Habitat Council calendars. More information atwww.TurfMutt.com.Photo/Video/Media contacts:Ami Neiberger-Miller, Four Leaf PR on behalf of the TurfMutt Foundation, 703-887-4877, [emailprotected]Debbi Mayster, Four Leaf PR on behalf of the TurfMutt Foundation, 240-988-6243,[emailprotected]SOURCE TurfMutt Foundation Related Links https://www.turfmutt.com

The TurfMutt Foundation Urges Public Green Spaces Remain Open Nature and its Calming Effects Should Be Available To All

ALPHARETTA, Ga., April 29, 2021 /PRNewswire/ --Priority Technology Holdings, Inc. (NASDAQ: PRTH) ("Priority"), a leading payments technology company, today announced the completion of its debt refinancing and preferred equity issuance. The new senior debt facility, which improves interest expense by 75 basis points, includes an initial term loan of $300 million used to refinance existing debt and pay debt placement fees and expenses. A committed delayed draw term loan of $290 million is in place and will be used to finance a portion of the Finxera acquisition at closing later this year. Also, a new $40 million revolving credit facility is immediately available. "The combination of these financings positions us for accelerated growth as we continue to strengthen our payments and banking as a service technology platform to be the market leading consolidator of SMB and ISV payment solutions," said Tom Priore, Chairman and Chief Executive Officer of Priority. "With our leverage below 4 times EBITDA post-transaction and meaningfully improving free cash flow, we have the full financial flexibility to thoughtfully pursue our organic and inorganic growth initiatives." Priority has also executed a strategic preferred equity investment from credit funds managed by certain affiliates of Ares Management that includes an initial issuance of $150 million used to refinance existing debt, pay stock issuance fees and expenses, and add cash to the balance sheet for acquisitions. A committed delayed issuance of $50 million will be used to finance a portion of the Finxera acquisition at closing later this year. An additional $50 million issuance is available within 18 months to finance other acquisitions. "We see significant growth potential for Priority given the company's significant momentum and scalable platform with recurring revenue streams," said Joel Holsinger, Co-Head of the Alternative Credit group of Ares Management Corporation. "We look forward to working closely with the outstanding Priority team to position the company for long-term growth and success." "We are thrilled to welcome Ares as our new, long-term partner," continued Priore. "Ares has an exceptional reputation and experience with financial services companies, and we look forward to leveraging the team's sector expertise. We are confident that with Ares's support, we will continue to expand our business." AboutPriority Technology Holdings, Inc. Priority is a leading provider of merchant acquiring, integrated payment software and corporate payment solutions, offering unique product and service capabilities to its merchant network and distribution partners. Priority's enterprise operates from a purpose-built payments infrastructure that includes tailored customer service offerings and bespoke technology development, allowing Priority to provide end-to-end solutions for payment and payment-adjacent software. Additional information can be found at www.PRTH.com. Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services, and other statements identified by words such as "may," "will," "should," "anticipates," "believes," "expects," "plans," "future," "intends," "could," "estimate," "predict," "projects," "targeting," "potential" or "contingent," "guidance," "anticipates," "outlook" or words of similar meaning. These forward-looking statements include, but are not limited to, our 2021 outlook. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive risks, trends and uncertainties that could cause actual results to differ materially from those projected, expressed, or implied by such forward-looking statements. These forward-looking statements may include, but are not limited to, statements about the effects of the COVID-19 pandemic on our revenues and financial operating results. Our actual results could differ materially, and potentially adversely, from those discussed or implied herein. We caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this press release in the context of the risks and uncertainties disclosed in our Securities and Exchange Commission ("SEC") filings, including our Annual Report on Form 10-K filed with the SEC on March 30, 2021 These filings are available online atwww.sec.govorwww.PRTH.com. We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences we anticipate or affect us or our operations in the way we expect. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements. SOURCE Priority Technology Holdings, Inc.

Priority Technology Holdings, Inc. Announces Completion of Debt Refinancing and Preferred Equity Issuance

FOUNTAIN VALLEY, Calif., Feb. 2, 2021 /PRNewswire/ --Hyundai Motor America reported total January sales of 43,394 units, a 2% increase compared with January 2020. Retail sales were up 1% and set an all-time January retail record. Hyundai fleet sales were up 12%, representing 6% of total volume. "We are off to a strong start to the year and remain optimistic for continued sales and market share gains in 2021," said Randy Parker, senior vice president, National Sales, Hyundai Motor America. "We've been able to consistently grow retail sales thanks to our outstanding product lineup and a commitment from our dealer partners to exceed customer expectations." Hyundai sold 40,597 retail units in January. Retail SUV sales were up 11% and represented 69% of the total retail mix. Retail sales rose for Venue (+34%), Kona (+9%), Tucson (+1%), Santa Fe (+45%) and the entire eco-friendly lineup (+8%). January Total Sales Summary Jan-21 Jan-20 2021 YTD 2020 YTD Hyundai 43,394 42,744 43,394 42,744 January Product and Corporate Activities Elantra North American Car of the Year: The 2021 Hyundai Elantra was named winner of the 2021 North American Car of the Yearaward; the second win for Elantra (2012) IONIQ 5 Teaser: Hyundai Motor Company unveiled the first teaserimage of the highly anticipated IONIQ 5 midsize CUV Racing Success: Paralyzed driver Michael Johnson and teammate Stephen Simpson scored Hyundai's first podium finish at Daytona Model Total Sales Vehicle Jan-21 Jan-20 2021 YTD 2020 YTD Accent 1,036 1,565 1,036 1,565 Elantra 7,242 7,874 7,242 7,874 Ioniq 937 1,278 937 1,278 Kona 5,233 4,208 5,233 4,208 Nexo 23 16 23 16 Palisade 5,669 6,188 5,669 6,188 Santa Fe 8,714 6,392 8,714 6,392 Sonata 5,020 5,501 5,020 5,501 Tucson 7,980 8,068 7,980 8,068 Veloster 193 665 193 665 Venue 1,347 989 1,347 989 Hyundai Motor AmericaAt Hyundai Motor America, we believe everyone deserves better. From the way we design and build our cars to the way we treat the people who drive them, making things better is at the heart of everything we do. Hyundai's technology-rich product lineup of cars, SUVs and alternative-powered electric and fuel cell vehicles is backed by Hyundai Assuranceour promise to create a better experience for customers. Hyundai vehicles are sold and serviced through more than 820 dealerships nationwide and nearly half of those sold in the U.S. are built at Hyundai Motor Manufacturing Alabama. Hyundai Motor America is headquartered in Fountain Valley, California, and is a subsidiary of Hyundai Motor Company of Korea. Please visit our media website at www.HyundaiNews.com Hyundai Motor America on Twitter | YouTube | Facebook | Instagram SOURCE Hyundai Motor America Related Links www.hyundainews.com

Hyundai Motor America Reports January 2021 Sales

BILLERICA, Mass., July 1, 2020 /PRNewswire/ --ProterixBio, Inc. today announced completing a licensing agreement with the Massachusetts General Hospital for a COVID-19 serology assay. The assay was developed and validated by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University which is a joint venture of Harvard University, Massachusetts Institute of Technology and Massachusetts General Hospital. The assay, an enzyme-linked immunosorbent assay or ELISA, measures antibodies that bind to the Receptor Binding Domain (RBD) of the SARS-CoV-2 spike protein. The Ragon Institute team has extensively characterized the assay, having tested more than 10,000 individuals as part of physician-led clinical research studies. Additionally, the assay is being used in on-going public health surveillance projects. There is a growing body of evidence linking antibodies to the spike and RBD proteins to immunity and neutralizing activity, highlighting the importance of this assay for characterizing COVID-19 immune response. The assay has several other features that are key for broad deployment and longitudinal monitoring of antibody response. First, the assay can be run from dried blood spots collected from individuals with a simple finger prick. Second, the assay includes a means of calibration so measurements can be tracked over time. "We are very excited to collaborate with the Ragon Institute to advance COVID-19 serology testing," said Michael Miller, Ph.D., President and Chief Executive Officer of ProterixBio. "The combination of convenient finger prick sample collection and high-performance clinical laboratory test methods delivers clear advantages and addresses a large unmet need for broadly deployable, high-quality COVID-19 serology assays." "The Ragon Institute mobilized in the very early phases of the COVID-19 outbreak to develop methods for characterizing an individual's immune response to the virus. Serology assays are an important tool for on-going disease research, vaccine and therapeutics development and public health programs," commented Dr. Galit Alter, Professor of Medicine at Harvard Medical School and Group Leader at the Ragon Institute. ProterixBio will submit a request to the U.S. Food and Drug Administration (FDA) for issuance of an Emergency Use Authorization (EUA) for the COVID-19 serological assay and offer it as a clinical testing service starting in the third quarter of this year. About ProterixBio ProterixBio develops and commercializes diagnostic solutions that address critical unmet needs in population health and chronic care. An area of focus has been vulnerable populations such as those with chronic obstructive pulmonary disease, diabetes and cardiovascular disease. The company has developed algorithms utilizing combinations of blood-based biomarkers for identifying individuals at high risk for severe outcomes. ProterixBio maintains a rigorous approach to test development that includes collaborating with leading academic medical centers and validating assays in large, carefully curated cohorts. ProterixBio is headquartered and operates a laboratory in Billerica, MA. For additional information, please visit https://proterixbio.com/covid19. About Ragon Institute The Ragon Institute was officially established in February 2009 at Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University with a donation of $100 million from Terry and Susan Ragon. The Institute's mission is to contribute to the accelerated discovery of a HIV/AIDS vaccine and to establish itself as a world leader in the collaborative study of immunology. The Institute is structured and positioned to significantly contribute to the field of immunology and efforts against global disease. With a HIV vaccine in clinical trials, the Institute has broadened its focus to apply the lessons learned from HIV to the immune system and its interface with other global infectious diseases. Contact: [emailprotected] SOURCE ProterixBio, Inc Related Links https://proterixbio.com

ProterixBio licenses COVID-19 serology test from Massachusetts General Hospital

DUBLIN, Jan. 21, 2021 /PRNewswire/ -- The "Vaccine Market By Technology, Indication, and End Use: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global vaccine market accounted for $32,463 million in 2019 and is expected to reach $54,168 million by 2027, registering a CAGR of 6.6% from 2020 to 2027.Vaccine is a biological preparation that is administered to produce acquired immunity in patients. Administration of vaccines aids to enhance the immune response against a specific pathogen. Vaccinations play a key role in sustaining people's health across different countries; hence, they are used in various national disease-prevention strategies. Due to the increased occurrence of both viral and bacterial infectious diseases, the demand for vaccines has grown over the past few years. Vaccinations are primarily provided to people of different ages, improving their immune system during their lives and ensuring defense against various forms of infectious diseases.It is estimated that vaccine market is expected to experience significant market growth during the forecast period as there has been an increase in adoption in several countries across the globe by national immunization programs. In addition, surge in pneumococcal, meningococcal disease outbreaks in several countries has led to upsurge in demand for meningococcal vaccines, which further facilitate the growth of the market. However, stringent government regulations for the approval of new vaccines and recall of several products due to contamination are expected to impede the market growth. In contrast, high population base in emerging markets and global increase in healthcare spending provides significant growth opportunities for the meningococcal vaccine market.Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped & better financed hospitals & clinics, high adoption rate for vaccine products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness about vaccination. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential due to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.The global vaccine market is segmented on the basis of technology, indication, end user, and region. Depending on technology, the market is classified into recombinant & conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines, and others. By indication, the market is classified into pneumococcal disease, influenza, human papilloma virus, meningococcal disease, rotavirus, varicella; diphtheria, pertussis, & tetanus (DPT), polio, hepatitis, measles; mumps, & rubella (MMR), and other indications. According to end user, the market is segmented into pediatric, adults, and travelers. By region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).The key players operating in the vaccine market include Serum Institute of India Pvt. Ltd., Pfizer, Johnson & Johnson, AstraZenecea, GlaxoSmithKline plc, Sanofi Aventis, Merck & Co., Inc., Emergent BioSolutions Inc., CSL Limited, Novavax, Inc.Key Benefits The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets. It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities. A comprehensive analysis of the countries in Latin America is provided to determine the existing opportunities. The key market players and their strategies have been analyzed to understand the competitive outlook of the market. Key Topics Covered: Chapter 1: Introduction1.1. Report Description1.2. Key Market Segments1.2.1. List of Key Players Profiled in the Report1.3. Research Methodology1.3.1. Primary Research1.3.2. Secondary Research1.3.3. Analyst Tools and ModelsChapter 2: Executive Summary2.1. Key Findings of the Study2.2. CXO PerspectiveChapter 3: Market Overview3.1. Market Definition and Scope3.1.1. Top Winning Strategies, 20193.2. Top Player Positioning3.2.1. Top Investment Pockets3.3. Key Forces Shaping Vaccine Industry/Market3.4. Market Dynamics3.4.1. Drivers3.4.1.1. Increase in Prevalence of Infectious Diseases3.4.1.2. Surge in Immunization Programs Across the Globe3.4.1.3. Increase in R&D Activities to Develop New Vaccine3.4.2. Restraint3.4.2.1. Longer Timelines Required for Vaccine Production3.4.2.2. High Cost Associated With the Development of Vaccine3.4.3. Opportunity3.4.3.1. Growth Opportunities in the Emerging Markets3.4.3.2. Increase in Healthcare Spending3.4.4. Impact Analysis3.1. Covid-19 Impact Analysis on Vaccine Market3.1.1. Overview3.1.2. Impact AnalysisChapter 4: Vaccine Market, by Technology4.1. Overview4.1.1. Market Size and Forecast4.2. Recombinant & Conjugate Vaccine4.2.1. Key Market Trends, Growth Factors, and Opportunities4.2.2. Market Size and Forecast, by Region4.2.3. Market Analysis, by Country4.3. Inactivated Vaccines4.3.1. Key Market Trends, Growth Factors, and Opportunities4.3.2. Market Size and Forecast, by Region4.3.3. Market Analysis, by Country4.4. Live Attenuated Vaccines4.4.1. Key Market Trends, Growth Factors, and Opportunities4.4.2. Market Size and Forecast, by Region4.4.3. Market Analysis, by Country4.5. Toxoid Vaccines4.5.1. Key Market Trends, Growth Factors, and Opportunities4.5.2. Market Size and Forecast, by Region4.5.3. Market Analysis, by Country4.6. Other Vaccines4.6.1. Key Market Trends, Growth Factors, and Opportunities4.6.2. Market Size and Forecast, by Region4.6.3. Market Analysis, by CountryChapter 5: Global Vaccine Market, by Indication5.1. Overview5.1.1. Market Size and Forecast5.2. Pneumococcal Disease5.2.1. Key Market Trends, Growth Factors, and Opportunities5.2.2. Market Size and Forecast, by Region5.2.3. Market Analysis, by Country5.3. Influenza5.3.1. Key Market Trends, Growth Factors, and Opportunities5.3.2.`Market Size and Forecast, by Region5.3.3. Market Analysis, by Country5.4. Human Papilloma Virus5.4.1. Key Market Trends, Growth Factors, and Opportunities5.4.2. Market Size and Forecast, by Region5.4.3. Market Analysis, by Country5.5. Meningococcal Disease5.5.1. Key Market Trends, Growth Factors, and Opportunities5.5.2. Market Size and Forecast, by Region5.5.3. Market Analysis, by Country5.6. Rotavirus5.6.1. Key Market Trends, Growth Factors, and Opportunities5.6.2. Market Size and Forecast, by Region5.6.3. Market Analysis, by Country5.7. Varicella, Measles, Mumps, and Rubella (Mmr)5.7.1. Key Market Trends, Growth Factors, and Opportunities5.7.2. Market Size and Forecast, by Region5.7.3. Market Analysis, by Country5.8. Diptheria, Pertussis, and Tetanus (Dpt)5.8.1. Key Market Trends, Growth Factors, and Opportunities5.8.2. Market Size and Forecast, by Region5.8.3. Market Analysis, by Country5.9. Polio5.9.1. Key Market Trends, Growth Factors, and Opportunities5.9.2. Market Size and Forecast, by Region5.9.3. Market Analysis, by Country5.10. Hepatitis5.10.1. Key Market Trends, Growth Factors, and Opportunities5.10.2. Market Size and Forecast, by Region5.10.3. Market Analysis, by Country5.11. Other Indications5.11.1. Key Market Trends, Growth Factors, and Opportunities5.11.2. Market Size and Forecast, by Region5.11.3. Market Analysis, by CountryChapter 6: Vaccines Market, by End-user6.1. Overview6.1.1. Market Size and Forecast6.2. Pediatric Vaccines6.2.1. Market Size and Forecast6.2.2. Market Analysis, by Country6.3. Adult Vaccines6.3.1. Market Size and Forecast6.3.2. Market Analysis, by Country6.4. Travelers Vaccines6.4.1. Market Size and Forecast6.4.2. Market Analysis, by CountryChapter 7: Global Vaccine Market, by Region7.1. Overview7.2. North America7.3. Europe7.4. Asia-Pacific7.5. LAMEAChapter 8: Company Profiles8.1. Astrazeneca plc.8.1.1. Company Overview8.1.2. Company Snapshot8.1.3. Product Portfolio8.1.4. Business Performance8.2. Csl Limited8.2.1. Company Overview8.2.2. Company Snapshot8.2.3. Operating Business Segments8.2.4. Product Portfolio8.2.5. Business Performance8.3. Emergent Biosolutions Inc.8.3.1. Company Overview8.3.2. Company Snapshot8.3.3. Operating Business Segments8.3.4. Product Portfolio8.3.5. Business Performance8.3.1. Key Strategic Moves and Developments8.4. GlaxoSmithKline plc.8.4.1. Company Overview8.4.2. Company Snapshot8.4.3. Operating Business Segments8.4.4. Product Portfolio8.4.5. Business Performance8.4.6. Key Strategic Moves and Developments8.5. Johnson & Johnson8.5.1. Company Overview8.5.2. Company Snapshot8.5.3. Operating Business Segments8.5.4. Product Portfolio8.5.5. Business Performance8.5.6. Key Strategic Moves and Developments8.6. Merck & Co. Inc.8.6.1. Company Overview8.6.2. Company Snapshot8.6.3. Operating Business Segments8.6.4. Product Portfolio8.6.5. Business Performance8.6.6. Key Strategic Moves and Developments8.7. Novavax, Inc.8.7.1. Company Overview8.7.2. Company Snapshot8.7.3. Operating Business Segments8.7.4. Product Portfolio8.7.5. Business Performance8.8. Pfizer Inc.8.8.1. Company Overview8.8.2. Company Snapshot8.8.3. Operating Business Segments8.8.4. Product Portfolio8.8.5. Business Performance8.8.6. Key Strategic Moves and Developments8.9. Sanofi S. A.8.9.1. Company Overview8.9.2. Company Snapshot8.9.3. Operating Business Segments8.9.4. Product Portfolio8.9.5. Business Performance8.9.6. Key Strategic Moves and Developments8.10. Serum Institute of India Pvt. Ltd8.10.1. Company Overview8.10.2. Company Snapshot8.10.3. Operating Business Segments8.10.4. Product PortfolioFor more information about this report visit https://www.researchandmarkets.com/r/drlhtn Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Outlook on the Vaccine Global Market to 2027 - Opportunity Analysis and Industry Forecast

BOTHELL, Wash., July 1, 2020 /PRNewswire/ --BioLife Solutions, Inc. (NASDAQ: BLFS)("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies,today announced estimated preliminary revenue for the second quarter of 2020 of $9.6 million to $9.8 million, representing 43% to 46% growth over the same quarter in 2019. Mike Rice, BioLife's CEO, commented, "Despite the continued impact of COVID-19 on the biotech industry and specifically, the cell and gene therapy market, we continued to drive revenue growth in the second quarter. In the first six months of 2020, we added 57 new customers and confirmed that our biopreservation media products have been embedded in 23 additional customer clinical trials." The financial data presented for the second quarter of 2020 should be considered preliminary and could be subject to change as these preliminary results are based on management's initial analysis of operations and are subject to further internal review and the Company's independent auditor, BDO USA, LLP, who have not completed their review. About BioLife Solutions BioLife Solutions is a leading supplier of cell and gene therapy bioproduction tools. Our tools portfolio includes our proprietaryCryoStorfreeze media and HypoThermosolshipping and storage media, ThawSTARfamily of automated, water-free thawing products, evocold chain management system, and Custom Biogenic Systemshigh capacity storage freezers. For more information, please visit www.biolifesolutions.com, and follow BioLife on Twitter. Cautions Regarding Forward Looking Statements Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning the expected financial performance of the company following the completion of its 2019 acquisitions and giving effect to the COVID-19 pandemic, the company's ability to implement its business strategy and anticipated business and operations, in particular following its 2019 acquisitions and giving effect to the COVID-19 pandemic, the company's anticipated future growth strategy, including the acquisition of synergistic cell and gene therapy manufacturing tools and services or technologies, the potential utility of and market for our products and services, potential revenue growth and market expansion, regulatory approvals and/or commercial manufacturing of our customers' products, and potential customer revenue. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including among other things, uncertainty regarding unexpected costs, charges or expenses resulting from the company's 2019 acquisitions, market adoption of the company's products (including the company's recently acquired products); the ability of the company's 2019 acquisitions to be accretive on the company's financial results; the ability of the company to implement its business strategy; uncertainty regarding third-party market projections; market volatility; competition; litigation; the impact of the COVID-19 pandemic; and those other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law. Media & Investor RelationsRoderick de GreefChief Financial Officer(425) 686-6002[emailprotected] SOURCE BioLife Solutions, Inc. Related Links www.biolifesolutions.com

BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020

KANSAS CITY, Mo., May 6, 2020 /PRNewswire/ --Conexon, the nation's leader in designing and managing the construction of rural fiber-optic networks, and South Carolina-based Tri-County Electric Cooperative are working together to build a fiber-to-the-home network to serve the 15,000 homes and businesses in co-op territory. Tri-County Electric's Board of Trustees and Management have selected Conexon to provide a complete turnkey solution of broadband services including project and construction management, engineering and design, and call center and customer support. Conexon subsidiary, Conexon Connect, will also serve as Tri-County Electric's phone provider of record. "Conexon had the experience and expertise we were looking for," Tri-County Electric Cooperative CEO Chad Lowder said. "Randy and Jonathan and the team work exclusively with cooperatives, so they understand rural territories, the co-op's commitment to service and the unique challenges we face. Based on the recommendations from other co-ops, and Conexon's end-to-end capabilities, we felt the company was the best solution for us. We're excited to get started on the project." Tri-County Electric's three-year deployment, with an estimated $50 million investment, will encompass 1,700 miles of fiber and the parts of six counties in central South Carolina served by the co-op. Fiber construction is expected to begin mid-2020 with the first members connected by fall 2020. The broadband network will deliver symmetrical gigabit internet capabilities among the fastest and most robust in the nation along with high-quality phone services. "I have been impressed by the quality of the Tri-County Board and Management Team," Conexon Partner Jonathan Chambers said. "The COVID-19 crisis accentuates a point rural communites have known for some time. For kids to have the same educational opportunity, for people to work from home, for young adults to find work without moving away, for the elderly to receive quality health care, rural America needs fiber broadband service. So, let's get started." The Tri-County fiber network will also bolster the co-op's electrical infrastructure with smart grid capabilities that will deliver benefits such as improved power outage response times, better load balancing, and more efficient electricity delivery. "The Tri-County Electric team has a great understanding of what it will take to bring broadband to its co-op communities, and is committed to a roadmap that both delivers benefits to members and strengthens the underlying infrastructure," Conexon Partner Randy Klindt said. "We look forward to a successful deployment and helping them fulfill their mission of service in an entirely new way." About ConexonConexon works with Rural Electric Cooperatives to bring fiber to the home in rural communities. The company is comprised of professionals who have worked in electric cooperatives and the telecommunications industry, and offer decades of individual experience in business planning, building networks, marketing and selling telecommunications. Conexon offers its electric cooperative clients end-to-end broadband deployment and operations support, from a project's conception all the way through to its long-term sustainability. It works with clients to analyze economic feasibility, secure financing, design the network, manage construction, provide operational support, optimize business performance and determine optimal partnerships. To date, Conexon has assisted more than 160 electric cooperatives, 40 of which are deploying fiber networks, with nearly 100,000 connected fiber-to-the-home subscribers across the U.S., and has secured more than $200 million in federal and state grants for its clients. SOURCE Conexon Related Links https://www.conexon.us

Tri-County Electric Cooperative (SC) and Conexon team up to launch fiber-to-the-home network; buildout will deliver world-class broadband speeds and capabilities to 15,000 rural South Carolina homes and businesses Conexon will provide turnkey suite of broadband operational services including engineering and design, construction management, phone service, customer support

LONDON--(BUSINESS WIRE)-- 25 January 2021 ECR MINERALS PLC (ECR Minerals, ECR or the Company) WARRANT EXERCISE & APPOINTMENT OF JOINT BROKER ECR Minerals plc (LON: ECR), the gold exploration and development company focussed on Australia, is pleased to announce an update confirming a significant warrant exercise, the current financial position of the Company and the appointment of a joint broker. Exercise of Warrants (Warrant Shares) ECR has received notice to exercise warrants over 55,856,391 new ordinary shares in the Company (Warrant Shares). Of this number, 55,356,391 new ordinary shares are being issued pursuant to the exercise of warrants at 2p per share, and 500,000 new ordinary shares pursuant to the exercise of warrants at 1.125p per share. Aggregate subscription monies of 1,112.752.82 have been received by ECR in respect of the exercise of these warrants. Company Financial Position Following receipt of the above warrant monies ECR now has cash balances of c.4 million and is therefore, in the Boards view, in an exceptionally strong financial position. This strength of the Companys financial position enables ECR to comfortably continue to embark on its previously announced exploration programmes with confidence. With our own in-house drilling capability we are planning to undertake extensive drill programmes across our Victoria Goldfields interests. Appointment of Joint Broker ECR is pleased to announce that it has appointed Novum Securities (Novum") as a joint broker with immediate effect. With the current cash position ECR currently has no intention of carrying out a placing. Novum are to undertake broker research on ECR Minerals plc, with a particular focus on enhancing market awareness of the Company, notably in the institutional investor community. Admission of Shares Admission of the Warrant Shares to trading on AIM is expected to occur on or around 28 January 2021 (Admission). Upon Admission, ECRs issued ordinary share capital will comprise 749,333,993 ordinary shares of 0.001p. This number will represent the total voting rights in the Company, and, following admission of the Warrant Shares, may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Warrant Shares will rank pari passu in all respects with the ordinary shares of the Company currently traded on AIM. MARKET ABUSE REGULATIONS (EU) No. 596/2014 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (MAR). Upon the publication of this announcement via Regulatory Information Service (RIS), this inside information is now considered to be in the public domain. FOR FURTHER INFORMATION, PLEASE CONTACT: ECR Minerals plc Tel: +44 (0)20 7929 1010 David Tang, Non-Executive Chairman Craig Brown, Director & CEO Email: info@ecrminerals.com Website: www.ecrminerals.com WH Ireland Ltd Tel: +44 (0)161 832 2174 Nominated Adviser Katy Mitchell/James Sinclair-Ford SI Capital Ltd Tel: +44 (0)1483 413500 Broker Nick Emerson ABOUT ECR MINERALS PLC ECR is a mineral exploration and development company. ECRs wholly owned Australian subsidiary Mercator Gold Australia Pty Ltd has 100% ownership of the Bailieston and Creswick gold projects in central Victoria, Australia. ECR is currently drilling high priority targets on the Bailieston gold project using the Companys own diamond drill rig. ECR has an experienced exploration team with significant local knowledge in the Victoria Goldfields. Following the sale of the Avoca, Moormbool and Timor gold projects in Victoria, Australia to Fosterville South Exploration Ltd (TSX-V: FSX), ECR has the right to receive up to A$2 million in payments subject to future resource estimation or production at those projects. ECR has earned a 25% interest in the Danglay gold project, an advanced exploration project located in a prolific gold and copper mining district in the north of the Philippines, and holds a royalty on the SLM gold project in La Rioja Province, Argentina.

Warrant Exercise & Appointment of Joint Broker

LONDON--(BUSINESS WIRE)-- FORM 8.5 (EPT/NON-RI) Amendment to sales PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (RI) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE) Rule 8.5 of the Takeover Code (the Code) 1. KEY INFORMATION 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Interests Short Positions Number (%) Number (%) (1) 4,827,980 1.88% 188,051 0.07% (2) 153,974 0.06% 4,073,200 1.59% (3) 0 0.00% 0 0.00% (4) 4,981,954 1.95% 4,261,251 1.66% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Purchase 290,189 8.7243 GBP 8.6843 GBP Sale 116,773 8.7115 GBP 8.6996 GBP (b) Cash-settled derivative transactions Number of reference securities 102 1,293 2,678 3,681 7,000 14,102 15,000 16,828 17,696 519 1,869 1,973 2,023 9,690 12,486 96,305 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments 020 3134 7213 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

FORM 8.5 (EPT/NON-RI) - AGGREKO PLC - AMENDMENT

MOUNTAIN VIEW, Calif., Aug. 17, 2020 /PRNewswire/ --Millennials are financially impacted the most during COVID-19. A new healthinsurance.com multigenerational survey polled Millennials, Gen Xers and Baby Boomers about their perspectives on everything from healthcare and the economy to technology and social media during the COVID-19 pandemic. (PRNewsfoto/healthinsurance.com) COVID-19 Healthcare and Financial Hardships51% of those surveyed say they have experienced financial insecurity due to COVID-19. Millennials were most impacted with 6 in 10 saying they have experienced financial insecurity during the Coronavirus pandemic. 52% of Millennials said they've also had to put off medical care because of cost. Baby Boomers were the least impacted generation with only 37% reporting financial hardships during COVID-19. Across the three generations, 3 in 10 respondents say theyhave or have known someone who has lost their health insurance during the COVID-19 pandemic -- nearly 40% of Millennials were impacted by this. And when asked broadly about the U.S. healthcare system, 82% of all surveyed say it's broken. Stimulating The American EconomyGen Xers, Millennials and Baby Boomers have all been busy hitting that checkout button: 72% report shopping more online during the Coronavirus pandemic. 77% alsosay they have made an effort to patronize small businesses during the pandemic. However, the overall economic outlook is bleak: 47% don't believe that small businesses will recover after the COVID-19 pandemic, and an additional two-thirds think it will take two or more years for the U.S. economy to recover. Slowing The Spread of COVID-19While 87% are comfortable having their temperature checked before walking into an establishment, only 4% feel it's an effective way to prevent the spread of COVID-19. Overall, 4 in 10 think masks are the most effective way to prevent the spread of COVID-19, but Millennials and Gen Xers think that social distancing and lockdowns are almost equally as effective. But the lockdowns are just a bummer to the Baby Boomers: only 12% think they are effective. All generations are worried about kids going back to school with 6 in 10 thinking students should not go back to classrooms or to college campuses this fall. When asked about getting vaccinated, 69% say they will. That number was slightly higher for Baby Boomers: 75% say they will get the vaccine when one becomes available.Trusting TelemedicineGen Xers are embracing telemedicine the most with 52% saying they've used telemedicine services during the pandemic. Meanwhile, 46% of Baby Boomers are trying virtual visits during COVID-19. Overall, 60% say they are more comfortable using telemedicine now than they were six months ago. More than half of respondents say their doctor has encouraged a telemedicine visit over an in-office visit. Lastly, 54% say they plan on using telemedicine when the COVID-19 pandemic is over. Depending on Digital50%have video chatted more with their parents and or kids since the COVID-19 pandemic began, with Millennials reporting the biggest increase. 71% of all respondentsfind themselves on the computer or phone more often since the pandemic started, which may be why 39% say they need a digital detox. At 51%, Millennials were the top generation needing a digital detox - a multigenerational divide that is very telling. Staying connected on Social Media Facebook is still King with 60% of all generations saying they use Facebook the most, followed by Instagram at 19% and Twitter at 11%. 75% of Baby Boomers say they use Facebook the most, compared to 45% of Millennials. Instagram comes in second among Millennials, with 27% saying it's their preferred social media platform. For more findings click here or for the entire multigenerational survey results click here.METHODOLOGY:The above results were gathered through an online poll of 1,595 Americans aged 24-74. The poll was conducted August 6-7, 2020, gleaning representative samples from each state based on population. Samples were weighted for even sample results for Millennials (ages 24-39), Gen X (ages 40-55) and Baby Boomers (ages 56-74). Percentages have been rounded to the nearest full percentage point.ABOUT HEALTHINSURANCE.COM:Healthinsurance.com combines the nation's leading health insurance carriers and advanced technology to offer a suite of private insurance solutions and Medicare plan options. In just a few clicks, our website provides consumers the ability to access powerful online comparison tools and educational resources that enable efficient self-guided navigation of available health insurance and Medicare options. For more information, visit www.healthinsurance.com.FORWARD-LOOKING STATEMENTS:Healthinsurance.com LLC is part of the Benefytt Technologies family companies (NASDAQ: BFYT). This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than historical fact, and may include statements relating to goals, plans and projections regarding new markets, products, services, growth strategies, anticipated trends in our business and anticipated changes and developments in the United States health insurance system and laws. Forward-looking statements are based on our current assumptions, expectations and beliefs are generally identifiable by use of words "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," or similar expressions and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include, among other things, our ability to maintain relationships and develop new relationships with health insurance carriers and distributors, our ability to retain our members, the demand for our products, the amount of commissions paid to us or changes in health insurance plan pricing practices, our ability to integrate our acquisitions, competition, changes and developments in the United States health insurance system and laws, and our ability to adapt to them, the ability to maintain and enhance our name recognition, difficulties arising from acquisitions or other strategic transactions, and our ability to build the necessary infrastructure and processes to maintain effective controls over financial reporting. These and other risk factors that could cause actual results to differ materially from those expressed or implied in our forward-looking statements are discussed in HIIQ's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) as well as other documents that may be filed by HIIQ from time to time with the Securities and Exchange Commission, which are available at www.sec.gov. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. You should not rely on any forward-looking statement as representing our views in the future. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.SOURCE healthinsurance.com Related Links http://www.healthinsurance.com

Multigenerational Survey On Life During COVID-19 Finds Millennials Most Impacted

PARIS--(BUSINESS WIRE)--Regulatory News: Korian (Paris:KORI) the leading European care and support services group for the elderly and fragile, announces its Q4 revenue and its 2020 results. Sophie Boissard, CEO of Korian Group: As we take stock of the year, our thoughts are primarily with all of those residents and families who have suffered in this pandemic. I am extremely grateful for the outstanding commitment, resilience and solidarity that Korian teams across the network have shown to maintain service continuity and ensure high level of care quality. I also express my thanks to our stakeholders for their continuous support. We come out of 2020 united around our purpose and our values of Trust, Responsibility and Initiative and with a renewed commitment to build on our care and medical expertise to provide to elderly and fragile people solutions that offer them freedom of choice. We will continue on these foundations to innovate and invest in our people and in our capabilities to tackle the longevity challenge and fit to the needs of patients and residents. Strong commitment and collective mobilisation to affront the pandemic Korian delivering on its ESG roadmap taken in 2020, with tangible results Revenue up 7.2% ( 3 874m) fuelled by resilient organic growth and active buy and build strategy EBITDA Margin above guidance at 13.6% excluding one-off costs (12.9% with Covid-19 one-off costs) Network of 1,000 facilities, 6,000 additional beds (+32% vs. 2019), of which 1,500 greenfield beds and 15 clinics with new outpatient places Acceleration of diversification strategy Strengthened balance sheet: financial leverage of 3.0x, real estate LTV of 55% on value of 2.7bn Proposed dividend of 0.30 per share Guidance confirmed for 2022: >4.5 billion revenue with 15.5% of EBITDA margin Adapted to a long term Covid-19 environment and vaccination programme well advanced Korian has been constantly mobilised throughout 2020 to protect its staff and residents from the Covid-19 virus pandemic. From March 2020, the Group has taken numerous initiatives to be able to operate on the long run in the Covid-19 environment, such as: - Deploying hospital level hygiene standards across the Group, audited by Bureau Veritas (98% outstanding or very good level of compliance) - adapted therapeutical protocols, in clinics as well as in nursing homes - access to dedicated teleconsultation platforms (operated by Omedys in France) - on-site testing capabilities for teams and external visitors - permanent rolling stocks of PPE covering 2 months utilisation - connexion tools to maintain links between patients and residents with families. The network is presently focused on finalising the first vaccination campaign in close coordination with the local authorities. To date, 76% of residents4 have received their first dose and 43% of staff5, this first campaign should be finalize by end of March 2021. Korian would like to thank its staff members, its patients and residents and all its local stakeholders for the resilience and the sense of solidarity they have demonstrated over the past months to contain and mitigate the virus threat. The positive feedback provided locally by internal and external stakeholders is a strong encouragement to all staff members to remain mobilized. As is the high level of the overall satisfaction score of patients and residents: according to the yearly survey performed in November across Europe in all Korian facilities, gross satisfaction scores at 94%, with a significant increase of 400 bps of the net satisfaction score6. Sustained ESG commitments: Korian ahead of its roadmap Over 2020, the Group has been focusing more than ever on its contribution to its different stakeholders, namely, patients and residents, their relatives, its staff members, local communities and partners, the medical community, academics and associations and the Groups investors and shareholders. In a context where strong solidarity is required to fight against the Covid-19 pandemic, Korian has dedicated part of its network taking care of Covid-19 patients and sharing the burden with public hospitals (5,620 patients cared for across Europe). It has also been actively contributing to 3 promising medical research programmes, through the Korian Foundation and the French Foundation for medical Research (FRM), conducted by the Institut Pasteur, INSERM and Paris University Hospital (AP-HP). All these actions have been financed through the Korian Covid-19 solidarity fund created in April 2020 and funded by the donations from Korian executives and directors. Korian has continued to invest in the quality of the care provided, notably the ISO 9001 certification has progressed this year with 11% of facilities now certified (versus 8% in 2019), the roll-out of Positive Care will be a priority in 2021 after being suspended during the pandemic. The Group has increased its investment into its people over the period, notably in terms of training and skill development. Korian has opened two new learning hubs in Europe (Lyon, Munich) to support internal qualifying training and promotion programs. It has also created in France the first integrated care apprenticeship school, that will train up to 500 nurse apprentices by 2022. Thanks to these actions, the Group has already reached by the end of 2020 its target to have 8% of its permanent staff (~4,320 people) engaged in qualifying training programmes, well ahead of its 2023 target. It has therefore decided to set a new target of 10% of its permanent staff by 2023. The Group has been driving numerous initiatives to improve the attractivity and the quality of work: - reducing the portion of temporary staff members by increasing the recruitment of permanent staff members (11,000 recruitments done in 2020), - promoting health and safety at work through adapted training, psychological support and qualitative work environment, - aligning and increasing compensation and benefit policies, along with the financial support provided by the public payers, especially in France and Germany, - teaming up with selected partner such as FACE to provide adapted support to staff members in their private life (legal support, education programme, medical support). Thanks to all these actions, Korian has been awarded as a Top Employer in Germany in 2020, being the first care company to earn this distinction. Korian, as an innovative move in the care industry, set out in early 2020 a comprehensive mid-term ESG roadmap, encompassing 15 objectives, based on its main stakeholders expectations and fully embedded in its corporate project In Caring Hands. At the end of the year the Group is ahead on its ESG roadmap. Over the year the following milestones have been achieved: Digital investments bringing value The pandemic has shown the value of each Korian facility being entirely integrated into its local ecosystem with the families and local healthcare professionals in particular. The Groups digital strategy has enabled an efficient integration in each local ecosystem, especially during the peak of the pandemic. The deployment of Omedys telemedicine system has been strongly contributing to care continuity in nursing homes and clinics during the pandemic with over 10,000 teleconsultations. MoveInMed, a Korian tech subsidiary was able to design and deploy e-rehabilitation platforms to ensure continuous supervision at home despite lockdown, while the Medicalib solution, as a market place for paramedical staff, supported the work of our local home care agencies. Last but not least, Korian Generation, a dedicated social network whose development is now supported by Technosens, another Korian digital company, has been used extensively to connect residents and families and is now used by over 8,500 families. All these initiatives pave the way for a further acceleration of the digitization of the service offering both in inpatient and outpatient fields. *** The consolidated audited financial statements for 2020 were approved by the Board of Directors at its meeting of 24th February 2021. The Statutory Auditors are in the process of issuing a report with an unqualified opinion. The consolidated financial statements were prepared in accordance with the IFRS 16 standard. For purposes of comparability, the financial information below is presented excluding the application of IFRS 16. *** Q4 revenue and Full year revenue and results 2020 Strong growth from recent acquisitions with resilient organic performance Revenue in Q4 2020 increased by 10.9%, topping 1 billion euros of revenue with 1,036.4 million. The organic growth was 4.7% driven notably by Germany and continued development in diversified solutions. This reflects the resilience of the Group and a strong contribution from bolt-on acquisitions. In 2020, revenue totalled 3,874 million, up 7.2%. The recent acquisitions of the Group have contributed and shown their pertinence, the Spanish and Dutch platforms contributing to 20% of the overall growth. The healthcare activities of the Group remain a key driver representing 40% of the Groups growth, reflecting the acquisitions in France and Italy and the ongoing transformation of the network and the increase in ambulatory care. The increase in chronic diseases and the need for innovative, ambulatory solutions will continue to drive demand. In 2020, Korian increased outpatient capacities by 25% in France and increased patients consultations by 70% in Italy. Organic growth of 2% reflects the solidity of the diversified geographic footprint, with notably a contribution of 4.2% organic growth of Germany and the diversified business model reflected in the 18% organic growth in Home Care (representing 0.4% of Group organic growth). The Group has added c.6,000 beds to its portfolio in 2020 and 107 additional facilities, reaching 88,651 beds and 1,000 facilities in operation at the end of the year. Korians multi-local strategy aims to provide a diversified care pathway, at a local level. The Group has delivered c. 1,500 greenfield beds in 2020 and has a strong pipeline of greenfield projects, notably in the Netherlands, France and Germany with a focus on small sized structures, as well as in healthcare. The Group aims to deliver c. 3,000 greenfield beds per year in the coming years. In 2020, the Group has completed 19 acquisitions, representing 1.2Bn of investment. The acquisitions had a focus on the medical capability of the Group. Investment in this area represents 68% of the investments. Overall, the 39 acquisitions of 2019 and 2020 should generate c. 600m of revenue at run rate. The Group has significantly increased its medical footprint in 2020 with notably 2 acquisitions in France: 5 Sant specialised in respiratory care and Inicea an innovative player in the growing mental health segment in France, making Korian the third largest player in mental health in France. The acquisition of Inicea provides Korian with a strong platform of mental health capabilities, with innovative and outpatient capacities. The mental health segment has proved exceptionnaly resilient to the Covid-19 crisis and there continues to be a growing demand. The pipeline of projects within Inicea and the ramp-up of the capabilities allows the Group to aim at 6% of organic growth in this segement in the coming years. Both of these acquisitions reflect the focus of the Group on specialised medical care and the development of ambulatory and outpatient care capacity. The Group has continued its step by step build up in Spain and Netherlands, two footholds taken by the Group in 2019. The Spanish platform has doubled the number facilities to 16 since the first acquisition and has proved its resilience during the pandemic with revenue up 30% to 33m in 2020. In the Netherlands, the Group has continued to acquire regional networks of small sized homes with a strong pipeline. It now has the 37 homes and the revenue has multiplied almost five times since 2019 to c. 60 million. Korian is now replicating this strategy in the large UK market, where there is a strong demand for high end care home solutions for an affluent population. In February 2021, the Group has entered into exclusive negotiation to acquire Berkley Care Group in the UK, a group with 6 high end care homes in the South of England, providing outstanding quality care with a high level of client satisfaction, in a very large market with a rising need for premium care. Korian will also acquire the real estate for 5 of the homes. The Group is expected to deliver c.25 million of revenue in 2021. The Groups EBITDAR in 2020 is 975m, excluding Covid-19 one-off costs, and the EBITDAR margin is 25.2% reduced by 100 basis points on 2019 reflecting the reduction of revenue due to the lockdown and the various restrictions associated with the pandemic situation. (Including Covid-19 one-off costs, EBITDAR amounts 948.3m, and the margin is 24.5%) The investment of Korian in its staff has been sustained with staff costs increasing by 10.3% in 2020 and representing 57% of revenue (up 2% on 2019 reflecting a maintained staff structure in a context of reduced occupancy). By country7: Korians EBITDA totalled 525.2 million excluding Covid-19 one-off costs (498.2 million with Covid-19 one-off costs), down 1.9% on 2019 as a reflection of the fixed rental costs. The margin stands at 13.6% (compared to 14.8% in 2019), or 12.9% with Covid-19 one-off costs.The Groups asset smart policy will bring an increased impact to EBITDA in the months to come since real estate investment were particularly focused on greenfield capex that will deliver beds in the years to come and acquisition of mature real estate was concentrated on the second part of the year. Korian now owns 219 facilities representing c.2.7 billion in value. These facilities are in all of the Groups geographies and represent 24% of the value of the real estate assets operated by the Group. In 2020, the Group invested 560m in real estate. Earnings before interest and taxes (EBIT) amounted to 298.3 million, i.e. 7.7% of revenue (versus 9.3% in 2019). Net profit (Group share) totalled 64.9 million (versus 136 million in 2019) after income tax expense of 25.8 million and a lowered tax rate of 27.4%. Strengthened financial structure The Group has generated 223m of operating free cash flow in 2020 representing a conversion rate of 42.5% of EBITDA with careful working capital management. Maintenance or operating capex, included here, represent 2.2% of revenue in 2020. Korians balance sheet improved following two operations to reinforce its equity, a capital increase and a participation in its real estate. This has led to an adjusted leverage of 3x in a context of high investment and a lower EBITDA as a consequence of the pandemic. The reinforced balance sheet will allow the group to play an active role in growing and consolidating care markets. The Group finalised at the end of 2020 a 15-year partnership with BNP Cardif and EDF Invest who invested in part of the Groups real estate for 336 million, with a guaranteed return for the investors and a possibility for Korian to buy back the shares with a capped price. This partnership, in line with the Group asset smart strategy launched in 2016, enables Korian to limit the equity allocated to its real estate portfolio without increasing the related debt, while keeping the control of its assets. It is a key component of Korians sustainable growth strategy. The Groups net financial liabilities increased to 3,515 million from 3,157 million at 31 December 2019, almost all of this increase coming from an increase in real estate debt. The real estate debt represents 1,471 million compared to a real estate portfolio value of 2,668 million and therefore a stable Loan-to-value ratio of 55%. Outlook The Group is committed to continue to grow and diversify its service offering to provide adapted care to chronic patients and ageing populations at a local level and to meet the increasing needs in all its geographies The Group is confident in the achievement of its 2022 targets of over 4.5 billion of revenue and an EBITDA margin excluding IFRS 16 of 15.5%. The Group is also focused on the delivery of its extra financial commitments and in particular its 15 ESG commitments for 2023. ESG targets, covering client satisfaction and care quality, quality of work, promotion of gender diversity in the top management and energy savings are now integrated in the incentive system of Korian management. The Group will hold a Capital Markets Day on 16th June 2021(details to follow). Dividend Proposition & Annual Shareholder Meeting The Board of Directors will submit to the next Annual Shareholders Meeting to be held on May 27th, 2021, the proposition to distribute a dividend of 0.30 euros per share with an option for payment in new shares. The Board, acting on the recommendation of the Compensation and Appointment Committee, will also propose the following renewals and appointments in the Boards membership to the shareholders at Annual Meeting: Given the ongoing sanitary situation and the extension by the French government of the state of medical emergency until at least June 1st 2021, the Annual shareholders meeting may be held at the Companys headquarters on a restricted attendance basis, under special rules applicable to behind closed doors shareholder meetings ( huis clos). Therefore and in accordance with applicable rules (including under Ordinance No. 2020-321 of March 25th 2020 as amended by Ordinance No. 2020-1497 of December 2nd 2020), the Board of Directors in its meeting on 24th February 2021 gave full powers to the CEO to hold the Annual Shareholders meeting on such a basis should the circumstances so require, at her discretion, pursuant to the specific regulations in force at that time. Presentation FY 2020 results Investor meeting (Virtual) Thursday 25 February 2021 at 10:00 am CET Details to access the live video webcast as well as dial-in numbers (voice only) are available below. The presentation document will be available online Access to join the live video webcast and submit written questions - FR : https://channel.royalcast.com/landingpage/korianfr/20210225_1/ - EN : https://channel.royalcast.com/landingpage/korianen/20210225_1/ Dial-in details to access the live audio webcast and ask questions verbally - FR: +33 (0) 1 7037 7166 - UK-Wide: +44 (0) 33 0551 0200 - US: +1 202 204 1514 - Please tell the operator if you want to join the conference in French or in English About Korian Korian, the leading European care services group for elderly and fragile people. www.korian.com Korian has been listed on Euronext Paris Section A since November 2006 and is included in the following indices: SBF 120, CAC Health Care, CAC Mid 60, CAC Mid & Small and MSCI Global Small Cap Euronext ticker: KORI - ISIN: FR0010386334 Reuters: KORI.PA Bloomberg: KORI.FP APPENDICES EBITDA En M FY 2020 FY 2019 Excl. IFRS 16 Excl. IFRS 16 Revenue 3 874,0 3 612,5 7,2% Staff costs (2 212,8) (2 005,3) 10,3% % of revenue 57,1% 55,5% +160 pb Other costs (686,0) (659,1) EBITDAR 975,2 948,1 2,9% % of revenue 25,2% 26,2% -100 pb External rents (450,0) (413,0) % of revenue 11,6% 11,4% EBITDA 525,2 535,1 (1,9%) % of revenue 13,6% 14,8% -120 pb One-off Covid costs (26,9) EBITDA incl. One-off Covid costs 498,2 535,1 % revenue 12,9% 14,8% GROUP INCOME STATEMENT m FY 2020 IFRS 16 adjustments FY 2020 FY 2019 Incl. IFRS 16 Excl. IFRS 16 Excl. IFRS 16 Revenue 3 874,01 - 3 874,0 3 612,5 7,2% Staff costs (2 228,5) - (2 228,5) (2 005,3) 11,1% % of revenue (57,5%) - (57,5%) 55,5% Other costs (707,9) 10,6 (697,2) (659,1) 5,8% % of revenue (18,3%) - (18,0%) 18,2% EBITDAR 937,6 10,6 948,3 948,1 0,0% % of revenue 24,2% - 24,5% 26,2% External rents (76,4) (373,5) (450,0) (413,0) 9,0% % of revenue (2,0%) - (11,6%) 11,4% EBITDA 861,1 (362,9) 498,2 535,1 (6,9%) % of revenue 22,2% - 12,9% 14,8% Amortisation & Depreciations (531,4) 329,8 (201,6) (178,3) 13,1% Provisions (25,3) - (25,3) (19,1) 32,2% EBIT 304,4 (33,1) 271,3 337,7 (19,7%) % of revenue 7,9% - 7,0% 9,3% Non current expenses (38,5) - (38,5) (15,7) 145,7% Operating income 265,9 (33,1) 232,8 322,1 (27,7%) % of revenue 6,9% - 6,0% 8,9% Financial result (205,8) 67,2 (138,7) (119,9) 15,6% Net income before tax 60,0 34,1 94,1 202,2 (53,4%) Income tax (17,2) (8,6) (25,8) (64,7) (60,2%) Tax rate 28,6% 27,4% 32,0% Income from companies accounted for by the equity method (0,8) (0,8) - - Minority Interests (2,7) - (2,7) (1,5) 75,7% Net profit - Group share 39,4 25,5 64,9 136,0 (52,3%) % of revenue 1,0% - 1,7% 3,8% GROUP CASH FLOW STATEMENT M FY 2020 IFRS 16 impact FY 2020 FY 2019 Incl. IFRS 16 Excl. IFRS 16 Excl. IFRS 16 EBITDA 861,1 362,9 498,2 535,1 (6,9%) Non cash & others (2,2) 20,6 (22,8) (38,8) Change in WCR 13,1 1,4 11,7 6,5 Operating Capex (86,9) - (86,9) (99,0) Operating cash flow 785,1 384,9 400,2 403,8 (0,9%) Income taxes paid (62,8) - (62,8) (58,9) Financial expenses paid/received (181,6) (67,2) (114,4) (114,3) Operating free cash flow 540,7 317,7 223,0 230,6 (3,3%) Development Capex (111,7) - (111,7) (99,4) Financial investments (bolt-on acquisitions) (530,0) - (530,0) (254,3) Net free cash flow (101,0) 317,7 (418,7) (123,2) Dividends paid (10,2) - (10,2) (33,4) Real estate investments / divestments (560,1) - (560,1) (278,8) Increase in equity 390,9 - 390,9 - Non-cash adjustments to net debt & other (108,0) (348,6) 240,6 2,2 Change in total net debt (388,6) (30,9) (357,7) (433,2) 1 Rates calculated on February 23, 2021 in the medico-social network 2 In France, only employees over 50 and/or with co-morbidities are eligible for this 1st vaccination campaign 3 Korian Satisfaktion survey: 39,347 respondents: 5 geographies, once a year in Oct-Nov in Nursing Homes/Assisted Living, and continuously for discharged patients in clinics. 4 Rates calculated on the eligible population for vaccination on February 23, 2021 in the medico-social network 5 In France, only employees over 50 and/or with co-morbidities are eligible for this 1st vaccination campaign 6 Korian Satisfaktion survey: 39,347 respondents: 5 geographies, once a year in Oct-Nov in Nursing Homes/Assisted Living, and continuously for discharged patients in clinics 7 EBITDA per country excluding Covid-19 one-off costs 8 Included Spain ( 33.4m) 9 Included Netherlands ( 57.6m)

Korian Continues Its Growth With Resilient 2020 Results and Enters the High End UK Care Home Market

ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (Algoma or the Company) (TSX: ALC), a leading provider of marine transportation services, today announced its results for the three and nine months ended September 30, 2020. All amounts reported below are in thousands of Canadian dollars, except for per share data and unless otherwise noted. Third quarter ended September, 2020 highlights include: Immediately prior to the quarter end, we took delivery of the Algoma Intrepid, the second Equinox Class 650' self-unloading dry-bulk carrier. This vessel, the ninth Equinox Class vessel to join the fleet, is expected to begin trading on the Great Lakes in November. EBITDA, which includes our share of joint venture EBITDA, for the three months ended September 30, 2020 was $65,797 an increase of 13% or $7,349, compared to the same period in 2019. EBITDA is determined as follows: Three Months Ended Nine Months Ended For the periods ended September 30 2020 2019 2020 2019 Net earnings $ 22,235 $ 21,049 $ 16,351 $ 20,362 Depreciation and amortization 22,720 22,365 68,258 62,486 Interest and taxes 11,438 14,792 20,190 19,908 Foreign exchange loss (gain) (385 ) 242 (449 ) 1,463 Impairment provision 9,789 9,789 EBITDA $ 65,797 $ 58,448 $ 114,139 $ 104,219 "The Algoma team has been working hard to offset the impact the COVID-19 pandemic has had on the industries we serve and we are seeing this hard work come to fruition in our results," said Gregg Ruhl, President and CEO of Algoma Central Corporation. "We are committed to providing the best and most efficient service and we have the right team here to get the job done," continued Mr. Ruhl. "As we approach the end of the year, we know we still have some challenges ahead as market recovery in Canada and around the world is still uncertain. What we are certain of is that the marine industry is a huge player in this recovery and we will continue to do our part in keeping supply chains moving. I am looking forward to the arrival of the Algoma Intrepid in the Great Lakes and we are ready for her to join our operating fleet in November." Outlook A five year pilot program to extend the Seaway navigation season has been approved and the 2020 navigation season will remain open into the beginning of January. We expect the Domestic Dry-Bulk fleet to be in full utilization for the remainder of the year and into 2021 with increased demand for grain and salt leading into the winter months to take advantage of these extra operating days. Volumes in the construction and iron and steel industries continue to improve but will remain below normal for the balance of the year. Offsetting this, Algoma Intrepid has begun her journey home and will commence operations in November, bringing the fleet size to 20 compared to 19 last year. Demand will be lower for Product Tanker fleet in the fourth quarter. In the Ocean Self-Unloader segment , the pace of recovery remains uncertain, especially within the U.S. construction markets, driven by the uncertainty caused by the COVID-19 pandemic. Two ocean vessels are scheduled for dry-dock in the fourth quarter. Three Months Ended Nine Months Ended For the periods ended September 30 2020 2019 2020 2019 Revenue $ 155,002 $ 167,901 $ 391,369 $ 398,923 Operating expenses (90,118 ) (109,589 ) (271,790 ) (291,938 ) Selling, general and administrative (6,086 ) (7,491 ) (21,759 ) (23,072 ) Depreciation and amortization (18,256 ) (19,227 ) (55,711 ) (50,827 ) Operating earnings 40,542 31,594 42,109 33,086 Interest expense (4,655 ) (5,777 ) (14,831 ) (14,361 ) Interest income 71 220 297 979 Foreign currency gain (loss) 259 (372 ) 432 (976 ) 36,217 25,665 28,007 18,728 Income tax expense (6,112 ) (7,758 ) (2,618 ) (1,528 ) Net (loss) earnings from investments in joint ventures (7,870 ) 3,142 (9,038 ) 3,162 Net Earnings $ 22,235 $ 21,049 $ 16,351 $ 20,362 Basic earnings per share $ 0.59 $ 0.55 $ 0.43 $ 0.53 Diluted earnings per share $ 0.55 $ 0.52 $ 0.43 $ 0.53 Three Months Ended Nine Months Ended For the periods ended September 30 2020 2019 2020 2019 Domestic Dry-Bulk Revenue $ 88,144 $ 91,716 $ 188,197 $ 196,543 Operating earnings 27,444 22,839 20,472 15,802 Product Tankers Revenue 29,798 36,169 90,245 103,184 Operating earnings 8,689 6,677 15,267 15,455 Ocean Self-Unloaders Revenue 34,235 36,939 104,130 89,508 Operating earnings 6,319 5,124 13,717 10,868 Corporate and Other Revenue 2,825 3,077 8,797 9,688 Operating loss (2,127 ) (3,046 ) (7,347 ) (9,039 ) The MD&A for the three and nine months ended September 30, 2020 includes further details. Full results for the three and nine months ended September 30, 2020 can be found on the Companys website at www.algonet.com/investor-relations and on SEDAR at www.sedar.com. Normal Course Issuer Bid On March 19, 2020, the Company renewed its normal course issuer bid with the intention to purchase, through the facilities of the TSX, up to 1,890,457 of its Common Shares ("Shares") representing approximately 5% of the 37,809,143 Shares which were issued and outstanding as at the close of business on March 4, 2020 (the NCIB). In order to preserve capital, no common shares were purchased under the NCIB during the third quarter. Cash Dividends The Companys Board of Directors have authorized payment of a quarterly dividend to shareholders of $0.13 per common share. The dividend will be paid on December 1, 2020 to shareholders of record on November 17, 2020. Use of Non-GAAP Measures There are measures included in this press release that do not have a standardized meaning under generally accepted accounting principles (GAAP). The Company includes these measures because it believes certain investors use these measures as a means of assessing financial performance. EBITDA is a non-GAAP measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. Please refer to the Managements Discussions and Analysis for the three and nine months ended September 30, 2020 for further information regarding non-GAAP measures. About Algoma Central Algoma owns and operates the largest fleet of dry and liquid bulk carriers operating on the Great Lakes - St. Lawrence Waterway, including self-unloading dry-bulk carriers, gearless dry-bulk carriers, cement carriers, and product tankers. Algoma also owns ocean self-unloading dry-bulk vessels operating in international markets and a 50% interest in NovaAlgoma, which owns and operates a diversified portfolio of dry-bulk fleets serving customers internationally.

Algoma Central Corporation Reports Operating Results for the Three and Nine Months Ended September 30, 2020

- After the massive increase in Q2 due to COVID-19, streaming hours continue to thrive in Q3 - Twitch remains the most popular streaming outlet despite increased competition from YouTube Gaming and Facebook Gaming - Stream Hatchet co-founder Eduard Montserrat nominated for Digital Executive of the Year in 2020 Tempest Esports Business Awards TORONTO, Oct. 2, 2020 /PRNewswire/ --Engine Media's (TSX-V: GAME;OTCQB: MLLLF) gaming live streaming data analytics and analysis experts Stream Hatchet have revealed the latest industry trends in its 2020/Q3 report showcasing the continued growth of the esports streaming market. VIEW REPORT: enginemediainc.com/Stream_Hatchet_Report_Q3_2020DOWNLOAD REPORT: enginemediainc.com/Stream_Hatchet_Report_Q3_2020_Download Stream Hatchet measures gaming live streaming data across all platforms and provides valuable data insight for esports teams, gaming studios, and major brands invested in gaming. The onset of the COVID-19 pandemic earlier this year caused esports streaming numbers to skyrocket in Q2 reaching 600 million hours watched per week for the first time (a 98 percent improvement compared to last year). Despite the return of traditional sports programming (including football, baseball, basketball and motorsport) on both television and streaming channels, interest in esports streaming has remained high and continued to earn numbers well above 500 million watched hours per week. This compares to 2019 which enjoyed steady growth, but averaged 291 million watched hours per week. Other highlights of the Stream Hatchet Q3 report include: Despite suffering a loss of 375 million watched hours per week in Q3 compared to Q2, Twitch remains the "top dog" in esports streaming with a total of 4.7 billion hours (compared to 5.1 billion last quarter). YouTube Gaming and Facebook Gaming continue to grow with Facebook Gaming set for a 200 percent increase (YoY) compared to last year. League of Legends remains the most watched game in esports streaming with 543.2 million hours watched in Q3 compared to Fortnite with 426.2 million. Stream Hatchet has identified the top esports streamers for Q3 and also investigated the popularity of key celebrity streamers who changed platforms last quarter including DrDisrespect, Ninja and Shroud. Popular party game Fall Guys enjoyed massive success in Q3 with live streaming but was quickly overtaken by Among Us in the past three months. "The latest report from Stream Hatchet again highlights the massive increase enjoyed by esports during the shutdown earlier this year. But rather than it being a blip on the radar, esports streaming has continued to enjoy massive popularity even with the return of regular sports programming," Engine Media's co-CEO, Darren Cox said. "The numbers remain massively up compared to last year and we believe many new viewers started watching gaming live streams in Q2 and that popularity has continued into Q3. Those new viewers have now discovered the great entertainment value that these streamers are providing." The Q3 report also takes a look at the most popular female streamers in the esports space with "Valkyrae" taking the top spot. The continued growth of female participation in the industry was highlighted yesterday by Engine Media's esports streaming and tournament platforms UMG.TV and UMG Gaming. UMG held its first Gamer Safe Place online seminar which featured leading female streamers and industry experts. The online event can be viewed on UMG.TV at umggaming.com/events/game-safe-place. The nomination of Stream Hatchet's co-founder Eduard Montserrat for Digital Executive of the Year for the 2020 Tempest Esports Business Awards was one of three nominations revealed for Engine Media this week. UMG's collaboration with FAZE Clan for the Fight2Fund COVID-19 fundraising event earlier this year was nominated in the Best Amateur/Semi-Pro event while Engine Media's groundbreaking World's Fastest Gamer competition and documentary series was nominated in the Esports-themed Program/Documentary (Non-competitive). World's Fastest Gamer brings together the best esports racing gamers from PC, console and mobile games and has them compete to earn a real-world racing contract. The six-part documentary has been showcased on more than 85+ networks around the world including ESPN in the US. "We are extremely proud of the nominations for these awards and our congratulations go to Eduard and his team at Stream Hatchet, everyone involved in the UMG/Faze Clan collaboration, and the amazing World's Fastest Gamer competition," Engine Media executive chairman, Tom Rogers said. "This insightful data and insights from Stream Hatchet not only provide Engine Media with valuable industry intelligence for us as we grow our businesses but Stream Hatchet has also become a key partner for esports teams, sponsors, studios and organizations around the world." The creation of Engine Media Inc. was confirmed in May when Torque Esports Corp. (TSX-V: GAME) (OTCQB: MLLLF) completed its acquisition of Frankly Inc. (TSX-V: TLK) (OTCQX: FRNKF) ("Frankly"), and WinView, Inc. ("WinView") placing Engine Media at the forefront of esports, gaming, news streaming and sports gaming across multiple media platforms. To date, the combined companies have clients comprised of more than 1,200 television, print, and radio brands including CNN, ESPN, Discovery / Eurosport, Fox, Vice, Newsweek, and Cumulus; dozens of gaming and technology companies including EA, Activision, Blizzard, Take2Interactive, Microsoft, Google, Twitch and Ubisoft; and have connectivity into hundreds of millions of homes around the world through their content, distribution, and platform. About Engine Media Holdings, Inc. Engine Media is focused on accelerating new, live, immersive esports and interactive gaming experiences for consumers through its partnerships with traditional and emerging media companies. The company was formed through the combination of Torque Esports Corp., Frankly Inc., and WinView, Inc. and trades publicly under the ticker symbol (TSX-V: GAME) (OTCQB: MLLLF). Engine Media will generate revenue through a combination of: direct-to-consumer and subscription fees; streaming technology and data SaaS-based offerings; programmatic advertising and sponsorships; as well as intellectual property licensing fees. To date, the combined companies have clients comprised of more than 1,200 television, print and radio brands including CNN, ESPN, Discovery / Eurosport, Fox, Vice, Newsweek and Cumulus; dozens of gaming and technology companies including EA, Activision, Blizzard, Take2Interactive, Microsoft, Google, Twitch and Ubisoft; and have connectivity into hundreds of millions of homes around the world through their content, distribution and technology. Cautionary Statement on Forward-Looking Information This news release contains forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Engine to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information contained in this news release include, but are not limited to, any regulatory or other approvals required in connection therewith and Engine's expectations for growth in its operations and business. In respect of the forward-looking information contained herein, Engine has provided such statements and information in reliance on certain assumptions that management believed to be reasonable at the time, including assumptions as to obtaining required regulatory approvals. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements stated herein to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Accordingly, readers should not place undue reliance on forward-looking information contained in this news release. The forward-looking statements contained in this news release are made as of the date of this release and, accordingly, are subject to change after such date. Engine does not assume any obligation to update or revise any forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf, except as required by applicable law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE Engine Media Holdings, Inc.

Esports streaming numbers continue to thrive in Q3 according to latest report from Engine Media's Stream Hatchet

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of 9F Inc. (9F or the Company) (NASDAQ: JFU) on behalf of investors concerning the Companys possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. In August 2019, 9F completed its initial public offering (IPO), selling approximately 8.9 million American Depositary Shares at $9.50 a share. On September 24, 2020, the Companys share price closed at $0.80. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased 9F securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz Announces Investigation of 9F Inc. (JFU) on Behalf of Investors

NEW YORK, May 27, 2020 /PRNewswire/ --With healthcare facilities increasingly turning to technology to power telehealth options, Ambra Health, makers of the leading cloud-based, medical image management suite, today announced the company was named a 2020 SIIA CODiE Award winner in the Healthcare Technology Solution category. "At this pivotal time in healthcare and public health, we are so grateful to have been recognized as the best healthcare technology solution," said Morris Panner, CEO of Ambra Health. "Providers and patients are looking for trusted solutions to enable virtual care. Ambra Health empowers facilities of all sizes to move to a fully digital model of image management to improve both internal operations and patient care. The CODiE seal of approval is hugely impactful." Acknowledged as the premier awards program for the software and information industries for 35 years, the SIIA CODiE Awards are produced by the Software & Information Industry Association (SIIA), the principal trade association for the software, education, media, and digital content industries. Ambra is one of only 43 CODiE Award category winners for products and services developed specifically by business-to-business (B2B) software, information, and media companies. In 2017, Ambra Health was also named the StartUp Company of the Year in the SIIA Company CODiE Awards. SIIA judges noted Ambra's robust functionality including integrations with Amazon and Google, the ability to share imaging with nearby facilities, physician collaboration features, and enabling patients to share images for second opinions. Judges commented specifically that, "(Ambra) is a well designed and well-executed product which meets the needs of a variety of customers in the complex healthcare environment." And, Ambra has a "very clean interface combined with robust functionality." Details about the CODiE Awards recipients can be found at https://www.siia.net/codie/2020-Winners. About the CODiE AwardsThe SIIA CODiE Awards is the only peer-reviewed program to showcase business and education technology's finest products and services. Since 1986, thousands of products, services and solutions have been recognized for achieving excellence. About SIIASIIA is the leading association representing the software and digital content industries. SIIA represents approximately 800 member companies worldwide that develop software and digital information content. SIIA provides global services in government relations, business development, corporate education, and intellectual property protection to the leading companies that are setting the pace for the digital age. For more information, visit www.siia.net. About Ambra HealthAmbra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. It empowers some of the largest health systems such as Memorial Hermann and New England Baptist Hospital as well as radiology practices, subspecialty practices, and clinical research organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our extensive knowledge to deliver innovative medical image management solutions for the future of healthcare, now. Discover what the Ambra medical imaging cloud can do for you at www.ambrahealth.com. SOURCE Ambra Health Related Links https://ambrahealth.com/

Ambra Health Named Best Healthcare Technology Solution at 2020 SIIA CODiE Awards Recognition comes as healthcare facilities of all sizes increasingly turn to technology to enable virtual care and telehealth

AUSTIN, Texas, March 13, 2020 /PRNewswire/ -- Today, U.S. District Judge Jason K. Pulliam of the Western District of Texas issued his ruling adopting the Report and Recommendations of U.S. Magistrate Judge Elizabeth Chestney, denying in its entirety the 12(b)(6) Motion to Dismiss filed by DeVry University and its parent company, Adtalem Global Education, Inc. in a mass action brought by 108 DeVry graduatesalleging the for-profit school engaged in an aggressive and deceptive marketing campaign designed tolure students to enroll and incur large student loan debt, with the false promise of near-perfect job placement rates and high starting salaries for graduates. With today's ruling all claims in Plaintiffs' Second Amended Complaint will now proceed on the merits, including claims for violations of the Texas Deceptive Trade Practices Act (DTPA), fraud, negligent misrepresentation and restitution for unjust enrichment. The case alleges that between 2008 and 2016, DeVryengaged in deceptive marketing practices by severely inflating the success rate of job placements and earnings of graduates through an aggressive marketing scheme grounded on deceptive data and flawed methodologies. For instance, DeVry's deceptive marketing campaign falsely asserted that 90% of DeVry graduates found employment in their field of study within six months of graduation. The case alleges that internal DeVry documents reveal the employment rate of graduates is significantly lower. The group of DeVry Texas graduates are represented by John Fabry and Luis Muoz of the Carlson Law Firm, P.C. Titled the We Major In Careers campaign, DeVry's deceptive ads were aggressively disseminated to persuade prospective students to enroll at DeVry, through various media outlets, including television commercials, websites, YouTube videos, marketing brochures, print advertisements, radio ads and in-person by DeVry recruiters and admissions counselors. The 8-year campaign specifically targeted students from low-income and minority communities, who are now saddled with massive student loan debt and grim career prospects. In the Report and Recommendations adopted today, the Court made clear the case successfully alleges that, "Defendants made material misrepresentations regarding DeVry's post-graduation employment and income rates with the intent that prospective students and current students would rely on the given statistics, purchase their educational services, and continue with their studies through graduation." Also the Court found that even though "Plaintiffs do not yet have access to the documents in Defendants' possession that could substantiate their belief that the representations were fraudulent" they have properly relied on the Civil Investigative Demandfiled by the Federal Trade Commission in its investigation of DeVry's deceptive marketing, which uncovered some 2 million documents supporting fraud allegations; statements from confidential witnesses and other documents produced by the Department of Education in connection with its own investigation; and investigations conducted by the attorneys general of New York and Massachusetts, the Higher Learning Commission, Veterans Administration and the U.S. Senate. Notably, the Court concluded that "Plaintiffs' Second Amended Complaint contains ample allegations connecting Adtalem's executives to the misrepresentations at issue and alleging that Adtalem controlled, approved, ratified and benefitted from DeVry's misrepresentations" sufficiently alleging that Adtalem's "high-level corporate officers and executives knew the 90% Representation was false or acted with reckless disregard for the truth and nonetheless were directly involved in drafting, reviewing, publishing, and disseminating the false and misleading statements at issue in this case." "Education is supposed to open doors and serve as the great social equalizer in America. Instead of improving their lives by earning a degree from DeVry, these students are now worse off, with massive student loan debt and a degree of little value," said John Fabry, the lead attorney on the case. "Without any effective regulation of deceptive marketing by for-profit schools, we must turn to the courts for a remedy. We are pleased that the Court has rejected DeVry's attempt to have the case thrown out." The Texas case against DeVry University is Civil Action No. SA-18-CV-00082-JKP; Luis Rangel, et al. v. Adtalem Global Education, Inc. and DeVry University, Inc.; In the United States District Court, Western District of Texas, San Antonio Division. A similar case by a group of 112 DeVry California graduates recently also survived 12(b)(6) Motion to Dismiss and been allowed to proceed in Oakland federal Court. The case makes identical allegations underpinning fraud claims against DeVry and Adtalem for their deceptive marketing scheme. The California case is Civil Action No. 19-cv-04079-JSW; Maria Alvarez, et al. v. Adtalem Global Education, Inc. and DeVry University, Inc.; In the United States District Court, Northern District of California, Oakland Division. About The Carlson Law Firm:The Carlson Law Firm is a Texas-based national law firm committed to providing exceptional legal services in the areas of personal injury, medical malpractice, dangerous drugs and defective products, mass torts, bankruptcy, family law, criminal defense, military criminal defense, nursing home abuse and consumer protection. The Carlson Law Firm has been successfully representing clients nationwide for over 40 years with 12 offices all over Texas. We Care. We Can Help. www.carlsonattorneys.com ATTORNEYS JOHN FABRY AND LUIS MUOZ ARE AVAILABLE FOR COMMENT: Contact Kazia Conway at 512-671-7277 SOURCE The Carlson Law Firm Related Links https://www.carlsonattorneys.com

The Carlson Law Firm: Today Texas Federal Court Rules Mass Action against DeVry University for Fraud Survives Motion to Dismiss and Proceeds on the Merits

DENVER, Feb. 26, 2021 /PRNewswire/ --Today, the Clough Global Opportunities Fund (NYSE MKT: GLO) (the "Fund"), a closed-end fund, paid a monthly distribution on its common stock of $0.1087 per share to shareholders of record at the close of business on February 18, 2021. The following table sets forth the estimated amount of the sources of distribution for purposes of Section 19 of the Investment Company Act of 1940, as amended, and the related rules adopted thereunder. The Fund estimates the following percentages, of the total distribution amount per share, attributable to (i) current and prior fiscal year net investment income, (ii) net realized short-term capital gain, (iii) net realized long-term capital gain and (iv) return of capital or other capital source as a percentage of the total distribution amount. These percentages are disclosed for the current distribution as well as the fiscal year-to-date cumulative distribution amount per share for the Fund. Current Distribution from: Per Share ($) % Net Investment Income 0.0000 0.00% Net Realized Short-Term Capital Gain 0.1087 100.00% Net Realized Long-Term Capital Gain 0.0000 0.00% Return of Capital or other Capital Source 0.0000 0.00% Total (per common share) 0.1087 100.00% Fiscal Year-to-Date Cumulative Distributions from: Per Share ($) % Net Investment Income 0.0000 0.00% Net Realized Short-Term Capital Gain 0.3968 100.00% Net Realized Long-Term Capital Gain 0.0000 0.00% Return of Capital or other Capital Source 0.0000 0.00% Total (per common share) 0.3968 100.00% The amounts and sources of distributions reported in this 19(a) Notice are only estimates and not for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes. Presented below are return figures, based on the change in the Fund's Net Asset Value per share ("NAV"), compared to the annualized distribution rate for this current distribution as a percentage of the NAV on the last business day of the month prior to distribution record date. Fund Performance & Distribution Information Fiscal Year to Date (11/01/2020 through 1/31/2021) Annualized Distribution Rate as a Percentage of NAV^ 9.68% Cumulative Distribution Rate on NAV^+ 2.95% Cumulative Total Return on NAV* 31.86% Average Annual Total Return on NAV for the 5 Year Period Ending 1/31/2021** 15.31% Past performance is not indicative of future results. ^ Based on the Fund's NAV as of January 31, 2021. +Cumulative distribution rate is based on distributions paid to date for the period November 1, 2020 through February 26, 2021. *Cumulative fiscal year-to-date return is based on the change in NAV including distributions paid and assuming reinvestment of these distributions for the period November 1, 2020 through January 31, 2021. **The 5 year average annual total return is based on change in NAV including distributions paid and assuming reinvestment of these distributions and is through the last business day of the month prior to the month of the current distribution record date. While the NAV performance may be indicative of the Fund's investment performance, it does not measure the value of a shareholder's investment in the Fund. The value of a shareholder's investment in the Fund is determined by the Fund's market price, which is based on the supply and demand for the Fund's shares in the open market. Shareholders should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's Managed Distribution Plan. Furthermore, the Board of Trustees reviews the amount of any potential distribution and the income, capital gain or capital available. The Board of Trustees will continue to monitor the Fund's distribution level, taking into consideration the Fund's net asset value and the financial market environment. The Fund's distribution policy is subject to modification by the Board of Trustees at any time. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund. ALPS Portfolio Solutions Distributor, Inc. FINRA Member Firm. Clough Global Opportunities Fund (NYSE MKT: GLO)1290 Broadway, Suite 1000Denver, CO 80203 SOURCE Clough Global Opportunities Fund

CLOUGH GLOBAL OPPORTUNITIES FUND SECTION 19(a) NOTICE Statement Pursuant to Section 19(a) of the Investment Company Act of 1940

BATESVILLE, Ind., June 9, 2020 /PRNewswire/ --Hillenbrand, Inc. (NYSE: HI) has announced the commencement and pricing of its public offering of $400 million aggregate principal amount of 5.7500% senior unsecured notes due 2025 (the "Notes"). The aggregate principal amount of the Notes to be issued in the offering was increased to $400 million from the previously announced $300million.The offering is expected to close on or about June 16, 2020, subject to customary closing conditions. Hillenbrand intends to use the net proceeds from this offering for general corporate purposes, including debt repayment, such as the repayment of the entire $150 million aggregate principal amount outstanding of the 5.5000% senior notes due 2020 at maturity. HSBC Securities (USA) Inc.,Citizens Capital Markets, Inc., J.P. Morgan Securities LLC and PNC Capital Markets LLCare the bookrunners for the offering. The offering of the Notes is being made only by means of a prospectus. A copy of the prospectus may be obtained by calling HSBC Securities (USA) Inc. at 866-811-8049, Citizens Capital Markets, Inc. at 617-960-1898,J.P. Morgan Securities LLC at 212-834-4533 or PNC Capital Markets LLCat 855-881-0697. This press release is not an offer to sell or a solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful. AboutHillenbrandHillenbrand is a global diversified industrial company with businesses that serve a wide variety of industries around the world. We pursue profitable growth and robust cash generation to drive increased value for our shareholders. Hillenbrand's portfolio includes industrial businesses such as Coperion, Milacron Injection Molding & Extrusion, and Mold-Masters, in addition to Batesville, a recognized leader in the death care industry in North America. Hillenbrand is publicly traded on the NYSE under "HI." Forward-Looking StatementsThroughout this release, we make a number of "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. As the words imply, these are statements about future plans, objectives, beliefs, and expectations that might or might not happen in the future, as contrasted with historical information. Forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand's (the "Company") expectations and projections. Words that could indicate that we are making forward-looking statements include the following: intend believe plan expect may goal would project become pursue estimate will forecast continue could anticipate target impact promise improve progress potential should This is not an exhaustive list, but is intended to give you an idea of how we try to identify forward-looking statements. The absence of any of these words, however, does not mean that the statement is not forward-looking. Here is the key point: Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. These factors include, but are not limited to: the impact of contagious diseases such as the COVID-19 pandemic and the societal, governmental, and individual responses thereto, including supply chain disruption, loss of contracts and/or customers, erosion of some customers' credit quality, closure or temporary interruption of the Company's or suppliers' manufacturing facilities, travel, shipping and logistical disruptions, loss of human capital or personnel, and general economic calamitiesthat could result in an extended shutdown or reduction of ouroperations, substantially reduced sales volumes, or supply constraints; the outcome of any legal proceedings that may be instituted against the Company, or any companies we may acquire; risks that the integration of Milacron or any other integration, acquisition, or disposition activity disrupts current operations or poses potential difficulties in employee retention or otherwise affects financial or operating results; the ability to recognize the benefits of the acquisition of Milacron or any other acquisition or disposition, including potential synergies and cost savings or the failure of the Company or any acquired company to achieve its plans and objectives generally; global market and economic conditions, including those related to the credit markets; volatility of our investment portfolio; adverse foreign currency fluctuations; involvement in claims, lawsuits and governmental proceedings related to operations; our reliance upon employees, agents, and business partners to comply with laws in many countries and jurisdictions; labor disruptions; the impact of the additional indebtedness that the Company has incurred in connection with the acquisition of Milacron and the ability of the Company to comply with financial or other covenants in its debt agreements or meet its de-leveraging goals; the dependence of our business units on relationships with several large providers; increased costs or unavailability of raw materials or certain outsourced services; continued fluctuations in mortality rates and increased cremations; competition in the industries in which we operate, including from nontraditional sources in the death care industry; our level of international sales and operations; cyclical demand for industrial capital goods; impacts of decreases in demand or changes in technological advances, laws, or regulation on the revenues that we derive from the plastics industry; certain tax-related matters; and changes to legislation, regulation, treaties or government policy, including any resulting from the current political environment. For a more in-depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in Part I, Item 1A of Hillenbrand's Form 10-K for the year ended September 30, 2019, filed with the Securities and Exchange Commission on November 13, 2019, and in Part II, Item 1A of Hillenbrand's Form 10-Q for the quarter ended March 31, 2020, filed with the Securities and Exchange Commission on May 6, 2020; and in Hillenbrand's other filings with the U.S. Securities and Exchange Commission, including on Forms 8-K and S-3. The forward-looking information in this release speaks only as of the date covered by this report, and the Company assumes no obligation to update or revise any forward-looking information. CONTACTS Corporate Communications for Hillenbrand Paul Whitmore, Manager of Corporate Communications Phone: 812-931-5412 E-mail: [emailprotected] Investor Relations for Hillenbrand Rich Dudley, Senior Director, Investor Relations Phone: 812-931-5001 E-mail: [emailprotected] SOURCE Hillenbrand, Inc. Related Links http://www.hillenbrand.com

Hillenbrand Announces Commencement and Pricing of Upsized $400 Million Senior Notes Offering

STOCKHOLM, May 7, 2020 /PRNewswire/ -- Bublar Group today announced the world's first location-based massive multiplayer online role-playing game Otherworld Heroes is now available in Sweden, Poland and Indonesia as the first markets to go live. The game will be available on Appstore and Google Play."I am really thrilled that we are now making our own game Otherworld Heroes available to play in countries with such a high rate of dedicated gamers as part of this soft launch. We will learn from players in the different markets and cultures and be able to fine-tune it before opening more markets according to our launch plan," said Wictor Hattenbach, Game Studio Director at Bublar. Otherworld Heroes, based on Bublar's technical platform, makes it possible to create games that need to process large volumes of data traffic in real time and are linked to physical locations in the real world. The team keeps raising the bar by fine tuning Otherworld Heroes' MMO engine but also by making continuous improvements in the game. The new game includes missions, enemies and resources to progress players in their adventures through multiple worlds of the game (so-called dimensions), compared to the first closed beta version where players only got to experience the first dimension. The second beta test, that opened in mid-February, showed KPIs above the industry benchmark for retention and engagement for a limited test pool of 2300 players. The game will be available on IOS and Android free of charge to download via Google Play or App store. Find out more on:https://otherworldheroes.com/ Otherworld Heroes nominated in Auggie Awards. Watch the video: Otherworld Heroes Auggie Awards nomination 2020 Follow Otherworld Heroeson SocialMedia: Facebook Otherworld Heroes FacebookInstagram Otherworld Heroes InstagramTwitter Otherworld Heroes TwitterReddit Otherworld Heroes Reddit Bublar GroupBublar Group AB (publ) is the Nordic region's leading listed XR technology company specializing in Augmented Reality (AR) and Virtual Reality (VR). The company offers XR solutions in E-commerce, Entertainment, Training and Manufacturing. The company includes the subsidiaries Vobling, Sayduck and Virtual Brains. Bublar is headquartered in Stockholm and is listed on Nasdaq First North Growth Market. In essence, Bublar Group will change the game. We change how we Work, Shop and Play. The company's share (BUBL) is traded on Nasdaq First North Growth Market Stockholm with G & W fondkommission as Certified Adviser, Kungsgatan 3, Stockholm, email: [emailprotected], phone +46 8-503 000 50 Bublar Group AB (Publ) Kungstensgatan 18, 113 57 Stockholm Phone +46 8 559 251 20 www.bublar.com For more information contact: Wictor Hattenbach Game Studio DirectorBublar GroupEmail: [emailprotected] Phone: +46-763-188-097 Maria A GrimaldiCEO Bublar Group, Email: [emailprotected] Phone: +46-70-828-38-34 This information was brought to you by Cision http://news.cision.com https://news.cision.com/bublar-group-ab--publ-/r/bublar-soft-launches-location-based-mmorpg-otherworld-heroes,c3106515 The following files are available for download: https://mb.cision.com/Main/16283/3106515/1243819.pdf Press release Otherworld Heroes enge https://news.cision.com/bublar-group-ab--publ-/i/otherworld-heroes-backdrop,c2782383 Otherworld Heroes backdrop https://news.cision.com/bublar-group-ab--publ-/i/otherworld-heroes-phone,c2782384 Otherworld Heroes phone https://news.cision.com/bublar-group-ab--publ-/i/otherworld-heroes-red,c2782385 Otherworld Heroes red https://news.cision.com/bublar-group-ab--publ-/i/otherworld-heroes-blue,c2782386 Otherworld Heroes blue SOURCE Bublar Group AB

Bublar Soft Launches Location-based MMORPG Otherworld Heroes

BOSTON, LONDRES Y TEL AVIV DISTRICT, Israel--(BUSINESS WIRE)--TA Associates, empresa de capital privado en crecimiento lder a nivel mundial, ha anunciado hoy que ha completado una inversin de crecimiento significativa en Priority Software Ltd., proveedor lder a nivel mundial de software de planificacin de recursos empresariales (Enterprise Resource Planning, ERP). TA se une al actual inversor Fortissimo Capital, una empresa lder de capital privado con sede en Israel y centrada en situaciones especiales y oportunidades de crecimiento, como inversor institucional en Priority Software. No se hanb revelado las condiciones financieras de la transaccin. El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda y deber ser comparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

TA Associates completa una importante inversin de crecimiento en Priority Software

CHARLOTTE, N.C.--(BUSINESS WIRE)--Bojangles, known for its iconic Southern food in more than 760 restaurants throughout the Southeast, announced today a new business venture with experienced operator Chaac Foods Restaurants in what theyre calling the 40 and 40 deal. The agreement calls for Chaac Foods to open 40 new Bojangles stores over the next seven years, including 20 in Georgia, five in Tennessee and 15 in the Orlando, Florida, area, marking a return for the Bojangles brand. Chaac Foods will also acquire 40 existing corporate-owned Bojangles locations across the Georgia, South Carolina and Tennessee markets. We are thrilled to join forces with the accomplished team at Chaac Foods, said Jose Costa, chief development officer for Bojangles. The companys caliber of operations is well-recognized, and to have a partner with that pedigree invest in Bojangles speaks volumes about our brand and our growth plans for the future. Chaac Foods Restaurants currently owns and operates a variety of establishments, most notably being 135 Pizza Huts, along with several Cru Food & Wine Bars, Ling & Louies, Applebee's and Panda Express, in nine states. Wanting to diversify and step into the fried chicken market, Chaac Foods turned to Bojangles to begin an exciting and promising journey. We welcome Bojangles to the Chaac Foods family and are excited to participate in the growth of this highly regarded brand, said Sam Banon, senior vice president at Gauge Capital, which acquired Chaac Foods in 2019. This is the second major franchise development announced this year by Bojangles. In March, the chain signed another large-scale expansion agreement with longtime franchisee Jeff Rigsby. Both deals include opening stores in brand new markets. About Bojangles, Inc. Bojangles, Inc. is a highly differentiated and growing restaurant operator and franchisor dedicated to serving customers high-quality, craveable food made from our Southern recipes, including breakfast served All Day, Every Day. Founded in 1977 in Charlotte, N.C., Bojangles serves menu items such as made-from-scratch biscuit breakfast sandwiches, delicious hand-breaded bone-in chicken, flavorful fixins (sides) and Legendary Iced Tea. Currently, Bojangles has approximately 760 system-wide restaurants in 14 states. For more information, visit www.bojangles.com or follow Bojangles on Facebook, Instagram and Twitter. About Chaac Foods Restaurants Headquartered in Irving, Texas, Chaac Foods Restaurants is a leading platform of established quick-service and casual dining franchisees, including Pizza Hut, Cru Food & Wine Bars, Ling & Louies, Applebee's, Panda Express and soon-to-be Bojangles. Funded by private equity firm Gauge Capital, Chaac Foods is backed by a management team with over 30 years' experience in the industry and a proven track record for success. The company strives to make customers lives easier by providing them with good food, at a fair price, and served promptly.

Bojangles and Chaac Foods Restaurants Announce Major Development Agreement Bojangles return to Orlando highlights new partnership between the home of chicken and biscuits and a seasoned restaurant developer in a deal involving 80 locations

NEW YORK, Aug. 7, 2020 /PRNewswire/ -- Color Star Technology Co., Ltd. (Nasdaq CM: HHT) (the "Company"," we", or "HHT") is pleased to announce that American rapper, singer, songwriter and actor Machine Gun Kelly will join the Color World app owned by the company for its online concert "Fearless, Color World" on September 9th. As one of the leading talents in global pop music, alternative, and hip hop, he is sure to bring fans of all background a moment to be remembered. "Fearless, Color World" online concert is a new type of concert launched by Color Star Technology which provides innovative art Training Service. The concert has invited many world-class artists to perform, hoping to make the audience feel the peace of the world, and the eternal love. Machine Gun Kelly is an American well-known rapper, he embarked on a musical career as a teenager, releasing a mixtape in 2006. After he joined Interscope Records which is owned by Universal Music Group, his first major label debut album "Lace Up" reached number 4 on the Billboard 200 chart and sold more than 178,000 copies. In addition, his singles "Till I die" and "A little More" for his second studio album debuted at number four in the US, and "Bad Things" in his third studio album "Bloom" peaked number 4 on the Billboard Hot 100.In addition to his music career, he has acted in a number of Americanfilms. Biao (Luke) Lu, CEO says "We are thrilled to partner with Machine Gun Kelly in the planned concert, a live event featuring colorful music, colorful life, and a colorful world. With warmth and hope, we celebrate our own lives and the hopes of the world. The performance brought by Machine Gun Kelly will channel through the Color World platform to reach hundreds of millions of potential audiences around the world. With dazzling stage design and top audio equipment, we believe that this online concert will definitely bring our platform users a brand-new online concert experience." About Color Star Technology Co., Ltd. Color Star Technology Co, Ltd. (Nasdaq: HHT) offers online and offline innovative education services for music and entertainment industries globally. Its business operations are conducted through its wholly-owned subsidiaries Color China Entertainment Ltd. and CACM Group NY, Inc. The Company's online education is provided through its Color World music and entertainment education platform. The Company also offers after-school entertainment tutoring inNew Yorkvia its joint venture entity Baytao LLC. Machine Gun Kelly Biography Colson Baker, also known as "Machine Gun Kelly," is a multi-hyphenate talent with an impressive career that started in Cleveland and has made him a globally known star in both music and film. As Machine Gun Kelly, he burst onto the music scene with therelease of his first albumLace Upvia EST 19XX/Bad Boy/Interscope Records. The album debuted at number two on Billboard's R&B/Hip-Hop Albums chart. He won "US Artist About to Go Global" at the 2012 MTV EMA's and MTV's 2012 "Breaking Woodie" Award. The following year he was awarded "Woodie of the Year" beating out A$AP Rocky, Fun, Grimes and Kendrick Lamar. His 2015 sophomore album,General Admissionclinched a #1 spot on Billboard's R&B/Hip-Hop Album charts. He's performed on THE VOICE, THE TONIGHT SHOW WITH JIMMY FALLON, THE LATE LATE SHOW WITH JAMES CORDEN, ELLEN, BET's 106 AND PARK, THE NICKELODEON KIDS CHOICE AWARDS and several other programs and award shows. His songs have appeared in soundtracks for the feature films BRIGHT and WHY HIM?. Spotify recently released that his songs were streamed 571,200,000 times in 79 countries in 2019. His most recent albumHotel Diablowas released July 5, 2019 and was supported by three singles: "Hollywood Whore", "El Diablo", and "I Think I'm Okay" (featuring Travis Barker and Yungblud). "I Think I'm Okay" became a certified Gold Single in December of 2019. In 2017, his albumbloomwent gold. The album track "Bad Things" featuring Camila Cabello, sold 8+ million worldwide, was nominated for a 2017Billboard Music Award and owned the Billboard 100 list for 16+ weeks in 2017. The song has had more than 245m+ streams with a radio audience of 145m, becoming RIAA certified 3x platinum (domestic) and 8x worldwide. "Machine Gun Kelly" was one of the top ten most searched artists of 2018 according to Google. In April 2020, he released "Bloody Valentine," the first single off his forthcomingTickets to My Downfall album, executive produced by Travis Barker. The two appeared on THE LATE LATE SHOW WITH JAMES CORDEN to perform the song, and the official video starring Megan Fox garnered over 4,000,000 views in under 24 hours. On the acting side, he received critical acclaim as thelead role as Tommy Lee in the Netflix'sTHE DIRT, a biopic based on the rise of the band Motley Crue directed by Jeff Tremaine. He also starred opposite Sandra Bullock, John Malkovich and Trevante Rhodes in Netflix's thriller film BIRD BOX. In its first week of streaming, 45,037,125 Netflix accounts watched the film, making it Netflix's most streamed film at the time. He appeared in BIG TIME ADOLESCENCE from writer/director Jason Orley, also starring Pete Davidson, Griffin Gluck and Jon Cryer, which premiered in competition at the 2019 Sundance Film Festival and wasreleasedby NEONon Hulu inMarch 2020. He will next be seen in Netflix's PROJECT POWER from Henry Joost and Ariel Shulman also starring Jamie Foxx and Joseph Gordon-Levitt which will premiere globally inAugust 14, 2020. Previously, Baker starred on Cameron Crowe's Showtime series ROADIES, playing Wes, a recently fired Pearl Jam roadie who joins his twin sister Kelly Ann (Imogen Poots) on tour for the fictitious Staton-House Band. The series also starred Luke Wilson and Carla Gugino and was executive produced by Cameron Crowe, JJ Abrams, Winnie Holzman and Bryan Burk. He appeared alongside Dave Franco and Emma Roberts in the Henry Joost/Ariel Shulman Lionsgate film NERVE, opposite Gugu Mbatha-Raw in Gina Prince-Bythewood's BEYOND THE LIGHTS, and in James Merendino's PUNKS DEAD: SLC PUNK 2. Additional films include the Rupert Wyatt directed film CAPTIVE STATE with Ashton Sanders, Vera Farmiga and John Goodman. At 6'4', the musician/actor has walked in New York Fashion Week, and his distinct look and love for fashion landed him a campaign as the face of John Varvatos for Fall/Winter 2017-2018. Combining his musical talents with the campaign, he played the opening of Varvatos' first ever store in Dubai in November 2018. He also collaborated with Reebok on their Club C sneaker campaign. When not touring or filming, he resides in Los Angeles. Forward-Looking Statements Certain statements made herein are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include the business plans, objectives, expectations and intentions of the parties following the completion of the acquisition, and HHT's estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, our actual results may differ materially from our expectations or projections. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: there is uncertainty due to the COVID-19 pandemic and the impact it will have on HHT's operations, the demand for the HHT's products and services, global supply chains and economic activity in general. These and other risks and uncertainties are detailed in the other public filings with the Securities and Exchange Commission (the "SEC") by HHT. Additional information concerning these and other factors that may impact our expectations and projections will be found in our periodic filings with the SEC, including our Annual Report on Form 20-F for the fiscal year ended June 30, 2019. HHT's SEC filings are available publicly on the SEC's website at www.sec.gov. HHT disclaims any obligation to update the forward-looking statements, whether as a result of new information, future events or otherwise. Color Star Technology Co., Ltd. Contact: Investor Relations FinancialBuzzIR [emailprotected]Tele: +1-877-601-1879 SOURCE Color Star Technology Co., Ltd.

Color Star Technology Announces Machine Gun Kelly will join its "Fearless, Color World" Online Concert

WILMINGTON, Del.--(BUSINESS WIRE)--The Bancorp, Inc. (The Bancorp) (NASDAQ: TBBK), a financial holding company, today announced that its board of directors has approved a new stock repurchase program to repurchase up to $10.0 million in value of shares of the Companys common stock in each fiscal quarter of 2021, for a maximum amount of $40.0 million of shares of common stock repurchased on or prior to December 31, 2021. Under the stock repurchase program, The Bancorp intends to repurchase shares through open market purchases, privately-negotiated transactions, block purchases or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934 (the Exchange Act). The board of directors also authorized The Bancorp to enter into written trading plans under Rule 10b5-1 of the Exchange Act. The Bancorp cannot predict when or if it will repurchase any shares of common stock and the timing and amount of any shares repurchased will be determined by management based on its evaluation of market conditions and other factors. Information regarding stock repurchases will be available in The Bancorps periodic reports on Form 10-Q and 10-K filed with the Securities and Exchange Commission as required by the applicable rules of the Exchange Act. About The Bancorp, Inc. The Bancorp, Inc. (NASDAQ: TBBK) is dedicated to serving the unique needs of non-bank financial service companies, ranging from entrepreneurial start-ups to those on the Fortune 500. The Companys subsidiary, The Bancorp Bank (Member FDIC, Equal Housing Lender), has been repeatedly recognized in the payments industry as the Top Issuer of Prepaid Cards (US), a top merchant sponsor bank and a top ACH originator. Specialized lending distinctions include National Preferred SBA Lender, a leading provider of securities-backed lines of credit, and one of the few bank-owned commercial vehicle leasing groups in the nation. For more information please visit www.thebancorp.com. Forward-Looking Statements This release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking terminology, including but not limited to the words may, believe, will, expect, look, anticipate, plan, estimate, continue, or similar words, and are based on managements current expectations, estimates and projections. The Bancorps business is subject to a number of risks and uncertainties which could cause the actual results, events or achievements to differ materially from those set forth in or implied by the forward-looking statements and related assumptions. These risks and uncertainties include those relating to the on-going COVID-19 pandemic, the impact it will have on The Bancorps business and the industry as a whole, and the resulting governmental and societal responses. For further discussion of the risks and uncertainties to which these forward-looking statements may be subject, see The Bancorps filings with the Securities Exchange Commission (SEC). The forward-looking statements speak only as of the date of this press release. The Bancorp does not undertake to publicly revise or update forward-looking statements in this press release to reflect events or circumstances that arise after the date of this release, except as may be required under applicable law.

The Bancorp, Inc. Announces New Stock Repurchase Program

GATLINBURG, Tenn.--(BUSINESS WIRE)--Ole Smoky Distillery, one of the nations fastest growing spirits companies, announced today a $35,000 donation to Friends of the Smokies. The East Tennessee non-profit organization assists the National Park Service in its mission to preserve and protect the Great Smoky Mountains National Park, the nations most visited National Park. In November, Ole Smokys four distilleries began selling their Limited Edition Friends of the Smokies Blackberry Moonshine to support the preservation and protection of Great Smoky Mountains National Park. A portion of those sales to date, make up todays donation. We are committed to helping our neighbors in East Tennessee and are thrilled that so many Ole Smoky fans purchased our commemorative Friends of the Smokies Blackberry Moonshine. We will continue to support this important effort throughout the year and look forward to welcoming back millions of Great Smoky Mountain visitors in 2021, said Robert Hall, CEO, Ole Smoky Distillery. Partnering with Ole Smoky Distillery was a perfect match raising both awareness and money for the programs that we support in Great Smoky Mountain National Park. Proceeds from the sale of commemorative jars of Ole Smoky Blackberry Moonshine will support the ongoing historic preservation of the largest collection of Appalachian structures. We are so thankful for the generous support from Ole Smoky and the opportunity to share the mission of Friends of the Smokies with the millions of tourists that visited their distilleries. Thanks to everyone that purchased a jar or two and being a Friend of the Smokies, what a tasty way to raise money, said Tim Chandler, Executive Director & CEO of Friends of the Smokies. The Limited Edition Commemorative Ole Smoky Friends of the Smokies Blackberry Moonshine can still be purchased at Ole Smokys distilleries in Gatlinburg, Pigeon Forge and Nashville. Additional Ole Smoky Distillery events and activities to support the Friends of the Smokies will continue throughout 2021. About Friends of the Smokies Friends of Great Smoky Mountains National Park assists the National Park Service in its mission to preserve and protect the Great Smoky Mountains National Park by raising funds and public awareness, and providing volunteers for needed projects. For more information, visit: https://friendsofthesmokies.org/. About Ole Smoky Distillery LLC: Ole Smoky is the leading distiller of premium moonshine in the world and the first federally licensed distillery in the history of East Tennessee. Founded in 2010, Ole Smoky's roots can be traced to the Smoky Mountains' earliest settlers, families who produced moonshine with enduring pride and Appalachian spirit. Today, Ole Smoky retails globally and offers more than 25 creative moonshine flavors and 17 inventive whiskey flavors. Ole Smoky can be found at the company's distilleries, online, in grocery and liquor stores nationwide, as well as in on-premise establishments, including some of the biggest music and sporting venues in the country. Ole Smoky's four famed distilleries include three in East Tennessee The Holler, The Barrelhouse and The Barn and 6th & Peabody in Nashville.

Ole Smoky Distillery Donates $35,000 to Friends of the Smokies

LOS ANGELES, July 15, 2020 /PRNewswire/ --Marketing services company LRW Group today announced that it is now operating under the name Material, formally integrating ten companies into one modern unified offering. Material combines long-standing capabilities and expertise in analytics, deep human understanding, and design thinking to turn insights into impact for clients and consumers. Material will surround its clients with comprehensive expertise under a completely new, modern, and unified marketing services model rooted in insights that are necessary to create meaningful interactions between brands and the people they serve. The company's innovative approach avoids the organizational silos that plague holding companies and traditional consulting firms. Instead, Material offers each client a fully collaborative team that won't fumble key details as it develops new insights and then put those insights into action. Each area of Material's expertise Material Analytics, Material Intelligence, Material Experience prioritizes what brands will need to get right to the core of what consumers want. Material's range of marketing services include, but are not limited to, behavioral and marketing data science, segmentation and strategic planning, brand strategy and visual identity, customer experience and loyalty, innovation and product development, and marketing communications. "Today's brands are craving a truly integrated partner that can create and implement marketing strategies that are built not only on data and analytics, but also on a deeper understanding of human behavior," said Dave Sackman, CEO, Material. "This is the white space that Material intends to fill. And we will do so through radical collaboration that ignites growth." Material employs a roster of 1,200 strategists, creators, technologists, designers, researchers, and storytellers that work side-by-side to help global brands such as Disney, Target and Microsoft solve modern-day problems, engender customer loyalty, and continue to grow their businesses. The new brand has been introduced across all former LRW Group channels and within each of the company's agencies, including Karma Agency, Kelton, Killer Visual Strategies, LRWGreenberg, LRW, LRWMotiveQuest, LRWTonic, Salt, Strativity and T3. Mr. Sackman will continue to guide Material as the company's chief executive. Joining him on the executive team are Jeremy Sack, President of Material Perspective; Gareth Schweitzer, President of Material Action; and Rachel Spiegelman, President of Material Connections. "We exist to drive material impact for our clients," said Rachel Spiegelman, President of Material Connections. "Through meaningful interactions and knowledge sharing both internally and with client partners Material will help brands meet the needs of modern consumers and shape the future of marketing services." ABOUT MATERIAL Material is a modern marketing services company that seamlessly combines insights, consulting and activation into one integrated offering. The company is powered by sophisticated analytics, deep human understanding and design thinking to help B2B and B2C brands put insights into action and create work with impact. Material is headquartered in Los Angeles, CA, with offices in 13 cities across the U.S. and the U.K. SOURCE Material

LRW Group Emerges as One Unified Company Under the Name Material Firm taps into deep human understanding to offer modern marketing services that drive brands forward

LOS ANGELES, Feb 12, 2021 /PRNewswire/ --The pilot episode of the new comedy series, Unsubscribe,is now available on Prime Video as part of the Prime Video Direct content submission portal in the US and UK.Unsubscribe is the comedic tale of a group of five friends who are vigorously independent; occasionally unbalanced; sporadically irresponsible; accidental troublemakers on their best day; trouble seekers on their worst; and are acutely aware of their power to unsubscribe from the countless annoyances of adulting. Continue Reading Karsyn Jarrett The pilot episode finds our heroes at a turning-point party, where they're at odds with the choices they've made to unsubscribe from the next level of adulthood. What they think is going to be a classic boozy soiree turns out to be a reality check when they're forced to feign interest in babies and marriage with their well-adjusted peers. Their problems culminate as their weekly Sunday brunch brings to light potentially nuclear discord within the group, all thanks to an unexpected, and frankly uninvited, brunch date. These characters are a modern-day band of misfits who struggle with holding on to the individualism of Generation X; while managing the expectations of instant gratification brought on by Millennialism; and still keeping up with the ever-changing, influential Internet that defines Generation Z. Trying to adult in a mixed generational genre has ignited both a rebellion against the ordinary and a reluctant urge to "keep up" with the world around them.Unsubscribehilariously explores both the surprise victories and unavoidable comedy of errors that follow when the characters try to navigate adulthood and their growing list of unsubscriptions. Do they always learn from their mistakes? Absolutely not. Are they actively trying to do better? Sometimes. These five characters have embraced the privilege of unsubscribing, occasionally take it 10 steps too far, sometimes don't unsubscribe fast enough and have a tendency to err on the side of "you do you."Created and written by Karsyn Jarrett and directed by Kerry Schwartz, Unsubscribe stars Conner Floyd (as Colton Nash), Karsyn Jarrett (as Tate Kelley), Amber Kellehan (as Brighton Blaire), Kiana Madani (as Parker Davenport) and Brandon Phillips (as Tyler Noble) as the series regular ensemble cast members, with Quinton Aaron (as Sammy) as a recurring guest star.Feedback following a private screening of the pilot episode in January 2020 ranged from viewers likening it to a "modern-day Friends;" wanting to know how soon they could "binge watch the entire season;" discussing how "relatable the concept and characters are;" and eagerly sharing their own adulthood unsubscriptions.If you've ever wanted to apply, or have been applying, the notion of unsubscribing to real, everyday life, this is the pilot and series for you! Watch now on Prime Video!Contact Information:Karsyn JarrettWriter, Creator, Actor, Producer[emailprotected]Related Imagesimage1.jpeg Related Videohttps://vimeo.com/381581095 SOURCE Karsyn Jarrett

Unsubscribe - Episode 1 Now Available on Amazon Prime Video as Part of the Prime Video Direct Content Submission Portal From Creator, Writer, Actor and Producer, Karsyn Jarrett, Comes the Comedy Pilot Reminding You That Adulting is Hard and Using Your Proverbial Unsubscribe Button for Everyday Life is Completely Acceptable

LONDON--(BUSINESS WIRE)--The set-top box market is expected to grow by USD 4.19 billion, progressing at a CAGR of over 3% during the forecast period. Click & Get Free Sample Report in Minutes The integration of voice control into set-top boxes is one of the major factors propelling market growth. However, factors such as the rising popularity of OTT services will hamper the market growth. More details: https://www.technavio.com/report/set-top-box-market-industry-analysis Set-top Box Market: Type Landscape Based on the type, the satellite set-top boxes segment is expected to post significant growth during the forecast period. Set-top Box Market: Geographic Landscape By geography, APAC is going to have a lucrative growth during the forecast period. About 52% of the markets overall growth is expected to originate from APAC. China, Japan, and India are the key markets for Set-top Box in APAC. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Related Reports on Consumer Discretionary Include: Water Heater Market by End-user, Distribution Channel, Type, and Geography - Forecast and Analysis 2020-2024: The water heater market size has the potential to grow by USD 2.76 billion during 2020-2024, and the markets growth momentum will accelerate during the forecast period. Click and get a FREE sample report in minutes Luxury Massage Chair Market in US by End-user and Distribution Channel - Forecast and Analysis 2020-2024: The luxury massage chair market size in US has the potential to grow by USD 27.47 million during 2020-2024, and the markets growth momentum will accelerate during the forecast period. Click and get a FREE sample report in minutes Companies Covered: What our reports offer: Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Key Topics Covered: PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: MARKET LANDSCAPE PART 04: MARKET SIZING PART 05: FIVE FORCES ANALYSIS PART 06: MARKET SEGMENTATION BY TYPE PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE PART 09: MARKET SEGMENTATION BY RESOLUTION PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES PART 12: MARKET TRENDS PART 13: VENDOR LANDSCAPE PART 14: VENDOR ANALYSIS PART 15: APPENDIX PART 16: EXPLORE TECHNAVIO About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Global Set-top Box Market 2020-2024: Market Analysis, Drivers, Restraints, Opportunities, and Threats - Technavio

SAN FRANCISCO--(BUSINESS WIRE)--Uber Technologies, Inc. (NYSE: UBER) today announced financial results for the fourth quarter and full year ended December 31, 2020. Financial Highlights for Fourth Quarter 2020 While 2020 certainly tested our resilience, it also dramatically accelerated our capabilities in local commerce, with our Delivery business more than doubling over the year to a nearly $44 billion annual bookings run-rate in December, said Dara Khosrowshahi, CEO. With two global businesses stitched together by world-class tech and increasingly valuable membership programs, we are more focused than ever on making peoples lives a little bit easierhelping them go wherever they want and get whatever they need. We made some big moves this year, acquiring businesses like Cornershop and Postmates while divesting others like ATG and Jump, and structurally lowering our cost base, said Nelson Chai, CFO. These decisions have resulted in a much more focused and ultimately stronger company. In Q4 we continued to deliver improving Adjusted EBITDA performance, up $171 million quarter-over-quarter, and remain well on track to achieving our profitability goals in 2021. Fourth Quarter 2020 Financial and Operational Highlights Three Months Ended December 31, (In millions, except percentages) 2019 2020 % Change % Change (Constant Currency (1)) Monthly Active Platform Consumers (MAPCs) 111 93 (16 )% Trips 1,907 1,443 (24 )% Gross Bookings $ 18,131 $ 17,152 (5 )% (4 )% Revenue $ 3,747 $ 3,165 (16 )% (15 )% Net loss attributable to Uber Technologies, Inc. (2) $ (1,096 ) $ (968 ) 12 % Mobility Adjusted EBITDA $ 742 $ 293 (61 )% Delivery Adjusted EBITDA $ (461 ) $ (145 ) 69 % Adjusted EBITDA (1) $ (615 ) $ (454 ) 26 % (1) See Definitions of Non-GAAP Measures and Reconciliations of Non-GAAP Measure sections herein for an explanation and reconciliations of non-GAAP measures used throughout this release. (2) Net loss attributable to Uber Technologies, Inc. includes stock-based compensation expense of $243 million in Q4 2019 and $236 million in Q4 2020. Full Year 2020 Financial and Operational Highlights Year Ended December 31, (In millions, except percentages) 2019 2020 % Change % Change (Constant Currency (1)) Trips 6,904 5,025 (27) % Gross Bookings $ 65,001 $ 57,897 (11) % (9) % Revenue $ 13,000 $ 11,139 (14) % (13) % Net loss attributable to Uber Technologies, Inc. (2) $ (8,506 ) $ (6,768 ) 20 % Mobility Adjusted EBITDA $ 2,071 $ 1,169 (44) % Delivery Adjusted EBITDA $ (1,372 ) $ (873 ) 36 % Adjusted EBITDA (1) $ (2,725 ) $ (2,528 ) 7 % (1) See Definitions of Non-GAAP Measures and Reconciliations of Non-GAAP Measure sections herein for an explanation and reconciliations of non-GAAP measures used throughout this release. (2) Net loss attributable to Uber Technologies, Inc. includes stock-based compensation expense of $4.6 billion in 2019 and $827 million in 2020. Results by Offering and Segment Gross Bookings Three Months Ended December 31, (In millions, except percentages) 2019 2020 % Change % Change (Constant Currency) Gross Bookings: Mobility $ 13,512 $ 6,789 (50) % (47) % Delivery 4,374 10,050 130 % 128 % Freight 219 313 43 % 43 % All Other 26 ** ** Total $ 18,131 $ 17,152 (5) % (4) % ** Percentage not meaningful. Revenue Three Months Ended December 31, (In millions, except percentages) 2019 (1) 2020 % Change % Change (Constant Currency (1)) Revenue: Mobility $ 3,050 $ 1,471 (52) % (51) % Delivery 418 1,356 224 % 220 % Freight 219 313 43 % 43 % ATG and Other Technology Programs (2) 25 25 ** All Other 35 (100) % ** Total $ 3,747 $ 3,165 (16) % (15) % (1) Our previously reported revenue in 2019 has been retrospectively adjusted to reflect the implementation of a new accounting policy. During the fourth quarter of 2020, we changed our accounting policy related to the presentation of cumulative payments to Drivers in excess of cumulative revenue from Drivers. Our policy for the presentation of these excess cumulative payments has changed from presenting them within cost of revenue, exclusive of depreciation and amortization, to presenting them as a reduction of revenue in our consolidated statements of operations. (2) Includes $25 million of collaboration revenue from Toyota recognized in each of Q4 2019 and Q4 2020. We announced the divestiture of our Autonomous Technologies Group (ATG) to Aurora Innovation. Additionally, we divested Elevate to Joby Aviation. Both transactions were closed in January 2021. ** Percentage not meaningful. Adjusted EBITDA and Segment Adjusted EBITDA Three Months Ended December 31, (In millions, except percentages) 2019 2020 % Change Segment Adjusted EBITDA: Mobility $ 742 $ 293 (61) % Delivery (461 ) (145 ) 69 % Freight (55 ) (41 ) 25 % ATG and Other Technology Programs (130 ) (72 ) 45 % All Other (67 ) 100 % Corporate G&A and Platform R&D (1), (2) (644 ) (489 ) 24 % Adjusted EBITDA (3) $ (615 ) $ (454 ) 26 % (1) Excludes stock-based compensation expense. (2) Includes costs that are not directly attributable to our reportable segments. Corporate G&A also includes certain shared costs such as finance, accounting, tax, human resources, information technology and legal costs. Platform R&D also includes mapping and payment technologies and support and development of the internal technology infrastructure. Our allocation methodology is periodically evaluated and may change. (3) Adjusted EBITDA is a non-GAAP measure as defined by the SEC. See Definitions of Non-GAAP Measures and Reconciliations of Non-GAAP Measure sections herein for an explanation and reconciliations of non-GAAP measures used throughout this release. Revenue by Geographical Region Three Months Ended December 31, (In millions, except percentages) 2019 2020 % Change United States and Canada $ 2,458 $ 1,814 (26) % Latin America ("LatAm") 531 302 (43) % Europe, Middle East and Africa ("EMEA") 531 664 25 % Asia Pacific ("APAC") 227 385 70 % Total $ 3,747 $ 3,165 (16) % Operating Highlights for the Fourth Quarter 2020 Platform Mobility Delivery Other Segments and Corporate Recent Developments Webcast and conference call information A live audio webcast of our fourth quarter and year ended December 31, 2020 earnings release call will be available at https://investor.uber.com/, along with the earnings press release and slide presentation. The call begins on February 10, 2021 at 1:30 PM (PT) / 4:30 PM (ET). This press release, including the reconciliations of certain non-GAAP measures to their nearest comparable GAAP measures, is also available on that site. We also provide announcements regarding our financial performance, including SEC filings, investor events, press and earnings releases, and blogs, on our investor relations website (https://investor.uber.com/). About Uber Ubers mission is to create opportunity through movement. We started in 2010 to solve a simple problem: how do you get access to a ride at the touch of a button? More than 15 billion trips later, were building products to get people closer to where they want to be. By changing how people, food, and things move through cities, Uber is a platform that opens up the world to new possibilities. Forward-Looking Statements This press release contains forward-looking statements regarding our future business expectations which involve risks and uncertainties. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as anticipate, believe, contemplate, continue, could, estimate, expect, hope, intend, may, might, objective, ongoing, plan, potential, predict, project, should, target, will, or would or similar expressions and the negatives of those terms. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks, uncertainties and other factors relate to, among others: the outcome of a legal appeal in the UK regarding the classification of Drivers and a related tax case before the UK tax authority, developments in the COVID-19 pandemic and the resulting impact on our business and operations, competition, managing our growth and corporate culture, financial performance, investments in new products or offerings, our ability to attract drivers, consumers and other partners to our platform, our brand and reputation and other legal and regulatory developments, particularly with respect to our relationships with drivers and delivery persons. For additional information on other potential risks and uncertainties that could cause actual results to differ from the results predicted, please see our most recent quarterly report on Form 10-Q for the quarter ended September 30, 2020 and subsequent annual reports, quarterly reports and other filings filed with the Securities and Exchange Commission from time to time. All information provided in this release and in the attachments is as of the date of this press release and any forward-looking statements contained herein are based on assumptions that we believe to be reasonable as of this date. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law. Non-GAAP Financial Measures To supplement our financial information, which is prepared and presented in accordance with generally accepted accounting principles in the United States of America (GAAP), we use the following non-GAAP financial measures: Adjusted EBITDA; and Adjusted EBITDA margin as a percentage of revenue, as well as, revenue growth in constant currency. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use these non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our recurring core business operating results. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. These non-GAAP financial measures also facilitate managements internal comparisons to our historical performance. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business. There are a number of limitations related to the use of non-GAAP financial measures. In light of these limitations, we provide specific information regarding the GAAP amounts excluded from these non-GAAP financial measures and evaluating these non-GAAP financial measures together with their relevant financial measures in accordance with GAAP. For more information on these non-GAAP financial measures, please see the sections titled Key Terms for Our Key Metrics and Non-GAAP Financial Measures, Definitions of Non-GAAP Measures and Reconciliations of Non-GAAP Measure included at the end of this release. UBER TECHNOLOGIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In millions) (Unaudited) As of December 31, 2019 2020 Assets Cash and cash equivalents $ 10,873 $ 5,647 Short-term investments 440 1,180 Restricted cash and cash equivalents 99 250 Accounts receivable, net 1,214 1,073 Prepaid expenses and other current assets 1,299 1,215 Assets held for sale 517 Total current assets 13,925 9,882 Restricted cash and cash equivalents 1,095 1,494 Collateral held by insurer 1,199 860 Investments 10,527 9,052 Equity method investments 1,364 1,079 Property and equipment, net 1,731 1,814 Operating lease right-of-use assets 1,594 1,274 Intangible assets, net 71 1,564 Goodwill 167 6,109 Other assets 88 124 Total assets $ 31,761 $ 33,252 Liabilities, mezzanine equity and equity Accounts payable $ 272 $ 235 Short-term insurance reserves 1,121 1,243 Operating lease liabilities, current 196 175 Accrued and other current liabilities 4,050 5,112 Liabilities held for sale 100 Total current liabilities 5,639 6,865 Long-term insurance reserves 2,297 2,223 Long-term debt, net of current portion 5,707 7,560 Operating lease liabilities, non-current 1,523 1,544 Other long-term liabilities 1,412 1,306 Total liabilities 16,578 19,498 Mezzanine equity Redeemable non-controlling interests 311 787 Equity Common stock Additional paid-in capital 30,739 35,931 Accumulated other comprehensive loss (187 ) (535 ) Accumulated deficit (16,362 ) (23,130 ) Total Uber Technologies, Inc. stockholders' equity 14,190 12,266 Non-redeemable non-controlling interests 682 701 Total equity 14,872 12,967 Total liabilities, mezzanine equity and equity $ 31,761 $ 33,252 UBER TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except share amounts which are reflected in thousands, and per share amounts) (Unaudited) Three Months Ended December 31, Year Ended December 31, 2019 2020 2019 2020 Revenue (1) $ 3,747 $ 3,165 $ 13,000 $ 11,139 Costs and expenses Cost of revenue, exclusive of depreciation and amortization shown separately below (1) 1,605 1,441 6,061 5,154 Operations and support 506 369 2,302 1,819 Sales and marketing 1,251 1,038 4,626 3,583 Research and development 608 483 4,836 2,205 General and administrative 647 531 3,299 2,666 Depreciation and amortization 101 180 472 575 Total costs and expenses 4,718 4,042 21,596 16,002 Loss from operations (971 ) (877 ) (8,596 ) (4,863 ) Interest expense (101 ) (118 ) (559 ) (458 ) Other income (expense), net 15 63 722 (1,625 ) Loss before income taxes and loss from equity method investments (1,057 ) (932 ) (8,433 ) (6,946 ) Provision for (benefit from) income taxes 25 23 45 (192 ) Loss from equity method investments (9 ) (7 ) (34 ) (34 ) Net loss including non-controlling interests (1,091 ) (962 ) (8,512 ) (6,788 ) Less: net income (loss) attributable to non-controlling interests, net of tax 5 6 (6 ) (20 ) Net loss attributable to Uber Technologies, Inc. $ (1,096 ) $ (968 ) $ (8,506 ) $ (6,768 ) Net loss per share attributable to Uber Technologies, Inc. common stockholders: Basic $ (0.64 ) $ (0.54 ) $ (6.81 ) $ (3.86 ) Diluted $ (0.64 ) $ (0.54 ) $ (6.81 ) $ (3.86 ) Weighted-average shares used to compute net loss per share attributable to common stockholders: Basic 1,710,260 1,793,084 1,248,353 1,752,960 Diluted 1,710,260 1,793,084 1,248,353 1,752,960 (1) During the fourth quarter of 2020, we changed our accounting policy related to the presentation of cumulative payments to Drivers in excess of cumulative revenue from Drivers. Our policy for the presentation of these excess cumulative payments has changed from presenting them within cost of revenue, exclusive of depreciation and amortization, to presenting them as a reduction of revenue in our consolidated statements of operations. Amounts presented for 2019 have been retrospectively adjusted to reflect the effects of the change to revenue and cost of revenue, exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to Uber Technologies, Inc., or net loss per share for any periods presented. The consolidated balance sheets and the consolidated statements of cash flows are not affected by this change in accounting policy. UBER TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) (Unaudited) Year Ended December 31, 2019 2020 Cash flows from operating activities Net loss including non-controlling interests $ (8,512 ) $ (6,788 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 472 575 Bad debt expense 92 76 Stock-based compensation 4,596 827 Gain on extinguishment of convertible notes and settlement of derivatives (444 ) Gain on business divestitures, net (204 ) Deferred income taxes (88 ) (266 ) Revaluation of derivative liabilities (58 ) Accretion of discount on long-term debt 82 45 Payment-in-kind interest 10 Impairment of debt and equity securities 1,690 Impairments of goodwill, long-lived assets and other assets 404 Loss from equity method investments 34 34 Unrealized (gain) loss on debt and equity securities, net (2 ) 125 Unrealized foreign currency transactions 16 48 Other (19 ) (43 ) Change in assets and liabilities, net of impact of business acquisitions and disposals: Accounts receivable (407 ) 142 Prepaid expenses and other assets (478 ) 94 Collateral held by insurer (1,199 ) 339 Operating lease right-of-use assets 201 341 Accounts payable 95 (133 ) Accrued insurance reserves 481 (3 ) Accrued expenses and other liabilities 960 83 Operating lease liabilities (153 ) (131 ) Net cash used in operating activities (4,321 ) (2,745 ) Cash flows from investing activities Proceeds from sale and disposal of property and equipment 51 3 Purchases of property and equipment (588 ) (616 ) Purchases of non-marketable equity securities (100 ) (10 ) Purchases of marketable securities (441 ) (2,101 ) Proceeds from maturities and sales of marketable securities 2 1,360 Proceeds from business disposal, net of cash divested 293 Acquisition of businesses, net of cash acquired (7 ) (1,471 ) Return of capital from equity method investee 91 Purchase of note receivable (185 ) Other investing activities 60 Net cash used in investing activities (790 ) (2,869 ) Cash flows from financing activities Proceeds from issuance of common stock upon initial public offering, net of offering costs 7,973 Taxes paid related to net share settlement of equity awards (1,573 ) (17 ) Proceeds from issuance of common stock related to private placement 500 Proceeds from issuance of subsidiary preferred stock units 1,000 247 Proceeds from the issuance of common stock under the Employee Stock Purchase Plan 49 125 Issuance of term loan and notes, net of issuance costs 1,189 2,628 Principal repayment on term loan and notes (27 ) (527 ) Principal repayment on Careem Notes (891 ) Principal payments on capital and finance leases (138 ) (224 ) Repurchase of stock subject to put options related to Yandex (74 ) Other financing activities 40 38 Net cash provided by financing activities 8,939 1,379 Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents (4 ) (92 ) Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents 3,824 (4,327 ) Cash and cash equivalents, and restricted cash and cash equivalents Beginning of period 8,209 12,067 Reclassification from (to) assets held for sale during the period 34 (349 ) End of period, excluding cash classified within assets held for sale $ 12,067 $ 7,391 Other Income (Expense), Net The following table presents other income (expense), net (in millions): Three Months Ended December 31, Year Ended December 31, 2019 2020 2019 2020 (Unaudited) Interest income $ 50 $ 4 $ 234 $ 55 Foreign currency exchange gains (losses), net (40 ) (24 ) (40 ) (128 ) Gains on business divestitures, net (1) 77 204 Unrealized gain (loss) on debt and equity securities, net (2) 1 (2 ) 2 (125 ) Impairment of debt and equity securities (3) (1,690 ) Change in fair value of embedded derivatives 58 Gain on extinguishment of convertible notes and settlement of derivatives (4) 444 Other, net 4 8 24 59 Other income (expense), net $ 15 $ 63 $ 722 $ (1,625 ) (1) During the year ended December 31, 2020, gains on business divestitures, net represented a $154 million gain on the sale of our Uber Eats India operations to Zomato Media Private Limited (Zomato) recognized in the first quarter of 2020 and a $77 million gain on the sale of our European Freight Business to sennder GmbH recognized in the fourth quarter of 2020, partially offset by a $27 million loss on the sale of our JUMP operations to Lime recognized in the second quarter of 2020. (2) During the years ended 2019 and 2020, we recorded changes to the fair value of investments in securities accounted for under the fair value option. (3) During the year ended December 31, 2020, we recorded an impairment charge of $1.7 billion, primarily related to our investment in Didi recognized during the first quarter of 2020. (4) During the year ended December 31, 2019, we recognized a $444 million gain on extinguishment of our 2021 and 2022 convertible notes and settlement of derivatives in connection with our IPO, recognized during the second quarter of 2019. Stock-Based Compensation Expense The following table summarizes total stock-based compensation expense by function (in millions): Three Months Ended December 31, Year Ended December 31, 2019 2020 2019 2020 (Unaudited) Operations and support $ 23 $ 20 $ 454 $ 72 Sales and marketing 13 13 242 48 Research and development 136 136 2,958 477 General and administrative 71 67 942 230 Total $ 243 $ 236 $ 4,596 $ 827 Through May 9, 2019, no stock-based compensation expense had been recognized for certain awards with a performance condition based on the occurrence of a qualifying event, such as an initial public offering (IPO), as such qualifying event was not probable. Upon our IPO in May 2019, the performance condition was met and $3.6 billion of stock-based compensation expense was recognized related to these awards. Key Terms for Our Key Metrics and Non-GAAP Financial Measures Adjusted EBITDA. We define Adjusted EBITDA as net income (loss), excluding (i) income (loss) from discontinued operations, net of income taxes, (ii) net income (loss) attributable to non-controlling interests, net of tax, (iii) provision for (benefit from) income taxes, (iv) income (loss) from equity method investments, (v) interest expense, (vi) other income (expense), net, (vii) depreciation and amortization, (viii) stock-based compensation expense, (ix) certain legal, tax, and regulatory reserve changes and settlements, (x) goodwill and asset impairments/loss on sale of assets, (xi) acquisition and financing related expenses, (xii) restructuring and related charges and (xiii) other items not indicative of our ongoing operating performance, including COVID-19 response initiatives related payments for financial assistance to Drivers personally impacted by COVID-19, the cost of personal protective equipment distributed to Drivers, Driver reimbursement for their cost of purchasing personal protective equipment, the costs related to free rides and food deliveries to healthcare workers, seniors, and others in need as well as charitable donations. Our board and management find the exclusion of the impact of these COVID-19 response initiatives from Adjusted EBITDA to be useful because it allows us and our investors to assess the impact of these response initiatives on our results of operations. COVID-19 response initiatives. To support those whose earning opportunities have been depressed as a result of COVID-19, as well as communities hit hard by the pandemic, we have announced and implemented several initiatives, including, in particular, payments for financial assistance to Drivers personally impacted by COVID-19, the cost of personal protective equipment distributed to Drivers, Driver reimbursement for their cost of purchasing personal protective equipment, the costs related to free rides and food deliveries to healthcare workers, seniors, and others in need as well as charitable donations. The payments for financial assistance to Drivers personally impacted by COVID-19 and Driver reimbursement for their cost of purchasing personal protective equipment are recorded as a reduction to revenue. The cost of personal protective equipment distributed to Drivers, the costs related to free rides and food deliveries to healthcare workers, seniors, and others in need as well as charitable donations are recorded as an expense in our costs and expenses. Driver(s). The term Driver collectively refers to independent providers of ride or delivery services who use our platform to provide Mobility or Delivery services, or both. Driver or restaurant earnings. Driver or restaurant earnings refer to the net portion of the fare or the net portion of the order value that a Driver or a restaurant retains, respectively. Driver incentives. Driver incentives refer to payments that we make to Drivers, which are separate from and in addition to the Drivers portion of the fare paid by the consumer after we retain our service fee to Drivers. For example, Driver incentives could include payments we make to Drivers should they choose to take advantage of an incentive offer and complete a consecutive number of trips or a cumulative number of trips on the platform over a defined period of time. Driver incentives are recorded as a reduction of revenue. Gross Bookings. We define Gross Bookings as the total dollar value, including any applicable taxes, tolls, and fees, of Mobility and New Mobility rides, Delivery meal or grocery deliveries, and amounts paid by Freight shippers, in each case without any adjustment for consumer discounts and refunds, Driver and restaurant earnings, and Driver incentives. Gross Bookings do not include tips earned by Drivers. Monthly Active Platform Consumers (MAPCs). We define MAPCs as the number of unique consumers who completed a Mobility or New Mobility ride or received a Delivery meal or grocery order on our platform at least once in a given month, averaged over each month in the quarter. While a unique consumer can use multiple product offerings on our platform in a given month, that unique consumer is counted as only one MAPC. All Other (formerly Other Bets). During the second quarter of 2020, we completed the divestiture of our JUMP business (the JUMP Divestiture), which comprised substantially all of the operations of our Other Bets reportable segment. Subsequent to the JUMP Divestiture, the Other Bets segment no longer exists and the continuing activities previously included in the Other Bets segment are immaterial for all periods presented. Certain of these other continuing business activities were migrated to our Mobility segment, whose prior period results were not restated because such business activities were immaterial. The other business activities that were not migrated represent an all other category separate from other reconciling items and are presented within the All Other caption. The historical results of the former Other Bets segment are included within the All Other caption. Prior to the second quarter of 2020, the All Other (formerly our Other Bets segment) consisted of multiple investment stage offerings, primarily our New Mobility products that provide consumers with access to rides through a variety of modes, including dockless e-bikes and e-scooters. All Other (formerly our Other Bets segment) also included Transit, UberWorks and our Incubator group. Segment Adjusted EBITDA. We define each segments Adjusted EBITDA as segment revenue less the following direct costs and expenses of that segment: (i) cost of revenue, exclusive of depreciation and amortization; (ii) operations and support; (iii) sales and marketing; (iv) research and development; and (v) general and administrative. Segment Adjusted EBITDA also reflects any applicable exclusions from Adjusted EBITDA. Segment Adjusted EBITDA margin. We define each segments Adjusted EBITDA margin as the segment Adjusted EBITDA as a percentage of segment revenue. Segment Adjusted EBITDA margin demonstrates the margin that we generate after direct expenses. We believe that each segments Adjusted EBITDA margin is a useful indicator of the economics of our segments, as it does not include indirect Corporate G&A and Platform R&D. Take Rate. We define Take Rate as revenue as a percentage of Gross Bookings. Trips. We define Trips as the number of completed consumer Mobility or New Mobility rides and Delivery meal or grocery deliveries in a given period. For example, an UberPOOL ride with three paying consumers represents three unique Trips, whereas an UberX ride with three passengers represents one Trip. Definitions of Non-GAAP Measures We collect and analyze operating and financial data to evaluate the health of our business and assess our performance. In addition to revenue, net income (loss), loss from operations, and other results under GAAP, we use Adjusted EBITDA, as well as revenue growth rates in constant currency, which are described below, to evaluate our business. We have included these non-GAAP financial measures because they are key measures used by our management to evaluate our operating performance. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors. Our calculation of these non-GAAP financial measures may differ from similarly-titled non-GAAP measures, if any, reported by our peer companies. These non-GAAP financial measures should not be considered in isolation from, or as substitutes for, financial information prepared in accordance with GAAP. Adjusted EBITDA We define Adjusted EBITDA as net income (loss), excluding (i) income (loss) from discontinued operations, net of income taxes, (ii) net income (loss) attributable to non-controlling interests, net of tax, (iii) provision for (benefit from) income taxes, (iv) income (loss) from equity method investments, (v) interest expense, (vi) other income (expense), net, (vii) depreciation and amortization, (viii) stock-based compensation expense, (ix) certain legal, tax, and regulatory reserve changes and settlements, (x) goodwill and asset impairments/loss on sale of assets, (xi) acquisition and financing related expenses, (xii) restructuring and related charges and (xiii) other items not indicative of our ongoing operating performance, including COVID-19 response initiative related payments for financial assistance to Drivers personally impacted by COVID-19, the cost of personal protective equipment distributed to Drivers, Driver reimbursement for their cost of purchasing personal protective equipment, the costs related to free rides and food deliveries to healthcare workers, seniors, and others in need as well as charitable donations. We have included Adjusted EBITDA because it is a key measure used by our management team to evaluate our operating performance, generate future operating plans, and make strategic decisions, including those relating to operating expenses. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors. In addition, it provides a useful measure for period-to-period comparisons of our business, as it removes the effect of certain non-cash expenses and certain variable charges. To help our board, management and investors assess the impact of COVID-19 on our results of operations, we are excluding the impacts of COVID-19 response initiative related payments for financial assistance to Drivers personally impacted by COVID-19, the cost of personal protective equipment distributed to Drivers, Driver reimbursement for their cost of purchasing personal protective equipment, the costs related to free rides and food deliveries to healthcare workers, seniors, and others in need as well as charitable donations from Adjusted EBITDA. Our board and management find the exclusion of the impact of these COVID-19 response initiatives from Adjusted EBITDA to be useful because it allows us and our investors to assess the impact of these response initiatives on our results of operations. Adjusted EBITDA has limitations as a financial measure, should be considered as supplemental in nature, and is not meant as a substitute for the related financial information prepared in accordance with GAAP. These limitations include the following: Adjusted EBITDA Margin as a Percentage of Revenue We define Adjusted EBITDA margin as a percentage of revenue as Adjusted EBITDA divided by revenue. Segment Adjusted EBITDA margin as a percentage of revenue is segment Adjusted EBITDA divided by segment revenue. Constant Currency We compare the percent change in our current period results from the corresponding prior period using constant currency disclosure. We present constant currency growth rate information to provide a framework for assessing how our underlying revenue performed excluding the effect of foreign currency rate fluctuations. We calculate constant currency by translating our current period financial results using the corresponding prior periods monthly exchange rates for our transacted currencies other than the U.S. dollar. Reconciliation of Non-GAAP Measures The following table presents reconciliations of Adjusted EBITDA to the most directly comparable GAAP financial measure for each of the periods indicated. Adjusted EBITDA Three Months Ended December 31, Year Ended December 31, (In millions) 2019 2020 2019 2020 (Unaudited) Adjusted EBITDA reconciliation: Net loss attributable to Uber Technologies, Inc. $ (1,096 ) $ (968 ) $ (8,506 ) $ (6,768 ) Add (deduct): Net income (loss) attributable to non-controlling interests, net of tax 5 6 (6 ) (20 ) Provision for (benefit from) income taxes 25 23 45 (192 ) Loss from equity method investments 9 7 34 34 Interest expense 101 118 559 458 Other (income) expense, net (15 ) (63 ) (722 ) 1,625 Depreciation and amortization 101 180 472 575 Stock-based compensation expense 243 236 4,596 827 Legal, tax, and regulatory reserve changes and settlements (92 ) 353 (35 ) Driver appreciation award 299 Payroll tax on IPO stock-based compensation 86 Goodwill and asset impairments/loss on sale of assets 32 8 317 Acquisition, financing and divestitures related expenses 43 86 Accelerated lease costs related to cease-use of ROU assets 22 102 COVID-19 response initiatives 16 106 Gain on lease arrangement, net (5 ) Restructuring and related charges (credits), net 12 (14 ) 57 362 Adjusted EBITDA $ (615 ) $ (454 ) $ (2,725 ) $ (2,528 )

Uber Announces Results for Fourth Quarter and Full Year 2020 Revenue of $3.2 billion grew 13% quarter-over-quarter (down 16% year-over-year) Mobility exceeded 1 billion trips in Q4 Delivery Gross Bookings grew 130% YoY with continued Adjusted EBITDA improvement

NEW YORK, March 17, 2020 /PRNewswire/ -- The global customer data platform size to grow at a CAGR of 34.0% during the forecast period Read the full report: https://www.reportlinker.com/p05570070/?utm_source=PRN The Customer Data Platform (CDP) market size is projected to grow from USD 2.4 billion in 2020 to USD 10.3 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 34.0% during the forecast period. The major growth factors of the CDP include increasing spending on marketing and advertising activities by enterprises, changing landscape of customer intelligence, and proliferation of customer channels.Services segment to grow at a higher CAGR during the forecast periodThe CDP market by component is segmented into solutions and services.The services segment is expected to grow at a rapid pace during the forecast period.The services considered in the report are consulting services and support and maintenance. The growth of this segment can be attributed to the increasing deployment of CDP, which leads to the increasing demand for pre- and post-deployment services, as these solutions require training due to technical complexities.Travel and hospitality industry vertical to grow at the highest CAGR during the forecast periodThe CDP market by industry vertical has been segmented into Banking, Financial Services and Insurance (BFSI), travel and hospitality, telecom and IT, retail and ecommerce, healthcare, media and entertainment, government, and others (government, automobile, and education).The travel and hospitality segment is expected to grow at a rapid pace during the forecast period.Organizations are adopting CDP solutions to understand customer behavior and design better campaigns to give a personalized experience to their customers.Asia Pacific to grow at the highest CAGR during the forecast periodAsia Pacific (APAC) is expected to grow at the highest CAGR during the forecast period. Increasing investments by the technology companies in major APAC countries, such as India, China and Japan; growing digitalization; increasing adoption of advanced big data and analytics technologies; and government regulations and initiatives are expected to drive the growth of the market in the APAC region.In-depth interviews were conducted with Chief Executive Officers (CEOs), innovation and technology directors, system integrators, and executives from various key organizations operating in the CDP. By Company: Tier I: 38%, Tier II: 41%, and Tier III: 21% By Designation: C-Level Executives: 65%, Directors: 20%, and Others: 15% By Region: North America: 45%, APAC: 15%, Europe: 30%, MEA: 5%, and Latin America: 5%The report includes the study of the key players offering data lake solutions and services.It profiles major vendors in the global CDP market.The major vendors are Oracle (US), SAP (Germany), Adobe (US), Salesforce (US), Microsoft (US), SAS (US), Teradata (US), Nice (Israel), Dun & Bradstreet (US), Leadspace (US), Zylotech (US), BlueVenn (UK), CaliberMind (US), Celebrus (UK), Tealium (US), AgilOne (US), BlueConic (US), Lytics (US), IgnitionOne (US) and Amperity (US). It also includes an in-depth competitive analysis of the key players in the CDP market, along with their company profiles, business overviews, product offerings, recent developments, and market strategies.Research CoverageThe market study covers the CDP market across segments.It aims at estimating the market size and the growth potential of this market, across different segments, such as component, deployment mode, organization size, application, industry vertical, and region.The study further includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.Key Benefits of Buying the ReportThe report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall CDP market and the subsegments.This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies.The report further helps stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.Read the full report: https://www.reportlinker.com/p05570070/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com

The Customer Data Platform (CDP) market size is projected to grow from USD 2.4 billion in 2020 to USD 10.3 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 34.0%

LONDON--(BUSINESS WIRE)--Sandbox, an operating platform for digital educational products and services has announced that it has acquired Teachit, a UK-based teacher resource provider from education charity AQA. Founded by English teacher, Siobhain Archer, in 1999, Teachit serves a community of over 550,000 primary and secondary teachers across a range of subjects sharing a high-quality library of 18,000+ learning resources which are made for teachers by teachers, through subscriptions and online product sales. This strategic acquisition will accelerate international growth and operations by collaborating with Sandboxs existing US-based teacher resource business, TeacherVision. The collaboration aims to strengthen both the company's market presence and global footprint to serve over 2 million teachers in both the UK and in the USA with online tools and resources, whilst leveraging the fast-growing e-learning market estimated to be worth $342bn by 2025. Bhav Singh, CEO & Founder at Sandbox said "As the global population grows and the need for quality education becomes more widespread, the demand for teachers is expected to go up in tandem. We are building a global platform to provide teachers with the digital resources to thrive in this dynamic new environment". Teachit is the latest acquisition from Sandbox since it became a majority shareholder of Hopster in November 2019. Teachit will join TeacherVision, FamilyEducation, Fact Monster & Infoplease as part of the Sandbox Learning suite of products under the direction of Mark Engelter. Sandbox's growing portfolio of 10 award-winning digital learning products and services reach in excess of 55m millennial families. About Sandbox and Sandbox & Co Sandbox is a millennial education company with engaging online products and services that make learning fun. At the intersection of the digital, learning and media industries, Sandbox brands embrace technological advancements, focus on globally relevant core subjects that centre on families interests and help develop 21st century skills. Sandbox & Co represents and strategically operates the Sandbox-controlled and invested entities a suite of 10 brands, most of which are leaders in their own segment and have won several awards. Portfolio companies include CoolMathGames, Poptropica, Tinybop, Curious World, Hopster, Family Education, TeacherVision, Super Awesome, Fact Monster, InfoPlease and Funbrain. Sandbox is committed to providing an unparalleled ecosystem of edutainment products, and currently reaches over 55 million children, their millennial parents and teachers. For more information, please refer to the Sandbox & Co. website at www.sandboxandco.com. About Teachit Founded by English teacher, Siobhain Archer, in 1999, Teachit was one of the first teaching and learning resource websites of its kind. Teachit is now a thriving community of over 550,000 primary and secondary teachers across a range of subjects (Teachit Primary, Teachit English, Teachit Maths, Teachit Science, Teachit Languages, Teachit Geography & Teachit History). The business has grown to offer high-quality resources, produced for teachers by teachers the content is editorially independent and exam board agnostic www.teachit.co.uk/family.

Sandbox Acquires Teachit to Bolster Its Portfolio & Accelerate Growth in Digital Learning

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--United Insurance Holdings Corp. (Nasdaq:UIHC) (UPC Insurance or the Company), a property and casualty insurance holding company, announced today that its Board of Directors declared a cash dividend of $0.06 per share of common stock outstanding, payable in cash on November 30, 2020 to shareholders of record on November 23, 2020. About UPC Insurance Founded in 1999, UPC Insurance is an insurance holding company that sources, writes and services personal and commercial residential property and casualty insurance policies using a group of wholly owned insurance subsidiaries through a variety of distribution channels. The Company currently writes policies in Connecticut, Florida, Georgia, Hawaii, Louisiana, Massachusetts, New Jersey, New York, North Carolina, Rhode Island, South Carolina and Texas. From its headquarters in St. Petersburg, UPC Insurance's team of dedicated professionals manages a completely integrated insurance company, including sales, underwriting, customer service and claims.

United Insurance Holdings Corp. Declares Quarterly Cash Dividend of $0.06 Per Share

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE:PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced that its Board of Directors has declared a quarterly cash dividend on the companys common stock of $0.05 per share. The dividend will be paid on December 8, 2020, to stockholders of record on November 17, 2020. About Pitney Bowes Pitney Bowes (NYSE:PBI) is a global technology company providing commerce solutions that power billions of transactions. Clients around the world, including 90 percent of the Fortune 500, rely on the accuracy and precision delivered by Pitney Bowes solutions, analytics, and APIs in the areas of ecommerce fulfillment, shipping and returns; cross-border ecommerce; office mailing and shipping; presort services; and financing. For 100 years Pitney Bowes has been innovating and delivering technologies that remove the complexity of getting commerce transactions precisely right. For additional information visit Pitney Bowes, the Craftsmen of Commerce, at www.pitneybowes.com.

Pitney Bowes Declares Common Stock Dividend

NEW YORK, May 28, 2020 /PRNewswire/ --Legg Mason, Inc. (NYSE: LM) and its affiliate, ClearBridge Investments, LLC, today announced the launch of Legg Mason's first exchange-traded fund (ETF) using the semi-transparent technology of Precidian Investments LLC, ActiveShares. The ClearBridge Focus Value ETF (CFCV), a series of Legg Mason's ActiveShares ETF Trust, trades on the Chicago Board Options Exchange (Cboe) and seeks long-term capital appreciation. The ETF is backed by ClearBridge's proven expertise in active management and through the use of Precidian's ActiveShares technology, its strategy is able to be delivered in a confidential format to safeguard both the ETF and its investors. The launch represents the culmination of many years' work in the development of the ActiveShares ETF structure. The methodology seeks to bring the best of the ETF structure and active management together. The ActiveShares ETF structure'sunique combination of cost and tax efficiencies, real-time pricing and confidential format can benefit both asset managers and investors. "This ground-breaking ETF is part of our commitment to delivering active investment excellence in the vehicles our clients and investors demand. This is another exciting step in the development of ETFs, giving investors greater choice and more opportunities to invest in otherwise inaccessible active strategies in a highly efficient and confidential ETF wrapper," said Terrence Murphy, CEO of ClearBridge Investments. ClearBridge Investments and Legg Mason partnered with Precidian Investments to develop the ETF and all are excited to offer this investment opportunity to investors. "I want to thank Joe Sullivan for his foundational support, and the various teams at Legg Mason who worked tirelessly to make this evolution in product structure a reality. Additionally, I am pleased to partner with Terrence Murphy, who has the vision to realize the potential of what we believe to be a burgeoning marketplace," said Dan McCabe, CEO of Precidian Investments. Legg Mason is affiliated with Precidian Investments and announced on its January earnings call that it had notified Precidian that it would begin the due diligence process on exercising its option to increase its 19.9% equity stake in Precidian Investments to a majority ownership stake. "The launch of this innovative ETF structure with Precidian, ClearBridge and other industry partners is the perfect example of how we have sought to provide investors with better choice of vehicles and strategies," said Joseph A. Sullivan, Chairman and CEO of Legg Mason." Mr. Sullivan added, "Precidian's ActiveShares structure is not only an evolution in ETFs, but also a potential game-changer for active management. It has the potential over time to transform how retail investors access the best active strategies. I congratulate Dan McCabe and his team for their persistence and dedication in working with Legg Mason and others in the industry to bring ActiveShares to market so successfully." Key third-party partners in launching the ClearBridge Focus Value ETF are BNY Mellon, IHS Markit, Cantor Fitzgerald, Mizuho and GTS Mischler, in addition to the Chicago Board Options Exchange (Cboe). "We are very excited to work with a group of innovative market participants to deliver a digital solution to the long-awaited semi-transparent actively managed ETF market," said Emily Portney, Global Head of Client Coverage and Head of Americas, BNY Mellon Asset Servicing. ActiveShares Background The first two actively-managed ETFs utilizing Precidian's proprietary ActiveShares structure were launched by American Century Investments (ACI) on April 2nd. There has been significant interest by asset managers in licensing the ActiveShares technology. Currently, the technology has been licensed by 14 licensees, covering 26% of the actively managed U.S. equity market. ETF Objective and ProcessPrecidian Funds LLC serves as the ETF's investment manager and . ClearBridge Investments, LLC, the subadviser, is responsible for managing the ETF on a day-to-day basis. The portfolio managers are Robert Feitler Jr. and Dmitry Khaykin, Managing Directors and Portfolio Managers with ClearBridge Investments. Feitler and Khaykin have 25 years and 23 years of industry experience, respectively. The ClearBridge Focus Value ETF offers investors access to a strategy that seeks to identify a select number of large capitalization stocks able to deliver attractive risk-adjusted returns. The ETF's portfolio managers employ fundamental research to identify such stocks, constructing the portfolio on a bottom-up basis. The ETF normally will invest at least 80% of its net assets in equity securities of companies with large market capitalizations. The ETF may also invest up to 20% of its net assets in equity securities of companies with lower market capitalizations. While most of the ETF's investments will be in U.S. companies, the ETF may also invest in American Depository Receipts (ADRs) and U.S.-listed shares of foreign companies. Under normal circumstances, the ETF will invest in a diversified portfolio typically consisting of 30 to 40 issuers. About Legg MasonGuided by a mission of Investing to Improve Lives, Legg Mason helps investors globally achieve better financial outcomes by expanding choice across investment strategies, vehicles and investor access through independent investment managers with diverse expertise in equity, fixed income, alternative and liquidity investments. Legg Mason's assets under management are $763.1 billion as ofApril 30, 2020. To learn more, visit our website, our newsroom, or follow us on LinkedIn, Twitter, or Facebook. Active share reflects the percent of a portfolio that differs from the index. American Depository Receipts ("ADRs") are U.S. traded securities that represent shares of a foreign-based corporation held by a custodian. The Fund is newly organized, with a limited history of operations.Equity securities are subject to price fluctuation and possible loss of principal. International investments are subject to special risks, including currency fluctuations and social, economic and political uncertainties, which could increase volatility. These risks are magnified in emerging markets. Short selling is a speculative strategy. Unlike the possible loss on a security that is purchased, there is no limit on the amount of loss on an appreciating security that is sold short. Derivatives, such as options and futures, can be illiquid, may disproportionately increase losses, and have a potentially large impact on Fund performance. The manager's investment style may become out of favor and/or the manager's selection process may prove incorrect, which may have a negative impact on the Fund's performance. Before investing, carefully consider a Fund's investment objectives, risks, charges and expenses. You can find this and other information in each prospectus, or summary prospectus, if available, which is available at www.leggmasonfunds.com. Please read it carefully. 2020 Legg Mason Investor Services, LLC, member FINRA, SIPC. Legg Mason Investor Services, is a subsidiary of Legg Mason, Inc. American Century Investments is not affiliated with Legg Mason, Inc. SOURCE Legg Mason, Inc. Related Links http://www.leggmason.com

Legg Mason And ClearBridge Investments Launch Semi-Transparent ETF Using Precidian Investments' Innovative ActiveShares Technology

CHARLOTTE, N.C., Nov. 12, 2020 /PRNewswire/ --The Carolinas-Virginia Minority Supplier Development Council will host its inaugural 2020 Virtual Conference titled "re-EMERGE," a combination of the organization's 43rd Business Opportunity Conference (BOC) and 14th annual MBE Summit, on Dec. 2-3. Out of an abundance of caution and safety concerns, the Council transitioned from its usual in-person conference to an online format. The two-day event, themed re-EMERGE: The Future of Your Business, will take place using the virtual conference platform Virtual Fusions. Virtual Cafe Networking opens at 9 a.m. on Wednesday and 8:30 a.m. on Thursday, with the online tradeshow open all day on both days and conference sessions running until early afternoon. "We spent the better part of 2020 sheltered in place," said Dominique Milton, CVMSDC President and CEO. "Many corporations and business owners made pivots and are thriving; while others still face challenges to re-open." Milton said that the true spirit of an entrepreneur is resiliency, so the 2020 re-EMERGE conference is designed to buoy support for business owners who have been challenged by the COVID-19 economic pressures and business closures. Conference events include workshops, panel discussions, MBE-2-MBE networking (Minority Business Enterprises), an awards ceremony, a live auction, silent auction, corporate-to-MBE matchmaking, and a construction-only matchmaking event. The keynote speaker is Dr. Alva Taylor, a business strategist and consultant at the Dartmouth College Tuck School of Business. Other guest presenters include political strategist and motivational speaker Anton Gunn and business coach Quinn Conyers. In addition, a virtual tradeshow exhibit floor will be open during the entire conference for attendees to visit and network with exhibitors. Several hundred participants are expected to attend the online conference, including scores of high school and college students who have future aspirations for entrepreneurship. As part of the Council's 'Next Generation of Our Work' series, the re-EMERGE conference is hosting a business pitch competition for young entrepreneurs to focus on solving a problem or meeting a need in the marketplace. The winner will be announced during the conference and will receive a website and app development package valued at $50,000. The Carolinas-Virginia MSDC is a non-profit corporation chartered to enhance business opportunities for minority-owned companies by providing support through developing mutually beneficial networking opportunities with corporate members and promoting minority business development. For more information or to register for the 2020 re-EMERGE conference, visit online at http://reemerge.cvmsdc.org. SOURCE Carolinas-Virginia Minority Supplier Development Council Related Links http://www.carolinasmsdc.org

CVMSDC To Host Virtual 're-EMERGE' Conference, Dec. 2-3, 2020

NEW YORK, Jan. 20, 2021 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for CLBS, NIO, BIOL, FCEL, and CCL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. CLBS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CLBS&prnumber=012020215 NIO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NIO&prnumber=012020215 BIOL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=BIOL&prnumber=012020215 FCEL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=FCEL&prnumber=012020215 CCL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CCL&prnumber=012020215 (Note: You may have to copy this link into your browser then press the [ENTER] key.) InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment. SOURCE InvestorsObserver Related Links http://www.investorsobserver.com

Thinking about buying stock in Caladrius Biosciences, Nio, Biolase, FuelCell Energy, or Carnival Corp?

HOUSTON--(BUSINESS WIRE)--Natural Resource Partners L.P. (NYSE:NRP) today reported fourth quarter and full year 2020 results as follows: For the Three Months Ended For the Year Ended December 31, December 31, (In thousands) (Unaudited) 2020 2019 2020 2019 Net income (loss) from continuing operations $ 14,687 $ (119,448) $ (84,819) $ (25,414) Asset impairments 2,668 147,730 135,885 148,214 Net income from continuing operations excluding asset impairments (1) $ 17,355 $ 28,282 $ 51,066 $ 122,800 Adjusted EBITDA (1) 24,917 37,974 104,714 199,228 Cash flow provided by (used in) continuing operations: Operating activities 13,155 19,394 87,568 137,319 Investing activities 776 259 1,745 8,221 Financing activities (29,714) (33,551) (87,788) (253,305) Distributable cash flow (1) (2) 13,932 19,602 90,248 144,933 Free cash flow (1) 13,815 19,764 88,690 139,040 Cash flow cushion (last twelve months) (1) (739) 7,762 (1) See "Non-GAAP Financial Measures" and reconciliation tables at the end of this release. (2) Includes net proceeds from the sale of the construction aggregates business which are classified as investing cash flow from discontinued operations. "While 2020 proved to be a challenging year for us all, I'm proud of the efforts and discipline of our team as they managed the business safely and effectively over the course of the year. We paid down $46 million of debt in 2020 and ended the year with $200 million of liquidity. As we look to 2021, demand for steel, energy and soda ash continues to improve and we continue to focus on maximizing unitholder value by de-levering the capital structure while maintaining strong liquidity during these uncertain times," stated Craig Nunez, NRP's President and Chief Operating Officer. NRP's liquidity was $199.8 million at December 31, 2020, consisting of $99.8 million of cash and $100.0 million of borrowing capacity available under its revolving credit facility. NRP declared a cash distribution of $0.45 per common unit and a distribution of $7.6 million on its preferred units for the fourth quarter of 2020. The preferred unit distribution included interest on previously paid-in-kind units and was paid one-half in cash and one-half in kind through the issuance of additional preferred units. Future distributions on NRP's common and preferred units will be determined on a quarterly basis by the Board of Directors. The Board of Directors considers numerous factors each quarter in determining cash distributions including profitability, cash flow, debt service obligations, market conditions and outlook, estimated unitholder income tax liability and the level of cash reserves that the Board determines is necessary for future operating and capital needs. Segment Performance Coal Royalty and Other Revenues and other income in the fourth quarter and full year of 2020 were lower by $7.8 million and $87.3 million, respectively, and free cash flow in the fourth quarter and full year of 2020 was $5.1 million and $54.7 million lower, respectively, as compared to the prior year periods. These decreases are primarily a result of a weakened market for metallurgical coal in 2020 due to a decline in global steel demand, and as a result, both sales volumes and prices for metallurgical coal sold were lower in the fourth quarter and full year of 2020 as compared to the prior year periods. Approximately 70% of coal royalty revenues and approximately 60% of coal royalty sales volumes were derived from metallurgical coal in 2020. In addition, weaker domestic and export thermal coal markets compared to the prior year periods resulted in lower revenues from NRP's thermal coal properties. Furthermore, the COVID-19 pandemic compounded already weak coal pricing and demand, and NRP's coal lessees saw significant negative impacts on their businesses. NRP also recorded $2.7 million and $135.9 million in non-cash asset impairment expense in the fourth quarter and full year of 2020, respectively, as compared to $147.7 million and $148.2 million in non-cash asset impairment expense for the fourth quarter and full year of 2019, respectively. Asset impairments in 2020 primarily related to weak coal markets that were compounded by the COVID-19 pandemic and resulted in the termination of certain coal leases, changes to lessee mine plans resulting in permanent moves off of certain coal properties and decreased oil and gas drilling activity which negatively impacted the outlook for NRP's frac sand properties. Domestic and export thermal coal markets remain challenged by lower utility demand, continued low natural gas prices, the secular shift to renewable energy and the ongoing negative effects from the COVID-19 pandemic. Metallurgical coal markets also remain challenged by the uncertainties around the COVID-19 pandemic, but prices have rebounded from the lows seen in the second quarter of 2020. In addition to actively managing its currently producing coal and hard mineral properties over the last year, NRP has also been working to identify potential alternative revenue sources across its coal and hard mineral property portfolio. The Partnership has been evaluating opportunities which may exist in its surface and mineral property assets, where coal or other hard mineral development operations have ceased or have never been developed, as locations for environmentally sustainable projects, such as carbon sequestration or renewable energy projects. While NRP does not expect these activities to generate significant revenues or cash flow over the next several years, NRP believes its large ownership footprint throughout the United States will provide opportunities to create value in this regard with minimal capital investment by the Partnership. Soda Ash Ciner Wyoming was negatively impacted by the COVID-19 pandemic as lower demand for glass in the global auto, beverage container and construction industries reduced demand for soda ash. Revenues and other income in the fourth quarter and full year of 2020 were lower by $4.7 million and $36.4 million, respectively, as compared to the prior year periods primarily due to a combination of lower pricing and volumes sold. Distributions received from Ciner Wyoming were lower by $6.4 million and $17.6 million in the fourth quarter and full year of 2020, respectively, as compared to prior year periods due to Ciner Wyoming's decision to suspend distributions as announced in August of 2020. While Ciner Wyoming has yet to recover to pre-COVID-19 levels, fourth quarter 2020 overall sales volumes increased 9.5% and overall production volumes increased 49.1% over the third quarter 2020 results. NRP believes Ciner Wyoming's facility is competitively positioned as one of the lowest cost producers of soda ash in the world, however, NRP expects the market to remain volatile as a result of ongoing uncertainties with the COVID-19 pandemic. As previously mentioned, Ciner Wyoming suspended its quarterly distribution in August 2020 in an effort to achieve greater financial and liquidity flexibility during the COVID-19 pandemic and accordingly, did not pay quarterly distributions for the second, third or fourth quarters of 2020. Ciner Wyoming will continue to evaluate on a quarterly basis whether to reinstate the distribution. Ciner Wyomings ability to pay future quarterly distributions will be dependent in part on its cash reserves, liquidity, total debt levels and anticipated capital expenditures. Corporate and Financing Corporate and financing costs were $1.1 million and $38.3 million lower in the fourth quarter and full year of 2020, respectively, as compared to the prior year periods. The decrease in costs for the fourth quarter of 2020 is primarily due to lower interest expense as a result of less debt outstanding. The decrease in costs for the full year of 2020 is primarily due to the loss on extinguishment of debt of $29.3 million related to the refinancing and extension of both NRP's 2022 Senior Notes and revolving credit facility in the second quarter of 2019, as well as lower interest expense as a result of less debt outstanding. Free cash flow was $5.5 million and $21.9 million higher in the fourth quarter and full year of 2020, respectively, as compared to the prior year periods primarily due to lower cash paid for interest as a result of less debt outstanding in 2020. As noted earlier, NRP declared a fourth quarter $7.6 million distribution on its preferred units which was paid one-half in cash and one-half in kind. The indenture governing the 2025 parent company notes restricts NRP from paying more than one-half of the quarterly distribution on the preferred units in cash if NRP's consolidated leverage ratio exceeds 3.75x, and as of December 31, 2020, NRP's leverage ratio was 4.6x. NRP expect its leverage ratio to continue to exceed 3.75x for the foreseeable future. Conference Call A conference call will be held today at 9:00 a.m. ET. To register for the conference call, please use this link http://www.directeventreg.com/registration/event/6473098. After registering a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Registration is open through the live call, however, to ensure you are connected for the full call we suggest registering at least 10 minutes prior to the start of the call. Investors may also listen to the call via the Investor Relations section of the NRP website at www.nrplp.com. To access the replay, please visit the Investor Relations section of NRPs website. Company Profile Natural Resource Partners L.P., a master limited partnership headquartered in Houston, TX, is a diversified natural resource company that owns, manages and leases a diversified portfolio of mineral properties in the United States including interests in coal, industrial minerals and other natural resources. In addition, NRP owns an equity investment in Ciner Wyoming LLC, a trona ore mining and soda ash production business. For additional information, please contact Tiffany Sammis at 713-751-7515 or tsammis@nrplp.com. Further information about NRP is available on the Partnerships website at http://www.nrplp.com. Forward-Looking Statements This press release includes forward-looking statements as defined by the Securities and Exchange Commission. All statements, other than statements of historical facts, included in this press release that address activities, events or developments that the Partnership expects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions made by the Partnership based on its experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Partnership. These risks include, among other things, statements regarding: the effects of the global COVID-19 pandemic; future distributions on the Partnerships common and preferred units; the Partnership's business strategy; its liquidity and access to capital and financing sources; its financial strategy; prices of and demand for coal, trona and soda ash, and other natural resources; estimated revenues, expenses and results of operations; projected future performance by the Partnership's lessees, including Foresight Energy; Ciner Wyoming LLCs trona mining and soda ash refinery operations; distributions from the soda ash joint venture; the impact of governmental policies, laws and regulations, as well as regulatory and legal proceedings involving the Partnership, and of scheduled or potential regulatory or legal changes; global and U.S. economic conditions; and other factors detailed in Natural Resource Partners Securities and Exchange Commission filings. Natural Resource Partners L.P. has no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Non-GAAP Financial Measures "Adjusted EBITDA" is a non-GAAP financial measure that we define as net income (loss) from continuing operations less equity earnings from unconsolidated investment, net income attributable to non-controlling interest and gain on reserve swap; plus total distributions from unconsolidated investment, interest expense, net, debt modification expense, loss on extinguishment of debt, depreciation, depletion and amortization and asset impairments. Adjusted EBITDA should not be considered an alternative to, or more meaningful than, net income or loss, net income or loss attributable to partners, operating income or loss, cash flows from operating activities or any other measure of financial performance presented in accordance with GAAP as measures of operating performance, liquidity or ability to service debt obligations. There are significant limitations to using Adjusted EBITDA as a measure of performance, including the inability to analyze the effect of certain recurring items that materially affect our net income (loss), the lack of comparability of results of operations of different companies and the different methods of calculating Adjusted EBITDA reported by different companies. In addition, Adjusted EBITDA presented below is not calculated or presented on the same basis as Consolidated EBITDA as defined in our partnership agreement or Consolidated EBITDDA as defined in Opco's debt agreements. Adjusted EBITDA is a supplemental performance measure used by our management and by external users of our financial statements, such as investors, commercial banks, research analysts and others to assess the financial performance of our assets without regard to financing methods, capital structure or historical cost basis. Distributable cash flow or "DCF" is a non-GAAP financial measure that we define as net cash provided by (used in) operating activities of continuing operations plus distributions from unconsolidated investment in excess of cumulative earnings, proceeds from asset sales and disposals, including sales of discontinued operations, and return of long-term contract receivable; less maintenance capital expenditures and distributions to non-controlling interest. DCF is not a measure of financial performance under GAAP and should not be considered as an alternative to cash flows from operating, investing or financing activities. DCF may not be calculated the same for us as for other companies. In addition, distributable cash flow is not calculated or presented on the same basis as distributable cash flow as defined in our partnership agreement, which is used as a metric to determine whether we are able to increase quarterly distributions to our common unitholders. Distributable cash flow is a supplemental liquidity measure used by our management and by external users of our financial statements, such as investors, commercial banks, research analysts and others to assess our ability to make cash distributions and repay debt. Free cash flow or "FCF" is a non-GAAP financial measure that we define as net cash provided by (used in) operating activities of continuing operations plus distributions from unconsolidated investment in excess of cumulative earnings and return of long-term contract receivable; less maintenance and expansion capital expenditures, cash flow used in acquisition costs classified as investing or financing activities and distributions to non-controlling interest. FCF is calculated before mandatory debt repayments. Free cash flow is not a measure of financial performance under GAAP and should not be considered as an alternative to cash flows from operating, investing or financing activities. Free cash flow may not be calculated the same for us as for other companies. Free cash flow is a supplemental liquidity measure used by our management and by external users of our financial statements, such as investors, commercial banks, research analysts and others to assess our ability to make cash distributions and repay debt. "Cash flow cushion" is a non-GAAP financial measure that we define as free cash flow less one-time beneficial items, mandatory Opco debt repayments, preferred unit distributions and common unit distributions. Cash flow cushion is not a measure of financial performance under GAAP and should not be considered as an alternative to cash flows from operating, investing or financing activities. Cash flow cushion is a supplemental liquidity measure used by our management to assess the Partnership's ability to make or raise cash distributions to our common and preferred unitholders and our general partner and repay debt or redeem preferred units. "Return on capital employed" or "ROCE" is a non-GAAP financial measure that we define as net income (loss) from continuing operations plus financing costs (interest expense plus loss on extinguishment of debt) divided by the sum of equity excluding equity of discontinued operations, and debt. Return on capital employed should not be considered an alternative to, or more meaningful than, net income or loss, net income or loss attributable to partners, operating income or loss, cash flows from operating activities or any other measure of financial performance presented in accordance with GAAP as measures of operating performance, liquidity or ability to service debt obligations. Return on capital employed is a supplemental performance measure used by our management team that measures our profitability and efficiency with which our capital is employed. The measure provides an indication of operating performance before the impact of leverage in the capital structure. -Financial Tables and Reconciliation of Non-GAAP Measures Follow- Natural Resource Partners L.P. Financial Tables (Unaudited) Consolidated Statements of Comprehensive Income (Loss) For the Three Months Ended For the Year Ended December 31, September 30, December 31, (In thousands, except per unit data) 2020 2019 2020 2020 2019 Revenues and other income Coal royalty and other $ 31,327 $ 37,032 $ 25,740 $ 120,166 $ 191,069 Transportation and processing services 2,194 4,539 2,204 8,845 19,279 Equity in earnings of Ciner Wyoming 5,528 10,256 1,986 10,728 47,089 Gain (loss) on asset sales and disposals 116 (111) 581 6,498 Total revenues and other income $ 39,165 $ 51,716 $ 29,930 $ 140,320 $ 263,935 Operating expenses Operating and maintenance expenses $ 5,595 $ 5,925 $ 5,781 $ 24,795 $ 32,738 Depreciation, depletion and amortization 3,013 3,186 2,111 9,198 14,932 General and administrative expenses 3,125 3,931 3,634 14,293 16,730 Asset impairments 2,668 147,730 934 135,885 148,214 Total operating expenses $ 14,401 $ 160,772 $ 12,460 $ 184,171 $ 212,614 Income (loss) from operations $ 24,764 $ (109,056) $ 17,470 $ (43,851) $ 51,321 Other expenses, net Interest expense, net $ (10,077) $ (10,392) $ (10,254) $ (40,968) $ (47,453) Loss on extinguishment of debt (29,282) Total other expenses, net $ (10,077) $ (10,392) $ (10,254) $ (40,968) $ (76,735) Net income (loss) from continuing operations $ 14,687 $ (119,448) $ 7,216 $ (84,819) $ (25,414) Income from discontinued operations 750 956 Net income (loss) $ 14,687 $ (118,698) $ 7,216 $ (84,819) $ (24,458) Less: income attributable to preferred unitholders (7,612) (7,500) (7,500) (30,225) (30,000) Net income (loss) attributable to common unitholders and the general partner $ 7,075 $ (126,198) $ (284) $ (115,044) $ (54,458) Net income (loss) attributable to common unitholders $ 6,934 $ (123,674) $ (279) $ (112,743) $ (53,369) Net income (loss) attributable to the general partner 141 (2,524) (5) (2,301) (1,089) Income (loss) from continuing operations per common unit Basic $ 0.57 $ (10.15) $ (0.02) $ (9.20) $ (4.43) Diluted 0.56 (10.15) (0.02) (9.20) (4.43) Net income (loss) per common unit Basic $ 0.57 $ (10.09) $ (0.02) $ (9.20) $ (4.35) Diluted 0.56 (10.09) (0.02) (9.20) (4.35) Net income (loss) $ 14,687 $ (118,698) $ 7,216 $ (84,819) $ (24,458) Comprehensive income from unconsolidated investment and other 152 1,208 2,428 2,916 868 Comprehensive income (loss) $ 14,839 $ (117,490) 9,644 $ (81,903) $ (23,590) Natural Resource Partners L.P. Financial Tables (Unaudited) Consolidated Statements of Cash Flows For the Three Months Ended For the Year Ended December 31, September 30, December 31, (In thousands) 2020 2019 2020 2020 2019 Cash flows from operating activities Net income (loss) $ 14,687 $ (118,698) $ 7,216 $ (84,819) $ (24,458) Adjustments to reconcile net income (loss) to net cash provided by operating activities of continuing operations: Depreciation, depletion and amortization 3,013 3,186 2,111 9,198 14,932 Distributions from unconsolidated investment 6,370 14,210 31,850 Equity earnings from unconsolidated investment (5,528) (10,256) (1,986) (10,728) (47,089) Loss (gain) on asset sales and disposals (116) 111 (581) (6,498) Loss on extinguishment of debt 29,282 Income from discontinued operations (750) (956) Asset impairments 2,668 147,730 934 135,885 148,214 Bad debt expense 86 620 258 4,001 7,462 Unit-based compensation expense 1,004 519 913 3,570 2,361 Amortization of debt issuance costs and other 832 464 1,577 1,323 3,687 Change in operating assets and liabilities: Accounts receivable 4,859 (3,924) 4,621 12,853 (6,035) Accounts payable 14 (412) 144 207 (1,234) Accrued liabilities 780 1,427 791 (2,205) (3,656) Accrued interest (7,559) (12,048) 7,248 (602) (12,029) Deferred revenue (461) 3,188 (273) 9,733 (732) Other items, net (1,124) 1,867 769 (4,477) 2,218 Net cash provided by operating activities of continuing operations $ 13,155 $ 19,394 $ 24,323 $ 87,568 $ 137,319 Net cash provided by (used in) operating activities of discontinued operations (4) 1,706 (8) Net cash provided by operating activities $ 13,155 $ 19,390 $ 24,323 $ 89,274 $ 137,311 Cash flows from investing activities Proceeds from asset sales and disposals $ 116 $ (111) $ $ 623 $ 6,500 Return of long-term contract receivable 660 392 332 2,122 1,743 Acquisition of non-controlling interest in BRP (1,000) Acquisition of mineral rights (22) (22) Net cash provided by investing activities of continuing operations $ 776 $ 259 $ 332 $ 1,745 $ 8,221 Net cash provided by (used in) investing activities of discontinued operations 1 (73) (65) (629) Net cash provided by investing activities $ 777 $ 186 $ 332 $ 1,680 $ 7,592 Cash flows from financing activities Debt borrowings $ $ $ $ $ 300,000 Debt repayments (20,335) (20,335) (6,780) (46,176) (463,082) Distributions to common unitholders and general partner (5,630) (5,630) (5,630) (16,890) (33,150) Distributions to preferred unitholders (3,750) (7,500) (7,500) (26,363) (30,000) Contributions from (to) discontinued operations 1 (77) 1,641 (637) Debt issuance costs and other (9) (26,436) Net cash used in financing activities of continuing operations $ (29,714) $ (33,551) $ (19,910) $ (87,788) $ (253,305) Net cash provided by (used in) financing activities of discontinued operations (1) 77 (1,641) 637 Net cash used in financing activities $ (29,715) $ (33,474) $ (19,910) $ (89,429) $ (252,668) Net increase (decrease) in cash and cash equivalents $ (15,783) $ (13,898) $ 4,745 $ 1,525 $ (107,765) Cash and cash equivalents at beginning of period 115,573 112,163 110,828 98,265 206,030 Cash and cash equivalents at end of period $ 99,790 $ 98,265 $ 115,573 $ 99,790 $ 98,265 Supplemental cash flow information: Cash paid during the period for interest $ 17,118 $ 22,327 $ 2,490 $ 39,830 $ 58,597 Non-cash investing and financing activities: Plant, equipment, mineral rights and other funded with accounts payable or accrued liabilities $ 23 $ $ 23 $ 970 $ Preferred unit distributions paid-in-kind 3,750 3,750 Natural Resource Partners L.P. Financial Tables (Unaudited) Consolidated Balance Sheets December 31, (In thousands, except unit data) 2020 2019 ASSETS Current assets Cash and cash equivalents $ 99,790 $ 98,265 Accounts receivable, net 12,322 30,869 Other current assets, net 5,080 1,244 Current assets of discontinued operations 1,706 Total current assets $ 117,192 $ 132,084 Land 24,008 24,008 Mineral rights, net 460,373 605,096 Intangible assets, net 17,459 17,687 Equity in unconsolidated investment 262,514 263,080 Long-term contract receivable, net 33,264 36,963 Other long-term assets, net 7,067 6,989 Total assets $ 921,877 $ 1,085,907 LIABILITIES AND CAPITAL Current liabilities Accounts payable $ 1,385 $ 1,179 Accrued liabilities 7,733 8,764 Accrued interest 1,714 2,316 Current portion of deferred revenue 11,485 4,608 Current portion of long-term debt, net 39,055 45,776 Current liabilities of discontinued operations 65 Total current liabilities $ 61,372 $ 62,708 Deferred revenue 50,069 47,213 Long-term debt, net 432,444 470,422 Other non-current liabilities 5,131 4,949 Total liabilities $ 549,016 $ 585,292 Commitments and contingencies Class A Convertible Preferred Units (253,750 and 250,000 units issued and outstanding at December 31, 2020 and 2019, respectively, at $1,000 par value per unit; liquidation preference of $1,700 per unit and $1,500 per unit at December 31, 2020 and 2019, respectively) $ 168,337 $ 164,587 Partners capital: Common unitholders interest (12,261,199 units issued and outstanding at December 31, 2020 and 2019) $ 136,927 $ 271,471 General partners interest 459 3,270 Warrant holders' interest 66,816 66,816 Accumulated other comprehensive income (loss) 322 (2,594) Total partners capital $ 204,524 $ 338,963 Non-controlling interest (2,935) Total capital $ 204,524 $ 336,028 Total liabilities and capital $ 921,877 $ 1,085,907 Natural Resource Partners L.P. Financial Tables (Unaudited) Consolidated Statements of Partners' Capital Common Unitholders General Partner Warrant Holders Accumulated Other Comprehensive Income (Loss) Partners' Capital Excluding Non-Controlling Interest Non-Controlling Interest Total Capital (In thousands) Units Amounts Balance at December 31, 2018 12,249 $ 355,113 $ 5,014 $ 66,816 $ (3,462) $ 423,481 $ (2,935) $ 420,546 Net loss (1) (23,969) (489) (24,458) (24,458) Distributions to common unitholders and general partner (32,487) (663) (33,150) (33,150) Distributions to preferred unitholders (29,400) (600) (30,000) (30,000) Issuance of unit-based awards 12 486 486 486 Unit-based awards amortization and vesting 1,804 1,804 1,804 Comprehensive income (loss) from unconsolidated investment and other (76) 8 868 800 800 Balance at December 31, 2019 12,261 $ 271,471 $ 3,270 $ 66,816 $ (2,594) $ 338,963 $ (2,935) $ 336,028 Cumulative effect of adoption of accounting standard (3,833) (78) (3,911) (3,911) Net loss (2) (83,123) (1,696) (84,819) (84,819) Distributions to common unitholders and general partner (16,552) (338) (16,890) (16,890) Distributions to preferred unitholders (29,511) (602) (30,113) (30,113) Acquisition of non-controlling interest in BRP (4,747) (97) (4,844) 2,935 (1,909) Issuance of unit-based awards Unit-based awards amortization and vesting 3,222 3,222 3,222 Comprehensive income from unconsolidated investment and other 2,916 2,916 2,916 Balance at December 31, 2020 12,261 $ 136,927 $ 459 $ 66,816 $ 322 $ 204,524 $ $ 204,524 (1) Net loss includes $30.0 million of income attributable to preferred unitholders that accumulated during the period, of which $29.4 million is allocated to the common unitholders and $0.6 million is allocated to the general partner. (2) Net loss includes $30.2 million of income attributable to preferred unitholders that accumulated during the period, of which $29.6 million is allocated to the common unitholders and $0.6 million is allocated to the general partner. Natural Resource Partners L.P. Financial Tables (Unaudited) The following tables present NRP's unaudited business results by segment for the three months ended December 31, 2020 and 2019 and September 30, 2020: Operating Segments Coal Royalty and Other Corporate and Financing (In thousands) For the Three Months Ended December 31, 2020 Revenues $ 33,521 $ 5,528 $ $ 39,049 Gain on asset sales and disposals 116 116 Total revenues and other income $ 33,637 $ 5,528 $ $ 39,165 Asset impairments $ 2,668 $ $ $ 2,668 Net income (loss) from continuing operations $ 22,382 $ 5,484 $ (13,179) $ 14,687 Adjusted EBITDA (1) $ 28,086 $ (44) $ (3,125) $ 24,917 Cash flow provided by (used in) continuing operations: Operating activities $ 33,655 $ (54) $ (20,446) $ 13,155 Investing activities $ 776 $ $ $ 776 Financing activities $ $ $ (29,714) $ (29,714) Distributable cash flow (1) (2) $ 34,431 $ (54) $ (20,446) $ 13,932 Free cash flow (1) $ 34,315 $ (54) $ (20,446) $ 13,815 For the Three Months Ended December 31, 2019 Revenues $ 41,571 $ 10,256 $ $ 51,827 Loss on asset sales and disposals (111) (111) Total revenues and other income $ 41,460 $ 10,256 $ $ 51,716 Asset impairments $ 147,730 $ $ $ 147,730 Net income (loss) from continuing operations $ (115,355) $ 10,230 $ (14,323) $ (119,448) Adjusted EBITDA (1) $ 35,561 $ 6,344 $ (3,931) $ 37,974 Cash flow provided by (used in) continuing operations: Operating activities $ 39,042 $ 6,344 $ (25,992) $ 19,394 Investing activities $ 259 $ $ $ 259 Financing activities $ $ $ (33,551) $ (33,551) Distributable cash flow (1) (2) $ 39,323 $ 6,344 $ (25,992) $ 19,602 Free cash flow (1) $ 39,412 $ 6,344 $ (25,992) $ 19,764 For the Three Months Ended September 30, 2020 Revenues $ 27,944 $ 1,986 $ $ 29,930 Gain on asset sales and disposals Total revenues and other income $ 27,944 $ 1,986 $ $ 29,930 Asset impairments $ 934 $ $ $ 934 Net income (loss) from continuing operations $ 19,173 $ 1,890 $ (13,847) $ 7,216 Adjusted EBITDA (1) $ 22,259 $ (96) $ (3,634) $ 18,529 Cash flow provided by (used in) continuing operations: Operating activities $ 28,573 $ (75) $ (4,175) $ 24,323 Investing activities $ 332 $ $ $ 332 Financing activities $ $ $ (19,910) $ (19,910) Distributable cash flow (1) $ 28,905 $ (75) $ (4,175) $ 24,655 Free cash flow (1) $ 28,905 $ (75) $ (4,175) $ 24,655 (1) See "Non-GAAP Financial Measures" and reconciliation tables at the end of this release. (2) Includes net proceeds from the sale of the construction aggregates business which are classified as investing cash flow from discontinued operations. Natural Resource Partners L.P. Financial Tables (Unaudited) The following tables present NRP's unaudited business results by segment for the years ended December 31, 2020 and 2019: Operating Business Segments Coal Royalty and Other Corporate and Financing (In thousands) Soda Ash Total For the Year Ended December 31, 2020 Revenues $ 129,011 $ 10,728 $ $ 139,739 Gain on asset sales and disposals 581 581 Total revenues and other income $ 129,592 $ 10,728 $ $ 140,320 Asset impairments $ 135,885 $ $ $ 135,885 Net income (loss) from continuing operations $ (40,180) $ 10,543 $ (55,182) $ (84,819) Adjusted EBITDA (1) $ 104,982 $ 14,025 $ (14,293) $ 104,714 Cash flow provided by (used in) continuing operations: Operating activities $ 124,737 $ 14,037 $ (51,206) $ 87,568 Investing activities $ 1,745 $ $ $ 1,745 Financing activities $ $ $ (87,788) $ (87,788) Distributable cash flow (1) (2) $ 127,482 $ 14,037 $ (51,206) $ 90,248 Free cash flow (1) $ 125,859 $ 14,037 $ (51,206) $ 88,690 For the Year Ended December 31, 2019 Revenues $ 210,348 $ 47,089 $ $ 257,437 Gain on asset sales and disposals 6,498 6,498 Total revenues and other income $ 216,846 $ 47,089 $ $ 263,935 Asset impairments $ 148,214 $ $ $ 148,214 Net income (loss) from continuing operations $ 21,211 $ 46,840 $ (93,465) $ (25,414) Adjusted EBITDA (1) $ 184,357 $ 31,601 $ (16,730) $ 199,228 Cash flow provided by (used in) continuing operations: Operating activities $ 178,863 $ 31,601 $ (73,145) $ 137,319 Investing activities $ 8,221 $ $ $ 8,221 Financing activities $ $ $ (253,305) $ (253,305) Distributable cash flow (1) (2) $ 187,106 $ 31,601 $ (73,145) $ 144,933 Free cash flow (1) $ 180,584 $ 31,601 $ (73,145) $ 139,040 (1) See "Non-GAAP Financial Measures" and reconciliation tables at the end of this release. (2) Includes net proceeds from the sale of the construction aggregates business which are classified as investing cash flow from discontinued operations. Natural Resource Partners L.P. Financial Tables (Unaudited) Operating Statistics - Coal Royalty and Other For the Three Months Ended For the Year Ended December 31, September 30, December 31, (In thousands, except per ton data) 2020 2019 2020 2020 2019 Coal sales volumes (tons) Appalachia Northern (1) 131 686 102 647 3,460 Central 2,468 2,908 2,247 10,111 13,377 Southern 69 498 172 889 1,670 Total Appalachia 2,668 4,092 2,521 11,647 18,507 Illinois Basin 1,540 555 758 3,381 2,201 Northern Powder River Basin 506 1,057 365 1,738 3,036 Total coal sales volumes 4,714 5,704 3,644 16,766 23,744 Coal royalty revenue per ton Appalachia Northern (1) $ 2.92 $ 0.88 $ 3.06 $ 2.36 $ 1.96 Central 3.84 4.58 3.83 4.17 5.53 Southern 5.28 5.96 4.78 4.75 6.69 Illinois Basin 2.21 4.53 1.63 2.36 4.66 Northern Powder River Basin 3.11 2.33 3.46 3.50 2.90 Combined average coal royalty revenue per ton 3.23 3.84 3.36 3.70 4.67 Coal royalty revenues Appalachia Northern (1) $ 383 $ 602 $ 312 $ 1,526 $ 6,775 Central 9,481 13,332 8,602 42,207 73,960 Southern 364 2,965 823 4,221 11,169 Total Appalachia 10,228 16,899 9,737 47,954 91,904 Illinois Basin 3,403 2,516 1,234 7,973 10,255 Northern Powder River Basin 1,576 2,462 1,262 6,086 8,809 Unadjusted coal royalty revenues 15,207 21,877 12,233 62,013 110,968 Coal royalty adjustment for minimum leases (2) (3,898) 174 (1,623) (10,145) (1,356) Total coal royalty revenues $ 11,309 $ 22,051 $ 10,610 $ 51,868 $ 109,612 Other revenues Production lease minimum revenue (2) $ 8,195 $ 2,737 $ 4,267 $ 21,749 $ 24,068 Minimum lease straight-line revenues (2) 4,447 3,758 3,553 16,796 14,910 Property tax revenues 1,530 1,871 1,896 5,786 6,287 Wheelage revenues 1,557 845 1,680 7,025 5,880 Coal overriding royalty revenues 1,658 3,333 1,314 4,977 13,496 Lease amendment revenues 859 1,271 858 3,450 7,991 Aggregates royalty revenues 649 610 221 1,717 4,265 Oil and gas royalty revenues 893 456 1,078 5,816 3,031 Other revenues 230 100 263 982 1,529 Total other revenues $ 20,018 $ 14,981 $ 15,130 $ 68,298 $ 81,457 Coal royalty and other $ 31,327 $ 37,032 $ 25,740 $ 120,166 $ 191,069 Transportation and processing services revenues 2,194 4,539 2,204 8,845 19,279 Gain (loss) on asset sales and disposals 116 (111) 581 6,498 Total Coal Royalty and Other segment revenues and other income $ 33,637 $ 41,460 $ 27,944 $ 129,592 $ 216,846 (1) Northern Appalachia includes NRP's Hibbs Run property that has significant sales volumes, but a low fixed rate per ton. (2) Effective January 1, 2020, certain revenues previously classified as coal royalty revenues are classified as production lease minimum revenues or minimum lease straight-line revenues due to contract modifications with Foresight Energy Resources LLC ("Foresight") that fixed consideration paid to us over a two-year period. Natural Resource Partners L.P. Financial Tables (Unaudited) Adjusted EBITDA Coal Royalty and Other Corporate and Financing (In thousands) Soda Ash Total For the Three Months Ended December 31, 2020 Net income (loss) from continuing operations 22,382 5,484 (13,179) $ 14,687 Less: equity earnings from unconsolidated investment (5,528) (5,528) Add: total distributions from unconsolidated investment Add: interest expense, net 23 10,054 10,077 Add: depreciation, depletion and amortization 3,013 3,013 Add: asset impairments 2,668 2,668 Adjusted EBITDA $ 28,086 $ (44) $ (3,125) $ 24,917 For the Three Months Ended December 31, 2019 Net income (loss) from continuing operations $ (115,355) $ 10,230 $ (14,323) $ (119,448) Less: equity earnings from unconsolidated investment (10,256) (10,256) Add: total distributions from unconsolidated investment 6,370 6,370 Add: interest expense, net 10,392 10,392 Add: depreciation, depletion and amortization 3,186 3,186 Add: asset impairments 147,730 147,730 Adjusted EBITDA $ 35,561 $ 6,344 $ (3,931) $ 37,974 For the Three Months Ended September 30, 2020 Net income (loss) from continuing operations $ 19,173 $ 1,890 (13,847) $ 7,216 Less: equity earnings from unconsolidated investment (1,986) (1,986) Add: total distributions from unconsolidated investment Add: interest expense, net 41 10,213 10,254 Add: depreciation, depletion and amortization 2,111 2,111 Add: asset impairments 934 934 Adjusted EBITDA $ 22,259 $ (96) $ (3,634) $ 18,529 Natural Resource Partners L.P. Financial Tables (Unaudited) Adjusted EBITDA Coal Royalty and Other Corporate and Financing (In thousands) Soda Ash Total For the Year Ended December 31, 2020 Net income (loss) from continuing operations $ (40,180) $ 10,543 $ (55,182) $ (84,819) Less: equity earnings from unconsolidated investment (10,728) (10,728) Add: total distributions from unconsolidated investment 14,210 14,210 Add: interest expense, net 79 40,889 40,968 Add: loss on extinguishment of debt Add: depreciation, depletion and amortization 9,198 9,198 Add: asset impairments 135,885 135,885 Adjusted EBITDA $ 104,982 $ 14,025 $ (14,293) $ 104,714 For the Year Ended December 31, 2019 Net income (loss) from continuing operations $ 21,211 $ 46,840 $ (93,465) $ (25,414) Less: equity earnings from unconsolidated investment (47,089) (47,089) Add: total distributions from unconsolidated investment 31,850 31,850 Add: interest expense, net 47,453 47,453 Add: loss on extinguishment of debt 29,282 29,282 Add: depreciation, depletion and amortization 14,932 14,932 Add: asset impairments 148,214 148,214 Adjusted EBITDA $ 184,357 $ 31,601 $ (16,730) $ 199,228 Natural Resource Partners L.P. Financial Tables (Unaudited) Distributable Cash Flow and Free Cash Flow Coal Royalty and Other Corporate and Financing (In thousands) Soda Ash Total For the Three Months Ended December 31, 2020 Net cash provided by (used in) operating activities of continuing operations $ 33,655 $ (54) $ (20,446) 13,155 Add: proceeds from asset sales and disposals 116 116 Add: proceeds from sale of discontinued operations 1 Add: return of long-term contract receivable 660 660 Distributable cash flow $ 34,431 $ (54) $ (20,446) $ 13,932 Less: proceeds from asset sales and disposals (116) (116) Less: proceeds from sale of discontinued operations (1) Less: acquisition costs Free cash flow $ 34,315 $ (54) $ (20,446) $ 13,815 For the Three Months Ended December 31, 2019 Net cash provided by (used in) operating activities of continuing operations $ 39,042 $ 6,344 $ (25,992) $ 19,394 Add: proceeds from asset sales and disposals (111) (111) Add: proceeds from sale of discontinued operations (73) Add: return of long-term contract receivable 392 392 Distributable cash flow $ 39,323 $ 6,344 $ (25,992) $ 19,602 Less: proceeds from asset sales and disposals 111 111 Less: proceeds from sale of discontinued operations 73 Less: acquisition costs (22) (22) Free cash flow $ 39,412 $ 6,344 $ (25,992) $ 19,764 For the Three Months Ended September 30, 2020 Net cash provided by (used in) operating activities of continuing operations $ 28,573 $ (75) $ (4,175) $ 24,323 Add: proceeds from asset sales and disposals Add: proceeds from sale of discontinued operations Add: return of long-term contract receivable 332 332 Distributable cash flow $ 28,905 $ (75) $ (4,175) $ 24,655 Less: proceeds from asset sales and disposals Less: proceeds from sale of discontinued operations Less: acquisition costs Free cash flow $ 28,905 $ (75) $ (4,175) $ 24,655 Natural Resource Partners L.P. Financial Tables (Unaudited) Distributable Cash Flow and Free Cash Flow Coal Royalty and Other Corporate and Financing (In thousands) Soda Ash Total For the Year Ended December 31, 2020 Net cash provided by (used in) operating activities of continuing operations $ 124,737 $ 14,037 $ (51,206) $ 87,568 Add: proceeds from asset sales and disposals 623 623 Add: proceeds from sale of discontinued operations (65) Add: return of long-term contract receivable 2,122 2,122 Distributable cash flow $ 127,482 $ 14,037 $ (51,206) $ 90,248 Less: proceeds from asset sales and disposals (623) (623) Less: proceeds from sale of discontinued operations 65 Less: acquisition costs (1,000) (1,000) Free cash flow $ 125,859 $ 14,037 $ (51,206) $ 88,690 For the Year Ended December 31, 2019 Net cash provided by (used in) operating activities of continuing operations $ 178,863 $ 31,601 $ (73,145) $ 137,319 Add: proceeds from asset sales and disposals 6,500 6,500 Add: proceeds from sale of discontinued operations (629) Add: return of long-term contract receivable 1,743 1,743 Distributable cash flow $ 187,106 $ 31,601 $ (73,145) $ 144,933 Less: proceeds from asset sales and disposals (6,500) (6,500) Less: proceeds from sale of discontinued operations 629 Less: acquisition costs (22) (22) Free cash flow $ 180,584 $ 31,601 $ (73,145) $ 139,040 Cash Flow Cushion For the Year Ended December 31, (In thousands) 2020 2019 Free cash flow $ 88,690 $ 139,040 Less: mandatory Opco debt repayments (46,176) (68,128) Less: preferred unit distributions and redemption of PIK units (26,363) (30,000) Less: common unit distributions (16,890) (33,150) Cash flow cushion $ (739) $ 7,762 Leverage Ratio (In thousands) For the Year Ended December 31, 2020 Adjusted EBITDA $ 104,714 Debtat December 31, 2020 $ 477,880 Leverage Ratio (1) 4.6x (1) Leverage Ratio is calculated as the outstanding principal of NRP's debt as of December 31, 2020 divided by the last twelve months' Adjusted EBITDA. Note that Adjusted EBITDA under the indenture governing NRP's 2025 parent company notes may be different than the amount shown above. However, NRP's last twelve months Leverage ratio as of December 31, 2020, was 4.6x as calculated under the indenture governing NRP's 2025 parent company notes. Natural Resource Partners L.P. Financial Tables (Unaudited) Return on Capital Employed ("ROCE") Coal Royalty and Other Corporate and Financing (In thousands) Soda Ash Total LTM Ended December 31, 2020 Net income (loss) from continuing operations $ (40,180) $ 10,543 $ (55,182) $ (84,819) Financing costs 79 41,275 41,354 Return $ (40,101) $ 10,543 $ (13,907) $ (43,465) As of December 31, 2019 Total assets of continuing operations $ 817,768 $ 263,080 $ 3,353 $ 1,084,201 Less: total current liabilities of continuing operations excluding current debt (11,542) (5,325) (16,867) Less: total long-term liabilities of continuing operations excluding long-term debt (51,700) (462) (52,162) Capital employed excluding discontinued operations $ 754,526 $ 263,080 $ (2,434) $ 1,015,172 Total partners' capital (1) $ 757,461 $ 263,080 $ (683,219) $ 338,963 Less: non-controlling interest (2,935) (2,935) Less: partners' capital from discontinued operations (1,641) Total partners' capital excluding discontinued operations $ 754,526 $ 263,080 $ (683,219) $ 334,387 Class A convertible preferred units 164,587 164,587 Debt 516,198 516,198 Capital employed excluding discontinued operations $ 754,526 $ 263,080 $ (2,434) $ 1,015,172 ROCE excluding discontinued operations (5.3)% 4.0% N/A (4.3)% Excluding asset impairments: Return $ (40,101) $ 10,543 $ (13,907) $ (43,465) Add: asset impairments 135,885 135,885 Return excluding asset impairments $ 95,784 $ 10,543 $ (13,907) $ 92,420 ROCE excluding discontinued operations and asset impairments 12.7% 4.0% N/A 9.1% (1) Total partners' capital includes $1.6 million from discontinued operations.

Natural Resource Partners L.P. Reports Fourth Quarter and Full Year 2020 Results

MIAMI, Nov. 9, 2020 /PRNewswire/ --Hemisphere Media Group, Inc. (NASDAQ: HMTV) ("Hemisphere" or the "Company"), the only publicly traded pure-play U.S. media company targeting the high growth U.S. Hispanic and Latin American markets with leading broadcast and cable television and digital content platforms, today announced financial results for the third quarter ended September 30, 2020. President and Chief Executive Officer of Hemisphere, Alan Sokol, said, "I am proud of our performance in the third quarter, especially given the headwinds we faced due to the pandemic. We delivered an impressive 27% increase in advertising revenue, a trend that we have continued into the fourth quarter, reaching an all-time historic high in advertising revenue in October. "We delivered terrific results at WAPA, fueled by a rebounding advertising market in Puerto Rico and our continued dominant ratings performance. WAPA achieved the highest third quarter ratings in its history in the key Adults 18-49 and 25-54 advertiser demographics. WAPA has now beaten its two major competitors combined in total day ratings for four consecutive quarters, which is a first since Nielsen commenced measuring ratings in Puerto Rico. "In the U.S., Pasiones, CentroAmerica TV and Cinelatino all defied overall viewing trends, growing total day ratings by over 10%, with CentroAmerica TV increasing total day ratings by nearly 40%. Pasiones delivered its 15th consecutive quarter of year-over-year audience growth, continuing to outperform in prime time. This terrific ratings performance drove strong year-overyear advertising revenue growth for our cable networks. "During the third quarter, we entered into a renewal of our retransmission agreement with the largest distributor in Puerto Rico, which will be effective January 1, 2021. This agreement provides for a substantial retransmission fee increase. "We continue to diversify our revenue streams by licensing our valuable content library to existing and new streaming platforms in the U.S. and Latin America. Pantaya remains a bright spot as our audience continue to enjoy its unique premium content offering, and we have an exciting pipeline of movies and series in production. "Our portfolio of unique assets has delivered outstanding performance and we are excited by our prospects for the fourth quarter and the upcoming year." Financial Results for the Three and Nine Months Ended September 30, 2020 Net revenues were $37.2 million for the three months ended September 30, 2020, an increase of 4%, as compared to net revenues of $35.8 million for the same period in 2019. The improvement was due to an increase in advertising revenue, which was offset in part by decreases in affiliate revenue and other revenue. Advertising revenue increased $3.8 million, or 27%, primarily due to the growth in the Puerto Rico television advertising market and an increase in WAPA's share of the advertising market, political advertising revenue, and an increase in core advertising revenue across our U.S. cable networks. Excluding political, advertising revenues increased 18% for the three months ended September 30, 2020 as compared to the same period in 2019. Affiliate revenue decreased $1.9 million, or 9%, due to a decline in subscribers to our U.S. cable networks and a decline in non-U.S. affiliate revenue as a result of subscriber and fee declines, due in part to unfavorable foreign currency movements. Other revenue decreased $0.5 million, or 47%, driven by the timing of the licensing of content to third parties. Net revenues were $104.3 million for the nine months ended September 30, 2020, a decrease of 5%, as compared to $110.1 million for the same period in 2019. The decline was due to decreases in affiliate revenue and advertising revenue, which were offset in part by an increase in other revenue. Affiliate revenue decreased $5.7 million, or 9%, due to a decline in subscribers to our U.S. cable networks, and a decline in non-U.S. affiliate revenue as a result of subscriber and fee declines, due in part to unfavorable foreign currency movements. Advertising revenue decreased $0.9 million, or 2%, due to the negative impact of the earthquakes in January and then the COVID-19 pandemic on the Puerto Rico television advertising market, which more than offset the growth in advertising revenue during the three month period ended September 30, 2020. Other revenue increased $0.8 million, or 23%, driven by the licensing of content to third parties. Operating expenses were $23.8 million for the three months ended September 30, 2020, a decrease of 6%, as compared to operating expenses of $25.3 million for the same period in 2019. This was primarily driven by a decrease in selling and general administrative costs, largely due to lower stock-based compensation and reduced marketing and research, including the termination of Nielsen ratings services for Cinelatino. These declines were offset in part by higher programming and production costs due to coverage of the elections in Puerto Rico, higher personnel expenses and an increase in the bad debt reserve. The third quarter also benefited from a gain from FCC spectrum repack of $1.0 million as compared to $0.2 million in the same period in 2019, due to the timing of reimbursements received from the FCC for equipment purchases required as a result of the FCC spectrum repack. Operating expenses were $77.9 million for the nine months ended September 30, 2020, an increase of 5%, as compared to operating expenses of $74.3 million for the same period in 2019. The increase was due to higher programming amortization in the current quarter, as a result of increased content licensed to third parties, and higher production expenses related to Guerreros, a daily reality show at WAPA, which commenced production in May 2019. The nine-month period also reflected a smaller gain from FCC spectrum repack and other of $0.8 million, as compared to $1.7 million in the same period in 2019, due to the timing of reimbursements received from the FCC and to the recording of a loss on the disposal of assets, as well as $3.0 millionin professional and advisory fees incurred in connection with pursuit of strategic transactions earlier this year. This was partially offset by cost savings measures implemented in response to the COVID-19 pandemic, including reduced personnel expenses and marketing and research costs, which resulted in lower selling, general and administrative expenses. Net income attributable to Hemisphere Media Group, Inc. was $5.3 million for the three months ended September 30, 2020, as compared to a net loss of $3.2 million for the same period in 2019. Net loss was $10.8 million for the nine months ended September 30, 2020, as compared to a net loss of $7.2 million for the same period in 2019. Adjusted EBITDA was $16.7 million for the three months ended September 30, 2020, an increase of 6%, as compared to Adjusted EBITDA of $15.7 million for the same period in 2019. Adjusted EBITDA was $41.5 million for the nine months ended September 30, 2020, a decrease of 14%, as compared to Adjusted EBITDA of $48.1 million for the same period in 2019. As of September 30, 2020, the Company had $205.3 million in debt and $117.7 million of cash. The Company's gross leverage ratio was approximately 3.4x, and net leverage ratio was approximately 1.5x. During the three months ended September 30, 2020, the Company funded $1.1 million into its joint ventures, bringing the year-to-date total to $7.5 million, down from $27.4 million in the same period in 2019. (1) See the Non-GAAP Reconciliations section of this earnings release for a discussion of non-GAAP financial measures used in this release. The following tables set forth the Company's financial performance for the three and nine months ended September 30, 2020 and 2019, as well as select financial data as of September 30, 2020 and December 31, 2019: HEMISPHERE MEDIA GROUP, INC.Comparison of Consolidated Operating Results(amounts in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (Unaudited) (Unaudited) Net revenues $ 37,172 $ 35,846 $ 104,316 $ 110,103 Operating Expenses: Cost of revenues 10,994 10,445 34,521 31,976 Selling, general and administrative 10,819 11,869 32,260 33,583 Depreciation and amortization 2,771 2,581 8,696 9,204 Other expenses 172 530 3,220 1,183 Gain from FCC spectrum repack and other (1,004) (154) (831) (1,661) Total operating expenses 23,752 25,271 77,866 74,285 Operating income 13,420 10,575 26,450 35,818 Other expenses, net: Interest expense and other, net (2,551) (3,113) (7,833) (9,078) Loss on equity method investments (988) (6,888) (18,196) (24,048) Impairment of equity method investment - - (5,479) - Total other expenses, net (3,539) (10,001) (31,508) (33,126) Income (loss) before income taxes 9,881 574 (5,058) 2,692 Income tax expense (4,664) (3,743) (5,873) (9,942) Net income (loss) $ 5,217 $ (3,169) $ (10,931) $ (7,250) Net loss attributable to noncontrolling interests 80 - 118 37 Net income (loss) attributable to Hemisphere Media Group, Inc. $ 5,297 $ (3,169) $ (10,813) $ (7,213) Reconciliation of net income (loss) attributable to Hemisphere Media Group, Inc. to Adjusted EBITDA: Net income (loss) attributable to Hemisphere Media Group, Inc. $ 5,297 $ (3,169) $ (10,813) $ (7,213) Add (Deduct): Net loss attributable to noncontrolling interests (80) - (118) (37) Income tax expense 4,664 3,743 5,873 9,942 Impairment of equity method investment - - 5,479 - Loss on equity method investments 988 6,888 18,196 24,048 Interest expense and other, net 2,551 3,113 7,833 9,078 Gain from FCC spectrum repack and other (1,004) (154) (831) (1,661) Transaction and non-recurring expenses 216 530 3,264 1,190 Depreciation and amortization 2,771 2,581 8,696 9,204 Stock-based compensation 1,315 2,175 3,951 3,535 Adjusted EBITDA $ 16,718 $ 15,707 $ 41,530 $ 48,086 Selected Financial Data:(amounts in thousands) As of As of September 30, 2020 December 31, 2019 (Unaudited) (Audited) Cash $117,741 $92,151 Debt (a) $205,346 $206,947 Leverage ratio (b): 3.4x 3.1x Net leverage ratio (c): 1.5x 1.7x (a) Represents the aggregate principal amount of the debt. (b) Represents gross debt divided by Adjusted EBITDA for the last twelve months. This ratio differs from the calculation contained in the Company's amended term loan. (c) Represents gross debt less cash divided by Adjusted EBITDA for the last twelve months. This ratio differs from the calculation contained in the Company's amended term loan. The following table presents estimated subscriber information (unaudited): Subscribers(a)(amountsinthousands) September 30, 2020 December 31, 2019 September 30, 2019 U.S. Cable Networks: WAPA America (b) 3,728 4,140 4,290 Cinelatino 3,831 4,364 4,497 Pasiones 4,147 4,626 4,739 Centroamerica TV 3,473 3,976 4,126 Television Dominicana 2,179 2,345 2,396 Total 17,358 19,451 20,048 Latin America Cable Networks: Cinelatino 14,138 16,132 16,165 Pasiones 13,931 16,763 16,686 Total 28,069 32,895 32,851 (a) Amounts presented are based on most recent remittances received from the Company's distributors as of the respective dates shown above, which are typically two months prior to the dates shown above. (b) Excludes digital basic subscribers. Non-GAAP Reconciliations Within Hemisphere's third quarter 2020 press release, Hemisphere makes reference to the non-GAAP financial measure, "Adjusted EBITDA." Whenever such information is presented, Hemisphere has complied with the provisions of the rules under Regulation G and Item 2.02 of Form 8-K. When presenting Adjusted EBITDA, Hemisphere's management adds back (deducts) from net income (loss) attributable to Hemisphere Media Group, Inc., net loss attributable to non-controlling interest, depreciation expense, amortization of intangibles, gain from FCC spectrum repack and other, impairment on equity method investment, loss on equity method investment, interest expense and other, net, transaction and non-recurring expenses, income tax expense, and stock-based compensation. The specific reasons why Hemisphere's management believes that the presentation of this non-GAAP financial measure provides useful information to investors regarding Hemisphere's financial condition, results of its operations and cash flows has been provided in the Form 8-K filed in connection with this press release. A reconciliation of net income (loss) attributable to Hemisphere Media Group, Inc. to Adjusted EBITDA can be found above in the table that sets forth Hemisphere's financial performance for the three and nine months ended September 30, 2020 and 2019. Conference Call Hemisphere will conduct a conference call to discuss its third quarter 2020 results at 10:00 AM ET on Monday, November 9, 2020. A live broadcast of the conference call will be available online via the Company's Investor Relations website located at http://ir.hemispheretv.com/. Alternatively, interested parties can access the conference call by dialing (877) 497-1436, or from outside the United States at (262) 558-6292, at least five minutes prior to the start time. The conference ID for the call is 9365609. A replay of the call will be available beginning at approximately 1:00 PM ET on Monday, November 9, 2020 by dialing (855) 859-2056, or from outside the United States by dialing (404) 537-3406. The conference ID for the replay is 9365609. Forward-Looking Statements Statements in this press release and oral statements made from time to time by representatives of Hemisphere may contain certain statements about Hemisphere and its consolidated subsidiaries that are "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These include, but are not limited to, the deterioration of general economic conditions, political instability, social unrest, and public health crises, such as the occurrence of a global pandemic like the novel coronavirus, either nationally or in the local markets in which Hemisphere operates, Puerto Rico's uncertain political climate, as well as delays in the disbursement of earmarked federal funds on the local economy and advertising market, the effects of Hurricane Maria and recent earthquakes in Puerto Rico on Hemisphere's business and the advertising market in Puerto Rico as well as Hemisphere's customers, employees, third-party vendors and suppliers, the effect on affiliate revenue that Hemisphere receives, short and long-term migration shifts in Puerto Rico, Hemisphere's ability to timely and fully recover proceeds under our insurance policies Hemisphere's ability to successfully integrate acquired assets and achieve anticipated synergies, statements relating to Hemisphere's future financial and operating results (including growth and earnings), plans, objectives, expectations and intentions and other statements that are not historical facts. These statements are based on the current expectations of the management of Hemisphere and are subject to uncertainty and changes in circumstance, which may cause actual results to differ materially from those expressed or implied in such forward-looking statements. Without limitation, any statements preceded or followed by or that include the words "targets," "plans," "believes," "expects," "intends," "will," "likely," "may," "anticipates," "estimates," "projects," "should," "would," "expect," "positioned," "strategy," "future," or words, phrases or terms of similar substance or the negative thereof, are forward-looking statements. In addition, these statements are based on a number of assumptions that are subject to change. Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements are discussed under the headings "Risk Factors" and "Forward-Looking Statements" in Hemisphere's most recent Annual Report on Form 10-K, filed with the Securities and Exchange Commission ("SEC"), as they may be updated in any future reports filed with the SEC. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, Hemisphere's actual results, performance, or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements included herein are made as of the date hereof, and Hemisphere undertakes no obligation to update publicly such statements to reflect subsequent events or circumstances. About Hemisphere Media Group, Inc. Hemisphere Media Group, Inc. (HMTV) is the only publicly traded pure-play U.S. media company targeting the high-growth U.S. Hispanic and Latin American markets with leading television and digital content platforms. Headquartered in Miami, Florida, Hemisphere owns and operates five leading U.S. Hispanic cable networks, two Latin American cable networks, the leading broadcast television network in Puerto Rico, and has ownership interests in a leading broadcast television network in Colombia, a Spanish-language content distribution company, and a Spanish-language OTT service in the U.S. Contact:Edelman Financial Communications for Hemisphere Media GroupDanielle O'Brien917-444-6325[emailprotected] SOURCE Hemisphere Media Group, Inc.

Hemisphere Media Group Announces Third Quarter 2020 Financial Results

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Black & Veatch announces that Patty Corcoran, executive sponsor of the companys growth accelerator and a catalyst in driving positive change across the company, has been named Chief Human Resources Officer (CHRO). As a member of the executive leadership team, Corcoran will be responsible for leading all elements of Human Resources and managing talent and organizational capability for the company. Corcoran began at Black & Veatch more than a decade ago as director of HR strategy and senior advisor to the CEO, which entailed working on special projects related to strategy and providing executive leadership coaching. In addition, she spent five years as vice president of innovation and strategy with the companys innovation incubator, the Growth Accelerator. She has served as interim co-leader of Human Resources at Black & Veatch since early 2020 Among her various accomplishments, she is credited with helping to launch the companys ASPiRE program, which focuses on fostering positive cultural and organizational change within the company. She also led the effort to analyze opportunities for increased revenue and market growth that eventually led to the creation of the companys Growth Accelerator, which focuses on company-wide strategic planning and innovation. Corcoran helped lead the effort to shift from annualized strategic planning to a continual strategic planning approach, and an effort to optimize professional talent and provide career growth and opportunity. Prior to joining Black & Veatch, Corcoran spent most of her career with civil engineering company OLSSON (formerly Olsson Associates), where she served as executive vice president for five years and two years as president. Patty was selected for her incredible experience across all components of human resources, and for her success in creating and implementing successful people and client experience strategies, said Steve Edwards, chief executive officer of Black & Veatch. I am looking forward to working with Patty to reinforce an environment for our employee-owners that supports our strategic business goals while enabling us to continue to deliver quality service to all our clients. At Black & Veatch, our people are our greatest asset and we see our culture and values as a competitive advantage, said Corcoran. Together, we are eager to continue this momentum as we stay abreast of changing professional and company needs including focusing on diversity, equity and inclusion while implementing new strategies that will help us better serve our clients while achieving our broader organizational goals. Editors Notes: About Black & Veatch Black & Veatch is an employee-owned global engineering, procurement, consulting and construction company with a more than 100-year track record of innovation in sustainable infrastructure. Since 1915, we have helped our clients improve the lives of people around the world by addressing the resilience and reliability of our most important infrastructure assets. Our revenues in 2020 exceeded US$3.0 billion. Follow us on www.bv.com and on social media.

Black & Veatch Names Patty Corcoran Chief Human Resources Officer Selected for her deep experience in professional development and innovation, Corcoran will align talent and strategy to position engineering/construction leader for the future

LONDON--(BUSINESS WIRE)--Technavio estimates the foodservice tea market in US to grow by USD 2.66 billion, progressing at a CAGR of almost 4% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising demand for mobile food service. However, the impact of overconsumption of tea might challenge growth. Get a Free Sample Report Delivered Instantly to Know More Foodservice Tea Market in US: Type Landscape Based on the type, the market saw maximum growth in the iced tea segment in 2019. The segment is driven by the rising demand for flavored iced tea from Gen Z and millennial consumers in the US. The market growth in the segment will be significant over the forecast period. Foodservice Tea Market in US: Distribution Channel Landscape The full-service restaurants segment led the market with a 35% share in 2019. The growth of the market in the segment is driven by the growth of the food delivery and takeaway market in the US. Develop Smart Strategies for Your Business: Get a Free Sample Report Now! Major Three Foodservice Tea Market Vendors in US: Aroma Espresso Bar Aroma Espresso Bar operates its business through the Unified segment. Some of the products offered by the company include iced tea and iced chai latte. Davids Tea Inc. Davids Tea Inc. operates its business through segments such as Canada and US. The company offers cheery berry punch and Caribbean crush. Dunkin Brands Group Inc. Dunkin Brands Group Inc. operates its business through segments such as Dunkin U.S., Baskin-Robbins U.S., Baskin-Robbins International, and U.S. Advertising Funds. Some of the products offered by the company include premium hot tea and iced tea. Give Your Business a Head Start for 2021: Download Our Free Sample Report Related Reports on Consumer Staples Include: Global Tea Market Global tea market is segmented by product (black tea, green tea, and others), distribution channel (offline and online), and geography (APAC, Europe, MEA, North America, and South America). Get a free sample report to know more Global Slimming Tea Market Global slimming tea market is segmented by distribution channel (retail stores and online channels), product (green tea, herbal tea, and others), and geography (APAC, Europe, MEA, North America, and South America). Get a free sample report to know more Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Subscribe to World-Class Market Intelligence and gain instant access to 17,000+ market research reports and connect with expert analysts What our reports offer: About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Foodservice Tea Market in US to Grow by $ 2.66 Billion During 2020-2024 | Featuring Aroma Espresso Bar, Davids Tea Inc., and Dunkin Brands Group Inc. among others | Technavio

BOSTON, Dec. 3, 2020 /PRNewswire/ --Nasuni, a leading provider of cloud file storage, announced today that it is participating in the launch of Professional Services in AWS Marketplace. Amazon Web Services (AWS) customers can now find and purchase professional services from Nasuni in AWS Marketplace, a curated digital catalog of software, data and services that makes it easy to find, test, buy and deploy software and data products that run on AWS. As a participant in the launch, Nasuni is one of the first independent software vendors to quote and contract services in AWS Marketplace to help customers implement, support and manage their software on AWS. As organizations migrate to the cloud, they want to use their preferred software solutions on AWS. With professional services from Nasuni available in AWS Marketplace, customers have a simplified way to purchase and be billed for both software and services in a centralized place. Customers can further streamline their purchase of software with standard contract terms to simplify and accelerate procurement cycles. "Organizations that are embracing cloud driven digital transformation are looking for the best ways to streamline the process - including procurement," said Jason DePardo, VP customer success for Nasuni. "Our team of cloud file storage experts is dedicated to helping companies migrate from legacy, on-premises file storage to the cloud by leveraging our experience from moving more than 500 enterprise customers to cloud file storage." IT organizations leverage professional services from Nasuni to ensure fast, low-risk migrations of file server and NAS workloads to Nasuni and Amazon Simple Storage Service (Amazon S3), and a successful implementation that adheres to best practices, delivering maximum benefits to business stakeholders, end users and IT administrators. With access to Nasuni's professional services in AWS Marketplace, customers can choose from a variety of prepackaged professional service offerings and streamline procurement. Nasuni also recently announced its AWS Outposts Ready Designation and AWS Digital Workplace Competency. Nasuni is also available for purchase in AWS Marketplace, and is available through the AWS Marketplace Private Offers (PPOs) and AWS Marketplace Consulting Partner Private Offers (CPPOs) programs. Nasuni is also an AWS Well-Architected Partner and AWS Advanced Technology Partner. Nasuni is a bronze sponsor of AWS re:Invent 2020, which runs from Nov. 30 - Dec. 18, 2020. If you are a registered attendee, pleasevisit our virtual booth, and get your cloud file storage on AWS questions answered. To register,please visit the main AWS re:Invent site. About Nasuni Nasuni provides modern, cloud file storage, powered by the world's only global file system. Nasuni is a cloud replacement for traditional network attached storage (NAS) and file server silos. Nasuni consolidates file data, with instantly expandable cloud storage at half the cost. Eliminating the need and complexity for legacy backup and disaster recovery infrastructure, Nasuni dramatically simplifies IT administration. Workers from leading companies rely on Nasuni to easily access and share files globally from the office, home or on the road. Sectors served by Nasuni include manufacturing, construction, creative services, technology, pharmaceuticals, consumer goods, oil and gas, financial services, and public sector agencies. Nasuni's corporate headquarters is based in Boston, Massachusetts, delivering services in over 70 countries around the globe. For more information, visit www.nasuni.com. Contact: JaeMi Pennington [emailprotected] SOURCE Nasuni Related Links http://www.nasuni.com

Nasuni Participates in the Launch of Professional Services in AWS Marketplace USA - English Deutschland - Deutsch

NEW YORK, Dec. 7, 2020 /PRNewswire/ --The American Kennel Club (AKC) and ESPN are happy to announce that they have signed a 3-year content agreement which brings 100% unique, high-energy dog programming to the channel and includes digital rights for selected events to stream live on the ESPN App. The agreement also brings the AKC National Championship Presented by Royal Canin, to ABC for the next three years. The three-hour show will air on Sunday January 17, 2021 at 2p ET. The show is the largest dog event in North America and features thousands of dogs from around the country and the world competing for the coveted title of National Champion and the prize of $50,000. Building on the success from their collaborations "ESPN Dog Day" and "ESPN Puppy Day," the AKC will produce championships and competitions for the leading sports network. Each show will give audiences an insight into the fun and intensely competitive world of dog sports. The slate includes: AKC Fastest Dogs USA AKC National Championship AKC Agility Premier Cup AKC National Agility Championship North America Diving Dog Premier Cup AKC Flyball National Championship Each program will have two re-airs on ESPN television channels as well as re-airs on the Nat Geo WILD Channel. The agreement also grants ESPN access to the AKC's extensive library of dog programming for potential future programming. "We are thrilled to expand on our amazing relationship with the leader in sports television," said Dennis B. Sprung, President and CEO of the AKC. "AKC Sports demonstrate the very best in canine athleticism and the strength of the human-canine bond. It is exciting to introduce new audiences to these action-packed events and showcase the stellar dogs that compete, and we cannot think of a better place to do so, than ESPN." Programming kicks off on Friday December 11th with AKC Fastest Dogs USA competition live-streamed on the ESPN App from 2-4p ET and airing on ESPN2 Sunday December 13th at 6p ET. The AKC National Championship evening and group events will also be live streamed on the ESPN App on December 12th and 13th at 4:30p ET each night. "People just love their dogs and our viewers responded very well to our previous AKC telecasts," said Burke Magnus, ESPN Executive Vice President, Programming and Original Content. "We're very pleased to be able to bring them more in the years to come, showcasing the beauty and athleticism of dogs and the great teamwork these events require, and making ESPN the home of dog action sports. I know my black labs Luna and Stella will be joining me to watch." The AKC is the largest purebred dog registry in the world and the leading governing body of dog sports in the United States. More than 22,000 competitions for AKC-registered purebred and mixed breed dogs are held under AKC rules and regulations each year including conformation, agility, obedience, rally, tracking, herding, lure coursing, coonhound events, hunt tests, field and earthdog tests. For more information on AKC sports, please visit www.akc.org. About the American Kennel ClubFounded in 1884, the American Kennel Club is a not-for-profit organization, which maintains the largest registry of purebred dogs in the world and oversees the sport of purebred dogs in the United States. The AKC is dedicated to upholding the integrity of its registry, promoting the sport of purebred dogs and breeding for type and function. Along with its more than 5,000 licensed and member clubs and its affiliated organizations, the AKC advocates for the purebred dog as a family companion, advances canine health and well-being, works to protect the rights of all dog owners and promotes responsible dog ownership. More than 22,000 competitions for AKC-registered purebred and mixed breed dogs are held under AKC rules and regulations each year including conformation, agility, obedience, rally, tracking, herding, lure coursing, coonhound events, hunt tests, field and earthdog tests. Affiliate AKC organizations include the AKC Humane Fund, AKC Canine Health Foundation, AKC Reunite and the AKC Museum of the Dog. For more information, visit www.akc.org. AKC, American Kennel Club, the American Kennel Club seal and design, and all associated marks and logos are trademarks, registered trademarks and service marks of The American Kennel Club, Inc. Become a fan of the American Kennel Club on Facebook, and follow us on Twitter @AKCDogLovers SOURCE American Kennel Club

The American Kennel Club And ESPN Ink Multi-Year Agreement For Dog Competitions North America's largest dog show to air on ABC through 2023

CALGARY, AB, Oct. 29, 2020 /PRNewswire/ - OBSIDIAN ENERGY LTD. (TSX: OBE) (OTCQX: OBELF) ("Obsidian Energy", the "Company", "we", "us" or "our") announces the extension of our syndicated credit facility to January 29, 2021. The syndicated credit facility has an underlying borrowing base of $550 million and amount available to be drawn of $450 million which remains unchanged. Under the agreement, the syndicated credit facility continues to be available on a revolving basis until January 29, 2021, subject to further extensions, with the end date of the term period set at November 30, 2021. In connection with the extension, the lenders have the option to complete a borrowing base redetermination onJanuary 29, 2021. Additionally, the lenders have elected to not proceed with the borrowing base redeterminations on October 31, 2020 and on November 30, 2020. Forward-Looking Statements Certain statements contained in this document constitute forward-looking statements or information (collectively "forward-looking statements"). Forward-looking statements are typically identified by words such as "anticipate", "continue", "estimate", "expect", "forecast", "budget", "may", "will", "project", "could", "plan", "intend", "should", "believe", "outlook", "objective", "aim", "potential", "target" and similar words suggesting future events or future performance. In particular, this presentation contains, without limitation, forward-looking statements pertaining to the extension of our syndicated credit facility to January 29, 2021, subject to further extensions and option to complete a borrowing base determination at that time, with end date of the term period set at November 30, 2021. With respect to forward-looking statements contained in this document, we have made assumptions regarding, among other things: we will have the ability to continue as a going concern going forward and realize our assets and discharge our liabilities in the normal course of business; our ability to complete asset sales and the terms and timing of any such sales; the impact of regional and/or global health related events, including the ongoing COVID-19 pandemic, on energy demand and commodity prices; that the Company's operations and production will not be disrupted by circumstances attributable to the COVID-19 pandemic and the responses of governments and the public to the pandemic; global energy policies going forward, including the continued ability of members of OPEC, Russia and other nations to agree on and adhere to production quotas from time to time; the economic returns that we anticipate realizing from expenditures made on our assets; future crude oil, natural gas liquids and natural gas prices and differentials between light, medium and heavy oil prices and Canadian, WTI and world oil and natural gas prices; future capital expenditure levels; future crude oil, natural gas liquids and natural gas production levels; drilling results; future exchange rates and interest rates; future taxes and royalties; future hedging activities; our ability to execute our capital programs as planned without significant adverse impacts from various factors beyond our control, including weather, infrastructure access and delays in obtaining regulatory approvals and third party consents; our ability to obtain equipment in a timely manner to carry out development activities and the costs thereof; our ability to market our oil and natural gas successfully; our ability to obtain financing on acceptable terms, including our ability (if necessary) to continue to extend the revolving period and term out period of our credit facility, our ability to maintain the existing borrowing base under our credit facility, our ability to renew or replace our syndicated bank facility and our ability to finance the repayment of our senior notes on maturity; and our ability to add production and reserves through our development and exploitation activities. Although Obsidian Energy believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Obsidian Energy can give no assurances that they will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the forward-looking statements contained herein will not be correct, which may cause our actual performance and financial results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things: the possibility that we are not able to continue as a going concern and realize our assets and discharge our liabilities in the normal course of business; the possibility that the Company will not be able to continue to successfully execute our business plans and strategies in part or in full, and the possibility that some or all of the benefits that the Company anticipates will accrue to our Company and our stakeholders as a result of the successful execution of such plans and strategies do not materialize; the possibility that the Company is unable to complete one or more of the potential transactions being pursued pursuant to our ongoing strategic alternatives review process (including the proposed acquisition of Bonterra Energy Corp.), on favorable terms or at all, or that the Company and its stakeholders do not realize the anticipated benefits of any such transaction that is completed (including the benefits of the proposed acquisition of Bonterra Energy Corp.); the possibility that the Company ceases to qualify for, or does not qualify for, one or more existing or new government assistance programs implemented in connection with the COVID-19 pandemic and other regional and/or global health related events or otherwise, that the impact of such programs falls below our expectations, that the benefits under one or more of such programs is decreased, or that one or more of such programs is discontinued; the impact on energy demand and commodity prices of regional and/or global health related events, including the ongoing COVID-19 pandemic, and the responses of governments and the public to the pandemic, including the risk that the amount of energy demand destruction and/or the length of the decreased demand exceeds our expectations; the risk that the significant decrease in the valuation of oil and natural gas companies and their securities and the decrease in confidence in the oil and natural gas industry generally that has been caused by the COVID-19 pandemic persists or worsens; the risk that the COVID-19 pandemic adversely affects the financial capacity of the Company's contractual counterparties and potentially their ability to perform their contractual obligations; the possibility that the revolving period and/or term out period of our credit facility and the maturity date of our senior notes is not further extended (if necessary), that the borrowing base under our credit facility is reduced, that the Company is unable to renew our credit facilities on acceptable terms or at all and/or finance the repayment of our senior notes when they mature on acceptable terms or at all and/or obtain debt and/or equity financing to replace one or both of our credit facilities and senior notes; the possibility that we breach one or more of the financial covenants pursuant to our agreements with our lenders and the holders of our senior notes; the possibility that we are forced to shut-in additional production or continue existing production shut-ins longer than anticipated, whether due to commodity prices failing to rise or decreasing further or changes to existing government curtailment programs or the imposition of new programs; the risk that OPEC, Russia and other nations fail to agree on and/or adhere to production quotas from time to time that are sufficient to balance supply and demand fundamentals for crude oil; general economic and political conditions in Canada, the U.S. and globally, and in particular, the effect that those conditions have on commodity prices and our access to capital; industry conditions, including fluctuations in the price of crude oil, natural gas liquids and natural gas, price differentials for crude oil and natural gas produced in Canada as compared to other markets, and transportation restrictions, including pipeline and railway capacity constraints; fluctuations in foreign exchange or interest rates; unanticipated operating events or environmental events that can reduce production or cause production to be shut-in or delayed (including extreme cold during winter months, wild fires and flooding); the possibility that fuel conservation measures, alternative fuel requirements, increasing consumer demand for alternatives to hydrocarbons and technological advances in fuel economy and renewable energy generation systems could permanently reduce the demand for oil and natural gas and/or permanently impair the Company's ability to obtain financing on acceptable terms or at all, and the possibility that some or all of these risks are heightened as a result of the response of governments and consumers to the ongoing COVID-19 pandemic; and the other factors described under "Risk Factors" in our Annual Information Form and described in our public filings, available in Canada at www.sedar.com and in the United States at www.sec.gov. Readers are cautioned that this list of risk factors should not be construed as exhaustive. Unless otherwise specified, the forward-looking statements contained in this document speak only as of the date of this document. Except as expressly required by applicable securities laws, we do not undertake any obligation to publicly update or revise any forward. SOURCE Obsidian Energy Ltd. Related Links https://www.obsidianenergy.com/

Obsidian Energy Announces Extension to our Syndicated Credit Facility

SANTA MONICA, Calif.--(BUSINESS WIRE)--The Recording Academy unveils the full run of show for its first-ever livestream announcing nominees for the 63rd Annual GRAMMY Awards. Chair and Interim Recording Academy President/CEO Harvey Mason jr. will be joined by an eclectic group of past GRAMMY winners, nominees and other special guests to announce nominees in 83 categories on Nov. 24. Four-time GRAMMY Award-winning regional Mexican singer/songwriter Pepe Aguilar, Nigerian Afropop singer Yemi Alade, GRAMMY Award-winning classical violinist Nicola Benedetti, two-time GRAMMY Award-winning contemporary Christian singer Lauren Daigle, country singer/songwriter Mickey Guyton, two-time GRAMMY Award-winning recording artist and past GRAMMY Awards Premiere Ceremony host Imogen Heap, CBS This Morning anchor Gayle King, two-time GRAMMY Award-winning singer/songwriter Dua Lipa, and The Talk host Sharon Osbourne will announce and celebrate this years nominees during an hour-long program that will begin at approximately 9:00 a.m. PT/12:00 p.m. ET. The livestream will be available to view on GRAMMY.com. 63rd GRAMMY Awards Nominations Livestream Run of Show Opening Remarks by Recording Academy President/CEO Harvey Mason jr. Production (Non-Classical and Classical) Fields Harvey Mason jr. Best Engineered Album, Non-Classical Producer Of The Year, Non-Classical Best Remixed Recording Best Engineered Album, Classical Producer Of The Year, Classical Rock, Alternative, Package, and Notes Fields Yemi Alade Best Rock Performance Best Metal Performance Best Rock Song Best Rock Album Best Alternative Music Album Best Recording Package Best Boxed Or Special Limited Edition Package Best Album Notes New Age and Jazz Fields Imogen Heap Best New Age Album Best Improvised Jazz Solo Best Jazz Vocal Album Best Jazz Instrumental Album Best Large Jazz Ensemble Album Best Latin Jazz Album Latin and Composing/Arranging Fields Pepe Aguilar Best Latin Pop Or Urban Album Best Latin Rock Or Alternative Album Best Regional Mexican Music Album (Including Tejano) Best Tropical Latin Album Best Instrumental Composition Best Arrangement, Instrumental Or A Cappella Best Arrangement, Instruments And Vocals American Roots Field Lauren Daigle Best American Roots Performance Best American Roots Song Best Americana Album Best Bluegrass Album Best Traditional Blues Album Best Contemporary Blues Album Best Folk Album Best Regional Roots Music Album Comedy, Musical Theater, Music For Visual Media, and Music Video/Film Fields Sharon Osbourne Best Comedy Album Best Musical Theater Album Best Compilation Soundtrack For Visual Media Best Score Soundtrack For Visual Media Best Song Written For Visual Media Best Music Video Best Music Film Classical Field Nicola Benedetti Best Orchestral Performance Best Opera Recording Best Choral Performance Best Chamber Music/Small Ensemble Performance Best Classical Instrumental Solo Best Classical Solo Vocal Album Best Classical Compendium Best Contemporary Classical Composition R&B and Rap Fields Gayle King Best R&B Performance Best Traditional R&B Performance Best R&B Song Best Progressive R&B Album Best R&B Album Best Rap Performance Best Melodic Rap Performance Best Rap Song Best Rap Album Pop, Contemporary Instrumental Music, Reggae, and Global Music Fields TBA Best Pop Solo Performance Best Pop Duo/Group Performance Best Traditional Pop Vocal Album Best Pop Vocal Album Best Contemporary Instrumental Album Best Reggae Album Best Global Music Album Dance/Electronic Music, Country, Childrens, and Historical Fields Dua Lipa Best Dance Recording Best Dance/Electronic Album Best Country Solo Performance Best Country Duo/Group Performance Best Country Song Best Country Album Best Childrens Music Album Best Historical Album Gospel/Contemporary Christian Music and Spoken Word Fields Mickey Guyton Best Gospel Performance/Song Best Contemporary Christian Music Performance Best Gospel Album Best Contemporary Christian Music Album Best Roots Gospel Album Best Spoken Word Album General Fields Harvey Mason jr. Record Of The Year Album Of The Year Song Of The Year Best New Artist Harvey Mason jr. Closing Remarks Immediately following the livestream, the press release and a full nominations list will be on GRAMMY.com and the Recording Academy's social media platforms. Select clips of each participant will be made available as well. The 63rd GRAMMY Awards will be broadcast in HDTV and 5.1 surround sound on the CBS Television Network, Sunday, Jan. 31, 2021, at 8:00 p.m. ET/5:00 p.m. PT. Follow "Recording Academy / GRAMMYs" on Twitter, Instagram, and Facebook and use #GRAMMYs to join the conversation as it unfolds on Nov. 24.

Recording Academy Unveils Run of Show For 63rd GRAMMY Awards Nominations Livestream Harvey Mason jr. and Previously Announced Talent to Celebrate This Years Nominees on the First GRAMMY Awards Nominations Livestream on Tuesday, Nov. 24

WATERLOO, Ontario--(BUSINESS WIRE)--Cognitive Systems Corp. announced today an integration with Airties to offer its patented WiFi Motion technology across Airties portfolio of WiFi 6 solutions. Cognitives WiFi Motion will make it easier than ever for service providers to access this revolutionary sensing technology. Over the past six years, Cognitive Systems has designed, developed, and implemented the first and most sophisticated WiFi-enabled motion sensing software on the market. WiFi Motion leverages connected IoT devices to turn the entire home into a motion-sensing network, introducing an innovative way to use WiFi. With 37 ISPs currently offering WiFi Motion around the globe, millions of homes already have access to this new service and its growing number of applications. Service providers are looking for new ways to differentiate from competitors and retain customers. Our priority is providing smart WiFi solutions that offer value beyond connectivity, said Taj Manku, Co-Founder and CEO of Cognitive Systems. Like us, Airties aims to shape the next generation of wireless solutions and see the possibilities for motion sensing, from smarter home monitoring to a higher standard of eldercare. Were doing the legwork with their Wi-Fi 6 portfolio to get WiFi Motion ready for some forward-thinking Airties service providers who want to offer these benefits to their customers as soon as possible. Cognitive Systems and Airties share a commitment to staying ahead of the market, both by being active members of the Wireless Broadband Alliance (WBA) and closely following emerging trends. In addition to the current home monitoring capabilities, WiFi Motions highly anticipated eldercare solution will bring peace of mind to caregivers by providing discreet wellness monitoring without the need for cameras or wearable devices. The market for remote wellness monitoring products is growing rapidly. Soon customers will be able to receive notifications and gain valuable insights into not only their homes but also the homes of loved ones. As a pioneer and leader in Wi-Fi sensing, we are pleased to be working with Cognitive Systems on new Wi-Fi 6 solutions, said Metin Taskin, Co-Founder and CTO of Airties. Cognitives product roadmap has a realistic game plan for both implementation and longevity. The integration of WiFi Motion and Airties can enable service providers to offer innovative value-add Wi-Fi services to their customers. About Cognitive Systems Cognitive Systems Corp. is on a mission to transform the way WiFi networks are used. Its flagship technology, WiFi Motion, uses wireless signals to sense motion in the home. WiFi Motion harnesses artificial intelligence and predictive analytics to reliably identify and localize motion for the smart home, home monitoring, and wellness monitoring markets. This patented technology is layered onto existing WiFi networks without additional hardware to enhance service provider and router manufacturer offerings. www.cognitivesystems.com https://www.linkedin.com/company/cognitive-systems-corp-/ About Airties Founded in 2004, Airties is the most widely deployed provider of managed in-home Wi-Fi solutions to operators around the globe. The company offers Smart Wi-Fi software, a cloud-based management platform, and Mesh extenders. Service providers turn to Airties for the design, implementation, and ongoing optimization of their customers broadband experience. With an installed base of over 30 million homes, Airties customers include: Altice USA, AT&T, Singtel, Sky, Telia, Telstra, and many others. More information is available at www.Airties.com.

Cognitive Systems Continues to Expand Global Reach with Airties WiFi 6 Portfolio WiFi Motion enables service providers to create next-gen customer experiences

CHARLESTON, S.C., April 13, 2021 /PRNewswire/ --The Bank of South Carolina Corporation (Nasdaq: BKSC) announced unaudited earnings of $1,810,075, or $0.33 and $0.32 basic and diluted earnings per share, respectively, for the quarter ended March 31, 2021 an increase of 19.00% from earnings for the quarter ended March 31, 2020 of $1,521,131, or $0.28 and $0.27 basic and diluted earnings per share. Annualized returns on average assets and average equity for the three months ended March 31, 2021 were 1.37% and 13.26%, respectively, compared with March 31, 2020 annualized returns on average assets and average equity of 1.38% and 11.70%, respectively. Fleetwood S. Hassell, President of the Bank of South Carolina, stated, "Robust mortgage activity continues to produce strong earnings for the bank, as interest rates remain low and housing inventory scarce. In addition, processing fee income derived from the Small Business Administration's and Department of Treasury's PPP program has further bolstered quarterly earnings. Loan demand is consistent - albeit with narrower margins. Moving forward, our challenge is to deploy excess liquidity into higher yielding assets in a rate environment that rivals that of the Great Recession. Overall, we are pleased with the Bank's first quarter performance, which allowed for payment of a special $0.10 per share cash dividend in addition to our regular $0.17 per share dividend. We look forward to the rest of the year." The following table shows the balance sheet and income statement highlights: (Unaudited)March 31, (Unaudited) March 31, 2021 2020 Common stock shares outstanding 5,524,616 5,530,363 Book value per share $ 9.60 $ 9.48 Total assets $ 554,099,360 $ 499,720,200 Three Months Ended Net income $ 1,810,075 $ 1,521,131 Basic earnings per share $ 0.33 $ 0.28 Diluted earnings per share $ 0.32 $ 0.27 Weighted average shares outstanding: Basic 5,521,707 5,530,256 Diluted 5,685,151 5,585,622 About Bank of South Carolina Corporation The Bank of South Carolina Corporation is the holding company of The Bank of South Carolina ("The Bank"). The Bank is a South Carolina state-chartered bank with offices in Charleston, North Charleston, Summerville, Mt. Pleasant, and the West Ashley community and has been in continuous operation since 1987. Our website is www.banksc.com. Bank of South Carolina Corporation currently trades its common stock on the NASDAQ stock market under the symbol "BKSC". SOURCE Bank of South Carolina Corporation Related Links http://www.banksc.com

Bank of South Carolina Corporation Announces First Quarter Earnings

DUBLIN, May 11, 2020 /PRNewswire/ -- The "Biometrics: Driven by Standardized Authentication, Adopted by Consumers" report has been added to ResearchAndMarkets.com's offering. In recent years, user authentication based on biometrics (biometric authentication) has become a new method for consumers to open their smartphones and select mobile apps. Market research indicates biometric use is increasing even as consumers adopt a greater variety of methods choosing among fingerprint, facial recognition, and voice recognition. Biometrics are important because they utilize new mobile security hardware and software to revamp authentication, lower the risk of fraud, address the mandates of the European Union's revised Payment Services Directive (PSD2), and induce changes in consumer behavior.U.S. Biometrics 2020: Driven by Standardized Authentication, Adopted by Consumers provides consumer sentiment, adoption rates, and forecasts on biometric authentication methods, both to unlock smartphones and for payment authentication. Additionally the report examines the FIDO Alliance, discussing how it has standardized authentication and the implications for biometrics and payments.Authentication using biometrics is rapidly being adopted by consumers, in part as a result of hardware manufacturers enabling its use, and in part because the standard for authentication created by the FIDO Alliance has increased the ease with which authenticators can utilize the mobile biometrics over the web and decrease authentication friction for consumers.Highlights of the report include: Historical data, forecast, and analysis (2013-2024) of consumer use of biometric authentication methods (facial recognition, voice recognition, fingerprint) in total and by smartphone brand, based on an annual survey of 3000 U.S. adults. Biometrics methods for payment authentication (2016-2019) preferred by U.S. payment app users and analysis of results. Explanation of multifactor biometrics and the role that biometric methods play in the overall authentication process. Discussion of FIDO Alliance standardizing authentication, the effects on biometrics, and implications for payments and payments players and authentication in general. Key Topics Covered 1. Executive Summary 2. Introduction 3. Gauging Biometrics Usage in the United States Smartphone Use Use of Biometric Security Methods Usage of Biometrics, by Method Biometrics Methods Used, by Smartphone Type Biometric Combination Use Biometric Use by Percentage of Population 4. Consumer Sentiment Toward Payment Biometrics 5. FIDO Alliance Is Standardizing Authentication FIDO Is Lowering Authentication Friction and Driving Biometric Usage 6. Conclusions Companies Mentioned Android Apple BlackBerry Google FIDO Alliance Microsoft Mozilla Foundation NXP PayPal Samsung W3C Yubico List of Figures Figure 1: Smartphone usage growth rate in the US is slowing as market saturation nears Figure 2: Adoption of biometric authentication is on the rise among US smartphone users Figure 3: Facial and voice recognition are gaining popularity among smartphone users in the US Figure 4: Facial and voice recognition are crowding out fingerprint readers among users of Android smartphones in the US Figure 5: Facial and voice recognition are crowding out fingerprint readers among iPhone users Figure 6: Biometric use among Blackberry, Windows, and other smartphones is roughly even Figure 7: US smartphone owners have used a combination of biometric authentication methods Figure 8: Biometric authentication methods are being adopted by US smartphone owners at a fast rate Figure 9: US smartphone owners' sentiment on using biometrics for payments, 2016-2019 For more information about this report visit https://www.researchandmarkets.com/r/15m473 About ResearchAndMarkets.com Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Biometrics in the United States, 2013-2024 - Forecast Predicts FIDO Will Speed Adoption of Biometric Authentication, Securing Frictionless Payments

PLANO, Texas, Dec. 8, 2020 /PRNewswire/ --Global InsureTech company Insubuy, Inc., an innovative and leading marketplace for travel insurance, is pleased to announce that it has been certified as PCI DSS (Payment Card Industry Data Security Standard) compliant, becoming one of the first travel insurance marketplaces to receive such a certification. Going forward, Insubuy will continue to improve its online payment security and its capacity for processing payment data. "Buying insurance is a matter of trust for the customers," says Narendra Khatri, co-founder and CEO of Insubuy, Inc. "While Insubuy has always followed the best practices for the security of the online credit card payments, being officially certified will significantly increase the trust of customers in feeling comfortable to buy insurance from Insubuy." PCI DSS includes a set of data security requirements for payment cards that was initially created by five major global credit card companies (namely, Visa, American Express, Discover Financial Services, JCB International, and MasterCard) and is currently maintained by PCI SSC (Payment Card Industry Security Standards Council). PCI DSS certification, one of the most stringent and comprehensive payment security certification standards in the world, has become a prerequisite for all companies working with payment providers. To obtain PCI DSS certification, a company must undergo a comprehensive and rigorous review from an independent assessment organization authorized by the PCI SSC. Once certification is granted, a company must then comply with relevant security requirements. With the increase in remote work, cybercrime has gone up significantly. Therefore, customers should purchase travel insurance only from a PCI DSS compliant business such as Insubuy to ensure their data is secure. About Insubuy, Inc.: Located in Plano, Texas, and established in 2000, Insubuy, Inc., is an InsureTech company that created the first marketplace for a wide variety of international and travel insurance products. Insubuy works with many insurance companies to ensure its customers have the most suitable coverage that best fits their needs. On www.insubuy.com, customers can get quotes from multiple companies, compare them side by side, and make an instant purchase online. Knowledgeable, licensed, and experienced agents are available for professional advice seven days a week. Insubuy is licensed to sell insurance in all 50 U.S. states and the District of Columbia. SOURCE Insubuy, Inc. Related Links https://www.insubuy.com

Insubuy, Inc. receives PCI DSS (Payment Card Security - Data Security Standard) Certification, Ensuring Secure Payments for Global Users

MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership of high-quality, net-leased restaurant properties (FCPT or the Company), is pleased to announce the acquisition of a corporate-operated BJs Restaurant (NASDAQ: BJRI) property for $3.8 million via a sale-leaseback. The property is located in Texas and is occupied under a triple-net lease with 15.0 years of term, and four, 5-year options. This transaction is part of a two-property sale-leaseback with BJRI. The transaction was priced at a cap rate in range with previous FCPT transactions. In conjunction with the sale-leaseback transaction, FCPT and BJRI also amended seven existing lease agreements by increasing rent, extending term, and including annual sales reporting among other items, in exchange for tenant allowance funds. Bill Lenehan, CEO of Four Corners Property Trust, stated: The relationship we have established with BJs Restaurants has allowed us to think creatively about how to partner together, especially during the pandemic. BJs and FCPT were able to strike a mutually beneficial agreement and expand our relationship. We look forward to continuing our working partnership and helping their team grow. Greg Lynds, EVP and Chief Development Officer of BJs Restaurants, Inc., stated: We are pleased to expand our relationship with Four Corners Property Trust to eleven restaurants with this multi-faceted transaction. We look forward to a long and prosperous relationship with Four Corners and the opportunity to grow our partnership even further. About FCPT FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease for use in the restaurant and retail industries. Additional information about FCPT can be found on the website at www.fcpt.com. About BJs Restaurants, Inc. BJs Restaurants, Inc. (BJs) is a national brand with brewhouse roots and a menu where craft matters. BJs broad menu with a wide variety of menu offerings has something for everyone: slow-roasted entrees, like prime rib, BJs EnLIGHTened Entrees including Cherry Chipotle Glazed Salmon, signature deep dish pizza and the often imitated, but never replicated world-famous Pizookie dessert. BJs has been a pioneer in the craft brewing world since 1996, and takes pride in serving BJs award-winning proprietary handcrafted beers, brewed at its brewing operations in five states and by independent third party craft brewers. The BJs experience offers high-quality ingredients, bold flavors, moderate prices, sincere service and a cool, contemporary atmosphere. Founded in 1978, BJs owns and operates 209 casual dining restaurants in 29 states: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Indiana, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia and Washington. All restaurants offer dine-in, take-out, delivery and large party catering. Due to the COVID-19 pandemic, one of our restaurants remains temporarily closed, and dine-in service is currently limited or not available and menu offerings and hours are limited in our remaining 208 restaurants. For more BJs information, visit http://www.bjsrestaurants.com.

FCPT Announces Sale Leaseback of a BJs Restaurant Property for $3.8 million

SAN FRANCISCO--(BUSINESS WIRE)--Asana, Inc. (NYSE: ASAN), a leading work management platform for teams, announced today that it will release financial results for the fourth quarter and fiscal year 2021 on Wednesday, March 10 following the close of the U.S. markets. In conjunction with the announcement, the company will host a conference call on the same day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss the results. The live webcast will be available on the Investor Relations section of the Company's website at https://investors.asana.com. The conference call can also be accessed by dialing 1-833-529-0220 or +1-236-389-2147 outside of the U.S. The conference ID is 859-8159. A replay of the webcast will be available at https://investors.asana.com. About Asana Asana helps teams orchestrate their work, from small projects to strategic initiatives. Headquartered in San Francisco, CA, Asana has more than 89,000 paying organizations and millions of free organizations across 190 countries. Global customers such as Accenture, Estee Lauder, Japan Airlines, Sky and Viessmann, rely on Asana to manage everything from company objectives to digital transformation to product launches and marketing campaigns. For more information, visit www.asana.com.

Asana to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on Wednesday, March 10, 2021

BOSTON, Nov. 27, 2020 /PRNewswire/ -- Overjet Inc, the leading provider of artificial intelligence (AI) for the dental community, was selected by AEGIS to share a curated series on how AI is transforming dentistry. The series will appear in Compendium in 2021 and bring together insights from leading experts in dental support organizations, distributors, academia, insurance, practices, and public health. Machine learning advances and growing dental digitization have ushered in new AI-based tools to support patient care, practice management, insurance claims review, and clinical research. The upcoming series will take a deep dive into the current state of dental AI technology and look at its likely impact on the future of dentistry. "In my over 30 years in the dental profession, I have not seen a new technology with as much promise to transform dentistry as artificial intelligence," said Dr. Robert Faiella, past-president of the American Dental Association and Chief Dental Officer of Overjet. Dr. Faiella and his Overjet colleagues are engaging experts from across the industry to bring together this dental artificial intelligence series. "Compendium helpsreaders stay informed on the latest technology and practices impacting dentistry," said Daniel W. Perkins, Founder and Chairman of AEGIS Publications. "As the industry leader, Overjet's expertise will help inform our dental artificial intelligence discussion in 2021." Overjet has an exciting lineup of dental experts. If you would like to be a contributor to the world's first dental AI series, please reach out at [emailprotected]. Readers can check Compendium soon for an overview of the multi-part series. About Overjet Inc:Overjet (www.overjet.ai) is the industry leader in dental artificial intelligence, helping both payers and providers improve patient care. The company was founded by experts from the Massachusetts Institute of Technology and Harvard School of Dental Medicine. Overjet's AI software powers claims review for some of the country's largest dental insurers. Overjet's in-practice AI software bolts on to existing practice management software and is designed to help dentists deliver high-quality care, automate administrative tasks, and identify areas for growth. SOURCE Overjet Related Links www.overjet.ai

Overjet Tapped by AEGIS for Dental Artificial Intelligence Article Series Leading provider of dental AI to bring together thought leaders from across the industry

DUBLIN, March 1, 2021 /PRNewswire/ -- The "Antimicrobial Coatings Market by Type (Silver, Copper, Titanium dioxide), Application (Medical & Healthcare, Foods & Beverages, Building & Construction, HVAC system, Protective Clothing, Transportation), & Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The antimicrobial coatings market size is estimated to reach USD 5,549.6 million by 2025, at a CAGR of 10.7% between 2020 and 2025. The major players in this market are AkzoNobel N.V. (Netherlands), DuPont de Nemours, Inc. (US), Axalta Coating Systems (US.), PPG Industries (US), Nippon Paint Holdings Co., Ltd. (Japan) and The Sherwin Williams Company (US). Stringent regulations and growing adoption among end-users are projected to drive the antimicrobial coatings market. The global market has witnessed growth primarily due to stringent government regulations to prevent the spread of healthcare-acquired infections (HAIs) and to ensure paramount safety & hygiene in the medical and healthcare sector. Due to the COVID-19 pandemic, the demand for antimicrobial coatings has been increasing drastically in the medical & healthcare industry. Factors such as technological advancement, new product development, and growing adoption among several industrial applications are supporting the growth of the antimicrobial coatings market. Silver-based antimicrobial coatings are projected to witness the highest CAGR during the forecast period. Silver-based antimicrobial coatings market is projected to witness the highest growth during the forecast period, both in terms of value and volume. The increase in this segment is attributed to its high efficacy rate, long-lasting effect, low toxicity, and suitability with the industrial application. The medical & healthcare segment projected to lead the antimicrobial coatings market from 2020 to 2025. The medical & healthcare segment is the largest and fastest-growing application. Stringent government regulation pertaining to the HAIs in the medical and healthcare sector supports the growth of the market. During the COVID-19 pandemic, the antimicrobial coatings have gained significant attention to prevent the spread of viruses and to safeguard the patient and Hospital staff at temporary built and existing healthcare facilities. With the growing adoption and development of the new medical devices and implants, incorporating antimicrobial coatings provides a boost for market growth. North America projected to account for the maximum share of the global antimicrobial coatings market during the forecast period. North America is projected to lead the global antimicrobial coatings market from 2020 to 2025. The North American antimicrobial coatings market is driven by the rising demand from the medical & healthcare sector to inhibit the growth of bacteria and microbes, causing HAIs. Due to the COVID-19 pandemic, the US is severely impacted and had the highest number of infected people. As a preventive measure, the touch surfaces, such as beds, handles, medical devices, instruments, and protective gear, were coated with antimicrobial coatings to ensure the utmost safety of people at healthcare facilities. Also, due to the stringent regulations pertaining to the indoor air quality, the HVAC system manufacturers are incorporating antimicrobial coatings on surfaces to ensure the required air quality by inhibiting the growth of mold and bacteria. Key Topics Covered: 1 Introduction2 Research Methodology3 Executive Summary4 Premium Insights 4.1 Significant Opportunities in the Antimicrobial Coatings Market 4.2 APAC Antimicrobial Coatings Market, by Type and Country, 2019 4.3 Antimicrobial Coatings Market, by Key Countries 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Medical & Healthcare Sector Will Lead the Market Growth During and Post-Covid-19 Pandemic 5.2.1.2 Growing Demand in HVAC Systems 5.2.1.3 Increasing Demand from the Food & Beverage Industry 5.2.2 Restraints 5.2.2.1 High Cost of Products and Highly Skilled Labor Requirement 5.2.2.2 Stringent Governmental Regulations 5.2.3 Industry Trend 5.2.3.1 Highly Integrated Supply Chain 5.2.4 Opportunities 5.2.4.1 Growing USage in Novel Applications 5.2.5 Challenges 5.2.5.1 Growing Concerns About the Toxicity of Nanoparticles 5.3 Porter's Five Forces Analysis 5.4 Supply Chain 5.5 Pricing Analysis 5.6 YC and Ycc Shift 5.6.1 YC Shift 5.6.2 YCC Shift 5.7 Antimicrobial Products Ecosystem 5.8 Forecasting Factors and Covid-19 Pandemic Impact 5.9 Market Attractiveness, by Application 5.9.1 Product Selection Criteria 5.10 Antimicrobial Coatings - Patent Analysis 5.10.1 Methodology 5.10.2 Document Type 5.10.3 Insights 5.10.4 Top Applicants List of Patents by Becton, Dickinson, and Company List of Patents by Rohm and Haas Company & Dow Global Technologies LLC. List of Patents by Argenlab Global Ltd. List of Patents by Ethicon Inc. Companies Mentioned Aereus Technologies Inc. Ak Steel Holding Corporation AkzoNobel N.V. Allied Bioscience, Inc. Axalta Coating Systems Ltd Basf Se Burke Industrial Coatings LLC Diamond Vogel Paint Company Dupont De Nemours, Inc. Fiberlock Technologies, Inc. Flora Coatings LLC H.B. Fuller Construction Products Inc. Hydromer Inc. IFS Coatings Inc. Koninklijke Dsm N.V. Lonza Group AG Medivators Inc. Nano-Care Deutschland AG Nippon Paint Holdings Co. Ltd. Ppg Industries, Inc. Protech-Oxyplast Group Rpm International Inc. Specialty Coating Systems Inc. The Sherwin-Williams Company Troy Corporation For more information about this report visit https://www.researchandmarkets.com/r/361cg9 Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Global Antimicrobial Coatings (Silver, Copper, Titanium dioxide) Market, 2020-2025: Becton, Dickinson, and Co, Rohm and Haas Company & Dow, Argenlab, Ethicon are the Top Patent Applicants

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that it has appointed Dr. Patrick Casey as an independent director to Legend Biotechs Board of Directors. Dr. Casey will serve as a Class II director. We are delighted to have Dr. Casey join our Board of Directors, said Sally Wang, Chairwoman of Legend Biotech. Dr. Casey brings extraordinary scientific expertise and research leadership experience that greatly enhances our Board. I am confident that Legend Biotech will greatly benefit from his participation as we continue to execute on our pipeline development strategy and objective to bring innovative and impactful cell therapies toward potential registration and commercialization. Patrick Casey, PhD, is the Senior Vice Dean of Research at the Duke-NUS Medical School and a James B. Duke Professor of Pharmacology and Cancer Biology at Duke University. Dr. Casey joined Duke University Medical Center as an Assistant Professor of Molecular Cancer Biology and Biochemistry in 1990. In 2005, Dr. Casey relocated to Singapore to spearhead the development of the Signature Research Programmes at Duke-NUS, where he currently oversees the administration and strategic planning of these programmes, and mentoring of faculty and trainees. He was also the founding Director of the Duke Center for Chemical Biologyan organization of Duke scientists dedicated to research and training in the application of fundamental chemical principles to the study of biology and the basis of disease and therapies. A recognized authority in the fields of lipid modifications of proteins and in G protein signaling, Dr. Casey has received several awards for his work, including the Established Investigator Award from the American Heart Association in 1992 and the Amgen Award from the American Society of Biochemistry and Molecular Biology in 2000. He was elected a Fellow of the American Association for the Advancement of Science in 2012. Dr. Casey serves on advisory panels for Agency for Science, Technology and Research (A*STAR), National Research Foundation (NRF) and National Medical Research Council (NMRC). Dr. Casey received his PhD in Biochemistry from the Brandeis University in 1986 and did postdoctoral work at the University of Texas Southwestern Medical Center in Dallas. About Legend Biotech Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Our team of over 800 employees across the United States, China and Europe, along with our differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture cutting edge cell therapies for patients in need. We are engaged in a strategic collaboration to develop and commercialize our lead product candidate, ciltacabtagene autoleucel, an investigational BCMA-targeted CAR-T cell therapy for patients living with multiple myeloma. This candidate is currently being studied in registrational clinical trials. To learn more about Legend Biotech, visit us on LinkedIn, or on Twitter @LegendBiotech or at www.legendbiotech.com. Cautionary Note Regarding Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to statements relating to Legend Biotechs strategic development and objectives and the potential contributions of its new board member. The words anticipate, believe, continue, could, estimate, expect, intend, may, plan, potential, predict, project, should, target, will, would and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the factors discussed in the Risk Factors section of the prospectus filed with the Securities and Exchange Commission on June 8, 2020. Any forward-looking statements contained in this press release speak only as of the date hereof, and Legend Biotech specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Readers should not rely upon the information on this page as current or accurate after its publication date.

Legend Biotech Announces Appointment of Dr. Patrick Casey to the Board of Directors

PITTSBURGH, Aug. 25, 2020 /PRNewswire/ -- An inventor from Wittmann, Ariz., wanted to fulfill the need for a hand care product designed to reduce the pain associated with carpal tunnel syndrome. The HAND THERAPY TUB has a simple design that is versatile and easy to use. It provides an alternative to taking prescription or over the counter anti-inflammatory medications that could have harmful side effects. It also gives the user freedom from pain. Additionally, it is perfect for those that suffer wrist/hand pain as a result of using computers, working or engaging in various sports. "I had carpal tunnel and I would often use my hand held shower head on my wrist for pain relief," said the inventor. The original design was submitted to the Phoenix office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-PHO-2698. InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com

InventHelp Inventor Presents a Hand Care Accessory (PHO-2698)

WARRENTON, Va., March 8, 2021 /PRNewswire/ --Pinnacle Management Systems, Inc., a leader in program and project management consulting and training services, is pleased to announce that they have been awarded a General Services Administration (GSA) Multiple Award Schedule (MAS) contract.The five-year, Indefinite Delivery, Indefinite Quantity (IDIQ) contract allows government customers the ability to easily acquire Pinnacle's professional services and training solutions. Continue Reading Pinnacle Management Systems, Inc. Being awarded this GSA contract differentiates Pinnacle as a top provider of Enterprise Project Management (EPM), Project Portfolio Management (PPM), and Integrated Program Management (IPM) solutions for government agencies.Pinnacle is partnered with the leading project management software vendors, including Microsoft, Oracle, Deltek, and forProject Technology, and has a 28-year proven track record of successfully helping clients get more value from their EPM and PPM investments.With this award, federal agencies now have easier access to Pinnacle's services using the following Special Item Numbers in the GSA Advantage marketplace: 611430: Professional Services - Training 54151S: Information Technology - IT Services 541611: Professional Services - Business Administrative Services "I am proud of our record of service with the federal government," said Michael Breuker, President of Pinnacle."We are dedicated to improving project performance and enabling our customers to be successful.This contract gives us another way to help agencies meet their project and portfolio management goals.""We understand that many federal agencies struggle with the unique challenges that come with the implementation of enterprise project management systems," said Jason Kinder, Pinnacle's Director of Marketing."This contract award benefits government agencies by giving them easy access to our depth of knowledge and proven solutions."Pinnacle's mission is simple - to help our clients improve performance through better management of projects, resources, and people across the enterprise. Our solutions can be leveraged across the enterprise for better project management of projects through a balanced integration of processes, information, tools, and people while maintaining a focus on adoption.About PinnaclePinnacle Management Systems, Inc.is a leading management consulting firm dedicated to helping our clients improve business performance through better management of projects, people, and resources.Founded in 1993, Pinnacle Management Systems, Inc. provides consulting, training, and system implementation services to a worldwide client base. Pinnacle specializes in enterprise-wide management systems and practices including Enterprise Project Management (EPM),Project Portfolio Management (PPM), Integrated Program Management (IPM), and Earned Value Management (EVM).To learn more about Pinnacle. Visit www.pinnaclemanagement.com.For media inquiries, contact:Jason Kinder, Director of Marketing(214) 774-4660[emailprotected] Related Imagesimage1.jpg SOURCE Pinnacle Management Systems, Inc.

Pinnacle Awarded GSA Schedule Contract

HOUSTON--(BUSINESS WIRE)--Ascend Performance Materials announced today a price increase for intermediate materials. The price increase takes effect immediately and includes the following terms: Material Price Increase Terms Hexamethylene Diamine (HMD) $100/MT Adiponitrile (ADN) $100/MT Acrylonitrile (AN) $85/MT Adipic Acid (AA) $80/MT Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials makes high-performance materials for everyday essentials and new technologies. Our focus is on improving quality of life and inspiring a better tomorrow through innovation. Based in Houston, Texas, and with regional offices in Shanghai, Brussels and Detroit, we are a fully integrated material solutions provider with eight global manufacturing facilities in the United States, Europe and China. Our 2,600-person global workforce makes the plastics, fabrics, fibers and chemicals used to make safer vehicles, cleaner energy, better medical devices, smarter appliances and longer-lasting apparel and consumer goods. We are committed to safety, sustainability and the success of our customers and our communities. Find out more about Ascend at www.ascendmaterials.com.

Ascend Performance Materials Announces Price Increase for Intermediate Materials

DUBLIN--(BUSINESS WIRE)--The "Organic Wine Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Packaging, Product Type, and Distribution Channel" report has been added to ResearchAndMarkets.com's offering. The market was valued at US$ 7,460.29 million in 2019 and is projected to reach US$ 16,647.81 million by 2027; it is expected to grow at a CAGR of 10.7% from 2020 to 2027. The report highlights key factors driving the market growth and prominent players along with their developments in the market. Organic wine is prepared from grapes cultivated organically, which mainly exclude the use of artificial chemical pesticides, fertilizers, fungicides, and herbicides. Organic wine is considered healthy as it has lots of antioxidants, vitamins, and minerals. Organic wine is produced by cultivating grapes without the use of artificial fertilizers or harmful chemicals. Organic wine has started gaining traction in the wake of alarming health issues and rising focus on healthy living. Therefore, rising demand for organic wine has positively influenced the number of organic vineyards. Further, according to the Research Institute of Organic Agriculture, Spain is considered one of the major regions, which strongly contributes to the production and consumption of organic wine. In the country, almost 80,000 hectares of land is considered to be used for organic farming of grapes. Other than this, France, Italy, the US, Turkey, and Germany are other major economies, which have a significant contribution in the production of organic grapes and wineries. Favorable climatic conditions, positive government approaches, and focus toward sustainable farming are some of the important factors influencing the growth of the organic wine market worldwide. Moreover, increase in population demanding healthier food options, along with rise in disposable income has fueled the demand for organic wine. The well-established countries are specifically experiencing massive growth in demand for organic food. Moreover, favorable government regulations to promote wine's organic cultivation are further expected to fuel market growth. All these factors are likely to increase the area and number of organic vineyards, thereby proliferating the growth of the market. Avondale, ELGIN RIDGE WINES, The Organic Wine Company, Bronco Wine Company, King Estate Winery, GRGICH HILLS ESTATE, EMILIANA, Societa Agricola QuerciabellaSpA, Frey Vineyards, and La cantina PizzolatoS.r.lare among the well-established players in the global organic wine market. Impact of COVID-19 Pandemic on Organic Wine Market The COVID-19 pandemic first began in Wuhan, China, in December 2019, and since then, it has spread at a fast pace worldwide. As of September 2020, the US, Brazil, India, Russia, Peru, South Africa, Mexico, and the UK are some of the worst affected countries in terms confirmed cases and reported deaths. The outbreak has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Food & beverages is one of the major industries suffering serious disruptions, such as office and factory shutdowns, and supply chain breaks, as a result of this outbreak. Key Topics Covered: 1. Introduction 2. Key Takeaways 3. Research Methodology 3.1 Scope of the Study 3.2 Research Methodology 4. Organic Wine Market Landscape 4.1 Market Overview 4.2 PEST Analysis 4.3 Expert Opinion 5. Organic Wine Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Increase in the number of Organic Vineyards 5.1.2 Growing Consciousness Towards Health 5.2 Market Restraints 5.2.1 Stringent Regulations Pertaining to Organic Wine 5.3 Market Opportunities: 5.3.1 Rising Focus towards Innovative Packaging 5.4 Future Trends: 5.4.1 Fine dining restaurants embracing natural wines 5.5 Impact Analysis of Drivers and Restraints 6. Organic Wine - Global Market Analysis 6.1 Organic Wine Market Overview 6.2 Organic WineMarket -Revenue and Forecast to 2027 (US$ Million) 6.3 Market Positioning of Key Players 7. Organic Wine Market Analysis - By Packaging 7.1 Overview 7.2 Organic Wine Market, By Packaging(2019 and 2027) 7.3 Plastic Bottles 7.3.1 Overview 7.3.1.1 Plastic Bottle: Organic Wine Market - Revenue, and Forecast to 2027 (US$ Million) 7.4 Glass Bottle 7.5 Cans 7.6 Others 8. Organic Wine Market Analysis - By Product Type 8.1 Overview 8.2 Red Organic Wine 8.2.1 Overview 8.2.1.1 Red Organic Wine: Organic Wine Market - Revenue, and Forecast to 2027 (US$ Million) 8.3 White Organic Wine 9. Organic Wine Market Analysis - By Distribution Channel 9.1 Overview 9.2 Food Service 9.2.1 Overview 9.2.1.1 Food Service: Organic Wine Market - Revenue, and Forecast to 2027 (US$ Million) 9.3 Supermarkets and Hypermarkets 9.4 Specialist Retailers 9.5 Online Channel 9.6 Others 10. Organic Wine Market - Geographic Analysis 10.1 Overview 11. Overview- Impact of COVID-19 11.1 North America: Impact Assessment of COVID-19 Pandemic 11.2 Europe: Impact assessment of COVID-19 Pandemic 11.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic 11.4 Middle East and Africa: Impact assessment of COVID-19 Pandemic 11.5 South America: Impact assessment of COVID-19 Pandemic 12. Industry Landscape 12.1 Business Strategy & Business Planning 12.2 Collaborations and Partnerships 13. Company Profiles 13.1 Key Facts 13.2 Business Description 13.3 Products And Services 13.4 Financial Overview 13.5 Swot Analysis 13.6 Key Developments For more information about this report visit https://www.researchandmarkets.com/r/5rkq17

Organic Wine Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Packaging, Product Type, and Distribution Channel - ResearchAndMarkets.com

LONDON--(BUSINESS WIRE)--The dry eye syndrome drugs market is poised to grow by USD 2.08 billion during 2021-2025, progressing at a CAGR of almost 7% during the forecast period. Worried about the impact of COVID-19 on your business? Here is an exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour. Get FREE Sample Report in Minutes! The report on the dry eye syndrome drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the growing geriatric population. The dry eye syndrome drugs market analysis includes the product and geography landscape. This study identifies the changing lifestyle and rising cases of diseases contributing to dry eye syndrome as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The dry eye syndrome drugs market covers the following areas: Dry Eye Syndrome Drugs Market Sizing Dry Eye Syndrome Drugs Market Forecast Dry Eye Syndrome Drugs Market Analysis Companies Mentioned Related Reports on Health Care Include: Global Parkinson's Disease (PD) Drugs Market- The Parkinson's disease (PD) drugs market is segmented by drug class (DA and levodopa-carbidopa, MAO inhibitors, AChE inhibitors, glutamate inhibitors, and others), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report Global Hepatitis C Drugs Market- The hepatitis C drug market is segmented by product (combination therapy and monotherapy), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Global Dry Eye Syndrome Drugs Market Research 2021-2025 | Industry Impact Analysis | Technavio

LAKE FOREST, Ill.--(BUSINESS WIRE)--Pactiv Evergreen Inc. (currently known as Reynolds Group Holdings Limited) (the Company) today announced the pricing of its initial public offering of 41,026,000 shares of its common stock at a price to the public of $14.00 per share. In addition, the Company granted the underwriters a 30-day option to purchase up to an additional 6,153,900 shares of common stock from the Company at the initial public offering price, less underwriting discounts and commissions. An entity affiliated with Mr. Graeme Hart, the beneficial owner of the Companys sole shareholder prior to the offering, has agreed to purchase 3,571,428 shares of common stock in the offering at the initial public offering price. The underwriters will not receive any underwriting discounts or commissions on these shares. The shares of common stock are expected to begin trading on the Nasdaq Global Select Market on September 17, 2020 under the ticker symbol PTVE. The offering is expected to close on September 21, 2020, subject to customary closing conditions. Credit Suisse, Citigroup, BofA Securities and Goldman Sachs & Co. LLC are acting as joint lead bookrunning managers. Baird, BMO Capital Markets, Deutsche Bank Securities, HSBC and RBC Capital Markets are also acting as joint bookrunning managers. Academy Securities, Loop Capital Markets, Rabo Securities USA, Inc., Ramirez & Co., Inc. and Siebert Williams Shank are acting as co-managers. The Company has filed a registration statement, including a prospectus, relating to these securities with the SEC, which was declared effective by the SEC on September 16, 2020. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and this offering. The offering is being made only by means of a prospectus. Copies of the final prospectus can be accessed, when available, through the SECs website at www.sec.gov. Alternatively, copies of the final prospectus relating to this offering may be obtained, when available, from: Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, United States, Telephone: 1-800-221-1037 or by emailing usa.prospectus@credit-suisse.com or Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, United States, Telephone: 800-831-9146. This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the Securities Act). About Pactiv Evergreen Inc. Pactiv Evergreen Inc. is a manufacturer and distributor of fresh foodservice and food merchandising products and fresh beverage cartons in North America and certain international markets. It supplies its products to a broad and diversified mix of companies, including full service restaurants and quick service restaurants, foodservice distributors, supermarkets, grocery and healthy eating retailers, other food stores, food and beverage producers, food packers and food processors.

Pactiv Evergreen Inc. (currently known as Reynolds Group Holdings Limited) Announces Pricing of Initial Public Offering

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS (Natixis SA and its affiliate Harris Associates LP) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree G4S Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 29th December 2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A NO 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 25p ordinary Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: 90 145 204 5,81 (2) Cash-settled derivatives: 6 790 000 0,44 (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 96 935 204 6,25 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit 25p ordinary Sale 426 759 GBP 2,5450 25p ordinary Sale 240 364 GBP 2,5460 25p ordinary Sale 399 652 GBP 2,5425 25p ordinary Sale 173 700 GBP 2,5490 25p ordinary Sale 61 GBP 2,5400 25p ordinary Purchase 10 GBP 2,5900 (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 30th December 2020 Contact name: Carole Sign Telephone number*: +33 1 58 32 17 94 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. *If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panels Market Surveillance Unit. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

Form 8.3 - G4S Plc

LAKE MARY, Fla. and TEL AVIV, Israel, Feb. 11, 2021 /PRNewswire/ -- AIO - Verified Financial Identity, a Fintech company based in Tel Aviv, and Finastra, today announced that they have been awarded a USD $1 million grant from the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation for the co-development of a digital customer onboarding solution. Developed by AIO and available on Finastra's FusionFabric.cloud open developer platform and app marketplace, the solution automates the process of establishing the financial identity of a loan applicant in order to meet Know Your Customer (KYC)/Know Your Business (KYB) regulations. The project received the largest available grant through the BIRD Foundation following a thorough review by BIRD-appointed evaluators from the National Institute of Standards and Technology (NIST) of the U.S. Department of Commerce and the Israel Innovation Authority. Driving factors that led to the grant being awarded to AIO and Finastra include the creation of an innovative solution that solves real-world problems and the ease with which financial institutions can leverage that technology. "It is an honor to be recognized by the BIRD Foundation for a solution that will fundamentally change how financial institutions assess loan applications, bringing tremendous efficiency to what is often an inefficient process," says Yoram Bechler, Co-founder and CEO at AIO. "In the world of COVID-19 there is also heightened demand and urgency for business loans. Our solution enables financial institutions to try to meet that demand, but also make lending decisions that are compliant, timely and cost-efficient. Working with Finastra, and making our solution available on its FusionFabric.cloud platform, we are able to reach more financial institutions, giving them the ability to leverage our customer-friendly mobile and web platform to meet KYC/KYB requirements and assess risk in just a few clicks." Current manual processes related to loan origination can be costly and time consuming. AIO's solution, which integrates with Finastra's Total Lending suite, speeds up customer onboarding by up to 80% and saves costs by securely automating the collection and verification of digital financial documents. Patented AIO technology maintains data collection with the customer, automatically verifying digital documents. These are then supplied digitally to the financial institution through Finastra's Total Lending. "This grant from the BIRD Foundation lends credence to a compelling solution, and also to our vision for open collaboration in financial services," said Mike Salfity, Global Head of Finastra Product Strategy and Head of North America Community Markets, Finastra. "We recognize the exciting offerings coming out of startups like AIO, and are committed to providing access to that innovation through FusionFabric.cloud. At the same time, we are able to extend the fintech's reach into the banking ecosystem. With this generous grant, AIO and Finastra will be able to better deliver an even more robust and impactful solution." The BIRD Foundation promotes collaborations between U.S. and Israeli companies in various technological fields for the purpose of joint product development. In addition to providing grants for approved projects, the Foundation assists by working with companies to identify potential strategic partners and facilitate introductions. "We are proud to support the project between AIO and Finastra to improve loan origination and reduce time and costs to both loan applicants and financial institutions," said Dr. Eitan Yudilevich, Executive Director of the BIRD Foundation. "The BIRD Foundation will continue to support projects which contain high level of innovation that address present needs." Several large multinational banks in the U.S. and Europe are currently piloting AIO's financial identity verification solution, with more expected to roll out in the coming months. finastra.com About AIO - Verified Financial Identity AIO is an award-winning Tel-Aviv based Fintech company driving trust in business relationships. AIO accelerates customer screening and onboarding by up to 80% and saves costs through digital collection and verification of financial identity documents. AIO's platform and mobile app enables financial institutions to quickly establish customers' financial identities, meet KYC/KYB requirements, and assess risk levels with just a few clicks. Using AIO's patented technology, digital documents from any trusted data provider worldwide are collected and automatically validated, without the need for integration. AIO's effortless digital experience protects customer data and privacy, increases customer satisfaction, and minimizes fraud. About Finastra Finastra is building an open platform that accelerates collaboration and innovation in financial services, creating better experiences for people, businesses and communities. Supported by the broadest and deepest portfolio of financial services software, Finastra delivers this vitally important technology to financial institutions of all sizes across the globe, including 90 of the world's top 100 banks. Our open architecture approach brings together a number of partners and innovators. Together we are leading the way in which applications are written, deployed and consumed in financial services to evolve with the changing needs of customers. Learn more at finastra.com LinkedIn | Twitter | YouTube Corporate headquarters4 Kingdom StreetPaddingtonLondon W2 6BDUnited KingdomT: +44 20 3320 5000 North American headquarters744 Primera BoulevardSuite 2000Lake Mary, FL 32746United StatesT: +1 800 989 9009 Logo: https://mma.prnewswire.com/media/967510/Finastra_Logo.jpg SOURCE Finastra Related Links https://www.finastra.com/

AIO and Finastra awarded $1M grant from the BIRD Foundation to expedite banks' customer onboarding and loan origination USA - English USA - English USA - English

DURHAM, N.C. & BEIJING--(BUSINESS WIRE)--Brii Biosciences (Brii Bio), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and with a high public health impact, today announced that its antibodies BRII-196 and BRII-198 failed to meet pre-specified efficacy criteria permitting expansion into the Phase 3 component of ACTIV-3. The ACTIV-3 study evaluated the safety and efficacy of the BRII-196 and BRII-198 combination and the impact of this monoclonal antibody combination on clinical outcomes in approximately 150 hospitalized participants, relative to a standard of care comparison arm of approximately 150 participants. As specified by protocol, data from 300 randomized patients at their day five ordinal scale were evaluated by the Data & Safety Monitoring Board (DSMB) for signs of clinical benefit against the current standard of care. The DSMB determined that pre-specified efficacy criteria in this hospitalized population have not been met, and thus the study will not be expanded to enroll additional patients. Brii Bio will work closely with the ACTIV-3 study team to further understand and to publish the data expediently. We anticipated that it would be very difficult to demonstrate additional benefits in the study population on top of current standard of care including VEKLURY (remdesivir) and dexamethasone, said Zhi Hong, Ph.D., CEO of Brii Bio. While we are disappointed that BRII-196 and BRII-198 have not shown clear benefits during the interim analysis against COVID-19 in hospitalized patients receiving the current standard of care, we remain committed to investigating this antibody combination in ambulatory COVID-19 patients through the ongoing ACTIV-2 trial. We continue to feel confident in this therapy and its antiviral activity against the newly emerging variants. I would like to thank the ACTIV-3 study team, investigators and participants for incredible efforts, as well as NIAID for the sponsorship. About ACTIV-3 The NIHs ongoing COVID-19 Therapeutic Interventions and Vaccines (ACTIV-3) master protocol is examining the clinical safety and efficacy of investigational agents, including the combination therapy of BRII-196 and BRII-198, relative to current standard of care (SOC) therapy in hospitalized patients with more severe COVID-19. An initial Phase 2 group of approximately 300 individuals, randomized 1:1 to BRII-196 and BRII-198 or SOC, was evaluated by the DSMB for clinical improvement after 5 days, using a seven-point ordinal scale. Following the decision not to progress into Phase 3, the evaluation of BRII-196 and BRII-198 will be unblinded, with data being submitted for publication as soon as is feasible. This study (NCT04501978) commenced dosing with BRII-196 and BRII-198 in December 2020. The ACTIV-3 study is Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH). About BRII-196 and BRII-198 BRII-196 and BRII-198 are non-competing SARS-CoV-2 neutralizing antibodies derived from convalesced COVID-19 patients. They have been specifically engineered to reduce the risk of antibody-dependent enhancement and prolong the plasma half-lives for potentially more durable treatment effect. Their non-overlapping epitope binding regions provide a high degree of neutralization activity against SARS-CoV-2, with preliminary in vitro evidence suggesting continued antiviral activity against commonly circulating variants from U.K. and South Africa. Phase 1 studies in healthy human volunteers in China have completed dosing and follow-up, providing safety and human PK profiles for both individual antibodies. In addition to ACTIV-3, the BRII-196 and BRII-198 antibody cocktail is also under clinical investigation in the ongoing ACTIV-2 (NCT04518410), sponsored by the NIAID. ACTIV-2 is a Phase 2/3 study evaluating the safety, antiviral activity and clinical efficacy investigational agents in ambulatory patients with COVID-19. The evaluation of BRII-196 and BRII-198 in ACTIV-2 will continue. The combination of BRII-196 and BRII-198 is also being studied in Hong Kong to investigate the clinical safety and efficacy in Asian populations with COVID-19. This study is expected to begin in 1Q 2021. BRII-196 and BRII-198 have been submitted as INDs to the U.S FDA, the Department of Health in Hong Kong, and in mainland China under an IND to the NMPA. About Brii Biosciences Brii Biosciences (Brii Bio) is a multi-national company committed to serving patients' needs and improving public health by accelerating the development and delivery of breakthrough medicines through partnerships, best-in-class research and development, and the disruptive application of digital and data insight. With operations in the People's Republic of China and the United States, Brii Bio is poised to serve as a bridge to carry transformative medicines to patients, help create significant growth for our partners and establish an innovation engine to help improve the public health and wellbeing of patients around the world. Brii Bio is developing treatments for illnesses with significant public health burdens, including infectious diseases, liver diseases, and CNS diseases. For more information, visit www.briibio.com.

Brii Biosciences Antibody Combination Will Not Progress into a Phase 3 Study Evaluating the Treatment of SARS-CoV-2 in Hospitalized Patients - The complete dataset from this study is evolving, including important sensitivity and sub-group analysis, which will help inform whether a treatment benefit can be observed in particular subgroups of hospitalized patients. - Additional studies of the BRII-196 and BRII-198 combination are ongoing in ambulatory COVID-19 patients through ACTIV-2 clinical trial in collaboration with NIH-NIAID

Year-end 2020 debt reduced nearly $500 million from mid-year 2020 2021 debt reduction target increased 25% to $1.25 billion including second half 2020 Multi-year debt target issued: $4.5 billion of total debt by year-end 2022 Company signs agreement to sell its Duvernay asset for $263 million Company generated significant non-GAAP Free Cash Flow for third consecutive year Strong well performance and realized prices combined with lower cash costs drive cash flow beat with lower-than-expected capital investments 2021 capital investment plan of $1.5 billion expected to generate ~$1 billion of non-GAAP Free Cash Flow DENVER, Feb. 17, 2021 /PRNewswire/ -Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced its fourth quarter and full-year 2020 financial and operating results, announced an agreement to sell its Duvernay assets, disclosed its year-end 2020 proved reserves and provided a strong 2021 Outlook. In addition, the Company issued a new target of reducing total debt to $4.5 billion by year-end 2022. A conference call and webcast will be held at 9 a.m. MT, Thursday, February 18, 2021 (details within). Highlights: Fourth quarter and full-year financial and operating results exceeded targets and consensus expectations. Full-year cash from operating activities was approximately $1.9 billion, equal to non-GAAP Cash Flow; 2020 non-GAAP Free Cash Flow was $193 million (inclusive of $90 million of one-time restructuring costs), with strong fourth quarter momentum of nearly $350 million in non-GAAP Free Cash Flow. Reduced total long-term debt, including current portion, by $257 million in the fourth quarter, representing a $481 million reduction since mid-year 2020. Delivered strong well performance, driving fourth quarter crude and condensate(1) production of 215 thousand barrels per day (Mbbls/d), above guidance of 200 Mbbls/d; Fourth quarter total production averaged 557 thousand barrels of oil equivalent per day (MBOE/d). Full-year 2020 production averaged 544 MBOE/d. Maintained disciplined capital investments with full year spending of $1.74 billion, well under the $1.8 billion guide. Further capital efficiency gains achieved with fourth quarter average completed well costs at least 25% lower than full-year 2019 averages; new pacesetter well costs attained in each of the three core plays. Achieved seventh consecutive "safest-year-ever". Flared and vented natural gas volumes in the fourth quarter of 2020 accounted for less than 0.5% of total natural gas production, down significantly from 1.2% in 2019. Reached an agreement to sell its Duvernay assets for $263 million including $12 million of contingent payments. Established total debt target of $4.5 billion by year-end 2022, a 35% reduction when compared to year-end 2020, inclusive of $1 billion in divestment proceeds. Ovintiv CEO Doug Suttles said, "We achieved outstanding financial, operating and environmental results in 2020. Through this combination, we 'beat our beat' in the fourth quarter with lower capital investments and very strong cash flows. The strengths of our company - a high-quality portfolio, industry-leading efficiencies, sophisticated risk management and a culture of innovation - were crucial to our success during a challenging time for the industry. For the third consecutive year, we delivered meaningful free cash flow, and we estimate $1 billion in free cash flow in 2021. We've made significant progress on debt reduction and today increased our year-end 2021 debt reduction target by 25% to $1.25 billion and set a year-end 2022 total debt target of $4.5 billion. The critical intersection of financial and operating results with environmental progress was evident through our industry-leading total flare and vent volumes of less than half-of-one percent in the fourth quarter." 1. Throughout this document, crude and condensate refers to tight oil including medium and light crude oil volumes and plant condensate. A conference call and webcast to discuss the 2020 fourth quarter and full-year results and the 2021 Outlook will be held at 9 a.m. MT on February 18, 2021. In addition to the release, supplemental slides and financial statements will be available on the Company's website, located at www.ovintiv.com. The Company also issued a separate release today on its enhanced compensation, governance, and environmental initiatives.To participate in the conference call, please dial 888-664-6383 (toll-free in North America) or 416-764-8650 (international) approximately 15 minutes prior to the call. The live audio webcast of the conference call, including slides, will also be available on Ovintiv's website, under Investors/Presentations and Events, and will be archived for approximately 90 days. Multi-Year Debt Reduction TargetReducing debt is Ovintiv's number one priority. The Company today set a year-end 2022 goal to reduce absolute debt to $4.5 billion, a 35% reduction from year-end 2020. This target includes $1 billion in divestment proceeds and maintaining crude and condensate production of approximately 200 Mbbls/d. The Company's previously announced leverage target of 1.5 times net-debt-to adjusted EBITDA and its long-term reinvestment framework of less than 75% of annual non-GAAP Cash Flow were reaffirmed. Sale of Duvernay AssetsThe Company through a wholly owned subsidiary, has agreed to sell its Duvernay assets for approximately $263 million including approximately $12 million in contingency payments based on future commodity prices. The agreement is subject to ordinary closing conditions, regulatory approvals and other adjustments and is expected to close in the second quarter of 2021. Duvernay production averaged approximately 10 MBOE/d (43% liquids) in the fourth quarter of 2020. Ovintiv will update its guidance once the transaction has closed. "Today's announcement of the sale of our Duvernay asset combined with our strong fourth quarter and 2021 guide clearly demonstrate our commitment to debt reduction and puts us squarely on track to achieve our $4.5 billion dollar year-end 2022 goal," said Suttles. Full Year and Fourth Quarter 2020 Financial and Operating ResultsFor 2020, the Company recorded a net loss of $6.1 billion, or ($23.47) per share of common stock, driven primarily by a non-cash ceiling test impairment of $5,580 million, before-tax, related to the decline in 12-month average trailing commodity prices which reduced SEC proved reserves (see proved reserves table within this release). Non-GAAP operating earnings were $91 million, or $0.35 per share of common stock. The Company recorded a net loss in the fourth quarter of $614 million, or ($2.36) per share of common stock. Cash from operating activities for the fourth quarter was $719 million and non-GAAP Cash Flow was $692 million. Production Summary and Asset HighlightsOvintiv's significantly higher than expected fourth quarter production was largely driven by strong well results across the portfolio. The Company's cube development approach and innovative completion designs continued to deliver industry-leading capital efficiencies. Fourth quarter crude oil and condensate volumes were 215 Mbbls/d. Fourth quarter liquids production averaged 297 Mbbls/d and total Company production was 557 MBOE/d. For the year, total production averaged 544 MBOE/d including liquids production of 289 Mbbls/d. See the "Capital Investment and Production" table below. In the fourth quarter, Ovintiv set new, record-low well costs in each of its Core 3 assets. The Company exceeded its stated goal of reducing 2020 well costs by 20% when compared to 2019 averages by delivering cost reductions of 25% or greater during the quarter. "Ovintiv has demonstrated industry-leading capital efficiencies across our portfolio," said Suttles. "The efforts of our teams to consistently find innovative ways to reduce costs have led to sustainable capital savings that will be durable even as commodity prices improve. More importantly, they never lost their focus on safety and 2020 marks our 'safest year ever' for the seventh consecutive year." PermianPermian production averaged 110 MBOE/d (81% liquids) in the fourth quarter. The Company averaged three rigs, drilled 22 net wells, and had 29 net wells turned in line (TIL). Fourth quarter drilling and completion (D&C) costs per lateral foot was $470, down more than 30% compared to 2019 average D&C cost. Full year production in the play averaged 109 MBOE/d (81% liquids). AnadarkoAnadarko production averaged 134 MBOE/d (62% liquids) in the fourth quarter. The Company averaged two rigs, drilled 11 net wells, and had 28 net wells TIL. Fourth quarter D&C costs per lateral foot was $440, down over 30% compared to 2019 average D&C cost. Full year production in the play averaged 144 MBOE/d (62% liquids). MontneyMontney production averaged 222 MBOE/d (26% liquids) in the fourth quarter. The Company averaged four rigs, drilled 22 net wells and had 28 net wells TIL. Fourth quarter D&C costs per lateral foot was $380, down approximately 25% compared to 2019 average D&C cost. Full year production in the play averaged 204 MBOE/d (25% liquids). Base AssetsThere were 23 net wells TIL in the base assets during the fourth quarter. All fourth quarter TILs were drilled in the first half of the year. Year-End 2020 ReservesUnder Canadian reserves protocol, proved and probable reserves were 4.2 billion BOE before royalties and 3.5 billion BOE after royalties. SEC proved reserves at year-end 2020 were 2.0 billion BOE, of which approximately 60% were liquids and 56% were proved developed. The significant gains in capital efficiency that the Company realized through the year resulted in an SEC total proved reserve replacement of 90% of 2020 production excluding price and net of acquisitions and divestitures. Balance Sheet and LiquidityOvintiv's total liquidity at year end was approximately $3.3 billion, which represents the Company's $4 billion committed, unsecured credit facilities, available capacity on uncommitted demand lines and cash-on-hand, net of the amount drawn on the credit facilities and commercial paper outstanding. Throughout 2020 Ovintiv took steps to capitalize on market dislocations, purchasing its notes at a discount in the open market, resulting in a $30 million gain as well as go-forward interest savings. During 2020, Ovintiv repurchased approximately $302 million in principal of its senior notes for a cash payment of approximately $272 million, plus accrued interest. The Company expects to incur lower interest expense of approximately $10 million on an annualized basis on the reduced fixed long-term debt balances. The Company has significant flexibility to manage its late 2021 and early 2022 maturities, including available cash on hand or the use of its credit facilities. More than 80% of the Company's total fixed-rate long-term debt is due in 2024 or later and has an aggregate weighted average bond maturity of approximately nine years. Refer to Note 1 Non-GAAP measures and the tables in this release for reconciliation to comparable GAAP financial measures. 2021 OutlookRegarding the Company's 2021 Outlook, Suttles said, "Our strong performance in 2020 sets us up well to deliver once again in 2021. We expect this will be our fourth consecutive year of generating significant free cash flow and we are confident in our ability to meaningfully reduce our debt over the next two years. Longer-term, our ongoing capital discipline and reinvestment rate commitment ensure that we will be able to return cash to shareholders all critical components of the 'new E&P' company." Ovintiv's 2021 planned capital investments are approximately $1.5 billion and are expected to generate non-GAAP Free Cash Flow of approximately $1 billion, assuming commodity prices of $50 WTI and $2.75 NYMEX. The capital program represents a cash flow reinvestment rate of about 60%, significantly lower than the Company's framework of less than 75%. Over 90% of total capital investment is earmarked for Ovintiv's Core 3 assetsPermian, Anadarko and Montney. The Company plans to execute a load-levelled program with consistent quarterly levels of activity and capital spending. Crude oil and condensate volumes are expected to be relatively flat through the year, averaging approximately 200 Mbbls/d. Full-year NGL (C2 C4) production is expected to be approximately 80 Mbbls/d and natural gas is expected to average approximately 1.55 billion cubic feet per day (Bcf/d). Total costs in 2021 are expected to average approximately $12.25 to $12.50 per barrel of oil equivalent (BOE). Ovintiv has strong risk management positions in place with about 65% of 2021 crude oil and condensate and natural gas production hedged. The majority of the hedges are in three-way structures that provide exposure to higher oil prices. Hedge tables can be found below. 2021 Guidance Capital Expenditures ($ million) $1,500 Oil & Condensate (Mbbls/d)(1) 200 Other NGLs (Mbbls/d) 80 Natural Gas (MMcf/d) (2) 1,550 Total Costs per BOE (3)(Upstream Transportation and Processing, Operating, Production, Mineral and Other Taxes, plus Corp G&A) $12.25 - $12.50 (1) Primarily tight oil, including minimal medium and light crude oil volumes, and approximately 25% plant condensate. (2) Primarily shale gas, including minimal conventional natural gas. (3) Operating and G&A costs exclude long-term incentive costs and CECL. Dividend declaredOn February 17, 2021, Ovintiv's Board declared a dividend of $0.09375 per share of common stock payable on March 31, 2021 to common stockholders of record as of March 15, 2021. Capital Investment and Production (for the period ended December 31) Q4 2020 Q4 2019 2020 2019 Capital Expenditures (1) ($ millions) 343 574 1,736 2,626 Oil (Mbbls/d) (2) 158.0 172.9 151.5 164.4 NGLs Plant Condensate (Mbbls/d) 56.8 52.9 52.1 52.9 NGLs Other (Mbbls/d) 82.6 96.2 85.3 84.6 Total NGLs (Mbbls/d) 139.4 149.1 137.4 137.5 Total Liquids (Mbbls/d) 297.4 322.0 288.9 301.9 Natural gas (MMcf/d) (3) 1,559 1,624 1,529 1,577 Total production (MBOE/d) 557.2 592.6 543.8 564.9 (1) Including capitalized overhead costs. (2) Primarily tight oil, including minimal medium and light crude oil volumes. (3) Primarily shale gas, including minimal conventional natural gas. Fourth Quarter and Year-End Summary Non-GAAP Cash Flow Reconciliation (for the period ended December 31) ($ millions, except as indicated) Q4 2020 Q4 2019 2020 2019 Cash from (used in) operating activities 719 730 1,895 2,921 Deduct (add back): Net change in other assets and liabilities (6) (42) (173) (97) Net change in non-cash working capital 33 (43) 139 87 Non-GAAP cash flow(1) 692 815 1,929 2,931 Non-GAAP cash flow margin(1) ($/BOE) 13.50 14.95 9.69 14.21 Non-GAAP Free Cash Flow Reconciliation Non-GAAP cash flow(1) 692 815 1,929 2,931 Less: capital expenditures 343 574 1,736 2,626 Non-GAAP free cash flow(1) 349 241 193 305 Non-GAAP Operating Earnings Reconciliation Net earnings (loss) before income tax (642) (68) (5,730) 315 Before-tax (addition) deduction: Unrealized gain (loss) on risk management (186) (345) (204) (730) Impairments (717) - (5,580) - Restructuring charges (2) (4) (90) (138) Non-operating foreign exchange gain (loss) 17 52 (16) 94 Gain (loss) on divestitures - (1) - 3 Gain on debt retirement 2 - 30 - Income tax expense (recovery) 61 20 39 226 Non-GAAP operating earnings (loss)(1) 183 210 91 860 (1) Non-GAAP cash flow, non-GAAP cash flow margin, non-GAAP free cash flow, and non-GAAP operating earnings are non-GAAP measures as defined in Note 1. Realized Pricing Summary Q4 2020 Q4 2019 2020 2019 Liquids($/bbl) WTI 42.66 56.96 39.40 57.03 Realized liquids prices (1) Oil 47.75 56.17 44.68 57.40 NGLs Plant Condensate 44.81 52.03 40.89 51.95 NGLs Other 10.94 12.90 9.41 14.04 Total NGLs 24.73 26.80 21.35 28.63 Natural gas NYMEX ($/MMBtu) 2.66 2.50 2.08 2.63 Realized natural gas price (1)($/Mcf) 2.33 2.25 2.13 2.28 (1) Prices include the impact of realized gains (losses) on risk management. Total Costs Summary (for the year ended December 31)($ millions, except as indicated) 2020 2019 Total Operating Expenses 11,484 6,128 Deduct (add back): Market optimization operating expenses 1,608 1,304 Corporate & other operating expenses (2) (3) Depreciation, depletion and amortization 1,834 2,015 Impairments 5,580 - Accretion of asset retirement obligation 29 37 Long-term incentive costs 31 35 Restructuring costs 90 138 Current expected credit losses 1 - Total Costs (1) 2,313 2,602 Divided by: Production Volumes (MMBOE) 199.0 206.2 Total Costs (1) ($/BOE) 11.60 12.59 Drivers Included in Total Costs (1) ($/BOE) Production, mineral and other taxes 0.87 1.23 Upstream transportation and processing 6.44 6.42 Upstream operating, excluding long-term incentive costs 2.88 3.35 Administrative, excluding long-term incentive costs, restructuring costs and current expected credit losses 1.41 1.59 Total Costs (1) ($/BOE) 11.60 12.59 (1) Calculated using whole dollars and volumes. Total Costs is a non-GAAP measure as defined in Note 1. Debt to Adjusted Capitalization ($ millions, except as indicated) December 31, 2020 December 31, 2019 Long-Term Debt, including current portion 6,885 6,974 Total Shareholders' Equity 3,837 9,930 Equity Adjustment for Impairments at December 31, 2011 7,746 7,746 Adjusted Capitalization 18,468 24,650 Debt to Adjusted Capitalization (1) 37% 28% (1) Debt to Adjusted Capitalization is a non-GAAP measure as defined in Note 1. Year-End 2020 Reserves Estimates 2020 Reserves Estimates Canadian Protocols (Net, After Royalties)(1) Using forecast prices and costs; simplified table (MMBOE) 1PProved 2PProved + Probable Canadian Operations 696.7 1,227.4 USA Operations 1,496.8 2,267.2 Total as of December 31, 2020 2,193.5 3,494.6 2020 Proved Reserves Estimates Canadian Protocols (Net, After Royalties)(1) Using forecast prices and costs; simplified table Oil(MMbbls)(3) NGLs(MMbbls) NaturalGas(Bcf)(4) Total(MMBOE) December 31, 2019 737.6 596.7 5,793 2,299.8 Technical Revisions (92.0) 43.3 54 (39.8) Economic Factors (23.1) (9.3) (120) (52.5) Extensions, improved recovery and discoveries 64.4 50.3 482 195.0 Acquisitions 10.8 19.5 140 53.7 Dispositions (9.4) (20.7) (201) (63.6) Production (55.4) (50.3) (560) (199.0) December 31, 2020 632.9 629.5 5,587 2,193.5 2020 Proved Plus Probable Reserves Estimates Canadian Protocols (Net, After Royalties)(1) Using forecast prices and costs; simplified table Oil(MMbbls)(3) NGLs(MMbbls) NaturalGas(Bcf)(4) Total(MMBOE) December 31, 2019 1,369.1 1,029.3 10,746 4,189.5 Technical Revisions (471.7) (164.3) (2,432) (1,041.3) Economic Factors (27.9) (4.8) (79) (45.9) Extensions, improved recovery and discoveries 210.3 144.6 1,568 616.3 Acquisitions 18.0 30.3 232 86.9 Dispositions (17.2) (38.2) (339) (111.9) Production (55.4) (50.3) (560) (199.0) December 31, 2020 1,025.3 946.6 9,137 3,494.6 2020 Proved Reserves Estimates U.S. Protocols (Net, After Royalties)(1) Using constant prices and costs; simplified table Oil(MMbbls)(3) NGLs(MMbbls) NaturalGas(Bcf)(4) Total(MMBOE) December 31, 2019 723.7 588.5 5,259 2,188.8 Revisions and improved recovery (2) (222.0) (62.2) (484) (364.9) Extensions and discoveries 144.4 105.8 764 377.5 Purchase of reserves in place 10.9 20.0 140 54.3 Sale of reserves in place (9.3) (21.4) (201) (64.1) Production (55.4) (50.3) (560) (199.0) December 31, 2020 592.3 580.5 4,918 1,992.5 1) Numbers may not add due to rounding. 2) Changes in reserve estimates resulting from economic factors, pricing and application of improved recovery techniques are included in revisions of previous estimates. 3) Primarily tight oil, including minimal medium and light crude oil volumes. 4) Primarily shale gas, including minimal conventional natural gas. Differences between estimates under Canadian and U.S. protocols primarily represent the use of forecast prices and escalating costs in the estimation of reserves under Canadian standards, while U.S. standards require the use of 12-month average historical prices which are held constant along with costs. For information on reserves reporting, see Note 2. 2021 Hedge Positions as of January 31, 2021 Oil & Condensate Hedges 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2021 WTI 3-Way Options Mbbls/d 90 74 69 69 75 Short Call ($/bbl) $50.03 $51.05 $52.65 $52.65 $51.48 Long Put ($/bbl) $40.66 $41.32 $42.53 $42.53 $41.68 Short Put ($/bbl) $32.58 $32.29 $32.82 $32.82 $32.62 WTI Swaps Mbbls/d 50 40 30 30 37 Swap Price ($/bbl) $44.49 $47.54 $46.37 $46.37 $46.06 WTI Costless Collars Mbbls/d 15 15 15 15 15 Short Call ($/bbl) $45.84 $45.84 $45.84 $45.84 $45.84 Long Put ($/bbl) $35.00 $35.00 $35.00 $35.00 $35.00 Natural Gas Hedges 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2021 NYMEX 3-Way Options MMcf/d 880 1,030 1,030 880 955 Short Call ($/Mcf) $3.55 $3.37 $3.37 $3.35 $3.41 Long Put ($/Mcf) $2.90 $2.87 $2.87 $2.88 $2.88 Short Put ($/Mcf) $2.50 $2.50 $2.50 $2.50 $2.50 NYMEX Swaps MMcf/d - - 165 165 83 Swap Price ($/Mcf) - - $2.51 $2.51 $2.51 About Ovintiv Inc.Ovintiv is one of the largest producers of oil, condensate and natural gas in North America. The Company is committed to preserving its financial strength, maximizing profitability through disciplined capital investments and operational efficiencies and returning capital to shareholders. A talented team, in combination with a culture of innovation and efficiency, fuels Ovintiv's economic performance, increases shareholder value and strengthens its commitment to sustainability in the communities where its employees live and work. NOTE 1: Non-GAAP measuresCertain measures in this news release do not have any standardized meaning as prescribed by U.S. GAAP and, therefore, are considered non-GAAP measures. These measures may not be comparable to similar measures presented by other companies and should not be viewed as a substitute for measures reported under U.S. GAAP. These measures are commonly used in the oil and gas industry and/or by Ovintiv to provide shareholders and potential investors with additional information regarding the Company's liquidity and its ability to generate funds to finance its operations. For additional information regarding non-GAAP measures, see the Company's website. This news release contains references to non-GAAP measures as follows: Non-GAAP Cash Flowis a non-GAAP measure defined as cash from (used in) operating activities excluding net change in other assets and liabilities, net change in non-cash working capital and current tax on sale of assets. Non-GAAP Cash Flow Margin is a non-GAAP measure defined as Non-GAAP Cash Flow per BOE of production. Non-GAAP Free Cash Flow is a non-GAAP measure defined as Non-GAAP Cash Flow in excess of capital expenditures, excluding net acquisitions and divestitures. Non-GAAP Operating Earnings (Loss)is a non-GAAP measure defined as net earnings (loss) excluding non-recurring or non-cash items that Management believes reduces the comparability of the Company's financial performance between periods. These items may include, but are not limited to, unrealized gains/losses on risk management, impairments, restructuring charges, non-operating foreign exchange gains/losses, gains/losses on divestitures and gains on debt retirement. Income taxes includes adjustments to normalize the effect of income taxes calculated using the estimated annual effective income tax rate. Total Costs is anon-GAAP measure which includes the summation of production, mineral and other taxes, upstream transportation and processing expense, upstream operating expense and administrative expense, excluding the impact of long-term incentive costs, restructuring costs and current expected credit losses. It is calculated as total operating expenses excluding non-upstream operating costs and non-cash items which include operating expenses from the Market Optimization and Corporate and Other segments, depreciation, depletion and amortization, impairments, accretion of asset retirement obligation, long-term incentive costs, restructuring costs and current expected credit losses. When presented on a per BOE basis, Total Costs is divided by production volumes. Management believes this measure is useful to the Company and its investors as a measure of operational efficiency across periods. Debt to Adjusted Capitalization is a non-GAAP measure which adjusts capitalization for historical ceiling test impairments that were recorded as at December 31, 2011. Management monitors Debt to Adjusted Capitalization as a proxy for the Company's financial covenant under the Credit Facilities which require debt to adjusted capitalization to be less than 60 percent. Adjusted Capitalization incudes debt, total shareholders' equity and an equity adjustment for cumulative historical ceiling test impairments recorded as at December 31, 2011 in conjunction with the Company's January 1, 2012 adoption of U.S. GAAP. Net Debt, Adjusted EBITDA and Net Debt to Adjusted EBITDA Net Debt is defined as long-term debt, including the current portion, less cash and cash equivalents. Management uses this measure as a substitute for total long-term debt in certain internal debt metrics as a measure of the company's ability to service debt obligations and as an indicator of the company's overall financial strength. Adjusted EBITDA is defined as trailing 12-month net earnings (loss) before income taxes, DD&A, impairments, accretion of asset retirement obligation, interest, unrealized gains/losses on risk management, foreign exchange gains/losses, gains/losses on divestitures and other gains/losses. Net Debt to Adjusted EBITDA is monitored by management as an indicator of the company's overall financial strength. Note 2: INFORMATION ON RESERVES REPORTING Detailed Canadian protocol disclosure will be contained in the Company's Form 51-101F1 for the year ended December 31, 2020 ("Form 51-101F1") and detailed U.S. protocol disclosure will be contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 ("Annual Report on Form 10-K"), each of which the Company anticipates filing with applicable securities regulatory authorities on or about February 18, 2021. A description of the primary differences between the disclosure requirements under Canadian standards and under U.S. standards will be set forth under the heading "Note Regarding Additional Reserves Information" in the Form 51101F1. ADVISORY REGARDING FORWARD-LOOKING STATEMENTS This news release contains certain forward-looking statements or information (collectively, "FLS") within the meaning of applicable securities legislation, including the United States Private Securities Litigation Reform Act of 1995. FLS include: targeted debt reduction; 2021 outlook, including with respect to expected capital investments, reinvestment rate, free cash flow, production and pricing; estimated hedging revenue and sensitivity to commodity prices; timing and size of expected asset sales; and contingent payments. FLS involve assumptions, risks and uncertainties that may cause such statements not to occur or results to differ materially. These assumptions include expectations and projections made in light of the Company's historical experience. Risks and uncertainties include: commodity price volatility and impact to the Company's stock price and cash flows; ability to secure adequate transportation and potential curtailments of refinery operations, including resulting storage constraints or widening price differentials; discretion to declare and pay dividends, if any; business interruption, property and casualty losses or unexpected technical difficulties; impact of COVID-19 to the Company's operations, including maintaining ordinary staffing levels, securing operational inputs, executing on portions of its business and cyber-security risks associated with remote work; counterparty and credit risk; impact of changes in credit rating and access to liquidity, including costs thereof; risks in marketing operations; risks associated with technology; risks associated with decommissioning activities, including timing and costs thereof; the occurrence of any event, change or other circumstances that could give rise to the inability to complete proposed asset sales; and other risks and uncertainties as described in the Company's Annual Report on Form 10-K, Quarterly Report on Form 10-Q and as described from time to time in its other periodic filings as filed on EDGAR and SEDAR. Although the Company believes such FLS are reasonable, there can be no assurance they will prove to be correct. The above assumptions, risks and uncertainties are not exhaustive. FLS are made as of the date hereof and, except as required by law, the Company undertakes no obligation to update or revise any FLS. SOLICITATION OF PROXIES Ovintiv intends to file a proxy statement and WHITE proxy card with the U.S. Securities and Exchange Commission (the "SEC") and Canadian securities regulatory authorities in connection with its solicitation of proxies for its 2021 Annual Meeting of Stockholders (the "2021 Annual Meeting"). OVINTIV STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT (AND ANY AMENDMENTS AND SUPPLEMENTS THERETO) AND ACCOMPANYING WHITE PROXY CARD WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain the proxy statement, any amendments or supplements to the proxy statement and other documents as and when filed by Ovintiv with the SEC without charge from the SEC's website at www.sec.gov and Canadian securities regulatory authorities at www.sedar.com. Certain Information Regarding ParticipantsOvintiv, its directors and certain of its executive officers may be deemed to be participants in connection with the solicitation of proxies from Ovintiv's stockholders in connection with the matters to be considered at the 2021 Annual Meeting.Information regarding the ownership of Ovintiv's directors and executive officers in Ovintiv common stock is included in their SEC filings on Forms 3, 4, and 5, which can be found through the SEC's website atwww.sec.gov. Information can also be found in Ovintiv's other SEC filings. More detailed and updated information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other materials to be filed with the SEC. These documents can be obtained free of charge from the sources indicated above. Further information on Ovintiv Inc. is available on the Company's website, www.ovintiv.com, or by contacting: Investor contact: Media contact: (888) 525-0304 (281) 210-5253 SOURCE Ovintiv Inc.

Ovintiv Reports Fourth Quarter and Full-Year 2020 Results, Announces Multi-Year Debt Reduction Target, Signs Agreement to Sell Duvernay and Provides Strong 2021 Outlook

NEW HAVEN, Conn., July 21, 2020 /PRNewswire/ --Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced today that it has successfully completed enrollment in the M-STAR study, an international Phase 3 clinical trial evaluating the safety and efficacy of verdiperstat in multiple system atrophy (MSA). Verdiperstat is an investigational drug and potential first-in-class myeloperoxidase (MPO) inhibitor designed to target sources of neuroinflammation that contribute to brain cell death in neurodegenerative diseases including MSA and amyotrophic lateral sclerosis (ALS). Verdiperstat has received Orphan Drug and Fast Track designations for MSA from the U.S. Food and Drug Administration (FDA), as well as Orphan Drug designation from the European Medicines Agency. The MSA Coalition Logo Defeat MSA Alliance Logo M-STAR Logo "The M-STAR trial has proceeded with great success despite the unique challenges created by COVID-19. This demonstrates the determination of the MSA community to work towards a potential new treatment for this devastating disease," commented Dr. Phillip A. Low, M.D., Robert D. and Patricia E. Kern Professor of Neurology, Mayo Clinic, Rochester, MN. "I applaud the true champions of the M-STAR trial the MSA patients whose hope has propelled us all." M-STAR is a Phase 3 randomized, double-blind, placebo-controlled clinical trial designed to evaluate the safety and efficacy of verdiperstat in approximately 300 patients with a clinical diagnosis of MSA between 40-80 years of age. Patients across approximately 50 sites inthe United States and Europeare randomized to 48 weeks of treatment with verdiperstat 600 mg oral tablet taken twice daily or placebo. The study's primary efficacy endpoint will assess disease progression measured by the change from baseline to week 48 on a modified version of the Unified MSA Rating Scale (UMSARS) in patients receiving verdiperstat versus placebo. Topline data are expected by the end of 2021. Irfan Qureshi, MD, Vice President of Neurology at Biohaven stated, "Verdiperstathas the potential to be the first disease-modifying treatment for people suffering from MSA, and we are deeply indebted to the international community of MSA investigators, our trial sites across the globe, and patients who helped complete trial enrollment in less than a year. The M-STAR trial participants and families are our inspiration. Thank you for your ongoing commitment as together we advance this first large pivotal trial in MSA, and we all look forward to the results by the end of next year." Philip M. Fortier, MA, Executive Director of the Defeat MSA Alliance, commented, "The MSA patient community is optimistic that the M-STAR study will figure prominently in the history of our collective efforts to defeat this debilitating disease. On behalf of MSA patients worldwide, we are thankful to Biohaven for their effort to stand with us against MSA." Cyndi Roemer, Chair of the Board of Directors, The MSA Coalition, Inc. added, "TheMSA Coalition is so pleased to hear about the outstanding momentum of enrollment in the M-STAR study. This news represents new medical possibilities and much needed hope for the patients and families who are living with MSA."MSA is a rare, rapidly progressive, and fatal neurodegenerative disease that leads to death within a median of 6-10 years after receiving a diagnosis, often due to cardiac or respiratory complications. MSA affects approximately 50,000 people in the United States and Europe alone. While it is often not diagnosed until the fifth or sixth decade of life, symptoms can first appear earlier in a person's 40s and go undiagnosed for years. In MSA, portions of the brain that regulate internal body functions and motor control progressively deteriorate, severely compromising the body's involuntary (autonomic) functions. Symptoms of autonomic failure that may be seen in MSA include fainting spells and problems with heart rate (due to orthostatic hypotension), erectile dysfunction, and bladder control issues. Motor impairments (loss of or limited muscle control or movement, or limited mobility) may include tremor, rigidity, and/or loss of muscle coordination as well as difficulties with speech and gait (the way a person walks). Some of these features are similar to those seen in Parkinson's disease, and early in the disease course it often may be difficult to distinguish these disorders. Currently, patients receive only symptomatic and palliative therapies as there are no disease-modifying treatments and no cure for MSA. About VerdiperstatVerdiperstat (BHV-3241) is an investigational first-in-class, potent, selective, brain-penentrant, and irreversible myeloperoxidase (MPO) enzyme inhibitor that Biohaven is developing for the treatment of neurodegenerative diseases. Verdiperstat may help preserve neurons through inhibition of MPO-induced pathological oxidative stress and further inflammation that contribute to cellular injury in neurodegenerative diseases such as MSA and ALS. Biohaven licensedverdiperstat (BHV-3241) from AstraZeneca in September 2018. The M-STAR study is a currently ongoing Phase 3 clinical trial designed to evaluate the efficacy of verdiperstat in MSA. Additional details about can be found at clinicaltrials.gov/ct2/show/NCT03952806.Verdiperstat has received Orphan Drug and Fast Track designations for MSA from the US FDA, as well as Orphan Drug designation from the European Medicines Agency. Verdiperstat also has the potential to be developed in a number of other diseases associated with oxidative stress, inflammation, and neurodegeneration. A clinical trial designed to evaluate the efficacy of verdiperstat in amyotrophic lateral sclerosis is being planned in collaboration with the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital. More information about the HEALEY ALS Platform Trial can be found at clinicaltrials.gov/ct2/show/NCT04436510 and www.massgeneral.org/als. More information about can be found at the Company's website: https://www.biohavenpharma.com/science-pipeline/mpo/verdiperstat.About BiohavenBiohaven is a biopharmaceutical company focused on the development and commercialization of innovative best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases. Biohaven's neuroinnovation portfolio includes FDA-approved NURTEC ODT (rimegepant) for the acute treatment of migraine and a broad pipeline of late-stage product candidates across three distinct mechanistic platforms: CGRP receptor antagonism for the acute and preventive treatment of migraine; glutamate modulation for obsessive-compulsive disorder, Alzheimer's disease, and spinocerebellar ataxia; and myeloperoxidase (MPO) inhibition for multiple system atrophy and amyotrophic lateral sclerosis. For more information, visit www.biohavenpharma.com.Forward-Looking StatementsThis news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of Biohaven's management. All statements, other than statements of historical facts, included in this press release, including the expected enrollment for Biohaven's Phase 3 trial of verdiperstat, the potential results of Biohaven's Phase 3 trial of verdiperstat in MSA, the potential role of verdiperstat in MSA, the possible benefits of verdiperstat as a disease modifying therapy for MSA patients, as well as the timetable for the topline data and completion of trials, are forward-looking statements. The use of certain words, including the "believe" and "will" and similar expressions are intended to identify forward-looking statements. Biohaven may not actually achieve the plans and objectives disclosed in the forward-looking statements and you should not place undue reliance on Biohaven's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by our forward-looking statements, including uncertainties relating to the future clinical success of troriluzole. Additional important factors to be considered in connection with forward-looking statements are described in the "Risk Factors" section of Biohaven's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2020 and Biohaven's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the Securities and Exchange Commission on May 7, 2020. The forward-looking statements are made as of this date and Biohaven does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.Biohaven ContactDr. Vlad CoricChief Executive Officer[emailprotected]SOURCE Biohaven Pharmaceutical Holding Company Ltd. Related Links http://biohavenpharma.com

Biohaven Completes Enrollment Ahead of Timelines in International Phase 3 Clinical Trial of Verdiperstat in Multiple System Atrophy

NEW YORK, June 19, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers ofWirecard AG("Wirecard"or "the Company") (OTCMKT: WCAGY; WRCDF).Investors who purchasedWirecard securitiesare encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/wcagy. The investigation concerns whetherWirecardand certain of its officers and/or directors have violated federal securities laws. On June 18, 2020,MarketWatch reported that Wirecard's auditor, Ernst & Young, said it did not have sufficient evidence for 1.9 billion euros in cash. Wirecard said "There are indications that spurious balance confirmations had been provided from the side of the trustee." Following this news, Wirecard stock has dropped over 63% during intraday trading on June 18, 2020. If you are aware of any facts relating to this investigation, or purchasedWirecardshares,you can assist this investigation by visiting the firm's site: www.bgandg.com/wcagy. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact:Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Hurwitz212-697-6484 | [emailprotected] SOURCE Bronstein, Gewirtz & Grossman, LLC Related Links https://www.bgandg.com

WCAGY; WRCDF Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Wirecard AG and Encourages Investors to Contact the Firm

DUBLIN--(BUSINESS WIRE)--The "Middle East & Africa Defense Drone Antenna Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology, Type, Frequency, and Application" report has been added to ResearchAndMarkets.com's offering. MEA Defense Drone Antenna Market is estimated to grow at a CAGR of 5.0 % from 2020 to 2027. The report provides trends prevailing in the MEA defense drone antenna market along with the drivers and restraints pertaining to the market growth. Progressive refinement in drone antenna and escalating research and development to introduce newer variants such as low-weight and 360 multibeam antenna are the major factor driving the growth of the MEA defense drone antenna market. However, challenge of signal overlapping with linear antennas hinder the growth of MEA defense drone antenna market. In case of COVID-19, MEA is highly affected specially Iran. Other major countries that are facing the economic impact of COVID-19 include Saudi Arabia, UAE, Egypt, Morocco, and Kuwait. The MEA defense drone antenna market is majorly affected by the disruption in the supply chain. Pertaining to the closure of borders of countries, the supply chain of several components and parts have been disturbed. The demand for advanced defense equipment and components for modernizing and strengthening the UAVs has weakened over the past couple of months. This has resulted in a loss of business among the local and international defense drone antenna manufacturers. The ongoing COVID-19 crisis will impact the defense drone antenna market growth of the MEA region for the next few quarters. The MEA market for defense drone antenna is segmented into technology, type, frequency, application, and country. Based on technology, the market is segmented into linear polarized directional antenna, linear polarized omni directional antenna, circular polarized directional antenna, and circular polarized omni directional antenna. In 2019, the linear polarized omni directional antenna segment held the largest share of market. Based on type, the market is divided into lightweight antenna, FPV antenna, telemetry antenna, NLOS antenna, and others. The lightweight antenna segment held the largest share of market in 2019. FPV antenna segment is expected to be the fastest growing segment over the forecast period. Based on frequency, market is segment into high frequency, very high frequency, and ultra-high frequency. The ultra-high frequency segment dominated the market in 2019. On the basis of application, the market is segmented into surveillance, navigation, communication, telemetry, and others. The communication segment contributed a substantial share in 2019 and surveillance segment is projected to be the fastest growing segment. Alaris Holdings Limited, Cobham Limited, PPM Systems, TE Connectivity, Trimble Inc. are among the leading companies in the MEA defense drone antenna market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. Key Topics Covered: 1. Introduction 2. Key Takeaways 3. Research Methodology 4. MEA Defense Drone Antenna Market Landscape 4.1 Market Overview 4.2 Porter's Five Forces Analysis 4.3 Ecosystem Analysis 5. MEA Defense Drone Antenna Market - Key Market Dynamics 5.1 Key Market Driver 5.1.1 Upswing in Drone Procurement by Military Forces due to Higher Defense Budgets 5.1.2 Soaring Interest in Circular Omni-Directional Antennas 5.2 Key Market Restraint 5.2.1 Challenge of Signal Overlapping with Linear Antennas 5.3 Key Market Opportunity 5.3.1 Escalating R&D to Introduce Newer Variants such as Low-weight and 360 Multibeam Antenna 5.4 Future Trends 5.4.1 Progressive Refinement in Drone Antenna 5.5 Impact Analysis of Drivers and Restraints 6. Defense Drone Antenna Market - MEA Analysis 6.1 MEA Defense Drone Antenna Market Overview 6.2 MEA Defense Drone Antenna Market - Revenue and Forecast to 2027 (US$ Million) 6.3 Market Positioning - Market Players Ranking 7. MEA Defense Drone Antenna Market Analysis - by Technology 7.1 Overview 7.2 MEA Defense Drone Antenna Market, by Technology (2019 and 2027) 7.3 Linear Polarized Directional Antenna 7.4 Linear Polarized Omni Directional Antenna 7.5 Circular Polarized Directional Antenna 7.6 Circular Polarized Omni Directional Antenna 8. MEA Defense Drone Antenna Market Analysis - by Type 8.1 Overview 8.2 MEA Defense Drone Antenna Market, by Type (2019 and 2027) 8.3 Lightweight Antenna 8.4 FPV Antenna 8.5 Telemetry Antenna 8.6 NLOS Antenna 9. MEA Defense Drone Antenna Market Analysis- by Frequency 9.1 Overview 9.2 MEA Defense Drone Antenna Market, by Frequency (2019 and 2027) 9.3 High Frequency 9.4 Very High Frequency 9.5 Ultra-High Frequency 10. MEA Defense Drone Antenna Market Analysis - by Application 10.1 Overview 10.2 MEA Defense Drone Antenna Market, by Application (2019 and 2027) 10.3 Surveillance 10.4 Navigation 10.5 Communication 10.6 Telemetry 11. MEA Defense Drone Antenna Market - Country Analysis 12. Impact of COVID-19 Outbreak 12.1 MEA: Impact Assessment of COVID-19 Pandemic 13. Industry Landscape 13.1 Market Initiative 14. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/66z0u4

Middle East & Africa Defense Drone Antenna Market Forecast to 2027 Featuring Alaris Holdings, Cobham Limited, PPM Systems, TE Connectivity, & Trimble - ResearchAndMarkets.com

EL SEGUNDO, Calif.--(BUSINESS WIRE)--24 Hour Home Care, one of the largest, most trusted in-home care companies in the nation, has been recognized in Forbes annual list of Americas Best-In-State Employers 2020. This prestigious award is presented by Forbes and Statista Inc., the world-leading statistics portal and industry ranking provider. Forbes and Statista selected Americas Best-In-State Employers based on an independent survey of approximately 80,000 U.S. employees working for companies employing at least 500 people in their U.S. operations. Surveys were administered using a series of online panels and provide a representative sample of the U.S. workforce. The study assessed organizations according to Atmosphere & Development, Company Image, Working Conditions, Salaries & Wages, and Diversity. Based on the study results, 24 Hour Home Care is recognized on Forbes annual list of Americas Best-In-State Employers. We are thrilled to be recognized by Forbes and Statista as one of this year's Best-In-State Employers, said Ryan Iwamoto, President and Co-founder of 24 Hour Home Care. 24 Hour Home Care's mission is purpose-driven, and our culture aims to support and honor our team as they make a difference in people's lives every day. We are proud of our best-in-class team of Support Staff and Caregivers who are the most sought after in the industry, with many graduating from the top programs in the country." 24 Hour Home Care provides professional in-home care to clients in California, Arizona, and Texas. To learn more about 24 Hour Home Care, visit www.24hrcares.com. About 24 Hour Home Care 24 Hour Home Care provides high-quality, customized, professional caregiving services to seniors and individuals with developmental disabilities, allowing them to continue full, active, and healthy lifestyles. Founded by David Allerby and Ryan Iwamoto in 2008, 24 Hour Home Care has expanded to 20 locations throughout California, Arizona, and Texas, hiring over 10,000 employees. Fortune named 24 Hour Home Care to the 50 Best Places to Work In Aging Services (2018 and 2019) and Top 100 Best Workplaces for Diversity. 24 Hour Home Cares owners received the Ernst & Young Entrepreneur of the Year Award (2017) and the company was named to Inc. Magazines list of Fastest-Growing Private Companies, the Inc. 5000, for the seventh consecutive year. 24 Hour Home Care has received additional accolades, including being listed by Forbes Magazine as the #24 Most Promising Company in America.

24 Hour Home Care Recognized as One of Americas Best-In-State Employers 2020

WAYNE, Pa., June 18, 2020 /PRNewswire/ -- Palladiem, LLC , Wayne, PA, announces the launch of two new direct indexes (investable) for investors; The Risk Managed Gold Index (GRIN) and The Crypto Opportunity Index (COIN). The launch is a collaborative effort with IDX Insights, Scottsdale, AZ. The indexes are available as a separately managed portfolio. These strategies are designed to mitigate the downside risk of holding each of these two assets classes in a long-only position and providing diversification away from equities and bonds. Continue Reading IDX Palladiem Don Robinson, CEO & Chief Investment Officer of Palladiem, LLC stated: "We are very excited to launch these two new indexes in partnership with IDX and believe the time is now to take advantage of this novel approach to managing downside risk in these two assets, while still reaping the benefits of a large part of the upside as well as better diversifying equity and bond portfolios. We have been an investor in gold on behalf of clients over the years, especially during periods of central bank money printing and great uncertainty. Cyrptocurrency has always piqued our interest based on the underlying blockchain technology and as an alternate currency. The extreme volatility in Bitcoin has prevented us from directly investing in the digital asset until now, with the launch of a risk-managed approach to buying and trading Cryptocurrency." Ben McMillian, Chief Investment Officer of IDX Insights, stated: "We've always been proponents of taking a risk-focused approach to exposure construction.Particularly with the level of interest we see in gold and crypto assets, we believe now it is more important than ever for investors to have access to exposures that seek to manage the inherent risk within these asset classes.Don and his team bring a long history of successfully managing risk in the OCIO space, and this is just the next evolution in that journey." For more information, please go to www.palladiem.comand www.idxinsights.com.About IDX Insights, LLCIDX Insights is a research firm focused on developing innovative direct indexing solutions for the RIA market.Learn more about our unique Indexing as a Service ("IaaS") at www.idxinsights.com/indexing-as-a-service-iaas.IDX Insights does not offer or provide investment advice or offer or sell any securities, commodities, or derivative instruments or products.The IDX Insights, LLC corporate name, and all related logos are the exclusive intellectual property of IDX Insights, LLC.More information available athttps://idxinsights.com/About Palladiem LLCPalladiem LLC is an independent, employee-owned investment advisory firm that provides customized investment strategies and services to independent financial advisors, broker-dealers and institutions through industry-leading capabilities in portfolio management, capital markets research, asset allocation, individually managed accounts and portfolio manager selection. The firm is headquartered inWayne, PA.News, research and other information about Palladiem are available athttp://www.palladiem.com/Media contact:John Wren[emailprotected] (800) 403-4349SOURCE Palladiem

Palladiem Announces the Launch of Two New Direct Indexes

SACRAMENTO, Calif.--(BUSINESS WIRE)--It is a problem that continues to haunt taxpayers every year. Ghost tax preparers. Who are they? Tax preparers who set up shop during tax season, prepare countless fraudulent tax returns, then disappear without a trace right after the tax filing deadline. A lot of them move from one city to another every year and reestablish their client base through word of mouth, said Fernando Angell, board member of the California Tax Education Council (CTEC), a state-mandated nonprofit organization that manages the registration of 40,000 tax preparers. I had a couple come to me for help because their immigration status depended on it, said Esperanza Escobedo, CTEC board member. The ghost tax preparer refused to answer the door after their attorney told them to get their return amended for a court case. There was at least $13,000 worth of Earned Income Tax Credit (EITC) fraud, not to mention social security fraud. Heres how ghost tax preparers work. They print out tax returns for clients, tell them to sign and mail it out. What many taxpayers fail to notice is the tax return will not show the tax preparers signature, which is required by law, or they mark it as self prepared. For electronic tax returns, their name is also left out. Other typical scams include One client I helped had a ghost tax preparer block their calls after getting notices from the IRS for two different tax years, Angell said. More victims from this ghost tax preparer keep coming to us for help. He had quite the scheme going. California taxpayers should always verify the tax preparer is legally qualified. State law requires anyone who prepares tax returns for a fee to be either an attorney, certified public accountant (CPA), CTEC-registered tax preparer (CRTP) or enrolled agent (EA). CTEC is a nonprofit organization that was established in 1997 by the California State Legislature to protect taxpayers against fraud and incompetent tax preparers. Visit CTEC.org for more true tax scam stories on the CTEC podcast, Taxpayer Beware.

True Stories About Ghost Tax Preparers and the Mess Victims Face Tax preparers share true stories about victims who came to them for help after dealing with fraud

PITTSBURGH, April 21, 2020 /PRNewswire/ -- "I wanted to create a space-saving way to arrange firearm magazines in a gun safe or gun cabinet," said an inventor, from Livonia, Mich., "so I invented "MAG-KEEP" THE GUNNERS BUDDY." The patent pending invention provides an improved way to organize and store firearm magazines. In doing so, it eliminates haphazardly storing magazines in a box or bag. As a result, it enhances organization and it provides added protection. The invention features a simple and attractive design that is convenient and easy to use so it is ideal for gun owners and law enforcement personnel. Additionally, it is producible in design variations and a prototype is available. The inventor described the invention, "My original design helps to organize and protect your magazines from damage." The original design was submitted to the Bingham Farms sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-BGF-2394, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com

InventHelp Inventor Develops Improved Way to Organize and Store Firearm Magazines (BGF-2394)

CHICAGO, May 6, 2020 /PRNewswire/ --Cars.com Inc. (NYSE: CARS) ("Cars.com" or the "Company"), a leading digital marketplace and solutions provider for the automotive industry, today released its financial results for the quarter ended March 31, 2020. The Company will report first-quarter operational and financial results and provide context around the impact of therestrictions imposed as a result of theCOVID-19 pandemic. Q1 Financial Highlights Revenue of $148.1 million, down $6.1 million, or 4% year over year, in line with expectations Non-cash goodwill and intangible asset impairment charge of $905.9 million, or $757.1 million, net of tax, triggered by the COVID-19 pandemic and related restrictions, resulted in a GAAP net loss of $787.4 million, or $11.76 per diluted share Adjusted Net Income of $21.8 million, or $0.32 per diluted share, compared to Adjusted Net Income of $20.7 million or $0.31 per diluted share in the prior year period Adjusted EBITDA of $35.2 million, or 24% of revenue, down $3.4 million year over year, ahead of expectations Net cash provided by operating activities of $28.9 million for the three months ended March 31, 2020 Generated Free Cash Flow of $23.1 million in the first quarter of 2020 $187.3 million of cash and cash equivalents on the balance sheet, primarily as a result of borrowing $165.0 million on revolving credit facility to increase liquidity and financial flexibility due to the uncertainty of the COVID-19 pandemic Q1 Key Metrics and Highlights Average Monthly Unique Visitors of 24.9 million, up 11% year over year Traffic (visits) of 158.9 million, up 20% year over year Mobile Traffic was 76% of total Traffic, compared to 71% in the first quarter of 2019 Dealer Customers grew from 18,834 at December 31, 2019 to 18,938 at March 31, 2020, marking the Company's second consecutive quarter of dealer growth Monthly average revenue per dealer ("ARPD") was $2,092, down 6% year over yearprimarily due to upsell cancellations and discounts given in the second half of March 2020 as a result of COVID-19 Operational Highlights Traffic was up 31% year over year in the first two months of the quarter; Traffic declined in the second half of March due to the impact of the COVID-19 restrictions and was up slightly for the full month of March, as compared to the prior year Strong Dealer Inspire revenue growth continues, achieving 22% year-over-year revenue growth in Q1, driven by a 34% increase in Dealer Customers to 3,600 compared to the prior year period; average number of monthly website launches was 140 in the first quarter, the highest level to date Successful launch of new FUELTM In-Market Video product at NADA in February 2020 Bolstering already strong growth at Dealer Inspire, the incremental business from General Motors remains on track to launch and bill over 800 additional websites by the end of 2020 with roll-out starting this summer #CARSSTRONG Leadership During COVID-19Pandemic Immediate Financial Relief to Dealer Customers: Invoice credits of 50% in April 2020 and 30% in May and June 2020 on certain products Virtual Retail Solutions: Launched collection of new, value-added no-cost merchandising and digital solutions including Home Delivery and Virtual Appointment badging and chat and video to drive traffic and improve dealers' ability to engage in remote sales CARS Cares: Established a customer support program, including dedicated website launched to keep our customers up to date on the retail solutions and real-time actions CARS is taking to best support and service customers Federal Aid and Support: Initiated state and federal dealer advocacy campaigns and lobbying efforts with nearly 5,000 auto dealers sending letters to the Department of Homeland Security ("DHS") as part of our successful effort to persuade the DHS and several local jurisdictions to add automobile sales and leasing to the list of essential services CARSFinancial Response to COVID-19 Restrictions Realigned the operational platform to respond to market conditions and enhance liquidity during restriction period. Substantially reduced expenses, including but not limited to: furlough of approximately 250 people on April 1 with ultimate reduction in force of approximately 170 people effective May 1, reduction of employee and board pay, reduction of variable marketing spend to match car buying audience demand and elimination of non-essential spending. These cost reductions were targeted to offset at least 50% of the revenue impact from COVID-19 restrictions Drew down $165 million on the Company's revolving credit facility for additional liquidity and flexibility, ending the quarter with $187 million in available cash "We built on our momentum in Q4 to deliver solid first-quarter Revenue and Adjusted EBITDA throughTrafficincreases, continued improvements in growing dealer count and solid OEM advertising. This serves as evidence that our business strategy had strong momentum pre-COVID-19 and will continue to deliver benefits to customers and consumers when we emerge from this crisis," said Alex Vetter, President and Chief Executive Officer of CARS. "We were well on our way to exit the year with positive Revenue and Adjusted EBITDA growth, through mid-March, when COVID-19 related restrictions were imposed across the country. We proactively worked with our customers to help them manage through the crisis, while also taking immediate measures within the company, including a 250-person furlough of our workforce, and from that furlough a permanent reduction of 170 people, in addition to a cessation of non-critical spending and a cut in compensation for the remaining workforce." Vetter continued, "While the impact of COVID-19 is severe, we know our digital solutions are part of the antidote for our industry and we worked in partnership with dealers to initiate efforts to get car sales classified as essential services,selling safely through digital platforms. This, coupled with strong traffic and meaningful financial support to our customers, reinforces our already strong position as true dealer advocates." Q1 Results Revenue for the first quarter of 2020 was $148.1 million, compared to $154.2 million in the prior year period. This decrease was primarily due to fewer dealer customers and lower ARPD than in the prior year. Year over year national advertising revenue declined 4%, representing a stabilization of the business driven by OEMs' 2020 upfront commitments in line with prior year. In the first quarter of 2020, the Company recorded a non-cash goodwill and intangible asset impairment charge of $905.9 million, based on the determination that there was a triggering event primarily caused by the COVID-19 pandemic and related restrictions. The impairment charge does not affect our liquidity, cash flow from operating activities or compliance with the financial covenants set forth in the credit agreement. The cash benefit from the deductible goodwill for tax purposes remains intact. Total operating expenses for the first quarter of 2020 were $1,053.2 million, or $147.3 million excluding the impairment charge, compared to $158.3 million for the prior-year period. This decrease was primarily due to a refocusof our marketing spenddue to the decreased category demand resulting from the COVID-19 pandemic and related restrictions and the realization of operational efficiency actions in the prior and current years. GAAP net loss for the first quarter of 2020 was $787.4 million,or $11.76 per diluted share, compared to GAAP net loss of $9.0 million, or $0.13 per diluted share, in the first quarter of 2019. Adjusted Net Income for the first quarter of 2020 was $21.8 million, or $0.32 per diluted share, compared to $20.7 million, or $0.31 per diluted share, in the first quarter of 2019. Adjusted EBITDA for the first quarter of 2020 was $35.2 million, or 24% of revenue, compared to $38.6 million, or 25% of revenue, for the prior-year period. For the first quarter, Average Monthly Unique Visitors grew 11% year over year and total traffic grew 20% year over year, supported by product innovations and investments in and efficiencies gained in SEO, brand awareness and paid channels. Mobile traffic grew 29% year over year and accounted for 76% of total traffic compared to 71% in the prior year. Dealer customers were 18,938 as of March 31, 2020, an increase of 1%, compared to 18,834 dealer customers as of December 31, 2019, primarily due to growth in digital solutions customers, partially offset by a decrease in local dealer customers. ARPD was $2,092 in the first quarter of 2020, down 6% from the prior year periodprimarily due primarily to downgrades and the impact of COVID-19 in the second half of March 2020. "We are pleased with our first-quarter results, which, prior to the impact of the COVID-19 restrictions, demonstrated continued momentum from our fourth-quarter 2019 results, validating our strategy and the strength of our business model," said Jandy Tomy, interim Chief Financial Officer of CARS. She continued, "Results in the second quarter will be impacted by our three-month discount program and any ongoing impact of prevailing economic conditions. To mitigate this impact, we took decisive actions including significant cost reductions, as well as a draw-down on our revolving credit facility in order to provide additional flexibility and liquidity during a restricted movement period of unknown duration. As the COVID-19 restrictions lift and economic conditions strengthen, we remain confident that CARS is well-positioned to continue our momentum towards achieving market leadership over time." Cash Flow and Balance Sheet Net cash provided by operating activities for the three-month period ended March 31, 2020 was $28.9 million, compared to $38.4 million in the prior year. Free Cash Flow for the three-month period ended March 31, 2020, was $23.1 million, compared to $35.0 million in the same period last year. Cash flow was impacted in both periods by payments associated with the early conversion of affiliate markets. Cash and cash equivalents was $187.3 million and debt outstanding was $799.7 million as of March 31, 2020. During the three-month period, the Company paid down $13.4 million of indebtedness and borrowed $165.0 million. Net leverage at March 31, 2020, was 4.1x, calculated in accordance with the Company's credit agreement. The Company is having collaborative discussions with its lenders about whether the credit agreement should be modified and will communicate an update in due course. Outlook Prior to the COVID-19 impact, the Company believed that it was in a position to deliver a robust second half of the year and to exit the year with revenue and Adjusted EBITDA growth. The effects of the COVID-19 pandemic restrictions have and will negatively impact results of operations, cash flow and financial position; however, the extent of the impact will vary depending on the duration and severity of the restrictions and economic consequences. Accordingly, on March 23, 2020, the Company suspended 2020 guidance. Q1 Earnings call Aspreviously announced, management will hold a conference call and webcast today at 9:00 a.m. Central Time. This webcast may be accessed atinvestor.cars.com. A replay of the webcast and the slideshow will be available at this website following the conclusion of the call until May 20, 2020. About CARS CARS is aleading digital marketplace and solutions provider for the automotive industry that connects car shoppers with sellers. Launched in 1998 with the flagship marketplace site Cars.com and headquartered inChicago, the Company empowers shoppers with the data, resources and digital tools needed to make informed buying decisions and seamlessly connect with automotive retailers. In a rapidly changing market, CARS enables dealerships and OEMs with innovative technical solutions and data-driven intelligence to better reach and influence ready-to-buy shoppers, increase inventory turn and gain market share.In 2018, CARS acquired Dealer Inspire, aninnovative technology company building solutions that future-proof dealerships with more efficient operations, a faster and easier car buying process, and connected digital experiences that sell and service more vehicles. CARS properties include Cars.com, DealerRater, DealerInspire,Auto.com,PickupTrucks.com andNewCars.com.For more information, visitwww.Cars.com. Non-GAAP Financial Measures This earnings release discusses Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted Net Income per diluted share and Free Cash Flow. These financial measures are not prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). These financial measures are presented as supplemental measures of operating performance because we believe they provide meaningful information regarding our performance and provide a basis to compare operating results between periods. In addition, we use Adjusted EBITDA as a measure for determining incentive compensation targets. Adjusted EBITDA also is used as a performance measure under our credit agreement and includes adjustments such as the items defined below and other further adjustments, which are defined in the credit agreement. These non-GAAP financial measures are frequently used by our lenders, securities analysts, investors and other interested parties to evaluate companies in our industry. For a reconciliation of the non-GAAP measures presented in this earnings release to their most directly comparable financial measure prepared in accordance with GAAP, see "Non-GAAP Reconciliations" below. Other companies may define or calculate these measures differently, limiting their usefulness as comparative measures. Because of these limitations, these non-GAAP financial measures should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP. Definitions of these non-GAAP financial measures and reconciliations to the most directly comparable GAAP financial measures are presented in the tables below. We define Adjusted EBITDA as net income (loss) before (1) interest expense (income), net, (2) income tax expense (benefit), (3) depreciation, (4) amortization of intangible assets, (5) stock-based compensation expense, plus (6) certain other items, such as transaction-related costs, costs associated with the stockholder activist campaign, severance, transformation and other exit costs and write-off and impairments of goodwill, intangible assets and other long-lived assets. Amortization of unfavorable contracts liability is not adjusted out of Adjusted EBITDA. We define Adjusted Net Income as net income (loss) excluding the after-tax impact of (1) amortization of intangible assets, (2) stock-based compensation expense, and (3) certain other items, such as transaction-related costs, costs associated with the stockholder activist campaign, severance, transformation and other exit costs and write-off and impairments of goodwill, intangible assets and other long-lived assets. Amortization of unfavorable contracts liability is not adjusted out of Adjusted Net Income. Transaction-related costs are certain expense items resulting from actual or potential transactions such as business combinations, mergers, acquisitions, dispositions, spin-offs, financing transactions, and other strategic transactions, including, without limitation, (1) transaction-related bonuses and (2) expenses for advisors and representatives such as investment bankers, consultants, attorneys and accounting firms. Transaction-related costs may also include, without limitation, transition and integration costs such as retention bonuses and acquisition-related milestone payments to acquired employees, in addition to consulting, compensation and other incremental costs associated with integration projects. We define Free Cash Flow as net cash provided by operating activities less capital expenditures, including purchases of property and equipment and capitalization of internal-use software and website development costs. Key Metric Definitions Traffic (Visits). Traffic is fundamental to our business. Traffic to the CARS network of websites and mobile apps provides value to our advertisers in terms of audience, awareness, consideration and conversion. In addition to tracking traffic volume and sources, we monitor activity on our properties, allowing us to innovate and refine our consumer-facing offerings. Traffic is defined as the number of visits to CARS desktop and mobile properties (responsive sites and mobile apps), measured using Adobe Analytics. Traffic does not include traffic to Dealer Inspire websites. Visits refers to the number of times visitors accessed CARS properties during the period, no matter how many visitors make up those visits. Traffic provides an indication of our consumer reach. Although our consumer reach does not directly result in Revenue, we believe our ability to reach in-market car shoppers is attractive to our dealer customers and national advertisers. Average Monthly Unique Visitors ("UVs").Growth in unique visitors and consumer traffic to our network of websites and mobile apps increases the number of impressions, clicks, leads and other events we can monetize to generate revenue. We define UVs in a given month as the number of distinct visitors that engage with our platform during that month. Visitors are identified when a user first visits an individual CARS property on an individual device/browser combination or installs one of our mobile apps on an individual device. If a visitor accesses more than one of our web properties or apps or uses more than one device or browser, each of those unique property/browser/app/device combinations counts towards the number of UVs. UVs do not include Dealer Inspire UVs. We measure UVs using Adobe Analytics. Dealer Customers.Dealer Customers represent dealerships using our products as of the end of each reporting period. Each physical or virtual dealership location is counted separately, whether it is a single-location proprietorship or part of a large consolidated dealer group. Multi-franchise dealerships at a single location are counted as one dealer. Average Revenue Per Dealer ("ARPD").We believe our ability to grow ARPD is an indicator of the value proposition of our products. We define ARPD as Direct retail revenue during the period divided by the average number of direct Dealer Customers during the same period. Forward Looking Statements This press release contains "forward-looking statements" within the meaning of the federal securities laws. All statements other than statements of historical facts are forward-looking statements. Forward-looking statements include information concerning the impact of COVID-19 on our industry, our dealer customers and our results of operations, our business strategies, strategic alternatives, plans and objectives, market potential, outlook, trends, future financial performance, planned operational and product improvements, potential strategic transactions, liquidity, including expense reduction and draws from our revolving credit facility, and other matters and involve known and unknown risks that are difficult to predict.As a result, our actual financial results, performance, achievements, strategic actions or prospects may differ materially from those expressed or implied by these forward-looking statements.These statements often include words such as "believe," "expect," "project," "anticipate," "outlook," "intend," "strategy," "plan," "estimate," "target," "seek," "will," "may," "would," "should," "could," "forecasts," "mission," "strive," "more," "goal" or similar expressions. Forward-looking statements are based on our current expectations, beliefs, strategies, estimates, projections and assumptions, based on our experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments, current developments regarding the COVID-19 pandemic and other factors we think are appropriate. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain.These statements are expressed in good faith and we believe these judgments are reasonable. However, you should understand that these statements are not guarantees of strategic action, performance or results. Our actual results and strategic actions could differ materially from those expressed in the forward-looking statements. Given these uncertainties, forward-looking statements should not be relied on in making investment decisions. Comparisons of results between current and prior periods are not intended to express any future trends, or indications of future performance, unless expressed as such, and should only be viewed as historical data. Whether or not any such forward-looking statement is in fact achieved will depend on future events, some of which are beyond our control. Forward-looking statements are subject to a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results and strategic actions to differ materially from those expressed in the forward-looking statements contained in this press release. For a detailed discussion of many of these and other risks and uncertainties, see our Annual Report on Form 10-K for the year ended December 31, 2019, our subsequent Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K and our other filings with the Securities and Exchange Commission, available on our website at investor.cars.com or via EDGAR atwww.sec.gov. All forward-looking statements contained in this press release are qualified by these cautionary statements. You should evaluate all forward-looking statements made in this press release in the context of these risks and uncertainties. The forward-looking statements contained in this press release are based only on information currently available to us and speak only as of the date of this press release. We undertake no obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise. The forward-looking statements in this report are intended to be subject to the safe harbor protection provided by the federal securities laws. CARS Investor Relations Contact:Kamal Hamid[emailprotected]312.601.5110 CARS Media Contact:Marita Thomas[emailprotected]312.601.5692 Cars.com Inc. Consolidated Statements of Loss (In thousands, except per share data) (Unaudited) Three Months Ended March 31, 2020 2019 Revenue: Direct $ 125,361 $ 115,094 National advertising 19,393 20,295 Other 3,340 3,949 Retail 148,094 139,338 Wholesale 14,860 Total revenue 148,094 154,198 Operating expenses: Cost of revenue and operations 26,030 25,579 Product and technology 14,873 17,863 Marketing and sales 54,922 60,343 General and administrative 14,117 23,888 Affiliate revenue share 6,369 2,454 Depreciation and amortization 30,961 28,125 Goodwill and intangible asset impairment 905,885 Total operating expenses 1,053,157 158,252 Operating loss (905,063) (4,054) Nonoperating expense: Interest expense, net (7,526) (7,566) Other (expense) income, net (9,501) 119 Total nonoperating expense, net (17,027) (7,447) Loss before income taxes (922,090) (11,501) Income tax benefit (134,656) (2,470) Net loss $ (787,434) $ (9,031) Weighted-average common shares outstanding: Basic 66,938 67,584 Diluted 66,938 67,584 Loss per share: Basic $ (11.76) $ (0.13) Diluted (11.76) (0.13) Cars.com Inc. Consolidated Balance Sheets (In thousands, except per share data) March 31, 2020 December 31, 2019 (unaudited) Assets: Current assets: Cash and cash equivalents $ 187,344 $ 13,549 Accounts receivable, net 95,069 101,762 Prepaid expenses 8,092 6,526 Other current assets 782 603 Total current assets 291,287 122,440 Property and equipment, net 43,782 43,696 Goodwill 505,885 Intangible assets, net 904,221 1,329,499 Investments and other assets 16,634 26,471 Total assets $ 1,255,924 $ 2,027,991 Liabilities and stockholders' equity: Current liabilities: Accounts payable $ 17,626 $ 12,431 Accrued compensation 9,056 16,738 Current portion of long-term debt 31,425 31,391 Other accrued liabilities 40,203 38,246 Total current liabilities 98,310 98,806 Noncurrent liabilities: Long-term debt 763,361 611,277 Deferred tax liability 132,996 Other noncurrent liabilities 46,363 43,844 Total noncurrent liabilities 809,724 788,117 Total liabilities 908,034 886,923 Commitments and contingencies Stockholders' equity: Preferred Stock at par, $0.01 par value; 5,000 shares authorized; no shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively Common Stock at par, $0.01 par value; 300,000 shares authorized; 66,961 and 66,764 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 670 668 Additional paid-in capital 1,516,174 1,515,109 Accumulated deficit (1,154,501) (367,067) Accumulated other comprehensive loss (14,453) (7,642) Total stockholders' equity 347,890 1,141,068 Total liabilities and stockholders' equity $ 1,255,924 $ 2,027,991 Cars.com Inc. Consolidated Statements of Cash Flows (In thousands) (Unaudited) Three Months Ended March 31, 2020 2019 Cash flows from operating activities: Net loss $ (787,434) $ (9,031) Adjustments to reconcile Net loss to Net cash provided by operating activities: Depreciation 5,683 4,033 Amortization of intangible assets 25,278 24,092 Amortization of unfavorable contracts liability (6,300) Goodwill and intangible asset impairment 905,885 Impairment of non-marketable security 9,447 Stock-based compensation 1,971 2,981 Deferred income taxes (133,064) (2,570) Provision for doubtful accounts 1,606 1,055 Amortization of debt issuance costs 556 311 Other, net 75 (9) Changes in operating assets and liabilities: Accounts receivable 5,087 12,274 Prepaid expenses (1,566) 1,847 Other current assets (218) 886 Other assets 458 (17,208) Accounts payable 5,133 574 Accrued compensation (7,682) (4,075) Other accrued liabilities (1,661) 14,087 Other noncurrent liabilities (662) 15,442 Net cash provided by operating activities 28,892 38,389 Cash flows from investing activities: Purchase of property and equipment (5,755) (3,363) Other, net (600) Net cash used in investing activities (5,755) (3,963) Cash flows from financing activities: Proceeds from revolving loan borrowings 165,000 Payments of long-term debt (13,438) (10,625) Stock-based compensation plans, net (904) (743) Repurchases of common stock (20,000) Other (181) Net cash provided by (used in) financing activities 150,658 (31,549) Net increase in cash and cash equivalents 173,795 2,877 Cash and cash equivalents at beginning of period 13,549 25,463 Cash and cash equivalents at end of period $ 187,344 $ 28,340 Supplemental cash flow information: Cash paid for income taxes, net of refunds $ 124 $ 38 Cash paid for interest 6,956 7,413 Cars.com Inc. Non-GAAP Reconciliations (In thousands, except per share data) (Unaudited) Three Months Ended March 31, 2020 2019 Reconciliation of Net loss to Adjusted EBITDA Net loss $ (787,434) $ (9,031) Interest expense, net 7,526 7,566 Income tax benefit (134,656) (2,470) Depreciation and amortization 30,961 28,125 Goodwill and intangible asset impairment 905,885 Stock-based compensation 1,911 3,099 Write-off of long-lived assets and other 9,483 111 Severance, transformation and other exit costs 1,404 6,453 Transaction-related costs 97 2,044 Costs associated with the stockholder activist campaign 2,695 Adjusted EBITDA* $ 35,177 $ 38,592 Reconciliation of Net loss to Adjusted net income Net loss $ (787,434) $ (9,031) Amortization of intangible assets 25,278 24,092 Goodwill and intangible asset impairment 905,885 Stock-based compensation 1,911 3,099 Write-off of long-lived assets and other 9,483 111 Severance, transformation and other exit costs 1,404 6,453 Transaction-related costs 97 2,044 Costs associated with the stockholder activist campaign 2,695 Tax impact of adjustments (134,860) (8,717) Adjusted net income* $ 21,764 $ 20,746 Adjusted net income per share, diluted $ 0.32 $ 0.31 Weighted-average common shares outstanding, diluted** 67,255 67,584 Reconciliation of Net cash provided by operating activities to Free cash flow Net cash provided by operating activities $ 28,892 $ 38,389 Purchase of property and equipment (5,755) (3,363) Free cash flow $ 23,137 $ 35,026 * There was no unfavorable contract liability amortization during 2020 as it was fully amortized as of September 30, 2019. Additionally, amortization of unfavorable contracts liability is not adjusted out of Adjusted EBITDA or Adjusted net income for 2019. ** Weighted-average common shares outstanding, diluted, includes shares excluded from GAAP loss per share due to the net loss position for the three months ended March 31, 2020 and March 31, 2019. Cars.com Inc. Supplemental Information (In thousands) (Unaudited) Expense category for the Three Months Ended March 31, 2020: As Reported Adjustments (1) Stock-Based Compensation As Adjusted Cost of revenue and operations $ 26,030 $ $ (37) $ 25,993 Product and technology 14,873 (566) 14,307 Marketing and sales 54,922 (496) 54,426 General and administrative 14,117 (1,537) (812) 11,768 Affiliate revenue share 6,369 6,369 Depreciation and amortization 30,961 30,961 Goodwill and intangible asset impairment 905,885 (905,885) Total operating expenses $ 1,053,157 $ (907,422) $ (1,911) $ 143,824 Total nonoperating expense, net $ (17,027) $ 9,447 $ $ (7,580) (1) Includes write-off and impairments of goodwill, intangible assets and other long-lived assets and other, severance, transformation and other exit costs, and transaction-related costs. Expense category for the Three Months Ended March 31, 2019: As Reported Adjustments (1) Stock-Based Compensation As Adjusted Cost of revenue and operations $ 25,579 $ $ (67) $ 25,512 Product and technology 17,863 (763) 17,100 Marketing and sales 60,343 (445) 59,898 General and administrative 23,888 (11,303) (1,824) 10,761 Affiliate revenue share 2,454 2,454 Depreciation and amortization 28,125 28,125 Goodwill and intangible asset impairment Total operating expenses $ 158,252 $ (11,303) $ (3,099) $ 143,850 Total nonoperating expense, net $ (7,447) $ $ $ (7,447) (1) Includes severance, transformation and other exit costs, costs associated with the stockholder activist campaign, transaction-related costs, write-off of long-lived assets and other. SOURCE Cars.com Inc. Related Links http://www.cars.com

CARS Reports First Quarter 2020 Results

CHICAGO--(BUSINESS WIRE)--Brainlab announced today that the company has reached two major milestones with the FDA clearance for both Loop-X Mobile Imaging Robot and Cirq, a robotic surgical system. Following on CE mark approvals last summer, the FDA clearance paves the way for Brainlab to now enter the US markets with the Cirq robotic alignment module for spine procedures, and Loop-X, the first fully robotic intraoperative imaging device on the market. The first-of-its-kind, Loop-X works seamlessly with the full Brainlab digital surgery portfolio or with a customers existing surgical setup. Independently moving imaging source and detector panels enable flexible patient positioning and non-isocentric imaging which reduces the amount of radiation exposure and increases the variety of indications which can be treated. This mobile imaging robot can be controlled wirelessly with a touchscreen tablet. Loop-X was developed in close collaboration between Brainlab and partner medPhoton based in Salzburg, Austria, where the first Loop-X was installed. Hospital San Juan de Dios Len in Spain recently performed the worlds first navigated spine surgery using Loop-X mobile imaging robot technology. Following on the success and growing install base for Cirq, a universal platform for robotic tasks, the new Cirq Robotic Alignment module is capable of fine tuning the alignment to a pre-planned trajectory and freeing up surgeons hands, enabling them to focus on the patients anatomy. Surgeons at Royal London Hospital in the United Kingdom have already used Cirq Robotic Alignment for a range of cases from routine lumbar fusions to complex deformity and cervical fractures. Were expanding and diversifying our digital surgery portfolio with robotics across all indications, said Sean Clark, President, Brainlab, Inc. Our customers want to offer their patients advanced technologies close to home. Brainlab technologies are designed to enable greater freedom for clinicians and enhance outcomes for patients. The recent availability of these robotic medical devices is bringing a futuristic vision of the modern digital operating room closer to reality supporting surgeons in their day-to-day work and bringing benefits to their patients. About Brainlab Brainlab is a digital medical technology pioneer founded in 1989 and headquartered in Munich. The company employs more than 1500 people in 20 offices around the globe. Brainlab serves physicians, medical professionals and their patients in over 5600 hospitals in 116 countries. Brainlab creates software-driven medical solutions that digitize, automate and optimize clinical workflows for neurosurgery, spine, trauma, craniomaxillofacial (CMF), general and vascular surgery as well as radiotherapy and radiosurgery. Core products center around surgical navigation, radiotherapy, digital operating room integration, and information and knowledge exchange. The Brainlab open framework operating system will allow third parties to develop medical applications to further advance the field of spatial computing and mixed reality. Brainlab is dedicated to creating an impact in healthcare. The company connects opportunities from emerging digital technologies to transform healthcare at scale and help improve the lives of patients worldwide. For more information, please visit Brainlab and follow on LinkedIn, Twitter, Facebook and Instagram. About medPhoton medPhoton develops and manufactures robotic imaging solutions for image guided radiation therapy and navigated surgery.

Brainlab Loop-X Mobile Imaging Robot and Cirq Robotic Alignment Module for Spine Both Receive FDA clearance Opening up new surgical possibilities with robotics

NORMAN,Okla., Jan. 19, 2021 /PRNewswire/ --In a world full of disruption at school and at work, innovative tools are spreading in popularity across the world to help individuals use their own skills records and to proactively navigate life's new directions.By combining credentials from multiple organizations in a consistent data format, Gradintelligence (https://gradintel.com/)and ELocker (https://www.elocker.org/) give lifelong learners access to portable, interoperable evidence of their development, related experience and associated attainments that are used to help them achieve their personal goals and live their best life wherever they are. In a joint development effort with ELocker and the University of Central Oklahoma Student Transformative Learning Record (STLR) (https://www.uco.edu/academic-affairs/stlr/)Olivedon's Gradintelligence team showcased these new interoperable learner records in IMS Global Learning Consortium (IMS) Comprehensive Learner Record (CLR) (http://www.imsglobal.org/clr)format and how they can be easily exchanged between credentials services internationally. The project also highlights how individuals can use their credentials data to verify their achievements and power meaningful connections to matched opportunities for employment and personal development. "We are proud to announce that on completion of the demonstration project, ELocker, an IMS Contributing Member, is one of the first organizations to receive certification for the CLR standard by IMS Global Learning Consortium," said Nick Hathaway, ELocker CEO. Driven by a mission to transform the transition from education to work and further study, the Olivedon Gradintelligence service now supports over 1.3 million students in the United Kingdom and graduates with digital access to their university credentials and targeted support services. Individual users control their own credentials data and can securely share them with third parties to verify their achievements. A rapidly growing receiving network of over 1,000 universities and thousands of employers, credential check agencies, education ministries and visa offices globally already use Gradintelligence services for this purpose. "We're thrilled that our partnership with ELocker and UCO has resulted in us being among the very first of hopefully many organizations to achieve CLR certification from IMS Global," John Bolland, managing director of Olivedon, said. "We are looking forward to introducing new ways for our student and graduate users to take control and apply their interoperable credentials. We also look forward to continued partnership with ELocker and collaboration with IMS as we extend our skills and competency framework developments to further enhance our education and employment ecosystem." ELocker CEO Nick Hathaway said, "ELocker is delighted about this achievement with Gradintelligence, UCO and IMS. Wherever their unique life's journey takes them, we'll be able to even more powerfully and effectively help learners achieve the heights of their personal ambitions in school and at work. We're excited to be bringing innovations to education and workforce that are as dynamic as the world around us." In leading UCO's STLR initiative, Jeff King said, "STLR's six years of success in helping students develop trans-disciplinary, employability, and life skills produces credentials that verify these capacities. The IMS CLR standard will enable employers and educational institutions to share these kinds of graduates' achievements within a common framework." To ensure that the learning impact of technology-enabled innovation is achieved around the world, IMS's communityof educational institutions, suppliers and government organizations develops open interoperability standards, supports adoption with technical services, and encourages adoption through programs thathighlight effective practices. "IMS Comprehensive Learner Record is a groundbreaking standard that empowers learners to curate their achievements and share the story of their learning journey from K-12 through higher education through workplace learning in a secure, verifiable digital record," said Dr. Rob Abel, CEO, IMS Global Learning Consortium. "We are grateful for ELocker's leadership in becoming one of the first IMS member organizations to certify CLR interoperability, enabling a more robust and connected digital credentials ecosystem." In May 2020, the American Association of Collegiate Registrars and Admissions Officers (AACRAO) issued a recommendation to its members in a comprehensive report stating, "The CLR Standard from IMS Global is the only comprehensive data standard in place today that meets the objectives of an official institutional learning-focused and comprehensive learner record." The American Association of Collegiate Registrars and Admissions Officers (AACRAO), a professional association of more than 11,000 higher education professionals representing approximately 2,600 institutions in more than 40 countries, provides professional development, guidelines, and voluntary standards to be used by higher education officials regarding the best practices in records management, admissions, enrollment management, administrative information technology, and student services. SOURCE ELocker Related Links https://www.elocker.org

ELocker Achieves Certification for Leading Standard

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Precigen, Inc. (Precigen or the Company) f/k/a Intrexon Corporation (Intrexon) (NASDAQ: PGEN, XON) securities betweenMay 10, 2017 and September 25, 2020,inclusive (the Class Period). Precigeninvestors have untilDecember 4, 2020to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. On September 25, 2020, the U.S. Securities and Exchange Commission (SEC) announced a $2.6 million civil penalty against the Company related to its statements about the purported success converting relatively inexpensive natural gas into more expensive industrial chemicals using a proprietary methane bioconversion (MBC) program. In its cease-and-desist order, the SEC noted that Intrexon was primarily using significantly more expensive pure methane for the relevant laboratory experiments but was indicating that the results had been achieved using natural gas. Though the Company had pitched the program to business partners throughout 2017 and 2018, the SEC pointed out that a number of the potential partners performed due diligence on the MBC program including reviewing lab results and plans for commercialization[, and] Intrexon has not yet found a partner for the MBC program. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Intrexon was using pure methane as feedstock for its announced yields for its methanotroph bioconversion platform instead of natural gas; (2) yields from natural gas as a feedstock were substantially lower than the aforementioned pure methane yields; (3) due to the substantial price difference between pure methane and natural gas, pure methane was not a commercially viable feedstock; (4) the Companys financial statements for the quarter ended March 31, 2018 were false and could not be relied upon; (5) Intrexon had material weaknesses in its internal controls over financial reporting; (6) the Company was under investigation by the SEC since October 2018; and (7) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased Precigen securities during the Class Period, you may move the Court no later than December 4, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased Precigen securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Precigen, Inc. f/k/a Intrexon Corporation (PGEN, XON) Investors

NEW YORK, April 26, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Peloton Interactive, Inc. (NASDAQ: PTON) resulting from allegations that Peloton may have issued materially misleading business information to the investing public. SO WHAT:If you purchased Peloton securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to http://www.rosenlegal.com/cases-register-2079.htmlor call Phillip Kim, Esq. toll-free at 866-767-3653 or email [emailprotected] or [emailprotected] for information on the class action. WHAT IS THIS ABOUT: OnApril 17, 2021, the U.S. Consumer Product Safety Commission ("CPSC") issued a press release entitled "CPSC Warns Consumers: Stop Using the Peloton Tread+". The release stated that the "Urgent Warning Comes After Agency Finds One Death and Dozens of Incidents of Children Being Sucked Beneath the Tread+ (Formerly Known as the Tread)". The release further stated that "[t]he urgent warning comes less than a month after Peloton itself released news of a child's death by a Peloton Tread+ and CPSC's announcement of an investigation into that incident[,]" and "[t]o date, CPSC is aware of 39 incidents including one death." On this news, Peloton's share price fell sharply during intraday trading on April 19, 2021, the next trading day, damaging investors. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [emailprotected] [emailprotected] [emailprotected] www.rosenlegal.com SOURCE Rosen Law Firm, P.A. Related Links www.rosenlegal.com

PTON BREAKING ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Peloton Interactive, Inc. Investors with Losses Exceeding $100K to Inquire About Class Action Investigation - PTON

MONTRAL, June 22, 2020 /PRNewswire/ - Objex, Digital Transformation Partners, today announced that it has joined the Google Cloud Partner Program as a Sales Partner giving Google Cloud customers the ability to hit the road running by utilizing its GCP expertise and certified cloud resources. As a Google Cloud partner, Objex offers customers digital transformation resources. Key features include expertise in: Infrastructure i.e., Compute Engine, Networking, Security Workload management i.e., Microservices, GKE, Cloud Run, Cloud Functions, App Engine, Apigee, Istio AX i.e, Google Analytics Platform, Stackdriver and Data studio AI i.e., ML, AutoML, Google Cloud Vision, Natural Language and Speech APIs Digital transformation is rethinking old operating models and to become more agile in your ability to experiment and respond to ever changing customer needs. Objex is a call away to help you in building your digital transformation platforms. Call us: 1 (800)-908-0052 ext. 101 or Visit: https://objex.tech About Objex Objex provides organizations with leading cloud infrastructure, cloud capabilities and enterprise solutions, along with consulting expertise, to transform their business with cloud computing infrastructure by certified cloud computing professionals. Our project management experts and application development teams are part of our delivery approach and ensure end-to-end solutions for customers. SOURCE Objex, Inc.

Objex, Inc. Joins Google Cloud Partner Program

FRISCO, Texas, July 14, 2020 /PRNewswire/ --Light Engine Design Corp.'s (OTC:TLED) subsidiary, Curtis Mathes, Inc. has changed its name to Curtis Mathes Therapeutics, Inc. (CMTI) and will focus of the development of novel lighting technologies for therapeutic applications. Drawing on extensive research by NASA, and various leading medical research institutions, CMTI will develop its own line of Red Light Therapy (RLT) solutions that will be tailored to accelerate recovery from various injuries, including burns, lacerations and deep muscle tissue damage. CMTI's innovation will also target the professional athlete and fitness markets with rapid and efficacious treatments to reduce inflammation and improve muscle oxygenation. RLT exposes injured tissues to a near-infrared (NIR) light source for a brief period of approximately 90 seconds. This exposure has been proven in clinical studies to decrease healing time dramatically. "We plan to investigate different methods to deliver this therapy that are more cost effective, targeted, and possibly, used in conjunction with other therapies or medicines," said Dr. Zacariah Hildenbrand, Chief Scientific Officer, "we hope to make a substantial impact in the field of sports medicine." Paul O. Williams, Chairman & Chief Financial Officer of Light Engine Design reported, "This new technology being developed by our team continues to diversify and stabilize our public company with additional products and new markets. We also believe that the horrible impact of Covid-19 around the world will continue to increase people's interest in taking better care of their health, including looking for any new innovative ways to treat and heal their bodies to speed recovery." About Light Engine Design Corp.: Curtis Mathes Therapeutics, Inc. is focused on research, development, manufacturing, and sales of state-of-the-art Solid-State Lighting (SSL) in the phototherapies industries. www.ledesigncorp.com / www.curtismathes.com. Forward Looking Statements: This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect TLED's business and TLED undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. SOURCE Light Engine Design Corp. Related Links http://www.ledesigncorp.com

TLED Subsidiary, Curtis Mathes, Inc. Changes Name and Will Focus on Therapeutic Lighting Technologies

NEW YORK, May 13, 2020 /PRNewswire/ -- DLA Piper is pleased to announce the launch of its new podcast, Beyond the Curve, which will help businesses and communities plan and adapt to the challenges and uncertainties resulting from COVID-19.DLA Piper lawyers and other business and community leaders will discuss forward-facing approaches to navigating these unprecedented times. In the first episode, John Sullivan, global co-chair and US chair of the firm's Real Estate practice, hears from Dean Shapiro of Oxford Properties about ways in which the company is serving its communities during the pandemic, including turning vacant real estate space at Hudson Yards in New York City into a commissary to feed healthcare workers. In addition, DLA Piper's Mariah DiGrino speaks with Kate Maehr, director of the Greater Chicago Food Depository, about the pandemic's effect on the organization's daily operations. The next two episodes in the line-up will help employers as they think about reopening workplaces and bringing employees back into offices, as well as opportunities and challenges for businesses as they seek to balance the need to meet contractual and financial obligations while also preserving cash. Future episodes will touch on the entertainment, healthcare, technology and retail sectors, among other topics. "We are expanding the ways in which we deliver our practical and proven guidance and assistance to our clients and communities," said John J. Gilluly III, global and US co-chair of DLA Piper's Corporate practice. "Beyond the Curve will highlight how companies and people around the world are overcoming the challenges of the moment to emerge better and stronger in the future." The Beyond the Curve podcast is available on DLA Piper's site. Sign up here to receive DLA Piper's daily digest of alerts, webinars and other publications and events. About DLA Piper DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. In certain jurisdictions, this information may be considered attorney advertising. dlapiper.com SOURCE DLA Piper Related Links http://www.dlapiper.com

DLA Piper launches Beyond the Curve podcast to help clients and communities move forward

TARRYTOWN, N.Y., March 30, 2020 /PRNewswire/ -- Results from separate positive Phase 3 trial of Praluent(alirocumab) in patients with HoFH also presented; FDA regulatory submission planned for Q2 2020 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that detailed Phase 3 results of evinacumab were presented today as a late-breaking presentation at the American College of Cardiology's Annual Scientific Session together with World Congress of Cardiology (ACC.20). Evinacumab is an investigational fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3), in patients with homozygous familial hypercholesterolemia (HoFH). Regeneron previously announced topline positive results of this trial in August 2019. HoFH is an inherited disease in which patients have severely elevated levels of bad cholesterol (otherwise known as low-density lipoprotein cholesterol, or LDL-C)and often experience early atherosclerotic disease, sometimes suffering cardiac events in their teenage years. Most patients with HoFH are less responsive (or unresponsive) to standard lipid-lowering therapies, including statins and PCSK9 inhibitors, which act mainly by inducing LDL receptor function, leaving these patients with high unmet need. Evinacumab acts by a different mechanism than other lipid-lowering therapies, raising the possibility that it might offer patients with HoFH profound LDL-C reductions. Supporting this possibility, genetic research has shown that reduction of ANGPTL3 is associated with decreased LDL-C levels, as well as significantly lower risk of coronary artery disease. In this Phase 3 trial, patients who added evinacumab to other lipid-lowering therapies reduced their LDL-C by 49% from baseline at 24 weeks compared to the placebo group, who received other lipid-lowering therapies alone, the primary endpoint of the trial (p<0.0001). Nearly all (95%) patients in the evinacumab arm entered the trial on statins and 79% were on PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. Nearly half of evinacumab-treated patients reduced LDL-C to under 100 mg/dL (nominal p=0.0203), despite entering the trial with average LDL-C levels of 260 mg/dL on other lipid-lowering therapies. "As a doctor, it can be heart-wrenching to see HoFH patients struggle to lower their potentially life-threatening LDL-C levels, despite taking every medical treatment available to them," said Professor Derick J. Raal, MMED, Ph.D., principal investigator and Professor & Head, Division of Endocrinology & Metabolism at the University of the Witwatersrand, South Africa. "In this trial, for the first time, evinacumab-treated HoFH patients lowered their LDL-C to previously unattainable levels, with nearly half achieving an LDL-C range that is considered 'normal' for healthy adults." "Despite medical advances, cardiovascular disease tragically remains the number one cause of death for men and women worldwide. Regeneron remains committed to advance medicines for people who have significant unmet need, including those with HoFH, and we are grateful to the patients and doctors who participated in our trials," said George D. Yancopoulos, M.D., Ph.D., Co-founder, President and Chief Scientific Officer of Regeneron. "Our investments in genetic research and biology enable us to identify completely new ways of targeting diseases. Evinacumab, a first-of-its-kind antibody that works entirely differently to other HoFH medicines, exemplifies the potential of genetic-based research to revolutionize patient treatment." Also shared today were Phase 3 results from another late-breaking presentation, demonstrating the effect of Praluent (alirocumab) on patients with HoFH. The trial met its primary endpoint, with Praluent-treated patients reducing their LDL-C by over a third at week 12, compared to placebo (p<0.0001). In addition, more than a quarter of patients reduced their LDL-C by at least half (p=0.0017), despite entering the trial with average LDL-C levels of 295 mg/dL while being on other lipid-lowering therapies and/or apheresis. No new safety signals were identified in the trial. The use of Praluent in patients with HoFH is investigational and the safety and efficacy have not been evaluated by any regulatory authority. Detailed ELIPSE HoFH Results In the Phase 3 ELIPSE HoFH trial, 65 patients were randomized to receive either evinacumab 15 mg/kg intravenously every four weeks (n=43) plus other lipid-lowering therapies, versus lipid-lowering therapies alone (placebo, n=22). At baseline, LDL-C was 260 mg/dL in the evinacumab group and 247 mg/dL in the placebo group. The ELIPSE HoFHtrial met its primary endpoint, with evinacumab-treated patients reducing their LDL-C from baseline by 49% compared to placebo at week 24 (47% reduction evinacumab, 2% increase placebo, p<0.0001). At the same time point, compared to baseline evinacumab-treated patients also experienced: Average LDL-C decreased by 132 mg/dL compared to placebo (135 mg/dL reduction evinacumab, 3 mg/dL reduction placebo, p<0.0001). 47% achieved LDL-C less than 100 mg/dL, compared to 23% in the placebo arm (nominal p=0.0203). More than three-fourths (84%) reduced their LDL-C by at least 30% and more than half (56%) reduced their LDL-C by at least 50%, compared to 19% and 5% for placebo, respectively (p<0.0001 and p=0.0003). Significant reductions were also observed in other key secondary endpoints including levels of apolipoprotein B (ApoB), non-high-density lipoprotein cholesterol (non-HDL-C), total cholesterol and triglycerides, compared to placebo (p<0.0001 for all). Similar levels of LDL-C lowering were also observed in the most difficult-to-treat patients who often don't respond to certain other therapies, described as "null/null" or "negative/negative" patients. In the trial, evinacumab was generally well-tolerated. During the double-blind treatment period, 66% of evinacumab patients and 81% of placebo patients experienced at least one adverse event (AE). During the double-blind treatment period, AEs that occurred in at least 5% of patients, and more commonly with evinacumab, were influenza-like illness (11% evinacumab, 0% placebo) and rhinorrhea (7% evinacumab, 0% placebo). There were no deaths, major adverse cardiovascular events or discontinuations due to AEs. Detailed results from this trial will be used as the basis of regulatory submissions around the world, with the U.S. Food and Drug Administration (FDA) submission expected to be completed by mid-2020. Detailed ODYSSEY HoFH Results In the Phase 3 ODYSSEY HoFH trial, 69 patients were randomized to receive either Praluent (n=45) plus other lipid-lowering therapies, excluding other PCSK9 inhibitors, versus lipid-lowering therapies alone (placebo, n=24). At baseline, LDL-C was 295 mg/dL in the Praluent group and 260 mg/dL in the placebo group; nearly all (>95%) patients were on a statin. The trial met its primary endpoint, with Praluent-treated patients experiencing a 36% reduction in LDL-C at week 12 compared to placebo (27% reduction Praluent, 9% increase placebo, p<0.0001). At the same time point, compared to baseline Praluent-treated patients also experienced: Average LDL-C levels decreased by 72 mg/dL compared to placebo (63 mg/dL reduction Praluent, 9 mg/dL increase placebo). More than half (57%) reduced their LDL-C by at least 30% and more than a quarter (27%) reduced their LDL-C by at least half, compared to 4% and 0% for placebo, respectively (p=0.0010 and p=0.0017). No serious AEs, permanent treatment discontinuations or deaths were reported during the double-blind treatment period. During the double-blind treatment period, the AE that occurred in at least 5% of patients, and more commonly with Praluent, was diarrhea (7% Praluent, 0% placebo). AEs that occurred in at least 5% of patients, and more commonly with placebo, were upper respiratory tract infection (4% Praluent, 8% placebo) and headache (4% Praluent, 8% placebo). Research into the use of Praluent in patients with HoFH is investigational and the safety and efficacy for this use have not been evaluated by any regulatory authority.Regeneron plans to submit these data as the basis of regulatory submissions with the FDA in the second quarter of 2020. About evinacumab and the ELIPSE HoFH TrialEvinacumab is a fully-human antibody that blocks ANGPTL3 and was invented by Regeneron using the company's proprietary VelocImmune technology that utilizes a proprietary genetically-engineered mouse platform endowed with a genetically-humanized immune system to produce optimized fully-human monoclonal antibodies. VelocImmune technology has been used to create multiple FDA-approved antibodies including Praluent (alirocumab), Dupixent (dupilumab), Libtayo (cemiplimab-rwlc) and Kevzara (sarilumab). Regeneron previously used these technologies to rapidly develop a treatmentfor Ebola virus infection, which is currently under review by the FDA, and is now being used in efforts to create prophylactic and treatment medicines for COVID-19. Evinacumab is currently being studied in patients with HoFH (Phase 3), refractory hypercholesterolemia (Phase 2) and severe hypertriglyceridemia (Phase 2). In 2017, the FDA granted Breakthrough Therapy designation for evinacumab for the treatment of hypercholesterolemia in patients with HoFH. Regeneron scientists discovered the angiopoietin gene family more than two decades ago. Human genetics research publishedin The New England Journal of Medicine in 2017 by scientists from the Regeneron Genetics Center found that patients whose ANGPTL3 gene did not function properly (called a "loss-of function mutation") have significantly lower levels of key blood lipids, including LDL-C, and this is associated with a significantly lower risk of coronary artery disease. ELIPSE HoFH is an ongoing Phase 3 randomized, double-blind, placebo-controlled, parallel-group trial evaluating the efficacy and safety of evinacumab 15 mg/kg administered intravenously every four weeks in 65 patients aged 12 years or older with HoFH (43 evinacumab, 22 placebo). The primary endpoint was reduction of LDL-C from baseline with evinacumab compared to placebo at 24 weeks. About Praluent and the ODYSSSEY HoFH Trial Praluent (alirocumab) inhibits the binding of PCSK9 (proprotein convertase subtilisin/kexin type 9) to the LDL receptor and thereby increases the number of available LDL receptors on the surface of liver cells to clear LDL, which lowers LDL-C levels in the blood. Praluent was developed by Regeneron and Sanofi under a global collaboration agreement and invented by Regeneron using the company's proprietary VelocImmune technology. In December 2019, the companies announced their intent to simplify the Praluent collaboration, with Regeneron expected to gain sole U.S. rights and Sanofi expected to gain sole ex-U.S. rights. Praluent is approved in more than 60 countries worldwide, including the U.S., Japan, Canada, Switzerland, Mexico, Brazil and the EU. In the U.S., Praluent is approved to reduce the risk of heart attack, stroke and unstable angina requiring hospitalization in adults with established cardiovascular disease. Praluent is also approved as an adjunct to diet, alone or in combination with other lipid lowering therapies (e.g., statins, ezetimibe), for the treatment of adults with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) to reduce LDL-C. Research into the use of Praluent in patients with HoFH remains investigational, and the safety and efficacy for this use have not been evaluated by any regulatory authority. In the Phase 3 ODYSSEY HoFH trial, patients on maximally-tolerated stains and/or apheresis were randomized to receive either Praluent 150 mg subcutaneously every 2 weeks (n=45) or placebo (n=24). The primary endpoint was reduction of LDL-C from baseline with Praluent compared to placebo at 12 weeks. Important Praluent Safety Information for the U.S. Do not use Praluent if you are allergic to alirocumab or to any of the ingredients in Praluent. Before you start using Praluent, tell your healthcare provider about all of your medical conditions, including allergies, and if you are pregnant or plan to become pregnant or if you are breastfeeding or plan to breastfeed. Tell your healthcare provider or pharmacist about any medicines you take, including prescription and over-the-counter medicines, vitamins or herbal supplements. Praluent can cause serious side effects, including allergic reactions that can be severe and require treatment in a hospital. Stop using Praluent and call your healthcare provider or go to the nearest hospital emergency room right away if you have any symptoms of an allergic reaction including a severe rash, redness, hives, severe itching, trouble breathing or swelling of the face, lips, throat, or tongue. The most common side effects of Praluent include: redness, itching, swelling, or pain/tenderness at the injection site, symptoms of the common cold, and flu or flu-like symptoms. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. Talk to your doctor about the right way to prepare and give yourself a Praluent injection and follow the "Instructions For Use" that comes with Praluent. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Praluent is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization. along with diet, alone or together with other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia), to reduce low-density lipoprotein cholesterol (LDL-C) or bad cholesterol. It is not known if Praluent is safe and effective in children. Please clickherefor the full Prescribing Information. AboutRegeneronRegeneronNASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world. For additional information about the company, please visitwww.regeneron.comor follow @Regeneron on Twitter. Regeneron Forward-Looking Statements and Use of Digital Media This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc.("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron's business and its employees, collaborators, suppliers, and other third parties on which Regeneron relies, Regeneron's ability to continue to conduct its research and clinical programs and manage its supply chain, net product sales of products marketed by Regeneron and/or its collaborators (collectively, "Regeneron's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of Regeneron's Products and Regeneron's product candidates and research and clinical programs now underway or planned, including without limitation evinacumab and Praluent (alirocumab); the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron's product candidates and new indications for Regeneron's Products, such as evinacumab for the treatment of homozygous familial hypercholesterolemia (HoFH), refractory hypercholesterolemia, and severe hypertriglyceridemia as well as Praluent for the treatment of HoFH; unforeseen safety issues resulting from the administration of Regeneron's Products (such as Praluent) and product candidates (such as evinacumab) in patients, including serious complications or side effects in connection with the use of Regeneron's Products and product candidates in clinical trials; uncertainty of market acceptance and commercial success of Regeneron's Products and product candidates and the impact of studies (whether conducted by Regeneron or others and whether mandated or voluntary) on the commercial success of Regeneron's Products and product candidates; ongoing regulatory obligations and oversight impacting Regeneron's Products (such as Praluent), research and clinical programs, and business, including those relating to patient privacy; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's Products and product candidates, including without limitation Praluent and evinacumab; the availability and extent of reimbursement of Regeneron's Products from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to Regeneron's Products and product candidates; the extent to which the results from the research and development programs conducted by Regeneron or its collaborators may be replicated in other studies and lead to therapeutic applications; the ability of Regeneron to manufacture and manage supply chains for multiple products and product candidates; the ability of Regeneron's collaborators, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron's Products and product candidates; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license or collaboration agreement, including Regeneron's agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable), to be cancelled or terminated without any further product success; and risks associated with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to Dupixent (dupilumab) and Praluent), other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron's business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2019. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update publicly any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise. Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website(http://newsroom.regeneron.com) and its Twitter feed (http://twitter.com/regeneron). Contacts: MediaRelations Joseph Ricculli Tel: +1 (914) 418-0405 [emailprotected] Investor Relations Justin Holko Tel: +1 (914) 847-7786 [emailprotected] SOURCE Regeneron Pharmaceuticals, Inc. Related Links https://www.regeneron.com

Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol

LEAWOOD, Kan., Feb. 9, 2021 /PRNewswire/ --RiseNow, a client advocacy supply chain solution provider serving the Global 2000 andTealbook Inc., the "Trusted Source of Supplier Data," today announced a new referral and certified integration partnership to provide integration capabilities for RiseNow customers through access to Tealbook's Supplier Intelligence Platform. Both companies each play a key role in helping enterprise procurement professionals achieve e-procurement transformation. By integrating Tealbook's platform with RiseNow's supply chain consulting capabilities, procurement customers will be able to find new suppliers, access accurate, comprehensive supplier information, including diversity spend, compliance, certifications and more. "The need for accurate and comprehensive supplier data continues to be a pain point for many of our integration customers," said Dave Bryan, Partner at RiseNow. "Whether enterprises are considering an ERP or a spend management solution to handle spend management needs, the Tealbook Supplier Intelligence Platform is a technology-agnostic data foundation that provides clean data and up-to-date information that powers e-procurement transformation. This partnership will enable RiseNow to better support our customers looking to integrate this data seamlessly into whatever technology they are currently using or planning to use." Tealbook's supplier data foundation offers an innovative and easy-to-implement approach to autonomously gathering and validating supplier information from over 400 million websites and 600+ data sources. The platform helps organizations to avoid supply disruptions in times of crisis, supports strategic objectives like increasing spend with diverse suppliers and improves the quality and savings from strategic sourcing, especially in new categories where there is less knowledge of the market. "Helping global enterprises enhance their supplier intelligence with the power of AI-generated supplier data and our advanced supplier network is a key initiative for us," said Stephany Lapierre, CEO of Tealbook. "The collaboration with RiseNow is a perfect complement to both of our organizations as we help customers truly attain e-procurement transformation. With RiseNow systems integration, procurement customers will have real-time access to their entire supplier base, eliminating arduous manual processes to quickly identify suppliers that meet a wide range of requirements enabling them to make better decisions and find new opportunities with more accurate and agile information." "Even with millions of dollars of investments in cloud S2P solutions, 93%* of supply chain and procurement executives are experiencing negative impacts to their business on a regular basis due to misinformation and poor supplier data," added Lapierre. "This includes financial loss, delayed timelines and projects, unhappy internal and external customers, termination of supplier relationships and more. The solution is Tealbook, a trusted data foundation that can be leveraged by eProcurement solutions to ensure these investments are successful." *Source: Wakefield Research About RiseNow, LLCRiseNowis a client advocacy supply chain solutions providerserving the Global 2000 to middle markets, including Healthcare, Higher Education, Manufacturing, Life Sciences, Financial Services and Public Sector verticals.RiseNowhas a diverse team of enterprise systems experts covering a wide range of platforms and services, including:Cloud Spend Management Implementations & Integration, Healthcare Consolidated Service Center Solutions, Procurement Transformation & Change Management, Strategic Sourcing Solutions and Education, Warehouse & Distribution Management Solutions, and InventoryManagement& Point-of-Use Solutions.RiseNowhas successfully partnered and delivered value for hundreds of organizations such asPPG, IBM, Dell, The California State University, Advent Health, Jones Lang Lasalle, Endo Pharmaceuticals, Indiana University, Trinity Health, and Kaiser Permanente. For more information, visitwww.risenow.com. About TealbookTealbook is a Big Data company that provides a platform to fix enterprise supplier data forever. Tealbook does this through proprietary Autonomous Data Enrichment technology which proactively captures and maintains changing supplier information. In addition, Tealbook provides a data foundation that can be leveraged by other eProcurement solutions to ensure these larger investments are successful. Tealbook has been adopted by Fortune 100 companies across multiple sectors and is the winner of many prestigious awards including Spend Matters 50 Vendors to Watch, Gartner's Cool Vendor, CIX Most Innovative Company and Most Upside Potential by C100. Tealbook's mission is to deliver a 'Trusted Source of Supplier Data' to an ever-growing procurement space. For more information, visit www.tealbook.com. Tealbook Media contact:Carin Warner[emailprotected] SOURCE RiseNow Related Links http://www.risenow.com/

RiseNow and Tealbook Team up to Power Digital Procurement Transformation Partnership provides RiseNow integration customers with technology agnostic, seamless supplier discovery, diversity and data information

HERNDON, Va.--(BUSINESS WIRE)--Tyto Athene LLC, Herndon, Virginia, was awarded a $31,032,919 indefinite-delivery/indefinite-quantity contract that will include terms and conditions for the placement of firm-fixed-price task orders to provide technical direction and labor for engineering, installation, and maintenance of electronic systems and equipment and the respective infrastructure for the Consolidated Cryptologic Program, Defense Cryptologic Program, and Tactical Cryptologic Program in support of U.S. Fleet Cyber Command. The contract will include a five-year base ordering period with an additional six-month ordering period option pursuant of Federal Acquisition Regulation 52.217-8 - option to extend services, which if exercised, will bring the total ceiling value to $34,611,137. The base ordering period is expected to be completed by March 2026; if the option is exercised, the ordering period will be completed by September 2026. Work will be performed in Norfolk, Virginia (50%); Fort Meade, Maryland (30%); and Oahu, Hawaii (20%). Fiscal 2021 operation and maintenance (Navy) funds in the amount of $10,000 will be obligated to fund the contracts minimum amount, and funds will expire at the end of the fiscal year. Individual task orders will be subsequently funded with appropriate fiscal year appropriations at the time of their issuance. This contract resulted from a full and open competitive solicitation through beta.SAM.gov, with four offers received. Naval Supply Systems Command Fleet Logistics Center Norfolk, Virginia, is the contracting activity (N00189-21-D-0008). About Tyto Athene Tyto Athene is a full-service systems integrator providing design, installation, and support of complex voice, data, and security networks. Our wide range of network services and solutions include VoIP/voice, video, data, transport, infrastructure, network management, and security. Tyto Athene has over fifty years of experience supporting the Federal Government, the Department of Defense, State and Local Governments, communities, first responders and organizations across the United States and around the globe. Tyto Athene is focused on helping clients securely access information in order to accelerate their ability to make decisions. Its team utilizes industry-leading technologies, innovative thinking, and proven processes to deliver successful outcomes to clients. We believe our success is owed to our employees, who at every level are valued and given the resources to continuously achieve excellence.

Tyto Athene Awarded a $31 Million Contract to Support the Consolidated Cryptologic Program, Defense Cryptologic Program, and Tactical Cryptologic Program in Support of U.S. Fleet Cyber Command

LONDON--(BUSINESS WIRE)--Technavio predicts the global mobile device management market to grow steadily at a CAGR of over 21% by 2024. One of the primary drivers of the market is the rising adoption of MDM solutions. The increased adoption of mobile devices across organizations has necessitated the need for MDM solutions that can perform the tasks of mobile app management (MAM), enterprise mobility management (EMM), and mobile information management (MIM). This is one of the key factors which is likely to propel the growth of the global mobile device management market during the forecast period. Download Free Sample Report with COVID-19 Impact Analysis The global mobile device management market is a part of the global wireless telecommunication services market. The global wireless telecommunication services market includes wireless telecommunication service providers. Our research reports provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. Latest reports related to mobile device management market analysis Global Unified Endpoint Management Market 2020-2024 Get FREE Sample Report Global PoS Mobile Card Reader Market 2020-2024 Get FREE Sample Report Global Telecom Expense Management Solutions Market 2020-2024 Get FREE Sample Report Technavios reports are aimed at providing key insights on mobile device management markets by identifying the key drivers, trends, and, challenges that are impacting the overall global wireless telecommunication services market. The research analyses the impact on these factors on the mobile device management markets, for the present market scenario and over the forecast period. Technavios reports provide a comprehensive analysis on the vendors and their offerings, major growth strategies adopted by stakeholders, and the key happenings in the market. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Wireless Telecommunication Services Market: Segmentation Wireless telecommunication services, the parent market, includes the global mobile devices management market within its scope and it is further segmented into multiple sub-segments. Technavios reports identify the high growth areas and opportunities for vendors operating in each sub-segment of the wireless telecommunication services market. The market is segmented as follows: Wireless telecommunication services Type Service type Application Geography Register for a free trial today and gain instant access to 17,000+ market research reports Technavio's SUBSCRIPTION platform Wireless Telecommunication Services Market: Geographic Segmentation The global wireless telecommunication services market has been analyzed across key geographical regions to identify region level market dynamics, developments, and the key growth countries for the forecast period. The regional level analysis identifies the market shares, growth momentum, and key leading countries in the market, which include (but are not limited to) the following: Vendor Landscape Technavios industry coverage utilizes multiple sources and tools to gather information of the multiple stakeholders and their offerings towards the market. Sources such as company websites, annual reports, whitepapers, subscription & in-house databases, industry journals, publications, and magazines are used in addition to other relevant sources. The vendor landscape provides a framework to estimate the health care supplies market, while also categorizing the vendors into pure-play, category-focused, or diversified based on their offerings. All market reports provide the key and contributing players across the value chain based on in-house influence index, developed using multiple industry and market parameters. About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Insights on the Global Mobile Device Management Market | COVID-19 Impact and Analysis of Related Markets Drivers, Opportunities and Threats | Technavio

LAS VEGAS, March 31, 2020 /PRNewswire/ --Due to the devastating financial losses Coronavirus is inflicting on the Travel Industry, BnB Chat has launched the world's first "Zero Commission" and "Zero Data Collection" Hospitality Search Engine. Say goodbye to all "Double-Merchant" paywall platforms like Expedia & Airbnb that have been collecting personal data and charging abhorrent fees & commissionsof 15% to 30% on every vacation rental booking over the past decade. BnB Chat has "shifted the paradigm" around expensive Online Travel Agents (OTAs) by allowing Travelers to connect directly with the reservation systems of Hotels, BnB's, Hostels, Individual Homeowners, Real Estate Brokers, Professional Property Managers, Yacht Owners, and other alternative accommodation owners with the click of a mouse. There's even a "Bid on a Room" feature whereby Travelers can negotiate directly with the reservation departments of Listers for a more favorable "room rate" that matches their budget and length of stay, which can be very beneficial during low-season, or a global pandemic like the Coronavirus. And for Hosts who don't own a sophisticated reservation system or website "No Problem!" BnB Chat has teamed-up with PayPal so Hosts can receive global room rental payments of Visa, MasterCard, AMEX, and Discover Card directly into their PayPal accounts without surrendering any personal data or financial information to any third-party platform. For years, Travelers and Hosts have been yearning for a fair, honest, neutral vacation rental distribution channel that doesn't charge middle-man fees & commissions, or collect any personal data, while delivering "unbiased" search results that haven't been auctioned off to the highest bidder. Well, look no further BnB Chat has arrived! Please join our efforts in creating a more fair & equitable hospitality marketplace by sharing this article with fellow Travelers & Hosts, and downloading the BnB Chat App today. Thank you for your support. SOURCE BnB Chat, Inc.

BnB Chat Launches "Zero Commission" Hospitality Search Engine

PARIS--(BUSINESS WIRE)--Regulatory News: With the Carbon Disclosure Project (CDP)* 2020 results, Mercialys (Paris:MERY) is once again ranked in the Climate A List, which recognizes the worlds most active companies in the fight against climate change. This recognition highlights Mercialys sustained ambition to reduce its carbon footprint and ensure environmental transparency. By maintaining its A List ranking for the third consecutive year, Mercialys has confirmed its position as one of the top 3% of companies leading the fight against climate change, out of more than 9,600 international participants for CDP 2020 (up 14% from last year). More specifically, this ranking acknowledges Mercialys exhaustive environmental reporting and its ambitious goals for reducing greenhouse gas emissions, as illustrated by the scientific certification of its carbon roadmap by the Science Based Targets initiative (SBTi)** in 2019 or its actions to reduce energy consumption and diversify its energy mix. By taking part in this questionnaire - whose answers are made public - for the past four years, Mercialys is also setting out its support for collective efforts to promote transparency and access to reliable and comparable environmental data to benefit CDPs 515 member investors and more generally all of its stakeholders. This latest recognition follows on from Mercialys multiple achievements in 2020 (continued Green Star rating with GRESB, Grands Prix de la Transparence All Categories Award and two EPRA Gold Awards), reaffirming Mercialys commitment to maintaining the same level of performance while renewing its CSR strategy, with its targets and commitments to be announced during the first half of 2021. *Carbon Disclosure Project (CDP): international not-for-profit organization that assesses, based on environmental data collected each year, how businesses, territories and organizations impact climate change, water and forests. **The Science Based Targets initiative (SBTi): international non-profit organization that assesses, based on criteria defined by scientific experts, the alignment between the greenhouse gas emission reduction targets set by companies and the recommendations of the Intergovernmental Panel on Climate Change (IPCC), in order to ensure that these targets effectively limit the increase in global temperatures to 2C by 2050 compared with 1990. * * * This press release is available on www.mercialys.com About Mercialys Mercialys is one of Frances leading real estate companies, focused exclusively on shopping centers and high-street retail assets. At June 30, 2020, Mercialys had a portfolio of 2,111 leases, representing a rental value of Euro 182.3 million on an annualized basis. At June 30, 2020, it owned properties with an estimated value of Euro 3.5 billion (including transfer taxes). Mercialys has had SIIC real estate investment trust (REIT) tax status since November 1, 2005 and has been listed on Euronext Paris Compartment A (ticker: MERY) since its initial public offering on October 12, 2005. At June 30, 2020, there were 92,049,169 shares outstanding. IMPORTANT INFORMATION This press release contains certain forward-looking statements regarding future events, trends, projects or targets. These forward-looking statements are subject to identified and unidentified risks and uncertainties that could cause actual results to differ materially from the results anticipated in the forward-looking statements. Please refer to Mercialys Universal Registration Document available at www.mercialys.com for the year ended December 31, 2019 for more details regarding certain factors, risks and uncertainties that could affect Mercialys business. Mercialys makes no undertaking in any form to publish updates or adjustments to these forward-looking statements, nor to report new information, new future events or any other circumstances that might cause these statements to be revised.

CDP 2020: Mercialys Maintains Its A List Ranking for the Third Consecutive Year

BAISE, China, Feb. 8, 2021 /PRNewswire/ -- China Central Television (CCTV)'s special program "Our Chinese Dream: 2021 Nationwide Celebration of Spring Festival" has recently been filmed in Baise, Guangxi Zhuang Autonomous Region, according to Baise Culture, Radio, Television and Tourism Bureau. The show will be premiered on CCTV-3 at 19:30 on February 10 and on CCTV-1 at 12:30 on February 11 (Chinese New Year's Eve), followed by continuous broadcasting on the both channels during the prime time throughout the Spring Festival. Recording scene by Haokun Lake in Lingyun County, Baise Recording scene in Baini Village of Leye County, Baise The program features Haokun Lake of Lingyun County, Baise as the main venue, Baini Village of Leye County as the sub-venue for the recording under the theme "The Road to Prosperity", and Xiajia Town of Lingyun County as the sub-venue for "Longevity Town" themed part of the show. Covering folklore, intangible cultural heritages, songs and dances, acrobatics, magic and other art forms, the performance adds to the festivity and peace amidst joy and laughter during the Spring Festival. Handicrafts such as colorful silk balls with local cultural features are seen everywhere on the stage. The traditional New Year delicacies, the traditional costumes of various ethnic groups in Baise, the giant Fu (Fortune) and Chun (Spring) calligraphy, and the mascots for the Year of the Ox, among others, set off a joyful and festive vibe. The program also incorporates a wide array of intangible cultural heritages such as Trombone of Lingyun County, Dragon Dance of Leye County, Malv Dance of Jingxi City, Taige Show of Debao County and Damoqiu Acrobatics of Longlin County, cultural performances with local characteristics, and local customs of celebrating the Spring Festival, bringing together excellent shows from around the city. Ding Lihua, director of Baise Culture, Radio, Television and Tourism Bureau, said that the program is an epitome of Baise's unique folk culture, local cuisine and cultural and tourist highlights. Through the demonstration of poverty alleviation achievement in Baise, the stories and spirit of the city in poverty alleviation are promoted and Baise's cultural and tourist brands will garner great popularity across the country and beyond.Image Attachments Links:Link: http://asianetnews.net/view-attachment?attach-id=383936Caption: Recording scene by Haokun Lake in Lingyun County, BaiseLink: http://asianetnews.net/view-attachment?attach-id=383950Caption: Recording scene in Baini Village of Leye County, BaiseSOURCE Baise Culture, Radio, Television and Tourism Bureau

Featured Spring Festival Celebration in Baise to Debut on China Central Television (CCTV) USA - English USA - English Deutschland - Deutsch - P France - Franais

WASHINGTON, April 14, 2020 /PRNewswire/ -- 54gene,the African genomics research, services, and development company has closed a Series A round of $15M, led by Adjuvant Capital, a life sciences fund backed by the International Finance Corporation, Novartis, and the Bill & Melinda Gates Foundation. The round included participation from Raba Capital, V8 Capital, Ingressive Capital, and follow on investment from Y Combinator, Better Ventures, Fifty Years, KdT Ventures, Aera VC and Pioneer Fund. In July 2019, 54gene secured a Seed round of $4.5M which brings the company's total VC investment to $19.5M. 54gene Closes $15M Series A (PRNewsfoto/54gene) The investment secured today will allow the company to scale operations in support of generating novel insights from human genetics research that result in high impact discoveries for improving human health through therapeutic development. The investment will also be used to accelerate discovery capabilities by bolstering operations in genetics, bioinformatics, preclinical, clinical and commercial programs. 54gene was launched in January 2019, to address the significant gap the genomics market currently poses for Africa, and build and use African genetic data sets to make landmark discoveries to support therapeutic development. As of 2018, less than 3% of the data used in Genome-wide Association Studies [GWAS] were of African ancestry and currently, less than 1% of global drug discovery occurs on the African continent. Located in Africa's most populous country, Nigeria, and in the US, 54gene aims to improve the development, availability and efficacy of medical products that will prove beneficial to Africans and the wider global population. As part of its next stage of growth, the company will further explore partnerships and opportunities for co-development of drug targets and therapeutics, and expects to partner with pharmaceutical, medical device and diagnostic companies for clinical programs in Africa, which will be led by 54gene's newly appointed Vice President of Clinical & Regulatory Affairs, Kemi Williams, who was formerly Head of Clinical Affairs for Siemens Healthineers US molecular diagnostics business, and previously worked at Roche, Abbott and Medtronic. In addition to its Series A raise, 54gene is also announcing the formation of its Scientific Advisory Board [SAB]. The SAB is composed of global leaders in clinical genetics, bioinformatics and data science; Michael F. Murray MD, Director of Clinical Operations, Center for Genomic Health Professor Dept of Genetics, Yale School of Medicine, Manuel Rivas PhD, Assistant Professor at Stanford University, Greg Hinkle PhD, VP Research Informatics, Alnylam Pharmaceuticals and Jeff Hammerbacher, Founder and General Partner, Related Sciences. Speaking on today's news, 54gene Founder and CEO Dr. Abasi Ene-Obong says, "This new partnership marks a significant evolution in the growth of our company. In the coming months we will be focusing on building a genomic resource that we hope will add significantly to global health, while also translating to the health benefits of patients in Africa. We will also be expanding our collaborations in Africa with both public and private stakeholders and investing in setting up a state-of-the-art research lab with high-throughput genetic processing and BSL 3 capabilities in Nigeria, and ensuring that we build some of our innovative pipelines on the African continent."54gene currently works with 300+ researchers, clinicians and geneticists across the continent, to improve the global collective knowledge of genomic determinants of health and to facilitate translational research. The company has also built an African Biobank, a state-of-the-art biorepository which stores biological samples to provide access to aggregated, de-identified data and bio-specimen mainly for secondary use by researchers, to support both academic and development research. Jenny Yip, Managing Partner of Adjuvant Capital adds, "There is enormous potential in expanding the reach of global drug and vaccine discovery by including more diverse populations in research efforts. We were impressed by 54gene's commitment to building a world-class network of African clinicians and geneticists and are excited to work with them as they scale and seek to drive meaningful improvements in global public health."Dr. Ene-Obongconcludes, "This funding comes at a historically meaningful time, allowing us to deliver global impact through continued investment in research and strategic partnerships with leaders in the biomedical industry. We want to support the crucial work of our partners in Africa while improving global health and are committed to promoting a safe, ethical and beneficial research practice." About 54gene- https://54gene.com/About Adjuvant Capital- www.adjuvantcapital.com.Photo - https://mma.prnewswire.com/media/1155052/54gene.jpg SOURCE 54gene

54gene Closes $15M Series A Adjuvant Capital leads round for African genomics company to transform genetic information into solutions for improving human health

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Minerva Neurosciences, Inc. (Minerva or the Company) (NASDAQ: NERV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 15, 2017 and November 30, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before February 8, 2021. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Minerva failed to inform investors of the true feedback from the FDA after its end-of-Phase 2 meeting. The Companys Phase 2b study failed to use the commercial formulation of roluperidone and was exclusively conducted outside of the United States. The Companys Phase 3 study was rendered incapable of proving the drugs effectiveness due to failing to meet its primary and key secondary endpoints. The Combination of the Phase 2b and Phase 3 trials would be highly unlikely to support an NDA submitted to the FDA. Based on these facts, the Companys public statements were false and materially misleading throughout the class period. When the market learned the truth about Minerva, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

NEW YORK, Nov. 3, 2020 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05982383/?utm_source=PRN - Smart home safety devices can be connected to Wi-Fi and accessed from anywhere using smart devices, such as smartphones, smartwatches, or voices. The smart home safety market is driven by the increasing crime rates across the world, which is forcing the people to focus on security and safety systems, especially in residential areas.- According to the FBI, a burglar strikes every 25.7 seconds in the United States adding up to two burglaries every minute and over 3,300 burglaries per day. Further, only 24% of Americans have a home security system to protect their property from burglary.- As per 2019 Continental Automated Buildings Association's survey, primary motivations for adopting the Smart Home technology across North America resulted in 51% opting for safety and security purposes. And, as per Alarm.org, the official site of the National Council for Home Safety and Security, the 63% home safety product buyers want smart locks and alarms for their home safety purposes.- With the growing adoption of smart home devices, including safety devices, data leaks have also been observed to have increased significantly. This has been led by using ransomware and phishing to expose personally identifiable information. In 2019, over 3,000 Ring camera customers' personal data was leaked. Therefore, customers are expected to continue to prioritize privacy for smart home safety solution adoption.Key Market TrendsGrowing Awareness Regarding Home Security Systems- The growing consumer propensity toward the adoption and usage of the connected devices is augmenting the demand in the market studied. For instance, as per Jaze Networks, the global internet-connected devices per person in 2020 were at 6.58 and number for connected devices per person is expected to reach 15 by 2030.- Furthermore, the statistics from the National Council for Home Safety and Security, suggests that currently, 47% of millennials in the United States own smart devices, while 70% of those who already have one smart product portrayed likeliness to opt for other smart devices as well.- Also, according to the Continental Automated Buildings Association (CABA), the installed bases of smart home devices in the United States are expected to reach 2691.8 million in 2023 from 1224.7 million in 2018. Similarly, the significant sales of smart home safety devices, such as video doorbell and security cameras, are augmenting growth, in lieu of rise of IoT and sophistication/innovation in security devices.- Asia-Pacific Accounts for Significant Market Share- China is at the forefront when it comes to the adoption of the latest technological innovation. The increasing adoption of AI technology leads to a rise in demand for the smart home market in the country. The State Council of China recently detailed its strategy to become the leading AI superpower by 2030, by building a USD 150 billion national AI industry in the future.- The favorable policies and the onset of IoT laid a solid foundation for the smart home market in the country. GSMA estimates that China may account for approximately 4.1 billion IoT connections, which is almost one-third of the global IoT connections, by 2025. Furthermore, initiatives, such as Smart Cities Projects, National New-type Urbanization Plan, and the Made in China 2025 strategy, are expected to fuel China's smart home safety market.- As more and more AI-powered security cameras are installed in homes, providing homeowners improved security features, including timely intruder alerts or notifications when their loved ones arrive home, companies are fighting for a stake in this market.- Wuhan-headquartered computer vision company, SimShine, founded in 2017, is one of them. Its new line of home security cameras, named SimCam, adopts AI edge computing, a technology that supports cloud-free data storage and analysis. In a competitive market, where established companies, like Amazon-owned Ring, Chinese electronics vendor Xiaomi, and Netgear's Arlos, are all strong players, SimShine aims to differentiate by providing AI security cameras with enhanced latency and better privacy protection.Competitive LandscapeThe Smart Home Security Market is highly fragmented, largely due to the low entry barriers. Further strategic partnerships and innovations are the driving force for the industry, and the market is evolving at a faster pace both in terms of technology and features. Key players are ADT Inc. and Honeywell International Inc. Recent developments in the market are -- Sep 2020 - Hangzhou Hikvision Digital Technology Co. Ltd launched its new generation of wireless alarm systems, the AX PRO which delivers comprehensive alarm solutions for both residential and commercial applications. It includes a compact panel hub for a wide range of detectors and peripherals, covering intrusion detection, video verification, smoke detection, flood detection, and home automation.- Mar 2020 - Ring Inc. Introduced two new video doorbells and its new, innovative pre-roll technology with battery-powered doorbells. Ring Video Doorbell 3 and Ring Video Doorbell 3 Plus are the latest additions to Ring's Video Doorbell lineup, for security and convenience to users' homes. Both new products include privacy zones, which allow users to black out portions of the camera's field-of-view from recording, and audio/motion detection toggles to disable recording as needed. It also announced its next generation Ring Chime and Chime Pro, which enable customers to hear audible ring notifications throughout their home.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p05982383/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1-339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com

The global smart home safety market is expected to register a CAGR of 17.27% during the forcast period 2020-2025

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--CSG (NASDAQ: CSGS) today announced that its Board of Directors approved the Companys quarterly cash dividend payment of $0.2350 per share of common stock to be paid on Sept. 28, 2020 for shareholders of record as of the close of business on Sept. 15, 2020. About CSG For more than 35 years, CSG has simplified the complexity of business, delivering innovative customer engagement solutions that help companies acquire, monetize, engage and retain customers. Operating across more than 120 countries worldwide, CSG manages billions of critical customer interactions annually, and its award-winning suite of software and services allows companies across dozens of industries to tackle their biggest business challenges and thrive in an ever-changing marketplace. CSG is the trusted partner for driving digital innovation for hundreds of leading global brands, including AT&T, Charter Communications, Comcast, DISH, Eastlink, Formula One, Maximus, MTN and Telstra. To learn more, visit our website at csgi.com and connect with us on LinkedIn and Twitter. Copyright 2020 CSG Systems International, Inc. and/or its affiliates (CSG). All rights reserved. CSG is a registered trademark of CSG Systems International, Inc. All third-party trademarks, service marks, and/or product names which are referenced in this document are the property of their respective owners, and all rights therein are reserved.

CSG Systems International Approves Quarterly Dividend

DUBLIN--(BUSINESS WIRE)--The "Architectural Paint Market in US - Industry Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included The study considers the present scenario of the U.S. architectural paint market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market. The U.S. architectural paint market share is expected to grow at a CAGR of over 4% during the period 2019-2025. The U.S. architectural paint market is witnessing a sort of revival. Home improvement projects are on the rise owing to the COVID-19 pandemic as a major chunk of the population is sheltering in place. A lot of consumers are looking to tackle the long ignored and overdue renovation of their spaces or are taking up paint projects to keep themselves occupied during the lockdown, which is expected to contribute to the growth of the U.S. architectural paint market. As spaces are becoming more creative, experiential, design-friendly, and environmentally-conscious, colors are witnessing heightened attention. Since paints allow for complete transformations of environments, they are constantly being used to adapt to the changing pace of business. Shortages in raw materials such as alcohol, pigments, and dyes, as well as delays in the transportation of materials owing to restrictions in travel, will have an impact on the market. Social distancing measures and lockdowns are likely expected to reduce economic activities further. Countries such as China are offering 12-15% of rebates on exports in a bid to regain value owing to tariff restrictions in 2019. An expected increase of about 7% in the construction rate of the residential sector is likely to drive construction spending by around 4%. The following factors are likely to contribute to the growth of the U.S. architectural paint market during the forecast period: U.S. Architectural Paint Market Segmentation The U.S. architectural paint market research report includes a detailed segmentation by end-user, channel, application, and formulation. The DIY segment is expected to reach revenues of over $5 billion by 2025 and will hold the largest U.S. Architectural Paint Market share. Retailers such as Lowe's and Home Depot are observing a spike in demand for home improvement materials. This surge in demand is expected to see an upward trajectory even after the lift in lockdowns, driving the sale of architectural paints as people continue to shelter in place until the pandemic is wholly wiped out. DIYers have been driving sales for characteristically soft, ultra-matte finish paints. In the midst of the renovation rush that has come on a decade after the recession, the need for interior paints has gone up across the United States. Gloss and semi-gloss finishes are expected to grow at the cost of flat finishes. However, the latter is still being preferred for low-traffic areas such as ceilings and hallways. Matte finishes are also being preferred over flat finishes. In San Francisco, California, muddy shades are covering walls, in New York City, nature-inspired colors are being incorporated, whereas, in Seattle, Washington, traditional colors are reigning. Moreover, exhibition spaces like museums and galleries occupy a more profound place in modern culture. This has driven operators to focus on how the paint can affect viewing experience, and renovate, driving demand for paints. Offline stores, especially improvement ones, have historically dominated the market. However, with the advent of technology and digital media, a lot of the demand has shifted online. Apart from the push that has come from e-commerce, the online medium has been feeding a frenzy for interior design, leading the medium to be a place of brand discovery and research. Motivations that drive purchases along the platforms differ and converge in certain aspects. However, younger consumers have a channel-agnostic view of shopping offline and online - the differences tend to be irrelevant. The expectations offline are passed on online as well. Amid the pandemic, most offline channels that deliver home improvement products have remained open as they have been deemed essential. The offline channel has performed strongly, with some stores even posting double the sale. Water-based paints have dominated the market and are likely to continue their dominance due to low odor, fast drying time, high color retention and film life, and easy cleanups. However, manufacturers have created waterborne coatings and enamels, which have a similar look and feel to oil-based paints. They offer the ease and convenience of water-based and durability of traditional oil paint, thereby further driving market share. Water-based come with their own set of challenges. As temperatures are soaring across the United States, characterized by heatwaves and unusually frigid weather, the application and performance of water-based owing to slower curing is compromised. This is proving to be a challenge in a market where labor shortage is critical, and so is the time is taken to complete a paint job. Insights by Vendors The U.S. architectural paint market is highly concentrated. PPG Industries, Sherwin-Williams Company, Benjamin Moore, and Behr Process Corporation account for 90% of the market. New players are, however, disrupting the market, largely in terms of addressing subtle pain points. For instance, while paint and coating companies are heavily regulated, disclosing ingredients is not a requirement, so traditional players do not reveal the contents of their paint. Leading players have established geographically diverse brands and cater to the entire spectrum of consumers from value-oriented to premium. Key Questions Answered 1. What is the U.S. architectural paint market size and growth forecast? 2. What are the factors, drivers, and trends impacting the growth of the US architectural paint market? 3. What is the revenue of the U.S. Architectural Coating market in the residential segment by 2025? 4. Which segment/application/formulation holds the highest market shares in the US region? 5. Who are the leading vendors in the market, and what factors are disrupting the market? 6. How is the COVID-19 pandemic significantly impacting the market growth of the architectural paint market size? Key Topics Covered 1 Research Methodology 2 Research Objectives 3 Research Process 4 Scope & Coverage 4.1 Market Definition 4.1.1 Inclusions 4.1.2 Exclusions 4.2 Base Year 4.3 Scope of The Study 4.4 Market Segments 4.4.1 Market Segmentation by End-Use 4.4.2 Market Segmentation by Channel 4.4.3 Market Segmentation by Application 4.4.4 Market Segmentation by Formulation 5 Report Assumptions & Caveats 5.1 Key Caveats 5.2 Currency Conversion 5.3 Market Derivation 6 Market at a Glance 7 Introduction 7.1 Overview 7.2 Impact of COVID-19 on Economy 7.3 Future of Housing After COVID-19 7.4 Generational Insights 7.5 Paint Finishes 8 Market Opportunities & Trends 8.1 DTC Companies Fix Paint-Buying Process 8.2 Artisanal Paint Companies Make Their Mark 8.3 Green Chemistry and Recycling 8.4 High Demand for White 9 Market Growth Enablers 9.1 Home improvement projects 9.2 Democratization of the Interior Design Landscape 9.3 Experimentations with Color 9.4 Paint Finds New Purpose 10 Market Restraints 10.1 Alternative Wall Treatments Find Favor 10.2 Falling Home Ownership 10.3 Lack of Disruptive Innovation 10.4 Dwindling Trained Workforce 11 Market Landscape 11.1 Market Size & Forecast 11.1.1 Revenue & Volume 11.2 Five Forces Analysis 11.2.1 Threat of New Entrants 11.2.2 Bargaining Power of Suppliers 11.2.3 Bargaining Power of Buyers 11.2.4 Threat of Substitutes 11.2.5 Competitive Rivalry 12 By End-use 12.1 Market Snapshot & Growth Engine (Revenue) 12.2 Market Snapshot & Growth Engine (Volume) 12.3 Market Overview 12.4 DIY 12.5 Residential Repaint 12.6 Commercial, Industrial, And Institutional Repaint 12.7 New Residential 12.8 New Commercial, Industrial, And Institutional 13 By Application 13.1 Market Snapshot and Growth Engine (Revenue) 13.2 Market Snapshot and Growth Engine (Volume) 13.3 Market Overview 13.4 Interior paints 13.5 Exterior paints 14 By Channel 14.1 Market Snapshot and Growth Engine (Revenue) 14.2 Market Snapshot and Growth Engine (Volume) 14.3 Market Overview 14.4 Offline 14.5 Online 15 By Formulation 15.1 Market Snapshot & Growth Engine (Revenue) 15.2 Market Snapshot & Growth Engine (Volume) 15.3 Market Overview 15.4 Water-based 15.5 Oil-based Paints 16 Competitive Landscape 16.1 Competition Overview 17 Market Vendor Analysis 17.1 Market Ranking Analysis 18 Key Company Profiles 18.1 PPG Industries 18.2 Sherwin-Williams 18.3 Behr Process Corporation 18.4 Benjamin Moore 19 Other Prominent Vendors 19.1 AFM 19.2 AURO 19.3 Backdrop 19.4 California Paints 19.5 Clare 19.6 Dunn-Edwards 19.7 Diamond Vogel 19.8 Kelly-Moore 19.9 The Little Greene Paint Company 19.10 Yenkin-MaJestic Paint 19.11 Cloverdale Paint 19.12 Color-Rare 19.13 Colortech 19.14 ECOS Paints 19.15 Farrow & Ball Paints 19.16 Lanco 19.17 O'Leary Paint 19.18 Real Milk Paint Co. 19.19 Recolor Paints 19.20 RomaBio 19.21 True Value Company For more information about this report visit https://www.researchandmarkets.com/r/1rzt9a Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

U.S. Architectural Paint Industry Outlook 2020-2025 - DTC Companies Fix Paint-Buying Process, Green Chemistry & Recycling Presents Opportunities - ResearchAndMarkets.com

CHICAGO, April 17, 2020 /PRNewswire/ -- At a time when the support of advocates is so desperately needed, Lawdragon magazine's annual guide of the 2020 Leading Plaintiff Consumer Lawyers in America shines a spotlight on attorneys who've excelled in fighting for those facing difficult experiences. That includes seven attorneys from one of Chicago's most successful and respected law firms: Power Rogers LLP. A Guide to The Nation's Top AttorneysLawdragon magazine is a trusted legal publication that's become known for its annual attorney listings. Each year, Lawdragon staff collect nominations from leading lawyers across the country, and subject candidates to a rigorous vetting process that includes peer review and independent research. The result is a list of attorneys who've enjoyed verifiable success, as well as the respect and esteem of their professional colleagues and the communities they serve. In total, seven of the firm's attorneys were recognized among the 500 Leading Plaintiff Consumer Lawyers in America, and two attorneys Partners Joseph Power and Larry Rogers Jr. were additionally selected for inclusion in the Lawdragon 500 Leading Lawyers in America guide, which honors the nation's top attorneys across all practice areas. Joseph A. Power Jr.* Larry R. Rogers Sr. Larry R. Rogers Jr.* Thomas M. Power Thomas G. Siracusa Devon C. Bruce Joseph W. Balesteri *Also named to 2020 Lawdragon 500 Leading Lawyers Recognition in one of Lawdragon's annual guides is a highly sought-after accolade. For attorneys at Power Rogers, however, it is one of many that back a legacy of truly impressive results and awards. That includes over $4 billion in verdicts and settlements for clients, $900 million more than its closest competitor since 2000, and 10 consecutive years atop Chicago Lawyer's Annual Settlement Survey. As the country continues to face fallout from the novel coronavirus, and much uncertainty about the future, plaintiffs with complex claims can feel confident knowing that Power Rogers' award-winning trial lawyers remain available to the injured and the wronged throughout these turbulent times. For more information about the Power Rogers LLP legal team, its record of success, and its areas of practice, visit www.prslaw.com. SOURCE Power Rogers LLP Related Links https://www.prslaw.com

Power Rogers LLP Attorneys Named to 2020 Lawdragon Leading Plaintiff Consumer Lawyers Seven attorneys from the Chicago-based personal injury law firm of Power Rogers LLP have been selected for inclusion in the 2020 Lawdragon Leading Plaintiff Consumer Lawyers in America

NEW YORK, March 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, AAPL, ADCT, BUD, and JPM. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast. SAVA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=SAVA&prnumber=031720213 AAPL: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AAPL&prnumber=031720213 ADCT: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=ADCT&prnumber=031720213 BUD: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=BUD&prnumber=031720213 JPM: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=JPM&prnumber=031720213 (Note: You may have to copy this link into your browser then press the [ENTER] key.) SOURCE InvestorsObserver Related Links http://www.investorsobserver.com

Thinking about trading options or stock in Cassava Sciences, Apple, ADC Therapeutics, Anheuser Busch, or JPMorgan Chase?

VALENCIA, Calif., April 21, 2021 /PRNewswire/ --Med Tech Solutions (MTS), provider of practice-centered IT solutions for healthcare organizations, today announced it has formed a strategic alliance with Avertium and LIFARS. The three-way partnership creates the first combined suite offering managed cloud services, a managed security operations center (SOC) and incident response for always-on, comprehensive IT security that is designed for the unique needs of healthcare organizations.The partners will also participate in an Xtelligent Healthcare Media panel discussion on how to plan and practice response to a security breach on April 29. Med Tech Solutions' secure, reliable IT infrastructure; optimized clinical and business applications; and full end-user support are depended on by thousands of healthcare organizations nationwide. With 100% of its focus on healthcare organizations, MTS is also one of the few IT services organizations to achieve HITRUST Common Security Framework (CSF) certificationthe gold standard for safeguarding personal health informationfor its cloud platform. The alliancewhich combines MTS' solutions with Avertium's security monitoring and LIFARS' digital forensics and cyber resiliency servicesexpands on MTS' security commitment by creating the first complete, high-level security team and product set to prepare and protect healthcare organizations from an attack. Typically, organizations must piece-meal security and cloud services, and there is little or no proactive interaction between the vendors. If a security incident occurswhen every second counts to limit damage and restore vital servicesthat is often the first time those vendors interact, which can cause expensive delays and additional losses. This alliance gives MTS cloud clients access to a coordinated team that understands each client's full environment and business practices, that can run proactive preparedness and incident response exercises and that is available 24/7/365 for immediate response. "Very few healthcare organizations can afford to create and maintain the level of always-on cloud security that is offered by this allianceand that the current threat environment requires," said Mona Abutaleb, CEO, Med Tech Solutions. "The combination of these three companies' technologies and expert services gives our clients a proven model to continue to improve their security posture and their ability to focus on what's most importantpatient care." According to a HIMSS cybersecurity survey, 70% of healthcare organizations experienced a security incident in 2020. Healthcare has become a prime target for cyberattacks designed to access or sell practices' business and patient data. In many cases, hackers install ransomware that shuts down a practice's access to data and costing them tens to hundreds of thousands of dollars in ransom, along with fines, damage to their brand and loss of patient trust. "Avertium's expertise in threat prevention, detection and response perfectly complements Med Tech Solutions' focus on delivering resilience to the healthcare industry," said Paul Caiazzo, SVP corporate development and CISO, Avertium. "Together, our team seamlessly integrates 24/7/365 visibility and coverage with operational expertise, deep customer engagement, and next-gen security technologies to protect healthcare organizations from modern threats like ransomware and data theft." "Just as fire drills save lives in case crisis occurs, incident response planning and preparedness are critical components to a healthcare organization's comprehensive security approach so they can return to caring for patients as quickly as possible if a breach occurs," said Steve Lubchansky, VP sales and alliances, LIFARS. "This union of LIFAR's digital forensics and cyber resiliency services along with MTS and Avertium sets the bar high with the first-of-its-kind comprehensive security team." On Thursday April 29 at 11am ET, Xtelligent Healthcare Media will host Med Tech Solutions, Avertium and LIFARS in a panel discussion webinar, "Your Practice Is at Risk: How to Build an Always-On Cloud Security Team." Attendees will learn about the security specialties required for an always-on team, how to plan and practice response to a security breach, and immediate preventive actions to improve their security posture. To register, visit https://medtechsolutions.com/webinar/. About Med Tech Solutions Med Tech Solutions (MTS) creates technology systems that work the way healthcare practices work. Its Practice-Centered Care services are supported by dedicated IT Care Teams to ensure technology systems support essential clinical workflows and strategic business plans. Provider organizations and networks can count on a secure, reliable IT infrastructure, optimized clinical and business applications, and full end-user support so they can focus on patient care. Founded in 2006, MTS serves thousands of healthcare practices nationwide. The company has been recognized as a six-time Inc. 5000 Fastest Growing Private Company and a Channel Futures MSP 501 provider, and it has achieved HITRUST Common Security Framework (CSF) certification for its cloud platform. Media contact Shermineh Rohanizadeh Market Street Group for Med Tech Solutions [emailprotected] SOURCE Med Tech Solutions Related Links http://medtechsolutions.com

Med Tech Solutions Announces Security Alliance with Avertium and LIFARS, Delivering Comprehensive, Always-On Cloud Security for Healthcare Organizations Three-way partnership creates the first solution to combine managed cloud services, managed security operations center (SOC) and incident response for the healthcare industry

NEWPORT BEACH, Calif., March 31, 2020 /PRNewswire/ -- At-home fitness continues to rise in popularity. Therefore, the demand for equipment and classes is increasing. CoreX Fit Life, a health and fitness company based in Newport Beach, CA, has created the CoreX, the only fitness machine that has the capability for over 100 exercises as well as sports simulation in a compact design. The CoreX allows for over 100 exercises for cardio, HIIT, strength training, Pilates, and toning. The CoreX also has simulated workouts for popular sports like rowing, kayaking, stand-up paddleboarding (SUP), and cross-country skiing. No workout is ever the same because the only limit is your imagination. Continue Reading New fitness machine CoreX lets you work out at home when and where you want offering over 100 exercises for a full body workout. Cardio, HIIT, strength training, Pilates and toning. Compact and easy to store, this modern machine fits in any small space, apartment or home. The CoreX will supply up to 225 pounds of resistance for strength training exercises like bench press and squats with the included steel weight bar and ground plate. Built to last, save time and get the body you want. CoreX is the only fitness machine that has the capability for over 100 exercises, as well as sports simulation, in a compact design. Less than a quarter of Americans are meeting all national physical activity guidelines (Prevention's National Center for Health Statistics (NCHS)). Yet the fitness industry is booming: According to the IHRSA (International Health, Racquet & Sportsclub Association), the $30 billion health and fitness industry in the U.S. has been growing by at least 3 - 4% annually for the last ten years and shows no signs of slowing down anytime soon. The U.S. spends over $10 billion a year on fitness equipment. CoreX was designed by Markus Scholten, a top automotive engineer and athlete, out of frustration from not being able to find a machine that could provide a workout that challenged all muscle groups and offered many exercises in one. Focusing on high quality and amazing precision, the CoreX is a complete, full-body, low impact machine that targets arms, legs, chest, glutes, and especially the core. The CoreX was designed to make working out at home as convenient and streamlined as possible. The CoreX is currently available on Kickstarter at special pricing: https://www.kickstarter.com/projects/904561417/corexCoreX provides inertia-free training. This allows you to isolate a muscle from the start till the end of the repetition with consistent resistance. The CoreX has two resistance adjusters that allow for 64 resistance levels. With options to adjust resistance both on the front and back of the flywheel, the CoreX makes workouts easily customizable. You decide how much resistance you need and you can level up or down at any time, on any exercise. The resistance knobs are easy to adjust, so you can quickly change levels during your workout. The CoreX will supply up to 225 pounds of resistance for strength training exercises like bench press and squats with the included steel weight bar and ground plate. The included aluminum bar is designed for lighter weight exercises like cardio to allow for a real life feel during rowing, kayaking, SUP and canoeing. The aluminum bar can also be used for other exercises up to 120 pounds of resistance. Accessories included are handles/foot straps, Velcro ankle straps, steel bar, aluminum bar, smart phone/tablet holder, ground plate, and cross country poles. All of the accessories are easy to remove and/or attach to the CoreX machine in seconds for an optimal variety of exercises. Customers who purchase the machine also receive a CoreX User Guide and CoreX guided workouts by top fitness professionals for all varieties of workouts including kayak, rowing, SUP, cross-country skiing, HIIT, strength training, Pilates, and toning. Every CoreX model includes an advanced smartphone/tablet holder. The metal arm allows to you twist and turn the face in any direction, allowing you to view it from both ends of the machine, so that you don't miss out on any instruction from your virtual trainer.The dynamic design maximizes minimum space, making working out in small spaces such as a bedroom or office possible. The CoreX features caster wheels on the front foot letting you roll the machine to easily store upright or move it from one side of the room to the other. The smart design makes it easy to lift on one side and move and store in seconds. The wheels let you move the machine from one angle to another to allow you to adjust the machine to your space. The CoreX comes in eight color options for the premier machine and four wood grain options. The CoreX premier machine retails for $2,199 and the wood CoreX machine retails for $2,999.ABOUT COREX - Within two short years of meeting, partners Markus Scholten and Rob Vanderwerf have created a way to improve the fitness industry. As a mechanical engineer with a successful career inventing and building designs for Karmann GmbH, BMW and Fisker Automotive, Markus has always been focused on how to improve design and think out of the box. When Markus created the CoreX in his garage for his own personal use, he didn't realize he was creating a new way of working out that would change the industry. Out of boredom and a sports injury came innovation. Markus wanted a machine that could offer a great full body workout. Markus continued to work on fine-tuning the machine for a year and at a chance meeting at a party, his secret project became a joint dream. Introduced by their wives who were friends, Rob and Markus struck up a conversation and it was an instant meeting of the business minds. Vanderwerf brought vast knowledge in business and finance from many years working in tech and with startups. Markus brought the design and engineering expertise. Scholten showed Rob the fitness machine he was building and they immediately decided they should create it for the consumer. Rob's ability to create systems and build companies from the ground up was the missing part to Markus' invention. Vanderwerf had always been athletic and was finding it frustrating finding the time and places to exercise. Putting in lots of overtime at work and during travel, Vanderwerf found his time and options to workout dwindling. In addition, living in major cities, space was at a premium for home equipment. Markus' machine was the answer.Their entrepreneurial minds and a shared love of health and fitness is the foundation of the company. Welcome to the next level of fitness.CONTACT:Lindsley Lowell[emailprotected] 310-770-0494SOURCE CoreX Fit Life

CoreX Launches Fitness Machine Creating the Next Level of At-Home Fitness Over 100 Exercises - Cardio, HIIT, Strength Training, Pilates, Toning

RADNOR, Pa., March 12, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Leidos Holdings, Inc. (NYSE:LDOS) ("Leidos") on behalf of those who purchased or acquired Leidos securities between May 4, 2020 and February 23, 2021, inclusive (the "Class Period"). Investor Deadline Reminder: Investors who purchased or acquired Leidos securities during the Class Period may, no later than May 5, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP:James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at [emailprotected]; or click https://www.ktmc.com/leidos-holdings-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=leidos Leidos is a science, engineering, and information technology company that provides services and solutions in the defense, intelligence, homeland security, civil and health markets, both domestically and internationally. The Class Period commences on May 4, 2020, when Leidos announced that it had completed the acquisition of L3Harris Technologies' Security Detection and Automation businesses ("SD&A Businesses"). According to the complaint, on February 16, 2021, Spruce Point Capital Management LLC ("Spruce Point") published a research report, alleging, among other things that "Leidos is potentially covering up at least $100m of fictitious sales, mischaracterizing $355 - $367m of international revenue." The report also alleged that Leidos was "concealing numerous product defects from investors, notably faulty explosive detection systems at airports and borders." Following this news, Leidos's share price fell $2.58, or 2.4%, to close at $105.22 per share on February 16, 2021. Then, on February 23, 2021, Leidos announced its fourth quarter and full year 2020 financial results in a press release. Therein, Leidos reported $89 million in revenue related to the SD&A Businesses for the fourth quarter, meaning that after two full quarters, the acquisition generated only $163 million in sales (or $326 million annualized), falling well short of projected $500 million sales. Leidos expected cash flow of $850 million, well below analyst estimates of $1.083 billion. Following this news, Leidos's stock price fell $10.29, or 9.91%, to close at $93.51 per share on February 23, 2021. Finally, on February 24, 2021, Spruce Point highlighted that Leidos had "materially expanded" the risk disclosures in its annual report for the year ended December 31, 2020, which had been filed after the market closed on February 23, 2021. Spruce Point tweeted: "We believe it is validating all the major points of our report."Spruce Point noted that Leidos expanded its risk disclosures regarding insurance coverage, as "Liedos is shipping defective products back from various countries [that] may not have the same protections as in the U.S." Following this news, Leidos's stock price fell $3.13, or 3.3%, to close at $90.38 per share on February 24, 2021. The complaint alleges that, throughout the Class Period, the defendants failed to disclose to investors that: (1) the purported benefits of Leidos's acquisition of L3Harris Technologies' SD&A Businesses were significantly overstated; (2) Leidos's products suffered from numerous product defects, including faulty explosive detection systems at airports, ports, and borders; (3) as a result of the foregoing, Leidos's financial results were significantly overstated; and (4) as a result of the foregoing, the defendants' positive statements about Leidos's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Leidosinvestors may, no later than May 5, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.In order to be appointed as a lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class.Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com. CONTACT: Kessler Topaz Meltzer & Check, LLPJames Maro, Jr., Esq.Adrienne Bell, Esq.280 King of Prussia RoadRadnor, PA 19087(844) 887-9500 (toll free)[emailprotected] SOURCE Kessler Topaz Meltzer & Check, LLP Related Links https://www.ktmc.com

LDOS Class Action Alert: Kessler Topaz Meltzer & Check, LLP Announces A Securities Fraud Class Action Filed Against Leidos Holdings, Inc.

POTTSVILLE, Pa., Feb. 2, 2021 /PRNewswire/ --D.G. Yuengling & Son, Inc., America's Oldest Brewery, is disrupting the beer scene with the launch of its edgy and flavorful brand, Yuengling Raging Eagle Mango Beer; a pilsner beer made with natural mango flavor for a refreshing taste.This contemporary addition to Yuengling's portfolio is the ideal beverage for legal drinking age adults who are looking for bold, invigorating flavor in their next beer adventure. At 6.0% ABV, Raging Eagle is brewed with classic hops for a crisp taste of mango freshness. (PRNewsfoto/D.G. Yuengling & Son, Inc.) (PRNewsfoto/D.G. Yuengling & Son, Inc.) "We saw an opportunity to leverage our six generations of brewing expertise to create a refreshing mango beer that appeals to adventurous drinkers and adds a bold new brand to our portfolio of iconic beers," saidJen Yuengling, 6thgeneration brewer, D.G. Yuengling & Son, Inc. "Raging Eagle Mango Beer feeds into the passion and energy of the 21-35 young adult who is often surrounded by friends and itching to embark on new and unique adventures." Starting today, the mango deliciousness will be available year-round in 24oz cans at convenience stores across Yuengling's 22-state footprint making it the ideal beer for the flavor-seeker who is always on the hunt for good times. More Yuengling Raging Eagle pack configurations will be available later in the year.As America's Oldest Brewery, Yuengling continues to create new opportunities for consumers to enjoy the brand, including the recent releases of Yuengling Golden Pilsner, Yuengling Hershey's Chocolate Porter and FLIGHT by Yuengling. Raging Eagle is the latest product inspired by consumer feedback, and fans can expect more bigger and bolder innovation from the brewery.To view high-res photos and videos, you can check out: Yuengling's Photo Gallery Raging Eagle Mango Beer Video Fans are also encouraged to follow the Yuengling social media accounts for the latest news on Raging Eagle and exciting, content that is sure to fuel more excitement. Fans can also find their nearest retailer selling Yuengling Raging Eagle by visiting the "Find Our Beer" link at www.yuengling.com. Be sure to "like" Yuengling's Facebook page (https://www.facebook.com/Yuengling), follow us on Twitter (https://twitter.com/Yuengling_Beer) and Instagram (https://www.instagram.com/yuenglingbeer/) or visitwww.Yuengling.comfor more exciting news to come in 2021. About D.G. Yuengling & Son, Inc.D.G. Yuengling & Son, Inc., America's Oldest Brewery, is family-owned and operated since 1829. Now sold in 22 states, production is supported by two breweries inPottsville, PAand one inTampa, FL.Principal beer brands include Yuengling Traditional Lager, Light Lager, Black & Tan,Golden Pilsner, Premium, Light, Dark Brewed Porter, Lord Chesterfield Ale, Oktoberfest, Yuengling Hershey's Chocolate Porter, Raging Eagle and newFLIGHTby Yuengling, the Next Generation of Light Beer. Get news, updates and access media imagesathttps://www.yuengling.com/news. Contact: Jessica Seiders Sydney Dodson Communications Manager Tierney Agency [emailprotected] [emailprotected] 570-622-0153 Ext 1541 215-790-4339 SOURCE D.G. Yuengling & Son, Inc.

Yuengling Launches new Raging Eagle Mango Beer with Bold Flavor Yuengling continues its innovation with the edgy, new brand full of Natural Mango fruit flavor

LOS ANGELES, Jan. 11, 2021 /PRNewswire/ --Today, Crew in a Box, the world's first professional-quality, plug-and-play, remote video production solution, revealed that they will be making their CES debut in January 2021. Invented by award-winning filmmakers Ira Rosensweig, a Clio Award-winning director of Super Bowl spots, Dallas Sterling, an innovative cinematographer, and Jeremy Fernsler, a VFX supervisor nominated for an Emmy for his work on Westworld, during the first days of lockdown, this innovation has enabled crew, talent, networks and brands to continue working safely during the pandemic, and offers a convenient long-term solution for quick turnaround shoots, reducing unnecessary travel and saving time while delivering professional, studio-quality results. Crew in a Box, the worlds first professional-quality, plug-and-play, remote video production solution, has enabled crew, talent, networks and brands to continue working safely during the pandemic. Crew in a Box has been used by 12 networks including NBC, FOX, ABC, FX and MTV, and has shot celebrities including Vanessa Hudgens, Patrick Mahomes, William Shatner and Keke Palmer. "Crew in a Box is a product for our time and might change the way talking heads are shot in the future." - IABM Awards Tweet this Earlier this month, Crew in a Box won the 2020 IABM BaM Create Award, voted the best technological innovation of 2020 in broadcast & media creation and acquisition by the International Trade Association for the Broadcast & Media Industry. Beyond being a solution for the pandemic, the cost benefits, convenience and efficiencies of this product are set to have a long-lasting effect, with the IABM judges remarking, "Great response to the present situation of COVID. Crew in a Box is a product for our time and might change the way talking heads are shot in the future. A very well implemented solution to remote presentation and interaction, especially since it has control and communications with a remote production team." Over the past several months, Crew in a Box has been utilized by many major brands, as well as 12 networks including NBC, FOX, ViacomCBS, ABC, FX, and MTV, who recently used Crew in a Box to shoot a promotional campaign featuring Vanessa Hudgens for the MTV Movie & TV Awards: Greatest of All Time show. Other celebrities who have used the product include NFL stars Patrick Mahomes and Deshaun Watson, and actors Keke Palmer, William Shatner, Kaitlin Olson, Aisha Tyler, and Eric Stonestreet. Using multiple units, clients are able to execute logistically complex projects such as Disney's "Choose Kindness" anti-bullying campaign, in which three Crew in a Box systems were used to film 14 actors, each in remote locations across multiple cities, over three days. Scott Edwards, EVP of Creative Advertising at Fox Entertainment, says, "Crew in a Box is likely going to redefine the remote production game entirely."How Crew in a Box WorksCrew in a Box is delivered directly to on-camera talent's doorstep in a fully disinfected military-grade case containing a 6k cinema camera, expandable 3-foot wide LED light capable of dimming and color temperature changes, direct address teleprompter/Interrotron, a second, detachable teleprompter/Interrotron monitor for off-axis eyelines, and two professional microphones. Each component works together in a fully integrated system that is completely remotely controlled.On-camera talent simply opens the box and plugs it in, and Crew in a Box automatically connects over the Internet to a remote team of filmmakers who control every component. This is achieved through cellular bonding, without needing to connect to the user's home Wi-Fi network, eliminating concerns of compromised security. Clients and crew join a video conference where they view a beautiful, high-resolution feed from the camera and participate as if they were on set, while the director appears on Crew in a Box's Interrotron to direct the talent, creating an incredibly seamless experience for all involved. High-resolution video, up to 6K, is recorded inside the box, but clients can also choose to livestream the shoot.The innovative Crew in a Box system excels in the following situations: Direct-to-camera address for commercials, promos, etc. Interviews featuring both into and off-camera eyelines Roundtable discussions with talent in different locations Variety and talk shows with remote guests Reality TV confessionals Press junkets Talent in locations without access to crews "Crew in a Box is incredibly excited to participate in CES and to be part of a showcase of groundbreaking technologies," said Founder Ira Rosensweig. "In a year that has seen a lot of hardship across the video production industry due to the pandemic, Crew in a Box is proud to have kept crews working, albeit remotely, and we look forward to continuing to provide a cost efficient solution in the future." To learn more, view projects shot by Crew in a Box, watch videos explaining all the integrated technology, and download photos and videos.About Crew in a BoxCrew in a Box is the world's first professional-quality, plug-and-play, remote video production solution. The product and service were invented in 2020 by Ira Rosensweig, Dallas Sterling and Jeremy Fernsler, in Los Angeles, CA. For more information, please visit www.crewinabox.com.SOURCE Crew in a Box Related Links https://www.crewinabox.com

Crew in a Box Makes CES Debut in 2021 with Revolutionary Remote Video Production Solution Award-winning Innovation delivers for 12 major networks including NBC, FOX, ViacomCBS, and more during pandemic

MIAMI, Oct. 1, 2020 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL;NYSE: CUK) has scheduled a conference call with analysts for Thursday, October 8, 2020 at 10 a.m. (EDT); 3 p.m. (BST) to provide a business update. A simulcast of the call will be available via the company's Web sites at www.carnivalcorp.com and www.carnivalplc.com. SOURCE Carnival Corporation & plc

Carnival Corporation & plc To Provide Business Update

CHICAGO, June 30, 2020 /PRNewswire/ --React Presents, LLC, a subsidiary of LiveXLive Media, Inc.(NASDAQ: LIVX) ("LiveXLive"),a globalplatform for live stream and on-demand audio, video and podcast content in music, comedy, and pop culture,announced today that the Midwest's largest all-electronic music festival, Spring Awakening Music Festival ("SAMF"), is going digital with a new virtual experience on July 4th and 5th, 2020 streaming on LiveXLive, in partnership with Corona Electric Beach benefiting MusiCares. React Presents also announced thefestival's lineup including Claude VonStroke, Bear Grillz, Krewella and Shiba San confirmed for the two-day event. Virtual Spring Awakening Music Festival will be featuring 22artists performing across the country as the world practices social distancing. Additional talent slated to perform includeChicago's own Birthdayy Partyy, DJ Yula, Gene Farris, Goodsex, Manic Focus, Porn and Chicken and Win and Woo joined byDestructo, Dr. Fresch, Goldroom, Justin Jay, Kaivon, Ookay, Regard, Shiba San, Slooze b2b Krilla, SNBRN, Vicetone and Westend. The event will air starting at 3 p.m. CT / 4 p.m. ET on July 4th and end on July 5th at 11:30 p.m. CT / 12:30 a.m. ET. For full schedule and tune-in information visit http://livexlive.com/springawakening. Stock up for Spring Awakening Music Festival 2020 and get Corona delivered to your door. Use code CORONA and save $5, courtesy of Drizly*. "This is a massive opportunity for us to pilot a new business model for Spring Awakening that unifies a digital and in-real-life concert-viewing experience, and takes it from being a regional event to being truly national," said Dermot McCormack, president of LiveXLive. "This year's lineup and digital ticketing paired with additional perks for subscribers is just the beginning of the vision for the 10th Anniversary Spring Awakening in 2021." In addition to an eclectic artist lineup, Virtual SAMF 2020 will feature exclusive merch, talent meet-and-greets, interviews with many of the artists, and look-backs at previous years' SAMF festivals -- all available as part of LiveXLive's music news and interview show LiveZone. React Presents will also give away tickets to the 10-year anniversary SAMF in 2021. Virtual Spring Awakening Music Festival will be encouraging donations to MusiCares Covid-19 Relief Fund supporting various music charity organizations. For more information on each organization visit grammy.com/musicares. *Drizly code disclaimer: "*21+ New Users Only. Void Where Prohibited. Drizly T&C apply". About React Presents, LLCFounded in 2008, React Presents, a subsidiary of LiveXLive Media, was born out of a passion for curating top-tier live music events that has helped propel Chicago to the forefront of the US music scene. Over the past decade, React Presents has grown into one of the premier largest concert promoters in the Midwest, producing several major music festivals and over 400 concerts annually in Chicago, Milwaukee, Detroit and more. It was acquired by LiveXLive in early 2020 to extend LiveXLive's live event production and festival business and scale its live streamed content library. About LiveXLive Media, Inc.Headquartered in Los Angeles, California, LiveXLive Media, Inc. (NASDAQ: LIVX) (the "Company") (pronounced Live "by" Live) is a globalplatform for live stream and on-demand audio, video and podcast content in music, comedy, and pop culture. LiveXLive, which has streamed over 1000 events in 2020, has become a go-to partner for the world's top artists and celebrity voices as well as music festivals concerts, including Rock in Rio, EDC Las Vegas, and many others. In April 2020, LiveXLive produced its first 48-hour music festival called "Music Lives" with tremendous success as it earned over 50 million views and over 5 billion views for #musiclives on TikTok on 100+ performances. LiveXLive's library of global events, video-audio podcasts and original shows are also available on Amazon, Apple TV, Roku and Samsung TVs in addition to its own app, destination site and social channels. For more information, visitwww.livexlive.com and follow LiveXLive onFacebook,Instagram,TikTok,Twitter at @livexlive, andYouTube. About Corona Electric BeachFeaturing world-renowned DJs traveling across the US and partnering with festival pioneers, Corona Electric Beach (CEB) is where "Beats meet the beach," Follow Corona Electric Beach on Instagram, Twitter, & Facebook. About Constellation BrandsAt Constellation Brands, our mission is to build brands that people love because we believe sharing a toast, unwinding after a day, celebrating milestones, and helping people connect, are Worth Reaching For. Today, we are a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Every day, people reach for our high-end, iconic imported beer brands such as Corona Extra, Corona Light, Corona Premier, Modelo Especial, Modelo Negra, and Pacifico, and our high-quality premium wine and spirits brands, including the Robert Mondavi brand family, Kim Crawford, Meiomi, The Prisoner brand family, SVEDKA Vodka, Casa Noble Tequila, and High West Whiskey. To learn more, follow us on Twitter@cbrandsand visitwww.cbrands.com. Forward-Looking StatementsAll statements other than statements of historical facts contained in this press release are "forward-looking statements," which may often, but not always, be identified by the use of such words as "may," "might," "will," "will likely result," "would," "should," "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "continue," "target" or the negative of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including: the Company's reliance on one key customer for a substantial percentage of its revenue; the Company's ability to consummate the proposed acquisition of PodcastOne and the timing of the closing of the proposed transaction, including the risks that a condition to closing would not be satisfied within the expected timeframe or at all or that the closing of the proposed acquisition will not occur; the Company's ability to attract, maintain and increase the number of its users and paid subscribers; the Company identifying, acquiring, securing and developing content; the Company's ability to maintain compliance with certain financial and other covenants; the Company successfully implementing its growth strategy, including relating to its technology platforms and applications; management's relationships with industry stakeholders; the effects of the global Covid-19 pandemic; changes in economic conditions; competition; and other risks, uncertainties and factors including, but not limited to, those described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2020, filed with the U.S. Securities and Exchange Commission (the "SEC") on June 26, 2020, and in the Company's other filings and submissions with the SEC. These forward-looking statements speak only as of the date hereof and the Company disclaims any obligations to update these statements, except as may be required by law. The Company intends that all forward-looking statements be subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Press Contact:Factory PR212.941.9934[emailprotected] LiveXLive IR Contact: 310.529.2500[emailprotected] SOURCE LiveXLive Media, Inc.

LiveXLive's React Presents Announces Its First-Ever Spring Awakening Music Festival (SAMF) Virtual Experience, Presented By Corona Electric Beach Benefiting MusiCares